<SEC-DOCUMENT>0001376339-21-000105.txt : 20211102
<SEC-HEADER>0001376339-21-000105.hdr.sgml : 20211102
<ACCEPTANCE-DATETIME>20211102164518
ACCESSION NUMBER:		0001376339-21-000105
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		76
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211102
DATE AS OF CHANGE:		20211102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MIMEDX GROUP, INC.
		CENTRAL INDEX KEY:			0001376339
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262792552
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35887
		FILM NUMBER:		211372096

	BUSINESS ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062
		BUSINESS PHONE:		(770) 651-9100

	MAIL ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Alynx, Co.
		DATE OF NAME CHANGE:	20060922
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mdxg-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c,d:c7c5801de75c41fe8d1189f73f0aadaa--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:mdxg="http://mimedx.com/20210930" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdxg-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF8zLTEtMS0xLTE_31b224cb-827d-416c-b0a9-68616c4140d2">0001376339</ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF80LTEtMS0xLTE_3f577da0-201a-4bc0-8ee0-775cabfadd98">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF83LTEtMS0xLTE_32818bfe-f9de-42cb-bdc9-b4f991e68e55">2021</ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF84LTEtMS0xLTE_0227a7eb-1cb4-4dd6-8901-cad5316c4cd2">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF8xMC0xLTEtMS0x_e0da7c74-7fb5-4a20-beb5-03bc1b0a4ad6">false</ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83OS9mcmFnOjBiYzA5MmMyZGFiNTQ3ZDc5OTFlOTQ2M2ZiZmJiOGQ4L3RleHRyZWdpb246MGJjMDkyYzJkYWI1NDdkNzk5MWU5NDYzZmJmYmI4ZDhfMzk_524ea83e-176d-4a7f-aed6-efc886cd340c" escape="true">Subsequent EventsNone noted.</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdxg-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iddbbfc1062f945efbf07e9ce08fb0ae4_I20211020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i520bd173cc4b40d2961217715f798b5e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8424268fe0f422699167479e062686d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7747d8031bb444f8a0d132a76929ab7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24deb84eee304bf8bd22b8b75a680e8f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4113e96817ee412daf4fb896ba4f907c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e9879aac5984ce69a94a4be82f2afc7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d911729a90a4336b491792e0f39a4b1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1e389a471143e09a8fe973bc129222_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9dab3f535941c8a7e99c7f45f0648e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870ec0719b704056ab5a603cee32bf21_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00bbd7d8fb234b8b906ba09f5de7f570_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319b98af263b4cca93e4f38f54ec70de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dbe6f366fa94babbed471b118618949_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica08a3b681bd4921a6e10b0e732812dc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e2569d084d4d16a061c3a2817e4517_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30ea68f67842422ea554a2c219d5df1f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fff381503ab470cb567487005105042_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48875c6ed61b4455a259bb6c00a985b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4481913816f8495b91664f2c94c198a2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0527aaa3a4344329744dd834938874f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907e1ab429324dafb8dede5c9e07fd49_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b398a86a27463d8c43135cf5d273e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125daf82d900495c9fe37f9848541647_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91714ed5b0024037979d7567ffba146c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61389415a5d84a8696dd0a0d0313b5d9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5967a4f404664bef9378ba0366b3c4f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c93f18d959c4e32bba8d358469e13b7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c1fc5c80bb4755a61a11f5bdf75e52_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib194ea304588466d9d6e058e63a66dde_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f87700978a544fa9d65867f626f385d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia643c1f3ffd5490daba314259b7b5dd8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e0382314754873b5d3463a70f2452c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ac9e9787fd4e5caa1e0fd68f13f431_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93598c6e79474e738b441aee60fd85fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d8f37a625b4a6eb4876d23445e7b8f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb8fc9cbb62e4e68bf85adfc66a44263_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3efc44c2885e4c7fb8e1a0ea72d8b77f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d4d540898ae4a45b41a0121cbd3d2bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf29e0d1c12430a95941dc867b6c928_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c20ff2657e341d984f4a7abc943473f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab18eb20e2647c28d0361be53d48426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i132835a21d9a4d3abe8660919b3bb23a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0a4568080142a39217fa3323b53cf4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbac19f0cae14d1db729010e4771ebde_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1353dc3b9164466fae81fcb311283da8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d92ee75364420e8e90918b9dc51633_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a67f851997741fb98d72955463632aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ce4df1ba99d4d4da5aa384183983463_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f30e1643e2b457cad73afc68fea533e_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:FinancingTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib568475ec03640c79dec4a7823674263_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5999d39b82454d3485d425e42e44c0ab_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf73b93b55dc4376983adc42db197d7d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id816d2b16745481584d1f3ad0216ba99_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2d9d8ddf0424a2ebc54c14f5fb90725_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07286d413f254827a20487a6cd9f485e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39e228029734a35b7f629da814e51c1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8c6ca35468445894a87c3f1396e899_D20210701-20250702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2025-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fdd3b5337e94c8fa60408bc1abc8f28_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6c60ec647934d8f96e30a1383affd50_D20210703-20220702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-03</xbrli:startDate><xbrli:endDate>2022-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idee297f90d0f45db8cbb6d3416d3d4ac_D20220703-20230702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-03</xbrli:startDate><xbrli:endDate>2023-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25cacd5716404a11aa3833043d143f64_D20230703-20250702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2025-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id98ba73abde34242a6ba47a62b0ef574_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b87261e163441c1ab6791378bfb180f_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ff1eec1ec3433284583249574c58e7_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e2f0127c424966a4196fa78dea5252_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb70228ca86484abc1647102df379f3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief91294d01924689b8c5a91709f9113c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191554e1c310493ca0b9f26eefe399a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i998a9400eb034fb8896247cfa7d4ce64_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8779dbf56be4207a62a288eb16426e3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5055a550b7f1489bb057050d4eb2e15f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ff8a9cfc574e8a813ba41191a77909_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3497639dc824203ac3bbc45e1fa7045_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97c4e39fb2044fd832ec14992093a99_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb8825862eb44cba52a62ed12d533bd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf86c04cf564e56bba2a505c07e5a27_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f9bbe152df94574a97c8077e072c43d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23dbe32c67d4052a1bcc960f0ea1014_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic394f69ff36c4356957ce104b3c4e050_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09f7d9159dc45a9b65feac3fa5d73f3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8570345d30404e7e9f7c73adbeac5a5b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia49639519ac8451195b5024845ee2aef_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica04d8b2902b463ab11876407debfe02_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63433c4d26449ff840c826632e10ccc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be316f6fd1b49e092d2a34cdc59474c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd009bf4fb074bf09897315c7972b8d7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc39a1be477444ca4a3b6da11859aaa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ef80048c2e14b599e756caca946ccb2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213f3703bf564f66b0f66915beb0fe28_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8876d452174d08a691695fdc40ebc8_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4155582a666f4b11b948e06e1bb09a77_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>mdxg:day</xbrli:measure></xbrli:unit><xbrli:unit id="director"><xbrli:measure>mdxg:director</xbrli:measure></xbrli:unit><xbrli:context id="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d492b0b584d4f269f2f61823174b39e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09204510e324170b6c22bff3068c0ac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947487d244a6487686e15b7ebb3df156_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabc3a726b7540c7ab857df0dbcf05a0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie143cb1da9a04290be81c5d71f845995_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a77cb321114af080584b94815e9ebe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff503e847be14ec685cb730dc81cca93_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2098fc34c48c488e9b8469ff9bb0d624_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61dd953b6b594540bad6517310eaba17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8fcc6d51244882af073962e13c8159_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie510c5f07feb4b34b1780b367608d0b9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9419a5870764efc954e2ea7f11c85ad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="securityclassaction"><xbrli:measure>mdxg:securityClassAction</xbrli:measure></xbrli:unit><xbrli:context id="i29f9998bd9f949179feb6e677def3f2d_D20190116-20190116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-16</xbrli:startDate><xbrli:endDate>2019-01-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mdxg:product</xbrli:measure></xbrli:unit><xbrli:context id="i1a36de01b5ac4820a5ecf7930998772a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa362db08bef44ea8f60684d8de52387_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90bdb86d833e4c83b10c73d297c90071_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aa490c58d174fbe8347c43a9c6d5e5d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8eea8c11844b23b19eb0cf0ab5959d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5946e34fb34c6da5e38e11bc904353_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5c8d9d9bd542fdb5a8db00cdeb2c77_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bb0ad1ba5b453e958dbe52d1fff145_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27dc4a45b59b47f188c9741959321706_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1522b620767440f3ae5389424e04dfed_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a8fb5e74c64fb59d625e7756ec9015_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied33a9c457d644dabec06946c8d55bcf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="distributionchannel"><xbrli:measure>mdxg:distributionChannel</xbrli:measure></xbrli:unit><xbrli:context id="i16ad22774d414f21aed7e4d4af64444c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48efc9d3e964bcebaec0d6b42ae86ca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4560a171d344f38b7d85fe0632ce4bf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3435571269948bfa711c7227cab69bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e209b570c4940fcbb3cfbb19e1709f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff5a0b29488b4f5fb8239054f04a74b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaac3427ddcd4497894f4bc23e3e9f0f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9107cfd22f4e39bf4115b0953ea93f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic53e6488a3b94530b36da38df1893203_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk2_c4f7df0a-f9eb-4bf7-be24-dce27ca10b28">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6Y2NjMjFhNzNmYjViNGE4YTg1OTRjYWYyZTFmMzg3OGUvdGFibGVyYW5nZTpjY2MyMWE3M2ZiNWI0YThhODU5NGNhZjJlMWYzODc4ZV8wLTAtMS0xLTE_c8f5bc93-cbdb-4f22-ad15-bf2226be0928">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Period Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xMjM_7a86b53d-720b-4d4e-9203-410dbdcb55fa">September&#160;30, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:25.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:483.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6MjVhMmViNTMwMmM1NDgwYzllYWI4MDY3Y2E5YzA0OWEvdGFibGVyYW5nZToyNWEyZWI1MzAyYzU0ODBjOWVhYjgwNjdjYTljMDQ5YV8wLTAtMS0xLTE_a1311eda-cc95-4939-9f76-4b95d5d152ce">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _____________________to______________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk3_3cc10f84-8439-4ded-b85f-d63dc0e9cc54">001-35887</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk4_4f23ed1e-9320-46b3-8e03-a308e12f98ea">MIMEDX GROUP, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZWI0ZjM4NWQzOTMxNDc2YWIzODliMjkxYzYzNzRhM2MvdGFibGVyYW5nZTplYjRmMzg1ZDM5MzE0NzZhYjM4OWIyOTFjNjM3NGEzY18wLTAtMS0xLTE_2e51e5f9-b8e1-48df-bc17-0c07142e810d">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZWI0ZjM4NWQzOTMxNDc2YWIzODliMjkxYzYzNzRhM2MvdGFibGVyYW5nZTplYjRmMzg1ZDM5MzE0NzZhYjM4OWIyOTFjNjM3NGEzY18wLTItMS0xLTE_294f353b-bd6e-449a-9fa6-e8ad6c4e1c71">26-2792552</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl80_d4ad8a5b-3c60-4d2f-ad41-a64312106256">1775 West Oak Commons Ct NE</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl83_732d7dbd-9719-4fcb-a2d8-6dd502ed9eb3">Marietta</ix:nonNumeric>, <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl8xMQ_04275597-0920-4ab0-9f26-f182ab56e59d">GA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTItMS0xLTE_41cfef5b-f950-43a2-a45c-dd4a0d3e9033">30062</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk5_50a9f6a9-420f-4c0c-96fb-2df51a89c8ff">770</ix:nonNumeric>) <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzkz_f874ef68-5013-434b-839e-969b8a6ce637">651-9100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTAtMS0xLTE_34434dd4-0c73-4afa-84ca-6b3d8595d18a">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTEtMS0xLTE_cf4c8170-7d80-4364-b05c-7cfadb980de4">MDXG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTItMS0xLTE_229ba6c9-fe5d-4187-8be9-534404de9ade">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk0_ef7067ea-d3f6-4c43-9633-19e816cb9f0b">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> x </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk1_d250e2ab-2537-427c-ade8-956f28f6c9f0">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> x </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo1MmViYTkyMmEwNWE0YzdjODA0MDU4ZGExOWRkYmJlZV81_685376e4-b40f-4da0-8c4d-d3a0b3e59ad7">Large accelerated filer</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated Filer  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Do not check if a smaller reporting company)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTMtMS0xLTEvdGV4dHJlZ2lvbjpkZmQ3NmIyNzMyZTY0MjRkYTBkNWJiNTRjYjcxNmY2Nl8zMA_5f5da301-3d39-41f2-8e7d-f2287f5338fa">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTQtMS0xLTEvdGV4dHJlZ2lvbjo4NmIzYWUyMTAzYTU0MmY4OTM4MTAyZDFjNzc4YzkwNV8yOA_dd1d2238-3bbb-402f-95ad-dc413887947a">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xODAx_a1775fb6-6e98-4392-b48c-08567a2017d6">&#9744;</ix:nonNumeric> No&#160;x</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="iddbbfc1062f945efbf07e9ce08fb0ae4_I20211020" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xMDk5NTExNjI5NTk3_8338fe71-b812-4791-a4ef-ec65c357de62">112,144,444</ix:nonFraction> shares of the registrant&#8217;s common stock, par value $0.001 per share, outstanding as of October 20, 2021.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part I&#160;&#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements (Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_19">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_22">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Stockholders&#8217; Deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_25">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_28">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to the Condensed Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_31">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_82">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_124">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_127">35</a></span></div></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part II&#160;&#160;&#160;OTHER INFORMATION</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_133">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_136">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unregistered Sales of Equity Securities and Use of Proceeds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_139">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defaults&#160;upon Senior Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_142">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_145">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_148">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_151">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_154">39</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the terms &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; refer to MiMedx Group, Inc., a Florida corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only MiMedx Group, Inc.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Cautionary Statement Regarding Forward-Looking Statements </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (this &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) contains forward-looking statements. All statements relating to events or results that may occur in the future are forward-looking statements, including, without limitation, statements regarding the following: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the end of the period of enforcement discretion announced by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), including our inability to market our micronized products and certain other products after May 31, 2021;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the timing, size, and prospects for our current and planned clinical trials; the clinical trial process is lengthy and expensive with uncertain outcomes, and often requires the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit, and delays or failures in our clinical trials could prevent us from commercializing any modified or new products and will adversely affect our business, operating results and prospects;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategic focus, as illustrated by our current business priorities and our ability to implement these priorities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the sufficiency of our liquidity and existing capital resources to implement our current business priorities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to fund our ongoing and future operating costs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the advantages of our products and development of new products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding the size of the potential market and any growth in such market;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding ongoing regulatory obligations and oversight and the changing nature thereof impacting our products, research and clinical programs, and business, including those relating to patient privacy;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to manufacture certain of our products in compliance with current Good Manufacturing Practices (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CGMP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in sufficient quantities to meet current and potential demand;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding costs relating to our compliance with regulatory standards, including those arising from our clinical trials, pursuit of Biologics License Applications (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and CGMP compliance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the likelihood, timing, and scope of possible regulatory approval and commercial launch of our late-stage product candidates and new indications for our products;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding government and other third-party coverage and reimbursement for our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding future revenue growth;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our belief in the sufficiency of our intellectual property rights in our technology;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to procure sufficient supplies of human tissue to manufacture and process our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the outcome of pending litigation and investigations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to remain in compliance with Securities and Exchange Commission (the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") reporting obligations and Nasdaq listing requirements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the ongoing and future effects arising from the investigation conducted by the Audit Committee (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the Company&#8217;s Board of Directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) into prior-period matters relating to allegations regarding certain sales and distribution practices at the Company and certain other matters (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the restatement of our consolidated financial statements previously filed in our Annual Report on Form 10-K for the year ended December 31, 2016, as well as selected unaudited condensed consolidated financial data as of and for the years ended December 31, 2015 (Restated) and 2014 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Restated), which reflected adjustments to our previously filed consolidated financial statements as of and for the years ended December 31, 2015 and 2014 (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and related litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding the ongoing and future effects of the Covid-19 Pandemic (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Covid-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) on our business, employees, suppliers and other third parties with whom we do business, and our responses intended to mitigate such effects;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demographic and market trends;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to remediate the identified material weaknesses in our internal control environment and to strengthen our internal control environment; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding research and development costs, including those arising from filing additional investigative new drug applications and pursuing new BLAs; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete effectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements generally can be identified by words such as &#8220;expect,&#8221; &#8220;will,&#8221; &#8220;change,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;future,&#8221; &#8220;plan,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;to be&#8221; and similar expressions. These statements are based on numerous assumptions and involve known and unknown risks, uncertainties and other factors that could significantly affect the Company&#8217;s operations and may cause the Company&#8217;s actual actions, results, financial condition, performance or achievements to differ materially from any future actions, results, financial condition, performance or achievements expressed or implied by any such forward-looking statements. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may cause such a difference include, without limitation, those discussed under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Quarterly Report and in our previously-filed Annual Report on Form 10-K for the year ended December 31, 2020 (our &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless required by law, the Company does not intend, and undertakes no obligation, to update or publicly release any revision to any forward-looking statements, whether as a result of the receipt of new information, the occurrence of subsequent events, a change in circumstances or otherwise. Each forward-looking statement contained in this Quarterly Report is specifically qualified in its entirety by the aforementioned factors. Readers are advised to carefully read this Quarterly Report in conjunction with the important disclaimers set forth above prior to reaching any conclusions or making any investment decisions and not to place undue reliance on forward-looking statements, which apply only as of the date of the filing of this Quarterly Report with the SEC.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimates and Projections</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This discussion includes certain estimates, projections and other statistical data. These estimates and projections reflect management&#8217;s best estimates based upon currently available information and certain assumptions we believe to be reasonable. These estimates are inherently uncertain, subject to risks and uncertainties, many of which are not within our control, have not been reviewed by our independent auditors and may be revised as a result of management&#8217;s further review. In addition, these estimates and projections are not a comprehensive statement of our financial results, and our actual results may differ materially from these estimates and projections due to developments that may arise between now and the time the results are final. There can be no assurance that the estimates will be realized, and our results may vary significantly from the estimates, including as a result of unexpected issues in our business and operations. Accordingly, you should not place undue reliance on such information. Projections, assumptions and estimates of our future performance and the future performance of the markets in which we operate are necessarily subject to a high degree of uncertainty and risk. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_16"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMy0xLTEtMS0x_e1bdb5ac-b41b-43d9-875b-885cb7e7c5a5">90,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMy0zLTEtMS0x_d2f9a6fb-cdfe-41d6-99e4-4d4e5e52c5d7">95,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNC0xLTEtMS0x_37c54c7e-0f2a-4d51-94b0-3a6435cee6e2">36,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNC0zLTEtMS0x_e575664a-9db0-4b9a-b8e8-eedc662b7509">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNS0xLTEtMS0x_921ea6ac-fe30-41fb-99d4-e2f6014dd0e5">11,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNS0zLTEtMS0x_596bd998-4022-40fc-a0d7-68943c8ee32c">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNi0xLTEtMS0x_4d2cdbb1-da7a-4ab3-9db2-4ab9da536530">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNi0zLTEtMS0x_91e9ba63-c7cf-4258-b09f-ad82e84be7e7">5,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNy0xLTEtMS0x_0aff3927-c55e-4dce-927a-b91e20711c7e">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNy0zLTEtMS0x_55e1ccc7-a639-4510-ae71-a9620ad921f0">10,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOC0xLTEtMS0x_28ff9c32-1c3e-4366-bd58-7315d445d7e5">860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOC0zLTEtMS0x_e20b6920-3ee5-46fe-b7b7-a382019fda42">3,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOS0xLTEtMS0x_53c4f09a-38b2-4358-948f-766006858178">141,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOS0zLTEtMS0x_56a79750-a118-4a99-bf5b-bca1e24ad987">160,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTEtMS0xLTEtMQ_ed65dfc6-e89e-43c7-bdbc-67c937000585">9,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTEtMy0xLTEtMQ_426f738c-ba86-40ba-bd2d-f3d9249140dc">11,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTItMS0xLTEtMQ_0182d4ed-6bef-48c4-a76a-a94295484772">2,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTItMy0xLTEtMQ_a038300d-3da8-45d9-9821-e8696840cb76">3,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTMtMS0xLTEtMQ_a6951d71-7ab2-4f95-a8cc-e5dc68f9e4ae">19,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTMtMy0xLTEtMQ_2f57d99d-8bf9-473a-9877-a4af4ba62aeb">19,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTQtMS0xLTEtMQ_61ceee83-ca89-4b1e-9395-9b389e4ff574">5,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTQtMy0xLTEtMQ_e72b6563-4ba5-46b3-929b-a6b7f6baa297">6,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTYtMS0xLTEtMQ_42a3daea-74f1-4b54-a259-5d7fc5ee8c84">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTYtMy0xLTEtMQ_9bcf7098-f64c-418b-9710-fdaf8737c041">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTctMS0xLTEtMQ_a2c04871-7db3-4186-992b-094deade5977">180,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTctMy0xLTEtMQ_10617667-ff35-49dc-ad25-ad613bab2083">202,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjAtMS0xLTEtMQ_d3c386ca-5bd0-4cbf-b915-2f8da998442f">6,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjAtMy0xLTEtMQ_1332df83-0805-4bb0-969f-04b2d62f08e6">8,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjEtMS0xLTEtMQ_a70e0c44-ae71-4479-a462-222ab48c29dc">19,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjEtMy0xLTEtMQ_c8603d9b-4475-43f4-8e8b-5854684d6578">18,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjItMS0xLTEtMQ_6fde1f88-5508-415e-a69d-ee3ad893075c">13,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjItMy0xLTEtMQ_50749d5a-f1fb-4189-ac3c-3dac6418d92d">30,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjctMS0xLTEtMQ_92037952-0c7a-4eb6-8ae1-dcc4c9f46375">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjctMy0xLTEtMQ_2fc405d1-0ee2-4549-b449-2603b8cdaf42">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjgtMS0xLTEtMQ_4e7ccfc7-d35a-4aea-99ee-a6551b78e1cc">41,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjgtMy0xLTEtMQ_e7eb5191-aeed-4a33-a506-1eafddfd2a25">59,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjktMS0xLTEtMQ_bdd8c08b-c290-4591-b766-7afc87096666">48,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjktMy0xLTEtMQ_272afe36-a271-4655-b7eb-cd4705d3d88f">47,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzAtMS0xLTEtMQ_b28ecf93-cab0-4163-8a87-60a8cabf4870">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzAtMy0xLTEtMQ_99b18205-49d1-42df-939e-6cbd1be4cd5e">3,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzEtMS0xLTEtMQ_46b7d80f-66e3-440f-b436-18639fc98a63">93,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzEtMy0xLTEtMQ_4f4362e7-2545-4a4d-8329-6cbf2c1b5d60">110,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies (Note 13)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzItMS0xLTEtMQ_d671f110-b379-4fe5-86ad-5f68d206211e"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzItMy0xLTEtMQ_34485c69-5ac9-4fe0-8959-19e7fd26938b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock Series B; $<ix:nonFraction unitRef="usdPerShare" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzQy_73f0a2b0-1e13-4692-bb84-d633c3d95e0e"><ix:nonFraction unitRef="usdPerShare" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzQy_b1e83236-c5f8-4e2d-bc37-b2bbee91e1f6">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_0b6bfa8b-1bfb-463b-811e-050c057e0e4e"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_501eb29d-80f0-4f75-bf34-c5bc470b0c94"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_5a9d9de3-4211-4eb8-b068-b5517da7fa64"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_ba796ff6-6f4e-4aa0-9e60-4f70306d06a9"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_c1d65a47-f036-4d25-acc6-1129f0cbbe44"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_dddabda3-3218-4507-bcc2-ac12c51d3ef4">100,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMS0xLTEtMQ_c1dc3e7d-119c-425a-85df-945023c0e197">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMy0xLTEtMQ_2a99a3f4-7fdb-486e-902f-424d9ddc82b1">91,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock Series A; $<ix:nonFraction unitRef="usdPerShare" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzMw_0718e63f-5873-4e01-8e33-6a60e36f5f7b"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzMw_55b1d58e-6c3a-4ca7-a76e-8a1658a1541a">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzQ0_adaa3dde-e477-48ac-bc43-eb601be737b4"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzQ0_c869683e-1174-433d-9f22-7f32ecad78f9">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_12672474-0f13-4018-adde-df4760c58157"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_5727be85-af5e-4329-aeaa-a6f1795b2175"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_6d70f179-2125-434b-8b04-247e77605fb8"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_acde9118-1ed3-48d1-b001-c392159652e6">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMS0xLTEtMQ_2f786f8e-5be3-4893-b911-2a6e2f5ca1bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMy0xLTEtMQ_6c3ed203-c271-4a2b-8691-100b7d1873ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzE4_0f984b53-16f0-4f92-972c-98fc500bd5d3"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzE4_7cb3b26a-d63c-40c9-961c-69b2009f4ec8">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzMy_bb1e1d9b-198d-4045-abb4-3f84a665a2b4">187,500,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzU0_39b7a82e-f5f8-4524-bc34-87482db16f4a"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzU0_64f7aff2-7f74-4283-98ad-f466a907e623">112,703,926</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i520bd173cc4b40d2961217715f798b5e_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzY4_3c2cadbe-3d40-406c-ac57-332c24a58f09">111,926,898</ix:nonFraction> outstanding at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzkz_39b7a82e-f5f8-4524-bc34-87482db16f4a"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzkz_64f7aff2-7f74-4283-98ad-f466a907e623">112,703,926</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzEwNw_ac6c373d-8a1d-4ab3-bc1b-3b96dae7a70a">110,930,243</ix:nonFraction> outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMS0xLTEtMQ_9050ecff-04ee-4aed-b516-a64c31aa73d2">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMy0xLTEtMQ_d00ae9f7-42a7-4cbe-9502-1bf80aede230">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzctMS0xLTEtMQ_56f2edfe-655d-4a58-8a76-8863b6083e45">162,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzctMy0xLTEtMQ_8ddc1b16-e6e6-40d7-a131-6fccbd0d8ab9">158,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock at cost; <ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMC0xLTEtMS90ZXh0cmVnaW9uOjZkYTVkZDMxMWY5ODQyYWI5MTcyNjM0NWYzZmQ0NTQ5XzI4_18287571-c8ab-4a37-ac34-8865a85c1329">777,028</ix:nonFraction> shares at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMC0xLTEtMS90ZXh0cmVnaW9uOjZkYTVkZDMxMWY5ODQyYWI5MTcyNjM0NWYzZmQ0NTQ5XzQ4_8ef37fc9-b2fa-4bd5-8d2e-ba0595b4fefc">1,773,683</ix:nonFraction> shares at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMS0xLTEtMQ_6a2323e7-8fe4-4271-a0fb-44021111616c">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMy0xLTEtMQ_79b6a662-2a86-4a63-a0da-005126fd6135">7,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzktMS0xLTEtMQ_e5434733-bc7a-4c60-bed3-fe98e52eccdd">163,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzktMy0xLTEtMQ_b3b0cf87-3734-4676-b5b8-c6dbd0f1f7f1">151,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDAtMS0xLTEtMQ_4ed25ebb-f57a-4de9-b85a-435587c1b149">5,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDAtMy0xLTEtMQ_44b24830-1af7-4fb7-9a9f-1e05fb20dd22">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDEtMS0xLTEtMQ_200c5324-40a6-4551-a821-9d9df221fc66">180,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDEtMy0xLTEtMQ_264fd861-904a-4479-b1a1-496d19866e9b">202,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy0xLTEtMS0x_e41e5fae-88a8-4cdd-a962-40917ce0207a">63,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy0zLTEtMS0x_6869323e-ccf1-43f7-9044-2a4e0ab34927">64,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy01LTEtMS0x_8a3ba30a-998b-4fbf-9e5a-2b3bd9ae25dc">191,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy03LTEtMS0x_9353dda0-03d4-4e37-ab44-32d3e2fd08c9">179,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC0xLTEtMS0x_97974610-db74-45d7-9d53-aad9965c166d">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC0zLTEtMS0x_092a8c5e-a0ed-4c45-8987-b5289ddd6430">10,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC01LTEtMS0x_138d2eed-520d-4ec9-9885-9a89adc7175d">32,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC03LTEtMS0x_a3564320-2562-40c6-b415-e6a71014e31d">28,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS0xLTEtMS0x_a878152a-751d-4598-8f77-6fabf6e39c07">52,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS0zLTEtMS0x_a9f76593-7f6d-43b6-b93b-6b0609913dc4">54,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS01LTEtMS0x_429d7e60-19d8-47fd-bf2c-14c40189a87a">158,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS03LTEtMS0x_91e726f4-c21b-4e93-a53b-ab6ef28adc44">151,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0xLTEtMS0x_c8a804c4-55c3-4639-9359-2d196711ac8e">46,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0zLTEtMS0x_17ea84d2-2bb7-48fa-aada-b62a70df3f44"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0zLTEtMS0x_34947376-1347-4fda-9fe8-55a3bbc065c6">48,046</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC01LTEtMS0x_355ae1e3-66c1-49b7-b1b1-a70fac8ff184">145,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC03LTEtMS0x_48b5fd95-ba2d-4f15-9471-4d73d8945a6b">132,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0xLTEtMS0x_702a6b03-7218-4d00-9518-2108b63c2328">3,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0zLTEtMS0x_47db79a4-1406-45d1-90e2-1be3fa5d3abb"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0zLTEtMS0x_fb447a92-454c-4b27-8998-ce223537905a">12,027</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS01LTEtMS0x_8d3ca897-ff19-4b1c-9af8-f2960faa49d4">8,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS03LTEtMS0x_98c98ce4-8bd5-414f-883f-7c2d2bac7e6a">39,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMS0xLTEtMQ_f682edc5-9f1f-4915-b9b7-c937545670ed">4,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMy0xLTEtMQ_b56e82c6-5bb0-4de3-9473-d28f4b6a51ed"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMy0xLTEtMQ_c08eddd8-5958-42de-9694-df5ec8b7a190">3,372</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtNS0xLTEtMQ_2d079301-7be6-4b2e-a360-33d0b8fa20e0">12,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtNy0xLTEtMQ_796c8b2f-16dd-444f-aff8-4c1a7c93c093">8,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMS0xLTEtMQ_4b424d20-948f-4736-b6e1-4c74726937c2">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMy0xLTEtMQ_09c223b1-0ff3-4875-8c27-14e09b89f72e"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMy0xLTEtMQ_f1d69415-33b7-40e8-814e-60704ec3989c">276</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtNS0xLTEtMQ_105571a9-27fd-4bbd-8dd7-33f55d05083f">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtNy0xLTEtMQ_44cee943-7b6f-4239-956a-0bb55ac89c2b">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtMS0xLTEtMQ_362db3ba-c073-40f5-9b36-d878fbaed920">1,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtMy0xLTEtMQ_ee254f90-af41-4289-9b40-020bb4a89bd7">9,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtNS0xLTEtMQ_a225c684-19bb-4e44-a648-ebe90f3aedad">8,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtNy0xLTEtMQ_f5276333-0c9a-4cd5-a04b-a5d2f30a5f9a">29,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtMS0xLTEtMQ_239acc6d-b921-4991-960f-219e399ff19d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtMy0xLTEtNTk5_3e342d17-069a-4e70-99dc-99a2f341e4be">8,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtNS0xLTEtMQ_d9a84feb-5c3f-49b0-8a15-efd7cf5411e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtNy0xLTEtMQ_c3cd7251-793d-499a-b50b-7c62498b9466">8,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMS0xLTEtMQ_6600b873-2950-4766-82b3-40efa4bede8a">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMy0xLTEtMQ_6f848c18-ba3b-4199-a7d8-6f3378a0fdda"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMy0xLTEtMQ_d048d3f6-af07-4697-acdc-3508f4e8eb7f">1,472</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctNS0xLTEtMQ_af74698f-68e0-4a34-8ce2-9bd9acd13ec5">3,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctNy0xLTEtMQ_461664cb-0b9f-40c5-bb29-13994ec27f2d">6,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMS0xLTEtMQ_54c4b57c-b8e6-4982-b411-7613446936c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMy0xLTEtMQ_ef616fad-483e-49ba-bdbe-a94146abb366"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMy0xLTEtMQ_f8919c5c-052d-47aa-8f1f-f36c1885fc68">1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtNS0xLTEtMQ_ad157549-59c5-471a-b619-4e18497ca391">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtNy0xLTEtMQ_36a157f3-e7e4-49a6-87f7-36f54d36b580">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktMS0xLTEtMQ_111eab87-1f9b-4cfa-b144-e716c4b3fa93">2,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktMy0xLTEtMQ_34560fc9-dce4-4c5f-a201-79fff7bfdee9">19,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktNS0xLTEtMQ_a7ce3956-86c6-470a-b92f-6051505328c8">12,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktNy0xLTEtMQ_b99c89db-39af-4a2f-96af-d1b62f9c22d3">43,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMS0xLTEtMQ_04257ccc-1832-4abc-bfdf-8153742e609b">301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMy0xLTEtMQ_b00d038b-831f-4c45-a77e-2b3a96d5c450"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMy0xLTEtMQ_e83f1926-e2d0-4b9f-9f81-cf486eefc5f4">38</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtNS0xLTEtMQ_b3afd829-7ef9-47bb-9c7b-c3fa99d9674b">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtNy0xLTEtMQ_dbff85ad-490b-4d79-a7a3-1581c45fa509">11,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtMS0xLTEtMQ_e3a6a1dd-23a0-4eee-a0c5-2b3e7f04b167">2,339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtMy0xLTEtMQ_59f15f9c-4e5d-410a-a1cc-3541048f39ac">19,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtNS0xLTEtMQ_bc1a1a42-db33-42fc-80e2-7824f086e36b">12,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtNy0xLTEtMQ_05ca5ece-53dd-4a61-b860-5415216b425c">32,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common shareholders (Note 9)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtMS0xLTEtMQ_ee40f574-dc41-4db3-be88-b0862e876dd9">3,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtMy0xLTEtMQ_29baf1a2-db56-4bca-9fb6-fdf7045bc2b5">51,982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtNS0xLTEtMQ_6aa708a3-97f8-44da-a25e-f12eb8d9a032">17,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtNy0xLTEtMQ_c8344bfb-6785-44dc-8e2b-379803ba3037">65,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtMS0xLTEtMQ_5d907682-666a-45c1-8e68-426d8e971e2d">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtMy0xLTEtMQ_5bc84fa4-27fc-4834-9b5b-8c01b0a2c481">0.48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtNS0xLTEtMQ_2c300bb4-fefe-42f1-973d-f44c047ed4d9">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtNy0xLTEtMQ_0dda7691-8f20-4854-b105-083142bb5b1d">0.60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtMS0xLTEtMQ_be7d997c-e498-4a5e-99c0-36baab7cda12">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtMy0xLTEtMQ_ae993c2d-ccaa-4616-8438-35b472d52327">0.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtNS0xLTEtMQ_8a5958ac-482a-4989-9dab-84e0c3509fea">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtNy0xLTEtMQ_95704cff-00c3-4097-9444-397b68d53411">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtMS0xLTEtMQ_54fde61d-a944-454d-a18e-9127a4b20b06">110,717,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtMy0xLTEtMQ_c99b9c57-4803-4f7c-84cb-933ffd4884da">108,493,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtNS0xLTEtMQ_7284e7ce-2ddb-4800-9b9b-dab08a47daa3">110,136,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtNy0xLTEtMQ_4bde1d0c-3d6c-4828-a13b-c51c534472ae">108,222,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktMS0xLTEtMQ_fcb0d94f-9f7f-4b72-a5db-3ac09d58375e">110,717,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktMy0xLTEtMQ_c37ff979-8ac0-4206-9406-19cc21fa70b7">108,493,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktNS0xLTEtMQ_056a6dab-b5e2-40f1-8692-0311ebf4b180">110,136,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktNy0xLTEtMQ_e58aac32-c1bd-49ff-ba87-685c48ed0c49">108,222,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_25"></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; DEFICIT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8424268fe0f422699167479e062686d_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0xLTEtMS0x_ff84b4e7-1e46-44b3-a710-87b42890e57e">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8424268fe0f422699167479e062686d_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0yLTEtMS0x_99638af3-a8ad-43c2-8583-29ad79d43c9b">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7747d8031bb444f8a0d132a76929ab7_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0zLTEtMS0x_70dcf76c-5bc7-4d1c-bf91-cd4b47c12739">158,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi00LTEtMS0x_21e7c4b2-2e50-41d8-970c-dfa7e051c4fe">821,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi01LTEtMS0x_2389d3ea-fa8b-45f0-a341-9415c88c5fc5">4,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24deb84eee304bf8bd22b8b75a680e8f_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi02LTEtMS0x_f9efc6a2-e1e8-46b6-9b9b-81833b8f3da1">161,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i520bd173cc4b40d2961217715f798b5e_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi03LTEtMS0x_7e778710-f296-4381-96dc-423b217c2021">7,137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNS0zLTEtMS0x_1770a88d-2059-475c-8957-3d6e9c2614b5">3,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNS03LTEtMS0x_35af59f9-78e2-469a-8df6-89f847f2e06f">3,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy0zLTEtMS0x_a1d6feaa-d0f8-498a-87aa-b164ce5bb921">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy00LTEtMS0x_8d94a437-358b-4263-b3d9-c67eff29bfb6">30,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy01LTEtMS0x_af0fdb1d-86d6-44f7-8630-f34d51e8c501">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy03LTEtMS0x_7104a95e-7808-48a3-ad2e-363e0e007665">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS0zLTEtMS0x_4e913115-eb99-4f8b-b973-1a541d533c6a">477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS00LTEtMS0x_97a9b96e-98e9-4e3d-85b4-4c31b00104fa">48,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS01LTEtMS0x_01b62a72-bd88-442a-bcf6-d7c504984266">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS03LTEtMS0x_005996cc-d07d-4b88-af63-80104fd14531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtMy0xLTEtMQ_71df1443-406a-4352-8d65-91376cbadee5">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNC0xLTEtMQ_f9b5e19c-f055-491a-9e96-cf5b738a71ee">18,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNS0xLTEtMQ_30f1a33b-90b4-4d75-9a9f-5ec8b1fd3cc8">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNy0xLTEtMQ_133d353e-00b3-4d4f-9366-2f8a89524a21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNC0xLTEtMQ_8101ae1a-2184-4014-b6d2-966288151ef9">15,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNS0xLTEtMQ_7bcf6b7c-b6ce-4310-aa29-c2a0f38709f8">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNy0xLTEtMQ_b6fe2f37-dd25-465e-b404-b49a21fd8096">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4113e96817ee412daf4fb896ba4f907c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTQtNi0xLTEtMQ_eb6c7515-c2b2-4632-8b90-6569e545a22e">2,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTQtNy0xLTEtMQ_d0f0dba9-726e-4daf-8530-0541616cbb5c">2,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMS0xLTEtMQ_587bc419-0d80-4515-bac4-e748a7c6a0c3">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMi0xLTEtMQ_aced27d6-3ee1-47cc-ac5b-eda22fd1a1c8">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9879aac5984ce69a94a4be82f2afc7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMy0xLTEtMQ_47b29edc-19b1-48f1-a5bb-08183b64f6c3">162,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNC0xLTEtMQ_2bb39d3a-2859-4a67-9b79-509befa5d471">777,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNS0xLTEtMQ_e74b956f-e42b-4ce4-b97b-b3217da7a343">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d911729a90a4336b491792e0f39a4b1_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNi0xLTEtMQ_cff5a3e5-29a5-485f-87a3-780e73b4e5c2">163,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNy0xLTEtMQ_339d0cb4-d5db-458f-a5bc-cdc01cd4036a">5,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c1e389a471143e09a8fe973bc129222_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0xLTEtMS0x_3ea6dffd-8630-477b-b705-de544e3779a0">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1e389a471143e09a8fe973bc129222_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0yLTEtMS0x_a691ee83-9ff3-4724-ac57-036e091ea64d">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9dab3f535941c8a7e99c7f45f0648e_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0zLTEtMS0x_d343069a-ddb7-46f5-ac54-a2d6c1da8afb">151,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i870ec0719b704056ab5a603cee32bf21_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi00LTEtMS0x_12d230be-d2a9-4808-a2bb-5e3bc89b7901">2,412,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i870ec0719b704056ab5a603cee32bf21_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi01LTEtMS0x_f136f6a4-cd40-4d57-a055-c31298ba75d2">13,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00bbd7d8fb234b8b906ba09f5de7f570_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi02LTEtMS0x_cd1433cf-e00c-4309-803b-ed4e75c8f1f9">115,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319b98af263b4cca93e4f38f54ec70de_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi03LTEtMS0x_d2dba78d-03b8-4e07-a508-b490b4cb8c9b">22,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy0zLTEtMS0zMDAzNA_7339453e-3ffd-4185-9e48-d41a4cdbf3e0">32,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy03LTEtMS0zMDA0OQ_24ca5ec7-6ebd-4573-bd66-aeacf347bf9b">32,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNC0zLTEtMS0zMDAzNA_e27f26b1-882e-4e41-9e34-56ad7fbe19dc">31,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNC03LTEtMS0zMDA0OQ_cc108811-c779-4609-9cc3-487affcef724">31,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy0zLTEtMS0x_7f8ea6b3-5216-482b-8af9-4010e60eefc6">8,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy03LTEtMS0x_cf189052-3aeb-466b-9c41-4a89d26c4fc6">8,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi0zLTEtMS0zMDA3OA_54e96db5-b951-4b85-a842-f14aeea3620c">328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi00LTEtMS0zMDA3OA_07017f66-440a-4ff9-b417-711ab8de0753">45,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi01LTEtMS0zMDA3OA_d53df6f5-ff65-4d8a-84e6-1f9beb253350">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi03LTEtMS0zMDA3OA_6258977a-5b70-4cf3-a7cc-deeafcd86fd8">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS0zLTEtMS0x_3b60037c-f5cf-48c6-b608-e1ba782b8160">2,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS00LTEtMS0x_8ad1eb20-b67a-4f38-866d-b4bf72548891">328,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS01LTEtMS0x_8ae55b02-acfc-4062-8c10-d8ce17871f35">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS03LTEtMS0x_5b526d19-4bbf-444a-9484-9d832400c00a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shares canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi0zLTEtMS0x_3acce249-9fb6-4731-8410-cb362751881b">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi00LTEtMS0x_9e1a25b4-6332-4b0e-9ee3-1718a452e5cf">59,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi01LTEtMS0x_ec53c923-dfa3-43c2-83d5-53df3a66fc58">526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi03LTEtMS0x_fdb3914f-80ef-4f00-9c66-b65a39ea7dc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS00LTEtMS0x_9b21f293-1d83-4a54-b74c-ad97b3fba10a">14,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS01LTEtMS0x_c1856c8e-c810-4e00-b665-6ca6dc717647">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS03LTEtMS0x_efdebb8b-0d6b-4585-b790-cb95a90cf187">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dbe6f366fa94babbed471b118618949_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTAtNi0xLTEtMQ_dca02f60-9827-476e-b94a-f339c6d110b9">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTAtNy0xLTEtMQ_86e5891b-e1bf-4078-8c73-7eece651be16">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMS0xLTEtMQ_12ae7bb6-571e-467e-9855-69d479aff1d9">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMi0xLTEtMQ_42f3e8d9-e43c-4c05-8485-967cbf8c0921">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica08a3b681bd4921a6e10b0e732812dc_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMy0xLTEtMQ_536c0198-4365-4e05-92d5-4d3bc1e2fc55">158,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNC0xLTEtMQ_660daf5d-ff6d-42a9-bc11-f8d486a370cc">2,112,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNS0xLTEtMQ_e2b5854d-2d0d-438e-89a9-cb09e7855047">10,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNi0xLTEtMQ_b34137de-6716-42c4-a22d-37fdab93d632">134,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNy0xLTEtMQ_ab2dd3b2-66d0-4904-8fa6-63dd45a45334">12,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0xLTEtMS0x_39b2e251-2f3e-400d-be7b-c00e5e69fed2">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0yLTEtMS0x_10efbcb7-e9c6-426f-9e4c-a735625db080">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fff381503ab470cb567487005105042_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0zLTEtMS0x_e04d9064-3320-4996-8228-6c5673de7fd5">158,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi00LTEtMS0x_d716078c-329a-433a-9070-c7ede15f089c">1,773,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi01LTEtMS0x_48b8f124-18c7-44be-a442-c9893483850d">7,449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48875c6ed61b4455a259bb6c00a985b4_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi02LTEtMS0x_60dac2c7-93c2-4cb1-a1fe-c651cb0b622f">151,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi03LTEtMS0x_69881b0c-4cc9-4c3d-8a8b-6587c6ef8c96">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correction of out-of-period error (Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4481913816f8495b91664f2c94c198a2_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy0zLTEtMS0x_4376669f-b0e6-4dc0-b88a-0d0a186b0f45">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930" decimals="INF" sign="-" format="ixt:num-dot-decimal" name="mdxg:TreasuryStockSharesAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy00LTEtMS0x_2eb18899-c798-409e-b658-79979bc7dc06">239,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy01LTEtMS0x_ba513794-fa95-4677-9b2c-99e253433557">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0527aaa3a4344329744dd834938874f_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy03LTEtMS0x_ecb46417-dc89-4224-94d1-6424c8b87c0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNC0zLTEtMS0x_3d067466-889f-4b42-91e7-92861a3d421e">926</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNC03LTEtMS0x_e8b4e48f-e4b8-4ab4-a23c-3e2b3c406a2f">926</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNS0zLTEtMS0x_935c5523-baaa-44d3-909e-129eeb4fad53">11,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNS03LTEtMS0x_7dec0a15-f40a-4203-925c-7c8bb44f6898">11,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi0zLTEtMS0x_c339023a-7cb0-425e-81dd-9cdc861a5787">1,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi00LTEtMS0x_2df6ee3f-b8c3-439e-8825-cee2e03432d5">482,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi01LTEtMS0x_97e17d1d-8aea-48f9-a786-f29a08997817">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi03LTEtMS0x_9eced3c0-2604-4c06-ab94-83c6d2f6e3bb">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy0zLTEtMS0x_c4864b4d-4f6f-4c88-be54-4c7cb4808547">4,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy00LTEtMS0x_7fe40c41-8a9c-49ae-b38d-e9b36dd6e9fd">810,405</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy01LTEtMS0x_cf28ad5e-68bb-4c76-b221-45bd8c02be95">4,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy03LTEtMS0x_67f570bb-d378-4ea1-8f52-fc7dec347b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC0zLTEtMS0x_b091b05e-45c6-488c-9513-c0d863ef91ad">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC00LTEtMS0x_4855925b-bab7-4a68-8b9e-11fb7435d4ca">66,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC01LTEtMS0x_ca62ab22-d36d-4431-a83c-9cea85e6e25b">450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC03LTEtMS0x_47bea69c-8b83-448e-9fff-9d609e636a27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS00LTEtMS0x_3bd61d5c-ea2f-4c33-973f-e40153255f01">469,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS01LTEtMS0x_ab78d4df-cbd1-46ee-ad67-f365a33037d9">4,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS03LTEtMS0x_f976d52f-f4ba-40a7-89c3-fd12299888db">4,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i907e1ab429324dafb8dede5c9e07fd49_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTAtNi0xLTEtMQ_e15eb60e-e02a-4752-ad81-2f8a6fda97be">12,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTAtNy0xLTEtMQ_8abbcb9b-ff7e-4b64-8ac7-e4a16445cef3">12,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMS0xLTEtMQ_d4cd6b37-8e84-44ea-8440-e7dc5dae1137">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMi0xLTEtMQ_22f829a5-8ed3-4802-b74e-3f3e5bf5d035">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9879aac5984ce69a94a4be82f2afc7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMy0xLTEtMQ_4f4d26c4-2253-4cfb-bd4e-1cc774f032cc">162,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNC0xLTEtMQ_723804c4-6ac9-4010-bc94-7ede398df869">777,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNS0xLTEtMQ_a0af8752-a5a0-492c-b997-c7ac35890b18">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d911729a90a4336b491792e0f39a4b1_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNi0xLTEtMQ_2f92449e-7938-4d8d-bdd3-b4a4d0511238">163,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNy0xLTEtMQ_8746db73-b6e7-47b5-8c75-58116eccaa6b">5,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b398a86a27463d8c43135cf5d273e1_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0xLTEtMS0x_8f8344c8-7fea-44d8-bf46-e11cac14203f">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b398a86a27463d8c43135cf5d273e1_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0yLTEtMS0x_f5f830cb-4dc0-47d7-a27f-b70dade9a1a2">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125daf82d900495c9fe37f9848541647_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0zLTEtMS0x_0bea1067-6da9-4ad2-820d-910c767829a3">147,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91714ed5b0024037979d7567ffba146c_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi00LTEtMS0x_669b0041-30cc-4431-beaa-8a21ff3c9a8d">1,885,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91714ed5b0024037979d7567ffba146c_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi01LTEtMS0x_ff8748ab-e710-476e-9ddc-0b1254730d2d">10,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61389415a5d84a8696dd0a0d0313b5d9_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi02LTEtMS0x_bfa2889a-6a9b-47cf-8498-e46f9934e549">102,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967a4f404664bef9378ba0366b3c4f2_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi03LTEtMS0x_a5675d8a-3824-46cc-99c1-d8a130aa81dc">34,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMy0zLTEtMS0zMDEwNw_b282697f-a387-4df1-9d09-37f87e533044">32,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMy03LTEtMS0zMDEwNw_1c30ddc9-2b8c-4b88-84a2-29624b9c1031">32,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC0zLTEtMS0zMDEwNw_9bce87a9-a3a4-45d8-8fdf-98b7b4d3d47c">31,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC03LTEtMS0zMDEwNw_187d9dd4-6b3d-44ae-92d4-a8b52dba556e">31,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC0zLTEtMS0x_7313eba9-75f2-42b9-921e-e3c0c9f7f97f">11,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC03LTEtMS0x_a0055901-9404-4340-9c88-95a578f3422f">11,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS0zLTEtMS0x_4324f622-43bd-4595-a1b1-273ade0a4d76">1,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS00LTEtMS0x_230c7ba7-6558-4805-ac65-f5752683029c">265,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS01LTEtMS0x_927e2d03-7100-4abd-b8ea-3286949726dc">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS03LTEtMS0x_a84b535b-bcee-418b-a332-c5edfd7915cb">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi0zLTEtMS0x_3b1ef36e-9c92-446f-b405-b51c09a8d7d2">2,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi00LTEtMS0x_7732746b-7086-4041-8e12-162a0bba7a67">328,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi01LTEtMS0x_9facc633-f1b7-4ac0-bc40-f39604bac02c">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi03LTEtMS0x_f19c231f-93e3-4937-8878-417f2ac425d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy0zLTEtMS0x_236bce20-a536-41ee-b15c-5f2660585e1e">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy00LTEtMS0x_63d57309-d44f-43b8-8466-b30cc49a6ccd">345,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy01LTEtMS0x_a446bc1e-2741-40cb-bc9b-23c8990106f5">2,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy03LTEtMS0x_bc6ac9fe-21c7-4427-8eeb-20697093e968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC0zLTEtMS0x_d0c8e06e-f191-46e7-aa2d-addb84c5e585">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC00LTEtMS0x_5e364eae-cfe0-4c90-95d1-670f8e285e4e">476,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC01LTEtMS0x_475c99dd-1968-4e10-962b-3e7b94460744">2,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC03LTEtMS0x_16d2b85d-8c13-4260-a5a5-5234b8ea7bfe">2,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c93f18d959c4e32bba8d358469e13b7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOS02LTEtMS0x_d8b55032-13d9-49ca-9710-dc4cac6c7785">32,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOS03LTEtMS0x_27ddc898-d8c8-4380-8387-dc7eb8b24637">32,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMS0xLTEtMQ_76b6df55-1ac4-45ee-b838-1879bc69e3e3">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMi0xLTEtMQ_5914a0c1-9bb2-4d1b-80fe-6949519cdb76">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica08a3b681bd4921a6e10b0e732812dc_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMy0xLTEtMQ_249394c1-3392-4b78-b858-3bcc820d760e">158,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNC0xLTEtMQ_091355e9-513f-431c-84e0-bae045836d9f">2,112,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNS0xLTEtMQ_ce7c30a4-4977-4ecb-850b-733ff53514e6">10,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNi0xLTEtMQ_a08b588b-053a-40ff-bc4d-9e1a1a05a3cb">134,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNy0xLTEtMQ_9e458af9-3ae1-403a-aca9-a8d760864dd0">12,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMy0xLTEtMS0x_5ec123e4-c926-4a75-ae50-a1d6d625676b">12,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMy0zLTEtMS0x_52d71fd2-57ab-4bcc-b91f-f15220c6369f">32,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNS0xLTEtMS0x_d19e3f8c-deef-45bb-9115-4bc91d00f183">11,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNS0zLTEtMS0x_2de677c3-9761-4a27-b50e-a9146eb99fb1">11,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNi0xLTEtMS0x_eee998c7-ead0-4315-bce0-acc294c421f6">3,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNi0zLTEtMS0x_bee69492-0415-45ef-99fc-8e42d21f2424">4,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNy0xLTEtMS0x_3b495783-f421-40fa-a57a-182c326761b1">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNy0zLTEtMS0x_844673e4-374b-4c9f-a305-424fb231a2a7">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOC0xLTEtMS0x_c7aac087-427f-4540-abd9-d9bcd006f8b2">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOC0zLTEtMS0x_4ecac232-da9f-4be8-8497-4c7d18c2daf5">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOS0xLTEtMS0x_8f6dc529-6c05-486e-b16f-4514ddadb163">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOS0zLTEtMS0x_8e370851-f7bf-4f52-99f2-3db15397d205">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of asset retirement obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTAtMS0xLTEtMQ_aa3cb79f-7fe4-43a5-8d7d-10961a186b73">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTAtMy0xLTEtMQ_c17009aa-fb12-41ce-aae7-2357cb704f49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on fixed asset disposal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTEtMS0xLTEtMQ_20e27f00-9895-4c13-9c82-4a2702cdaeab">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTEtMy0xLTEtMQ_3cba4fcb-503f-4593-ac01-8fe8bc55bc1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTMtMS0xLTEtMQ_ea1facd5-db65-4c82-9fbf-694deea17bbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTMtMy0xLTEtMQ_997622ca-c35c-4b3f-955f-4e2a535ee22d">8,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash resulting from changes in:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTUtMS0xLTEtMQ_b63e044a-529f-4bef-8373-24dd927dbe1f">1,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTUtMy0xLTEtMQ_95b3c18f-12fa-470a-b659-f635ca2d4c91">715</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTYtMS0xLTEtMQ_da124f9a-1d74-499b-96b0-9d719a35416e">835</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTYtMy0xLTEtMQ_9ff60504-a451-4c62-b7aa-ba40cd36a299">1,919</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTctMS0xLTEtMQ_f66a35d2-0b07-403c-aa33-41c7cb498e6f">3,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTctMy0xLTEtMQ_4c29a9a6-c0c9-469b-8843-6be2cca4b753">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTgtMS0xLTEtMQ_78e8dd66-0f06-4fce-aeb2-956712015da0">9,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTgtMy0xLTEtMQ_56407df8-a6b5-45fa-b20e-63c6f608210f">10,835</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTktMS0xLTEtMQ_45830ab4-2c4e-4967-bff8-72b0b4c010f6">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTktMy0xLTEtMQ_9a69a107-7d1c-44ea-b9a6-5b1590678b8e">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjAtMS0xLTEtMQ_586dfbba-9325-45ae-a6b8-61569632b237">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjAtMy0xLTEtMQ_205c8b86-df8a-4de4-a5bf-367ee632a500">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjEtMS0xLTEtMQ_f83fe2f4-0fa5-4d28-9d44-28f4922cdf5c">2,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjEtMy0xLTEtMQ_5bbc2739-61ad-441b-9f28-a6a57c6dd206">2,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjItMS0xLTEtMQ_24fdc56b-4573-42ac-a1be-38767188d88c">16,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjItMy0xLTEtMQ_7f931dc8-2b63-4d77-8248-b8493a0dd338">4,835</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjMtMS0xLTEtMQ_eb45c59f-03bb-4cf8-aab1-19ddb356ed70">840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjMtMy0xLTEtMQ_6aca4061-1f17-4a68-9050-d254183bcb92">840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjQtMS0xLTEtMQ_00c116ab-94cb-4e72-8a4d-365a653c2d6b">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjQtMy0xLTEtMQ_7dc76874-947b-41a2-b289-3e6bfc448479">19,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjctMS0xLTEtMQ_d90e6826-657f-4644-b368-5da071b98b86">2,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjctMy0xLTEtMQ_20668f96-89dd-47e5-bfc3-9a9d6c9a3cbe">2,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments from note receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjgtMS0xLTEtMQ_51726f52-ad34-447c-a96a-bb24b389eee4">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjgtMy0xLTEtMQ_e43a8cee-0c5d-48d3-bbc2-db8c9ebc8ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent application costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:PaymentsforApplicationCostsPatent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzAtMS0xLTEtMQ_d1a6786b-c374-4c3d-9533-6bc70bef241a">263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:PaymentsforApplicationCostsPatent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzAtMy0xLTEtMQ_ad57e797-9eb9-430d-a8e8-86329df95cc2">209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzEtMS0xLTEtMQ_7195777f-34cb-456f-b178-d2377e0b74d5">3,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzEtMy0xLTEtMQ_c1568293-7246-47de-9f59-e78b177fd452">2,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzQtMS0xLTEtMQ_8577068d-e4ab-4e5b-bfbc-db8c920a9d19">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzQtMy0xLTEtMQ_25a49c0a-1984-41c8-8df2-d685150721d6">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchased for tax withholdings on vesting of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzUtMS0xLTEtMQ_de48c0ff-eb87-4cdb-a2c0-382a819f7628">4,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzUtMy0xLTEtMQ_40ab03d9-c105-4ab2-942c-e2802b96c140">2,409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on finance lease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzYtMS0xLTEtMQ_09a25b46-3630-4d90-b14f-001686300565">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzYtMy0xLTEtMQ_bd6e952c-270e-475c-b25c-df1f5f0d1b34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzctMS0xLTEtMQ_98999670-d891-49e2-88ef-2d86410cf514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzctMy0xLTEtMQ_452cbefc-b65e-4943-9538-cdff8d84bef3">2,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RepaymentsOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzgtMS0xLTEtMQ_b8dbbf41-32fb-4c10-a746-17bc11a2a451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzgtMy0xLTEtMQ_b0198c30-0ba3-41de-9dd2-cccbdb9a259c">83,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzktMS0xLTEtMQ_74b2f0f2-9042-4c24-8944-bbb696759b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzktMy0xLTEtMQ_95474cda-22aa-4d91-871a-23881016c36e">59,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of Series B convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:ProceedsfromIssuanceofTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMS0xLTEtMzA0OTA_254e183a-eb58-4d35-bf7a-8b053450cbe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:ProceedsfromIssuanceofTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMy0xLTEtMzA0OTc_49b1846c-2590-4a8c-ad79-6e1aa86e9c5a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDEtMS0xLTEtMzA0OTA_8c484414-7840-4d8d-8075-1d366bc6ee46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDEtMy0xLTEtMzA0OTc_e2741791-f015-4393-a33f-b35ffc7e9fdd">6,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayment premium on early repayment of term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMS0xLTEtMzA0OTA_174c9cad-b9f2-47c5-8eb4-86e04c31f9a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMy0xLTEtMzA0OTc_77f1f5d7-43dd-435f-aa60-0d0ded4647bb">1,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMS0xLTEtMQ_df781bfa-0d63-4843-a2c4-44c23f3edc87">3,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMy0xLTEtMQ_6e39fd8f-677a-4a37-8090-9f7000fc71c6">62,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMS0xLTEtMQ_a5c4023a-2d41-41d5-8eff-9d3831338282">5,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMy0xLTEtMQ_7d69ccf4-4198-4943-b62c-0f08d40687ed">40,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDQtMS0xLTEtMQ_0595cc0c-7b3c-44b0-ac42-76d66c82a557">95,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5967a4f404664bef9378ba0366b3c4f2_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDQtMy0xLTEtMQ_358e44a3-46ef-4714-99d5-9e74276584d0">69,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDUtMS0xLTEtMQ_93fa485c-e07f-4659-871e-4a4a6798c4e4">90,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDUtMy0xLTEtMQ_23dfffc2-3017-4acf-8f26-d244fe091603">109,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_34"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDg3Ng_f1f4f9a7-7f10-403a-8326-d307ccb2fbc1" continuedAt="i83fa581327a2464aadbb22aa2640f799" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="i83fa581327a2464aadbb22aa2640f799" continuedAt="if7f2f996c54d475a9bf4e851bb7dbd40"><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#174; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model is focused primarily on the United States of America, but the Company is pursuing opportunities for international expansion.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enforcement Discretion</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA exercised enforcement discretion with respect to Investigational New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products in the United States and is precluded from marketing such products until a Biologics License Application (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is granted. If and when the FDA approves a BLA, the Company expects to be allowed to market its Section 351 products in the United States, but only for specific indications as permitted by the FDA. Sales of the Company&#8217;s Section 351 products were $<ix:nonFraction unitRef="usd" contextRef="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjYzMQ_ecac833f-96b6-4a10-8311-aad9379968ee">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjYzOA_42162848-763c-4de6-8c5f-e52bde4d9b82">8.2</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjY5Nw_f1364675-16c1-4783-9045-d58473225ffb">17.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjcwNA_5e3a468d-18b7-4ef5-8368-a4d4759fea90">23.1</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively. Sales of Section 351 product during the three months ended September&#160;30, 2021 were derived from sales outside of the United States of America..</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently markets EPICORD&#174; and AMNIOCOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D&#174; tissue products derived from human umbilical cord as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#8217;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#8217;s revenue, business, financial condition, and results of operations. Net sales of the Company&#8217;s umbilical cord-derived products were $<ix:nonFraction unitRef="usd" contextRef="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzM1MA_3f914133-14e2-42d7-b698-7a821d914abd">6.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzM1Nw_cd36ad4b-e13f-45d2-80a8-9ea74cbb2f73">4.2</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzQxNg_59c2550d-80ce-4341-b7b4-5102df601d97">17.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzQyMw_bf960f2d-bc21-4b78-b033-4d3fac73fbd9">11.4</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#8217;s cord inventory, which would be at risk for write-down in the case of such a determination, was $<ix:nonFraction unitRef="usd" contextRef="i81c1fc5c80bb4755a61a11f5bdf75e52_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzU1NQ_4d834128-a492-4aeb-b4d6-f01b517b079b">1.5</ix:nonFraction> million as of September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-of-Period Adjustment</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#8217;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#8217;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#8217;s reported consolidated balance sheets and consolidated statements of stockholders&#8217; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#8217; (deficit) equity or earnings per share in any period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an out-of-period adjustment during the nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which resulted in a decrease of $<ix:nonFraction unitRef="usd" contextRef="i4481913816f8495b91664f2c94c198a2_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDQzNg_56bae51b-fb8b-467e-a1fd-87630dcf9b5e">2.0</ix:nonFraction> million to the balance of additional paid-in capital for the nine months ended September&#160;30, 2020, respectively, and an increase of $<ix:nonFraction unitRef="usd" contextRef="ib194ea304588466d9d6e058e63a66dde_D20210101-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDU1MA_ae01c50d-8720-4d17-9d62-11ffbca913fe">2.0</ix:nonFraction>&#160;million to the balance of treasury stock during those same periods.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if7f2f996c54d475a9bf4e851bb7dbd40">The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.</ix:continuation></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_37"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMDc_570a5016-b04c-4b3c-bdb6-09f748e7270d" continuedAt="i46309076f2b8409a89ae24513fd5c44a" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i46309076f2b8409a89ae24513fd5c44a" continuedAt="i258cf6059d0d4f49851270035b9fcdc3"><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Note 2 to the Company&#8217;s Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for a description of all significant accounting policies.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMjg_10f66a92-2da5-45cc-8ef9-7722fa09e771" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and nine months ended September&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMDY_d712d32d-8987-49c3-8453-17062e1dc8b8" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion and other regulatory factors with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMTU_8ce35a56-7522-4b74-b430-ae974d510e21" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMjk_cd62a5af-227e-42bd-82b6-888a91830294" continuedAt="i018d0ad155674cc3b9aaf62037bb6f4d" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i018d0ad155674cc3b9aaf62037bb6f4d">Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.</ix:continuation> As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded <ix:nonFraction unitRef="usd" contextRef="i3f87700978a544fa9d65867f626f385d_D20200101-20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfNjg3NQ_3f9f6da4-7d37-4234-b928-be3f821a177f">no</ix:nonFraction> impairment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i258cf6059d0d4f49851270035b9fcdc3"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMTA_365a7cf8-f39b-4e86-9b71-0ac8465f2ca9" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, this ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under Accounting Standards Codification (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</span></div><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of September&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the nine months ended September 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div></ix:nonNumeric></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_1270"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.    <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:AccountsAndNontradeReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGV4dHJlZ2lvbjowYjAxMWE5M2IzOTc0NThkODkwZDBlYThiMWY5ZmVkYV8yNzQ4Nzc5MDY5NjM1_e56b2a68-a857-4917-8a5e-f428290672e5" continuedAt="i693d826b4ab649929310c4338751e698" escape="true">Accounts Receivable, Net</ix:nonNumeric></span></div><ix:continuation id="i693d826b4ab649929310c4338751e698"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGV4dHJlZ2lvbjowYjAxMWE5M2IzOTc0NThkODkwZDBlYThiMWY5ZmVkYV8yNzQ4Nzc5MDY5NjM2_4e0c3c93-9cfe-4c09-946f-e106b0a3c784" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18xLTEtMS0xLTEwNw_2bd94874-6845-4e9d-8a6d-b59f8f249751">37,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18xLTMtMS0xLTExMQ_64b40dfa-2e53-4a39-bd72-321ff95594bb">36,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18yLTEtMS0xLTEwNw_ac1f1bf8-8a6b-4d80-9121-65cbe7d8b45c">867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18yLTMtMS0xLTExMQ_f42e730d-e7fe-477f-9d8f-1bd9d7522164">737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18zLTEtMS0xLTEwNw_ddcb1a31-6791-4e23-8085-7bce713d72b7">36,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18zLTMtMS0xLTExMQ_ab0318c5-b78e-48c4-b33b-88492e75682f">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_43"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMzk0_64e400ae-74d6-4f03-bf0c-9742b2a8f2cb" continuedAt="ia2f821087a434e3dbb6254c9881c5f55" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="ia2f821087a434e3dbb6254c9881c5f55"><div style="margin-bottom:9pt;margin-top:6pt"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfNDAw_88e176c3-db71-49a1-818d-855fcad46532" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMS0xLTEtMS0x_c7db972c-5d1b-456a-bef7-fe1e8bb049b5">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMS0zLTEtMS0x_4832ca16-042c-4714-946b-ca8984f50b71">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMi0xLTEtMS0x_4795fdd7-75d5-4081-a10c-3e37cea1b220">6,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMi0zLTEtMS0x_23190888-64a5-4ec6-b017-d77d296b4f2d">4,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMy0xLTEtMS0x_0e8e51fc-a71c-4efb-ab05-191ee1bf533c">4,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMy0zLTEtMS0x_39adc14e-f4c1-44ff-980f-76f819fd6c7a">5,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfNi0xLTEtMS0x_96c8d5ac-6b97-4538-8049-9135b7df0cd9">11,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfNi0zLTEtMS0x_79cc8ac0-d1f6-4394-8d15-65f325469c68">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the conclusion of the FDA&#8217;s period of Enforcement Discretion on May 31, 2021, the Company wrote down $<ix:nonFraction unitRef="usd" contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMTkw_05b619f5-9a0d-4b57-90cb-bcfd400dd383">1.0</ix:nonFraction> million of its Section 351 product inventory during the nine months ended September&#160;30, 2021. In addition, during the three and nine months ended September&#160;30, 2021, the Company reserved $<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMjc0ODc3OTA3MDU4OA_9ff1e982-0810-4947-aa6d-47e23e54998c">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMTA5OTUxMTYyODI2Ng_dfd0ecee-d46a-4b80-9ee1-99eb8adf3e96">0.7</ix:nonFraction> million, respectively, for inventory related to product lines which have been discontinued. These amounts are included as part of cost of sales on the unaudited condensed consolidated statements of operations for those period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDE3_6bc09718-480a-4635-9e88-fd894f2f5ddd" continuedAt="i81871b356dbb4dae98f7dd0b6c392848" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i81871b356dbb4dae98f7dd0b6c392848"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDI5_a1372576-5e97-4926-98eb-4595f4cdc629" escape="true"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia643c1f3ffd5490daba314259b7b5dd8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMS0xLTEtMS0x_f513da49-3c96-46a9-9f02-95ecf440b4a6">8,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e0382314754873b5d3463a70f2452c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMS0zLTEtMS0x_ed413ba3-8641-4de7-9e03-db529a5e6be3">6,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ac9e9787fd4e5caa1e0fd68f13f431_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMi0xLTEtMS0x_92aa562b-1c9f-4db8-a68e-0347391eed9b">16,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93598c6e79474e738b441aee60fd85fa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMi0zLTEtMS0x_d45f9e6f-90d7-4f7c-b556-5b023eb69c71">15,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d8f37a625b4a6eb4876d23445e7b8f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMy0xLTEtMS0x_bace15d2-69b6-4fe1-9f09-e5ff952183b2">14,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8fc9cbb62e4e68bf85adfc66a44263_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMy0zLTEtMS0x_bcfec5be-07ec-43a4-89f4-0227a029949d">15,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3efc44c2885e4c7fb8e1a0ea72d8b77f_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNC0xLTEtMS0x_d92e848b-1eb1-450f-a9e5-f65e2df712d3">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4d540898ae4a45b41a0121cbd3d2bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNC0zLTEtMS0x_2b5983f4-17a9-4108-87f0-9a4890014316">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf29e0d1c12430a95941dc867b6c928_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNS0xLTEtMS0x_49c2b4bb-4846-4e91-801c-cf1d82ca3a83">880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c20ff2657e341d984f4a7abc943473f_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNS0zLTEtMS0x_8875ea1a-04aa-412a-9db9-61b7b9b59609">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNi0xLTEtMS0x_a97527a0-aa76-4412-a84a-c6d4236d9014">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNi0zLTEtMS0x_f61dfbe3-4112-4b52-8c40-0fde795f4e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNy0xLTEtMS0x_2ef3d976-87c3-4f94-908f-2c4e4ec5db4c">41,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNy0zLTEtMS0x_f7fe3853-207a-4931-9a27-968713dd03e5">40,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOC0xLTEtMS0x_cbd63475-38b5-4b8b-8210-0da391ac2e5a">32,076</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOC0zLTEtMS0x_255095d4-02a8-4503-bc74-b3ff52308560">29,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOS0xLTEtMS0x_abbc79f5-753f-485c-aafb-9c7f1b1fc9b7">9,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOS0zLTEtMS0x_2f8104b4-c384-49d1-96ce-f8318cd14877">11,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="mdxg:ScheduleOfDepreciationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDIz_329d1a6d-4c0e-4f7f-abf1-cf60487b8560" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for each of the three and nine months ended September&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi0xLTEtMS0x_110fd109-d785-432d-b3f5-65d58396aa3f">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi0zLTEtMS0x_b77702b0-695a-43d7-b24c-35b3a814764e">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi01LTEtMS0x_efd14751-f9ef-47da-a0fc-12ddfef2e95d">3,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi03LTEtMS0x_a37b17b0-d85e-4f73-8bb1-bcef9d2d1d9b">4,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is allocated amongst cost of sales, research and development expense, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.</span></div></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_52"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzE0_f9c3e8f5-74e8-4b4e-9d42-645645b4e788" continuedAt="id2b22d7375e74756a9669b4a0dfcccb1" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="id2b22d7375e74756a9669b4a0dfcccb1" continuedAt="i27f3449b04094c35aa81944a51a21eb5"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzAz_9c6886f0-934e-4ff8-98d7-97df53eb9dee" escape="true"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzA5_b4316a91-c5cf-488c-9b84-536781e28951" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:38.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know-how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0xLTEtMS0x_6b4cd9ae-c048-4f9f-af4d-f41fdd10e0b7">9,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0yLTEtMS0x_061f058a-851f-495d-b418-00aeb92583a4">6,238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0zLTEtMS0x_0923c0b9-1c23-4f75-9057-4e9f28e6cd82">3,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy01LTEtMS0x_7d5b484c-3260-48ca-bd8f-5569b0bc8360">9,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy02LTEtMS0x_2adb09ba-420a-45fd-a09a-ed35672bbaca">5,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy03LTEtMS0x_0dc72663-6db3-4474-93cb-d880aabb8743">3,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0xLTEtMS0x_47717e94-0767-49a4-a6b2-a971164d1fe6">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0yLTEtMS0x_ea520a04-8813-4455-9fb6-f8b031ddda7c">1,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0zLTEtMS0x_6324d946-c085-45b7-865e-6da787345943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC01LTEtMS0x_347d97bd-5494-4e2c-bbe4-55bcffb69930">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC02LTEtMS0x_a6c7a9c3-69eb-481c-96b8-d4d65ba79690">1,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC03LTEtMS0x_7292331e-6ac1-429b-847f-c97829c6b64e">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0xLTEtMS0x_a45cfd53-5b84-49f9-90f5-d9ccc579a446">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0yLTEtMS0x_1d1fb6a3-c58f-4cbd-ab7a-a45f015b9ec8">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0zLTEtMS0x_d799fb62-1f03-45dc-a04e-07fc011d090f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS01LTEtMS0x_0f2932fd-0ada-433f-b2ee-88ee72ae5fdb">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS02LTEtMS0x_44abd17d-f504-475c-b111-4703ea20fd93">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS03LTEtMS0x_e776765c-6d42-4986-b8f4-3df92bee5e8f">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0xLTEtMS0x_469852b4-ece0-4f33-b63c-77d80a0d030d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0yLTEtMS0x_154417ea-a592-4827-8bb2-08d96c7dd126">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0zLTEtMS0x_7c60d645-bdbb-4bc0-8fda-7bc4d7b0f198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi01LTEtMS0x_8c076daf-d901-415c-a306-adaa74569e80">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi02LTEtMS0x_3b8cfb98-a5a4-4b7e-a2ba-5438f3ac10bd">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi03LTEtMS0x_4f24a686-fb66-4e0b-b97a-d4585287f2fe">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0xLTEtMS0x_ffda948b-609a-4023-8bc5-777a4ba999a7">11,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0yLTEtMS0x_de25bf56-5516-4526-a9fe-2a29320689a1">7,957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0zLTEtMS0x_3cb7fd25-5e3b-457e-847b-5e088dab951c">3,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy01LTEtMS0x_878cd872-54e9-4600-b93d-37d0fcdc8552">11,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy02LTEtMS0x_08a6d98f-5600-4202-aecb-9d719bcc3b20">7,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy03LTEtMS0x_1a2b8c7c-2b8e-44f5-84c9-9ead2cbd8fec">3,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Intangible Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtMS0xLTEtMQ_5a9a0a64-fc4a-4d66-b6da-163a4650c92b">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtMy0xLTEtMQ_478a3577-26fb-4ce3-a7ea-7cb028ea89da">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a67f851997741fb98d72955463632aa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtNS0xLTEtMQ_af4fbb32-5513-477d-bfd1-41ae02ed9b92">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a67f851997741fb98d72955463632aa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtNy0xLTEtMQ_f2d16a29-fb5f-4039-9086-5089389895f0">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in Process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce4df1ba99d4d4da5aa384183983463_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtMS0xLTEtMQ_91220f0a-0874-4c60-bbbe-c593e3b8ffb0">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce4df1ba99d4d4da5aa384183983463_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtMy0xLTEtMQ_95c966f0-59c4-45c9-9eb7-9fc53e54dcbb">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtNS0xLTEtMQ_350a9a3e-1f77-4fe0-a6f8-d86ab3026c5a">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtNy0xLTEtMQ_d2f11986-d1f4-46dd-9b9b-b83ec12c6a5d">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItMS0xLTEtMQ_192ca969-4e0f-4163-96be-475710822bc6">13,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItMy0xLTEtMQ_327c2a6d-d0f5-4aff-b607-ed7f8edb4816">5,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItNS0xLTEtMQ_152dcf30-78ef-402f-965a-5c5372f6c612">13,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItNy0xLTEtMQ_361c0766-4b25-4cec-bf03-21b53d9dc0c2">6,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and nine months ended September 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0xLTEtMS0x_4b424d20-948f-4736-b6e1-4c74726937c2">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0zLTEtMS0x_09c223b1-0ff3-4875-8c27-14e09b89f72e"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0zLTEtMS0x_f1d69415-33b7-40e8-814e-60704ec3989c">276</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi01LTEtMS0x_105571a9-27fd-4bbd-8dd7-33f55d05083f">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi03LTEtMS0x_44cee943-7b6f-4239-956a-0bb55ac89c2b">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i27f3449b04094c35aa81944a51a21eb5"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzEx_2bfa411c-36c4-41b8-834d-8a7edd2a2616" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of September&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMS0xLTEtMS0x_2c8c5129-d5f8-40b4-8f97-9c5ba7f2eb71">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMi0xLTEtMS0x_febea814-0dfb-4c99-98a5-a23211461e95">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMy0xLTEtMS0x_7bd62720-7866-4a99-8c1d-fc23315f3fa8">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNC0xLTEtMS0x_74359017-3007-4ad3-b76e-d0007d6b2e91">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNS0xLTEtMS0x_ea106e23-a21c-447a-98bd-10dc2bbb62b6">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNi0xLTEtMS0x_9e7a5a1a-911b-4d29-9eda-9e50754774b1">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNy0xLTEtMS0x_763329fc-867e-4164-aa02-d7aec5173250">3,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_55"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.     <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RleHRyZWdpb246Zjg5MWVlYjRmODBiNGUwOGIwZDk3MGRkNDNiYmNiYmZfOTA_4f163cba-2b7f-401a-90ba-4a91701c800a" continuedAt="ic939ffd524674cfeb1291ebc25459e80" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="ic939ffd524674cfeb1291ebc25459e80"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RleHRyZWdpb246Zjg5MWVlYjRmODBiNGUwOGIwZDk3MGRkNDNiYmNiYmZfODk_644a6ade-8e6f-40df-8c04-98e64ca7299f" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"></td><td style="width:53.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMS0xLTEtMS0x_7136a4ba-1fc3-43ce-899b-d3696df309a4">8,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMS0zLTEtMS0x_828c0e00-2154-47c6-8d8e-51a1f46fbf50">24,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMy0xLTEtMS0x_65068986-ef7c-47af-b062-b7d3411f1277">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMy0zLTEtMS0x_221f22fc-752b-4bea-8a0c-ca192442484c">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNC0xLTEtMS0x_19b48b36-6c8d-420b-8c9a-429dc8763d1f">797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNC0zLTEtMS0x_58aa4f29-fa34-4291-87ff-e7565954ff1f">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="mdxg:AccruedClinicalTrialsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNS0xLTEtMS0x_b46c3f7e-c96b-45ba-8170-88a0da9f9498">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="mdxg:AccruedClinicalTrialsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNS0zLTEtMS0x_8ced6cbd-f425-4f8c-90cd-925f0ab41dad">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNi0xLTEtMS0x_6949ea3e-2c68-4b8d-8162-4066e162a3c0">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNi0zLTEtMS0x_5981112c-ad11-4552-9435-ac8605777d93">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" name="mdxg:AccruedRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNy0xLTEtMS0x_6a84dd1b-5951-4280-8c94-daa34bc47636">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="mdxg:AccruedRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNy0zLTEtMS0x_1bdb093c-2fa3-43d5-8379-262b04419353">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOC0xLTEtMS0x_4bb4d935-26d8-46bf-be12-2b06d2faf9c3">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOC0zLTEtMS0x_27fe58bd-ed2c-4d77-94e0-f438d36a6568">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOS0xLTEtMS0x_5620991e-4b5c-43a5-bb82-b771e9f8fc32">13,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOS0zLTEtMS0x_e67eecbb-ab3d-4b20-bdb1-c4aaabddf409">30,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accrual for settlement costs, which was presented separately in previously-issued financial statements, is included as part of legal costs in the table above.</span></div></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_58"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTY_27377ff8-7e6c-4d95-bf2e-6db35f036f66" continuedAt="ia28f2bf0a9f94809a98fd204a1e21aa4" escape="true">Long Term Debt</ix:nonNumeric></span></div><ix:continuation id="ia28f2bf0a9f94809a98fd204a1e21aa4" continuedAt="i47c64f16767e47398745ad12f208a729"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Term Loan Agreement</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), providing  the Company with a senior secured term loan in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNDIw_df787ed5-83e7-4192-8db0-2256bd129c03">50</ix:nonFraction> million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hayfin Loan Agreement also provided the Company an option to draw on an additional delayed draw term loan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD TL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively with the Term Loan, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the form of a committed but undrawn facility until June 30, 2021. The Company did not exercise the option.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#8217;s Series B Convertible Preferred Stock (as defined and described in Note 10, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="i1f30e1643e2b457cad73afc68fea533e_I20200702" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTMyNg_813f49da-91e2-43b8-bc15-67c4b23b0abc">100</ix:nonFraction> million (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in order to:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Refinancing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the lenders thereunder and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i47c64f16767e47398745ad12f208a729" continuedAt="i513e09cb89f34bdbb34f265f99d34deb"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of <ix:nonFraction unitRef="number" contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentInterestRateFloorPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTk5MA_871a9b25-3248-4862-b7ed-09262537a820">1.5</ix:nonFraction>%) plus a margin of <ix:nonFraction unitRef="number" contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjAxMQ_a7a19fd0-e490-4cae-91f8-7db4bdb1ad53">6.75</ix:nonFraction>% per annum (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). If LIBOR is unavailable, the Term Loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="ib568475ec03640c79dec4a7823674263_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjE3Mw_e094e9d9-6a2e-473a-a640-36733fd2e9dc">0.5</ix:nonFraction>% per annum, and <ix:nonFraction unitRef="number" contextRef="i5999d39b82454d3485d425e42e44c0ab_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjE5MQ_fdb86488-90ca-4d31-b1c9-d61060278db7">2.5</ix:nonFraction>%. The Margin is eligible for a reduction depending on the Company&#8217;s Total Net Leverage Ratio  (as defined in the Hayfin Loan Agreement) for the quarter; as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="number" contextRef="idf73b93b55dc4376983adc42db197d7d_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjMwNg_8ea756ef-b218-4245-8cd1-b9b2d19e9e6b">6.5</ix:nonFraction>% per annum if the Total Net Leverage Ratio is less than <ix:nonFraction unitRef="number" contextRef="id816d2b16745481584d1f3ad0216ba99_D20220101-20220930" decimals="INF" name="mdxg:DebtInstrumentCovenantNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQwNg_020faee4-0e43-4017-a3ed-9fb3b9c107f6">2.0</ix:nonFraction>x but greater than or equal to <ix:nonFraction unitRef="number" contextRef="ie2d9d8ddf0424a2ebc54c14f5fb90725_D20220101-20220930" decimals="INF" name="mdxg:DebtInstrumentCovenantNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQzOQ_6b06b15a-0077-4b36-a29c-49dd5f81de52">1.0</ix:nonFraction>x, or</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="number" contextRef="i07286d413f254827a20487a6cd9f485e_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQ0Nw_c7867bbf-60c9-4a6f-a3d6-9296d0013e9a">6.0</ix:nonFraction>% per annum if the Total Net Leverage Ratio is less than <ix:nonFraction unitRef="number" contextRef="i07286d413f254827a20487a6cd9f485e_D20220101-20220930" decimals="INF" name="mdxg:DebtInstrumentCovenantNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjUwNQ_6d4e0e29-7434-41b3-b8cb-6b588b0abdf4">1.0</ix:nonFraction>x.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional <ix:nonFraction unitRef="number" contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentDefaultInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjUyNA_1db6fe5f-5bc2-42bb-89ea-c2bf623a452e">3.0</ix:nonFraction>% margin is applied to the interest rate in the event of a default as defined by the Hayfin Loan Agreement. At issuance and as of September&#160;30, 2021, the Term Loan carried an interest rate of <ix:nonFraction unitRef="number" contextRef="ia39e228029734a35b7f629da814e51c1_D20210101-20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjY5OQ_9c614de6-fe06-4a89-b922-2deef607f16c">8.3</ix:nonFraction>%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain financial covenants (as defined in the Hayfin Loan Agreement) requiring the Company, on a consolidated basis, to maintain the following:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Maximum Total Net Leverage Ratio of <ix:nonFraction unitRef="number" contextRef="i2f8c6ca35468445894a87c3f1396e899_D20210701-20250702" decimals="INF" name="mdxg:DebtInstrumentCovenantNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjkxMQ_512c69cb-eaf3-496c-8f39-0d66f0c3438e">4.0</ix:nonFraction>x, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Minimum Liquidity of $<ix:nonFraction unitRef="usd" contextRef="i5fdd3b5337e94c8fa60408bc1abc8f28_D20200702-20200702" decimals="INF" format="ixt:num-dot-decimal" name="mdxg:DebtCovenantMinimumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzA2NA_ed831bf6-3a20-4d76-8308-8c7a0638b533">10</ix:nonFraction> million, an at-all-times financial covenant tested monthly.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before July 2, 2022: <ix:nonFraction unitRef="number" contextRef="ib6c60ec647934d8f96e30a1383affd50_D20210703-20220702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzg0NQ_fefc3984-b45b-488d-955b-02f8ff256df6">2</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2022 and on or before July 2, 2023: <ix:nonFraction unitRef="number" contextRef="idee297f90d0f45db8cbb6d3416d3d4ac_D20220703-20230702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzkzMQ_33ff56d2-c007-4bfc-8497-4d19f9eba561">1</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2023: <ix:nonFraction unitRef="number" contextRef="i25cacd5716404a11aa3833043d143f64_D20230703-20250702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNDAxNg_fb79d4f5-a469-4a58-90eb-6989b0d2c6be">0</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. Mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event (as defined in the Hayfin Loan Agreement). Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Company&#8217;s Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. No such prepayments have been required as of September 30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayfin maintains a first-priority security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock (described below in Note 10) and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="mdxg:ScheduleofDebtIssuanceCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTk_62285356-bcb1-435d-9791-c540268f1f5d" continuedAt="i398a2b491c224b41a7496affb8b8c086" escape="true">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><ix:continuation id="i398a2b491c224b41a7496affb8b8c086"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"></td><td style="width:24.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98ba73abde34242a6ba47a62b0ef574_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy0xLTEtMS0x_d97e71f0-632f-4b6f-8d30-475984ee83ec">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b87261e163441c1ab6791378bfb180f_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy0zLTEtMS0x_9d1a55cb-1d75-43a6-9317-31466068afa5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ff1eec1ec3433284583249574c58e7_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy01LTEtMS0x_02930902-4c36-4fd1-9c5e-40b6e705878d">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98ba73abde34242a6ba47a62b0ef574_I20200702" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC0xLTEtMS0x_979698a1-9f6d-4ebe-8f7e-79eed8afdf54">2,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b87261e163441c1ab6791378bfb180f_I20200702" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC0zLTEtMS0x_328c8649-b828-490b-a6f4-4b30ec80c626">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ff1eec1ec3433284583249574c58e7_I20200702" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC01LTEtMS0x_d218834c-5908-4967-827c-bea19aa42569">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i513e09cb89f34bdbb34f265f99d34deb" continuedAt="ia6d518c746ad441aa63b4b51e17e0ffc"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of September&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of <ix:nonFraction unitRef="number" contextRef="i33e2f0127c424966a4196fa78dea5252_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNjgzMw_a7e4e80d-2889-4dbc-b139-640a8787dc72">1</ix:nonFraction>% per annum of the amount undrawn, which is recognized as interest expense.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTI_4a0d12aa-704e-4626-826c-f09a72a954bf" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of September&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"></td><td style="width:33.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb70228ca86484abc1647102df379f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMS0xLTEtMS0x_dd587171-00df-4373-ae24-b772a2390bd9">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief91294d01924689b8c5a91709f9113c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMS0zLTEtMS0x_dc989915-ff3d-4e9d-beaa-990eca52c928">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fb70228ca86484abc1647102df379f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMi0xLTEtMS0x_dfc7097a-4cca-4433-ad8c-ca86231b62ee">1,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief91294d01924689b8c5a91709f9113c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMi0zLTEtMS0x_5f76cd14-2b72-4a16-bc87-45687ea2ead7">1,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fb70228ca86484abc1647102df379f3_I20210930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMy0xLTEtMS0x_bb441782-6cdd-4f93-9ca1-818b73588331">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief91294d01924689b8c5a91709f9113c_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMy0zLTEtMS0x_18b30fe3-6b55-44d1-9ee5-01a1cdc38a27">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb70228ca86484abc1647102df379f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfNC0xLTEtMS0x_3febeef6-bf90-411a-9c7e-ba318f7d3d25">48,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief91294d01924689b8c5a91709f9113c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfNC0zLTEtMS0x_29ee734c-ed3d-4630-8449-ddd914383294">47,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="mdxg:ScheduleofInterestExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTM_8bc7a925-4b53-495f-90d7-2cd7ae8494a6" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:33.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.774%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0xLTEtMS0x_ea2999fb-7aba-4a78-9fc1-300c6657c52f">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0zLTEtMS0xMjAz_2dc4c1f2-be88-498d-a60f-d73ec868d51a">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0zLTEtMS0x_67c02a9b-2cd9-4b10-98f0-ea15ce3860b6">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi03LTEtMS0xMjEy_f2a80b11-9903-40ce-9295-45def7159a50">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0xLTEtMS0x_7f9c0c4f-2ee6-449f-bae5-4a21353bdda9">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0zLTEtMS0xMjAz_8bf0c6c1-4c31-4729-82e1-82f10dcb8072">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0zLTEtMS0x_31f9be71-5cc6-4c0b-bd47-ba2020409aae">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy03LTEtMS0xMjEy_2692c710-5081-43df-bfb7-82d5b861f09a">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0xLTEtMS0x_02fa5db1-58da-4443-a5e7-d84f6f3d486a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0zLTEtMS0xMjAz_53a11123-6709-4ae8-ac4b-f55b67741c8a">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0zLTEtMS0x_c898526a-2d9c-43a7-96ad-ca081b10d078">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC03LTEtMS0xMjEy_8a38a31b-118a-4a04-bc8e-eaeb0ed41fec">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0xLTEtMS0x_1b97a643-db03-4c9c-9337-e47bdeb3ecb8">1,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0zLTEtMS0xMjAz_28a93db9-e37e-482f-bec7-604c6b65dd88">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0zLTEtMS0x_42b67ee0-1ecd-48bd-8980-a6eb027427d8">3,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS03LTEtMS0xMjEy_40d36e0c-c450-49ad-b599-ac1b46dcdd59">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">`</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:34.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0xLTEtMS0x_22cd2a37-dd4d-4ccd-b230-f38c431dcb4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930" decimals="-3" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0zLTEtMS0xMjI0_c0322def-787c-4ae8-abaf-28fae7141a6c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930" decimals="-3" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0zLTEtMS0x_61f82452-0293-42ce-a0a9-5a9cb11a0fc1">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930" decimals="-3" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi01LTEtMS0x_3fcfcabe-7af9-4a6c-98d7-e19de719773b">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0xLTEtMS0x_54c8923d-274b-4229-b907-50ddee83d132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0zLTEtMS0xMjI0_6dbfcc1b-bb28-486b-a2eb-60d62e8b5131">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0zLTEtMS0x_8fa42e1e-241c-44ec-adaa-ba9edeaa53de">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy01LTEtMS0x_c8367151-0e04-4497-aa9c-35513acc6199">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0xLTEtMS0x_3a13bcf2-026a-4eda-850c-74436bd299af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0zLTEtMS0xMjI0_e86f9035-43d0-4fcc-b758-bfc8d1b3aada">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0zLTEtMS0x_7cc40045-faef-49c4-805e-9da833f6a09c">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC01LTEtMS0x_dbdcd6c0-fe30-4940-b4e5-072b0f3455a8">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0xLTEtMS0x_d57a0a12-ef98-4b01-a01f-79fbf6b99ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0zLTEtMS0xMjI0_e4ca9039-2ccc-4661-8e08-ac0fe05b6c2d">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0zLTEtMS0x_e39f73b9-9a34-4d44-985f-5e3e782f7136">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS01LTEtMS0x_14dca226-a69e-4321-b9f9-bcc46ab39cc6">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ia6d518c746ad441aa63b4b51e17e0ffc" continuedAt="i1bb80a7242824bb08293093f9f7e4c94"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MDg_a63ff06c-feee-48dd-bf1a-780edb75de28" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of principal payments due on the Term Loan, by year, from September&#160;30, 2021 through maturity are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMS0xLTEtMS0x_946d3cf3-a8b7-40d6-895f-923583612dc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMi0xLTEtMS0x_8587eccb-e5b0-434c-b7a0-7842b3b12467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMy0xLTEtMS0x_5843efd0-972b-485f-a35b-e8965c774b82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNC0xLTEtMS0x_78428814-e78e-4c5c-8963-9d82cf46f391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNS0xLTEtMS0x_a658fb3b-e794-4016-b89c-a07ba5846fb6">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:LongTermDebtMaturityAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNi0xLTEtMS0x_49578fec-1294-4ce1-96d6-ca381341e476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNy0xLTEtMS0x_cb2e6ce1-974c-4463-b75e-a997608f6a17">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1bb80a7242824bb08293093f9f7e4c94">As of September&#160;30, 2021, the fair value of the Term Loan was determined to be $<ix:nonFraction unitRef="usd" contextRef="i191554e1c310493ca0b9f26eefe399a4_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNzUzMw_76e122da-b2c2-48df-9962-a4218d75d8b2">51.3</ix:nonFraction>&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. The remaining cash flows associated with the Term Loan were discounted to September&#160;30, 2021 using this discount rate</ix:continuation> to determine fair value.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_61"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.   <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwMA_5da4c347-f24e-4151-9f43-be7c17661a75" continuedAt="i6389b157831540e38f8a87a5a111c6eb" escape="true">Net Loss Per Common Share</ix:nonNumeric></span></div><ix:continuation id="i6389b157831540e38f8a87a5a111c6eb" continuedAt="if45edbe971de41ef84347dcbfcfe73b9"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per common share is calculated using two methods: basic and diluted.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#8217;s Series B Convertible Preferred Stock during the period, (ii) periodic amortization of the beneficial conversion feature, and (iii) periodic accretion of the increasing-rate dividend feature.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwMw_abe5a6ca-cf6c-4c3d-be21-9aabc98cb9ea" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and nine months ended September&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi0xLTEtMS0x_458cc4ad-349c-4998-bd06-9b76a396e2b6">2,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi0zLTEtMS0x_c849406d-cfee-46fd-a80a-85d13c235fcd">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi01LTEtMS0x_bc1a1a42-db33-42fc-80e2-7824f086e36b">12,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi03LTEtMS0x_c295b5a9-b9c3-4a9c-80cb-23874ac1460a">32,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net loss available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC0xLTEtMS0x_f2fcc5bf-dfac-4c46-bb51-d09f68c08835">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC0zLTEtMS0x_f475adcb-d585-47d2-854d-26f9a5880578">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC01LTEtMS0x_52fe8018-7dde-4ea9-bdd9-aa72cb673847">3,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC03LTEtMS0x_3a3d0964-ced1-4618-be1b-590ff2162f3e">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of beneficial conversion feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS0xLTEtMS0x_7eb8020e-aa66-4821-96c0-8b18a7d23aa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS0zLTEtMS0x_017c6415-5806-4191-9978-402ed131dc4f">31,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS01LTEtMS0x_2f799e87-da19-40ff-81bc-0c0b6eed7c03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS03LTEtMS0x_f8143ab1-6895-49a0-aa56-9e217f9c9718">31,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi0xLTEtMS0x_c2018194-c46d-4299-8bbe-784a67d7778f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi0zLTEtMS0x_bc6b8635-e28f-4166-afcb-058efbf5be5e">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi01LTEtMS0x_6ab20f1a-ada7-4b48-901e-be83e685e801">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi03LTEtMS0x_9b70ecf3-4938-43b4-80eb-bb19cab38f1a">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy0xLTEtMS0x_ab29448d-9dad-490b-864c-1baef9206878">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy0zLTEtMS0x_7d955775-3177-4108-915c-bbd054d881d0">32,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy01LTEtMS0x_a2c3fe16-c77e-48b4-be4f-5d4c8444ccdc">4,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy03LTEtMS0x_fc5b27d3-3c2a-4b5d-9697-9a5a35483044">32,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC0xLTEtMS0x_324ae521-f241-45b9-8e56-ce6bfd23b73d">3,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC0zLTEtMS0x_f739b91d-d7cf-47a9-95b9-7ecf77ff89e6">51,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC01LTEtMS0x_6aa708a3-97f8-44da-a25e-f12eb8d9a032">17,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC03LTEtMS0x_c8344bfb-6785-44dc-8e2b-379803ba3037">65,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS0xLTEtMS0x_54fde61d-a944-454d-a18e-9127a4b20b06">110,717,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS0zLTEtMS0x_c99b9c57-4803-4f7c-84cb-933ffd4884da">108,493,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS01LTEtMS0x_7284e7ce-2ddb-4800-9b9b-dab08a47daa3">110,136,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS03LTEtMS0x_4bde1d0c-3d6c-4828-a13b-c51c534472ae">108,222,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtMS0xLTEtMQ_63e65c29-996b-4c0a-95a0-ce455f8a226d">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtMy0xLTEtMQ_cdfb0189-eb63-4312-aa9a-b614fdb2e333">0.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtNS0xLTEtMQ_e25da0af-af61-40d5-b436-cfc019a04540">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtNy0xLTEtMQ_fcc4bd4d-c1a1-4da8-ab96-3567d3debbcb">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#8217;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back periodic accrued or deemed dividends on the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="if45edbe971de41ef84347dcbfcfe73b9"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s Series B Convertible Preferred Stock, and assumes conversion as of the later of the beginning of the period and the original transaction date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive or does not reduce net loss per common share, the effect is excluded from the calculation.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwNQ_5e078cb0-0f1b-4ce6-a923-112951b52030" escape="true"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi0xLTEtMS0x_598a7fae-f469-4733-aaaf-9f05cde9361e">3,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi0zLTEtMS0x_f739b91d-d7cf-47a9-95b9-7ecf77ff89e6">51,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi01LTEtMS0x_6aa708a3-97f8-44da-a25e-f12eb8d9a032">17,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi03LTEtMS0x_c8344bfb-6785-44dc-8e2b-379803ba3037">65,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy0xLTEtMS0x_402b5960-d51e-48d0-adb8-c9d371ca24b8">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy0zLTEtMS0x_7d955775-3177-4108-915c-bbd054d881d0">32,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy01LTEtMS0x_a2c3fe16-c77e-48b4-be4f-5d4c8444ccdc">4,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy03LTEtMS0x_fc5b27d3-3c2a-4b5d-9697-9a5a35483044">32,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC0xLTEtMS0x_846422e1-4e76-454f-a5fb-4e5772d6691e">3,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC0zLTEtMS0x_0ec1a2c3-6bbf-456a-963b-656f994f414d">51,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC01LTEtMS0x_670aa2f0-1e91-4d9b-8df8-fbb63996d290">17,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC03LTEtMS0x_b3074cff-d363-4222-9834-5ba02fdbbbb7">65,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS0xLTEtMS0x_0ac4f409-745b-4d24-bee8-fd6815c54a19">110,717,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS0zLTEtMS0x_d6aa7397-810e-47a6-85d5-783cd83bc5a9">108,493,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS01LTEtMS0x_8bf5b030-2264-4944-ba0b-6bd2110fca80">110,136,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS03LTEtMS0x_6546e8af-c639-4982-9da4-da19c0371f18">108,222,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi0xLTEtMS0x_c2bf84f4-4578-404e-8c20-9e5d93f65022">30,658,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi0zLTEtMS0x_b17a7ecb-d877-463a-8b0f-6aca0a0d4718">28,625,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi01LTEtMS0x_97208fe1-57bb-4beb-9425-12ae061487f5">30,185,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi03LTEtMS0x_1e50b4b8-752d-4d96-9a94-bf50c8234405">11,032,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy0xLTEtMS0x_fcb0d94f-9f7f-4b72-a5db-3ac09d58375e">110,717,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy0zLTEtMS0x_c37ff979-8ac0-4206-9406-19cc21fa70b7">108,493,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy01LTEtMS0x_056a6dab-b5e2-40f1-8692-0311ebf4b180">110,136,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy03LTEtMS0x_e58aac32-c1bd-49ff-ba87-685c48ed0c49">108,222,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC0xLTEtMS0x_55d64409-e017-4036-971b-fbc4282c4885">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC0zLTEtMS0x_c93dd1ee-1f43-4a65-914a-1bcd3175f496">0.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC01LTEtMS0x_4d75a471-23b6-451a-a6f0-8280bdeed81a">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC03LTEtMS0x_c8c02d08-59e1-4188-b2f1-e3ad35c396d5">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjc0ODc3OTA3MjI5NQ_43f20a5f-8781-4d4a-abfe-272730ce1465" continuedAt="i68c53055225b47c8a8bb653da0ee4596" escape="true">The effect of each of these adjustments on the calculation is presented in the table below:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><ix:continuation id="i68c53055225b47c8a8bb653da0ee4596"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i998a9400eb034fb8896247cfa7d4ce64_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi0xLTEtMS0x_91771997-39d7-48c2-8aa3-681842e2852c">27,027,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8779dbf56be4207a62a288eb16426e3_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi0zLTEtMS0x_9b601593-939c-40ab-b8e2-0e972e351959">25,691,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5055a550b7f1489bb057050d4eb2e15f_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi01LTEtMS0x_87f8fbd8-f500-4664-9a1c-02d8b6ad8bc7">26,497,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56ff8a9cfc574e8a813ba41191a77909_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi03LTEtMS0x_dc33f017-727a-4cd4-9537-c90d096732a1">8,626,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3497639dc824203ac3bbc45e1fa7045_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy0xLTEtMS0x_72ed4d31-07bc-44ae-b5b8-a4af95ac2bc1">974,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia97c4e39fb2044fd832ec14992093a99_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy0zLTEtMS0x_99b07f68-7a1f-49c9-9a3d-64de9f7a0ba4">1,203,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddb8825862eb44cba52a62ed12d533bd_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy01LTEtMS0x_2fa1c016-2498-4b3e-ba3b-ce5e518d82d8">1,287,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaaf86c04cf564e56bba2a505c07e5a27_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy03LTEtMS0x_445e6499-4e33-40bc-8690-538c693b8f86">1,281,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f9bbe152df94574a97c8077e072c43d_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC0xLTEtMS0x_0e922265-7152-49ee-807e-a2719a9658be">1,840,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id23dbe32c67d4052a1bcc960f0ea1014_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC0zLTEtMS0x_2de3d220-5ee8-468f-ae5f-11d032e1c8d8">919,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic394f69ff36c4356957ce104b3c4e050_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC01LTEtMS0x_2751466c-4c6c-4c52-a8d0-079142baffb3">1,500,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib09f7d9159dc45a9b65feac3fa5d73f3_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC03LTEtMS0x_3d7a0be2-bc54-48c5-a8db-0820d5c258fc">359,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8570345d30404e7e9f7c73adbeac5a5b_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS0xLTEtMS0x_6e0d0f8e-b6a2-43db-b20b-d4b6c8ec6e78">805,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia49639519ac8451195b5024845ee2aef_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS0zLTEtMS0x_17e08992-618f-4fef-ae3d-1c66d87bd261">772,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica04d8b2902b463ab11876407debfe02_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS01LTEtMS0x_5144fed1-862f-4033-9b9d-cdad25dd7766">875,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib63433c4d26449ff840c826632e10ccc_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS03LTEtMS0x_fcdd843c-b173-4a57-b4b0-41b4a5d8517e">739,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3be316f6fd1b49e092d2a34cdc59474c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi0xLTEtMS0x_6a17ecca-6a01-4e45-8de7-9049a110830b">10,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd009bf4fb074bf09897315c7972b8d7_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi0zLTEtMS0x_b15aad7e-0cd8-49c3-bbdf-bb7689ab0dde">37,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iccc39a1be477444ca4a3b6da11859aaa_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi01LTEtMS0x_a8999126-a522-4cea-b4a5-70e1eef1a834">24,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ef80048c2e14b599e756caca946ccb2_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi03LTEtMS0x_af43f6a6-07a0-47db-a5a4-527ba54549f4">25,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy0xLTEtMS0x_c2bf84f4-4578-404e-8c20-9e5d93f65022">30,658,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy0zLTEtMS0x_b17a7ecb-d877-463a-8b0f-6aca0a0d4718">28,625,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy01LTEtMS0x_6a0b4cc6-552c-44ca-9387-5c63d4038281">30,185,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy03LTEtMS0x_1e50b4b8-752d-4d96-9a94-bf50c8234405">11,032,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_64"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3MQ_36effd3c-5b59-4ac7-accd-a7451ac64dc2" continuedAt="ia46d3b4e69ed4df0b6ece03fcfaf99be" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="ia46d3b4e69ed4df0b6ece03fcfaf99be" continuedAt="ie4b84c6024e746e9b00010964f431392"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Convertible Preferred Stock of the Company (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) paid a <ix:nonFraction unitRef="number" contextRef="i213f3703bf564f66b0f66915beb0fe28_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNzE0_d3cd1e30-1e1d-403f-a57e-4e8bd8138c19">4.0</ix:nonFraction>% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a <ix:nonFraction unitRef="number" contextRef="ifd8876d452174d08a691695fdc40ebc8_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfODIz_7e3797f2-f6f4-4561-b721-8a749ed66123">6.0</ix:nonFraction>% cumulative dividend per annum thereafter. Dividends, if declared, are paid in cash at the end of each quarter based on dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into the Company&#8217;s common stock at any time at the option of the Holder at a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTU1NA_332efc4d-a936-4373-ace8-60d86008cc82">3.85</ix:nonFraction> per common share, or <ix:nonFraction unitRef="number" contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702" decimals="INF" name="mdxg:TemporaryEquityConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNzE0NjgyNTU4ODYxNg_14681477-9cfa-4e9c-b95c-19343ad3be0e">259.74</ix:nonFraction> common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date (July 2, 2023 for the <ix:nonFraction unitRef="shares" contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjc0ODc3OTA3NzUyNg_275c56ae-200f-4b51-bc89-addb5781b943">100,000</ix:nonFraction> shares currently outstanding), provided that the common stock has traded at <ix:nonFraction unitRef="number" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTkxMQ_913f1a80-b807-4cb6-87a1-d27ea083b9bd">200</ix:nonFraction>% or more of the conversion price for <ix:nonFraction unitRef="day" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTk1MA_c98e779e-2a1a-4dde-85d5-f021e3499fea">20</ix:nonFraction> out of the preceding <ix:nonFraction unitRef="day" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTk2MA_7654cba5-2f6b-4abb-a17b-2bd45066abbf">30</ix:nonFraction> consecutive trading days and on the trading date immediately prior to the date of conversion, the common stock traded at <ix:nonFraction unitRef="number" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjA1MA_d2bb5ec1-bcb0-47c1-ae32-d6f4148ed49a">200</ix:nonFraction>% or more of the conversion price.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect <ix:nonFraction unitRef="director" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjE3OA_d447295f-f642-4bd9-9ed1-df29c05fa1ba">two</ix:nonFraction> members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#8217;s shareholders on an as-converted basis as a single class with the common stock not to exceed <ix:nonFraction unitRef="number" contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjQxNg_6bd4366c-a8d5-45da-a2c8-4f36e933344c">19.9</ix:nonFraction>% of the total voting stock of the Company. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ie4b84c6024e746e9b00010964f431392" continuedAt="ie76e86cd40684b0d8c2e90019670f82d"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $<ix:nonFraction unitRef="usd" contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702" decimals="-5" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityIncreasingrateDividendFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzI0NA_3dbcfac7-e128-43c7-a104-f5afe946ae7a">1.8</ix:nonFraction> million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and nine months ended September&#160;30, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzQ3Mg_4c706f24-1c20-4716-92ce-a38c940909c9">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzQ3OQ_4ce5be1f-6f09-40e8-af70-8125ca6428e8">0.9</ix:nonFraction> million of deemed dividends related to the amortization of the increasing rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends, into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#8217;s control, the Series B Preferred Stock is classified as temporary equity.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3Mw_b3804922-102d-4c0b-aeb4-10688c402151" continuedAt="i4250bba2c3c843e5b40dea9999305612" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"></td><td style="width:42.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d492b0b584d4f269f2f61823174b39e_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMi0xLTEtMS0x_6cb6f98f-cc7f-491e-bd39-6f1c00ac09f4">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d492b0b584d4f269f2f61823174b39e_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMi0zLTEtMS0x_3862de77-3639-448b-94b1-e64fa046c2fc">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMy0zLTEtMS0x_0653d1be-a4bd-404e-ac0c-fff11f65cee7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfNC0xLTEtMS0x_94dd26dd-e830-4495-9315-11be26e1eda7">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfNC0zLTEtMS0x_a9ce1e1e-e73d-4b8f-8e8d-49e4948b0c49">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"></td><td style="width:42.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if09204510e324170b6c22bff3068c0ac_I20200630" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMi0xLTEtMS00NDU_5039a1b9-de31-426d-a62a-b30c0eb8fe2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09204510e324170b6c22bff3068c0ac_I20200630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMi0zLTEtMS00NDU_6d0f5366-5670-4c07-8bd5-12a69c41023d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0xLTEtMS01Njc_746cbe91-a75d-404e-a552-77b5f76d0e0f">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0zLTEtMS01NzE_23a445be-3f24-48ce-aad6-1d0a0ced11fe">59,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0zLTEtMS00NDU_7fe569f3-8844-4493-85d5-ca053c9b48c2">31,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfNS0xLTEtMS0xMjc2_7cc59056-c207-44e5-8398-ada3c2deceef">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfNS0zLTEtMS0xMjc2_c342fb2d-9b66-4921-9437-e14afd8275af">91,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"></td><td style="width:42.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie143cb1da9a04290be81c5d71f845995_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMi0xLTEtMS0x_8364687b-cdeb-4113-890c-1f863768d451">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie143cb1da9a04290be81c5d71f845995_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMi0zLTEtMS0x_efda7d98-75ba-46ae-b968-3dcac576296d">91,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMy0zLTEtMS0x_623b9b84-132a-4f33-9bfb-869fca16869f">926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfNC0xLTEtMS0x_f60a32fd-10ea-4a66-9bc3-0357e8975c55">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfNC0zLTEtMS0x_54347366-0846-4dc2-b1b5-d48117c51d34">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ie76e86cd40684b0d8c2e90019670f82d" continuedAt="ice645533b6aa46518abe38917b18ae6a"><ix:continuation id="i4250bba2c3c843e5b40dea9999305612"><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"><tr><td style="width:1.0%"></td><td style="width:48.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.529%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40a77cb321114af080584b94815e9ebe_I20191231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMi0xLTEtMS01MzA_6ac32584-0eb1-4818-b209-c326fca65e95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a77cb321114af080584b94815e9ebe_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMi0zLTEtMS01MzU_578d19d3-5787-4ee4-95c0-f8f97d838d29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMy0xLTEtMS01NDY_e41a50a7-7bbc-4b18-9548-5d823e1ef186">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMy0zLTEtMS01NTA_4b9632e5-0ec2-4e49-8514-a8e168d19db2">59,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNC0zLTEtMS01NTg_763ec5ba-582f-4fa4-b089-cea6e77e4a36">31,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNS0xLTEtMS0xMzQ4_3c105bde-79a6-4ed7-a8a2-02ce8da0fc1e">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNS0zLTEtMS0xMzQ4_fccec487-d55b-4f0f-9234-caa3faba9df9">91,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends accumulated but not paid as of September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTAzMA_d5b35e22-4763-48fa-b064-6f198164fcf5">5.6</ix:nonFraction> million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of September&#160;30, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on accumulated dividends as of September&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of <ix:nonFraction unitRef="shares" contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquitySharesIssueduponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTI5Nw_6e8d9675-f409-4fe4-8623-dee1747176c3">27,435,993</ix:nonFraction> shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued several classes of restricted stock awards to employees: restricted stock (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), restricted stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and performance stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The following is summary information for restricted stock awards for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTY0OQ_ac7b2ad3-1b4b-4d27-b619-c3f12112730e">28.2</ix:nonFraction>&#160;million of unrecognized share-based compensation expense related to restricted stock awards. This expense is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTgxMw_f931b329-2795-4f4e-8b9a-e72c901374fe">2.21</ix:nonNumeric> years, which approximates the remaining vesting period of these grants.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI2OQ_989133b7-45bd-412f-9516-0cd0676a6d78" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through September&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of September&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:31.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.291%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi0xLTEtMS0x_ebd945f2-0d91-4441-92dd-2aacb3954973">2,175,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi0yLTEtMS0x_19769a59-1684-4554-98b2-759b1289f162">4.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2098fc34c48c488e9b8469ff9bb0d624_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi00LTEtMS0x_20012ef9-c658-4f78-b077-c9a99af24fa0">2,325,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2098fc34c48c488e9b8469ff9bb0d624_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi01LTEtMS0x_62dd74bc-0004-4c82-ada0-c7148cef2111">5.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61dd953b6b594540bad6517310eaba17_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi03LTEtMS0x_4659f429-990a-49c2-b17a-c67faefb4881">35,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61dd953b6b594540bad6517310eaba17_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi04LTEtMS0x_03f9bc19-e67a-41a5-8778-436eff9a63d7">7.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy0xLTEtMS0x_f269b951-128f-4096-8ebc-073a07a373c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy0yLTEtMS0x_ffad5f43-19aa-447b-9efc-b1d9c087fc1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy00LTEtMS0x_f7cefe1f-2366-48ac-b2e4-a86cdf32a873">2,991,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy01LTEtMS0x_2de08f0c-672f-4e7e-959c-f960c4db2bea">10.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy03LTEtMS0x_a77fa648-55c7-4a66-8210-339e7c789911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy04LTEtMS0x_1f61810e-aa52-426c-bfbf-55f8b6a43147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC0xLTEtMS0x_8b34aded-d65a-4b57-a70b-3180e1bab3d3">975,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC0yLTEtMS0x_cf235a7b-e19c-4ef5-9d64-e0f5d43513e5">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC00LTEtMS0x_234e70ae-784a-4d0a-a823-5725f92b94d6">775,193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC01LTEtMS0x_724123e1-e0b0-459e-8213-e0ebb724bfd8">5.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC03LTEtMS0x_f6136b71-b4c5-4f56-9da6-15a49037bcba">35,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC04LTEtMS0x_27a9c827-349a-40fa-bc40-9e5863599bb5">7.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS0xLTEtMS0x_769c6cac-0b66-4745-9cac-e69527b83377">66,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS0yLTEtMS0x_a8d04b10-85c7-43d2-957f-61947e20a90a">3.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS00LTEtMS0x_c00666d5-1efa-4731-9572-7cbc4bf3e31e">252,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS01LTEtMS0x_25e751a8-5c0a-4607-8354-51e4cac7f722">8.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS03LTEtMS0x_050e1d6c-f797-4040-bd50-002ff5621d74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS04LTEtMS0x_87d8c6da-7d71-4897-8d23-34a653ed41b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8fcc6d51244882af073962e13c8159_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi0xLTEtMS0x_6e1ef917-3f53-41e1-95fc-2e3e7f595c59">1,134,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d8fcc6d51244882af073962e13c8159_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi0yLTEtMS0x_385a6c36-362c-4391-b6d9-c98c4f01984b">4.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie510c5f07feb4b34b1780b367608d0b9_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi00LTEtMS0x_dd8ea1a9-6619-45cd-80ed-78bc5fb981e2">4,288,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie510c5f07feb4b34b1780b367608d0b9_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi01LTEtMS0x_669f196c-09e9-4644-8ec8-682a79fbf535">8.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9419a5870764efc954e2ea7f11c85ad_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi03LTEtMS0x_d9a51d8d-77bd-4278-acd9-502712e6f776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9419a5870764efc954e2ea7f11c85ad_I20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi04LTEtMS0x_f6128f08-57cf-4d23-bb88-f1966c901e62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3MA_68ba0cab-5209-4bda-93a5-ae6a46ec6be8" continuedAt="i145a7d6c07df423e8052a31529431aca" escape="true">A summary of stock option activity for the nine months ended September 30, 2021 is presented below:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><ix:continuation id="ice645533b6aa46518abe38917b18ae6a"><ix:continuation id="i145a7d6c07df423e8052a31529431aca"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:48.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMS0xLTEtMS0x_7acb1336-ce24-47b6-8f46-f96f604cb707">2,025,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMS0zLTEtMS0x_5f95f5ca-59d3-4ecb-9164-70eeff9fd35e">4.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMi0xLTEtMS0x_3a9c108f-528f-429c-b053-0eaf1b0163ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMi0zLTEtMS0x_5edd79b1-e8f4-4c09-b447-2b1495fc2a0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMy0xLTEtMS0x_89e7e2e9-f016-4844-a4bb-a7e72e3e4a30">524,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMy0zLTEtMS0x_6c1187ac-1cfe-4a61-8f3d-93b5fe7ee440">3.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNC0xLTEtMS0x_26fb7852-841e-4c13-bff6-91cb8015ecf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNC0zLTEtMS0x_ad057bd1-3ed5-476a-bb56-a634da937170">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNS0xLTEtMS0x_8d45b4b2-3142-487f-b924-8cd5752b1f07">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNS0zLTEtMS0x_a52d7e6e-199a-40b4-ac36-bed10f04df15">1.23</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi0xLTEtMS0x_d1348d2c-f5b1-4c5e-984b-a0a45dea0762">1,451,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi0zLTEtMS0x_c9452272-bf39-43a9-8e9f-e50be5c1331c">5.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi01LTEtMS0x_c9727a32-ca1a-4ce9-ab28-d7947c29c6da">1.77</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi03LTEtMS0x_33247ac5-1732-4ace-8627-e3c412b62db8">1,982,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy0xLTEtMS0x_32089a8c-e1c1-45f6-9c67-2ec010592516">1,451,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy0zLTEtMS0x_a3767348-a469-4b6f-a3f2-54d2c5bb9b6d">5.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy01LTEtMS0x_acbd4118-56c9-4287-9b64-560be3d7b7b5">1.77</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy03LTEtMS0x_4c4204a4-03f4-402e-9d89-f77fda03a90f">1,982,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_67"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.  <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNzg4_eb7a5081-3d0b-4bc5-9556-d9b63d43df1c" continuedAt="iae9bae7bd2454ad38466e82a9c06de64" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="iae9bae7bd2454ad38466e82a9c06de64"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (<ix:nonFraction unitRef="number" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNjg_e9707e7d-7cf7-43b6-96a5-848308568264">14.8</ix:nonFraction>)% and (<ix:nonFraction unitRef="number" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNzU_3c1696ec-70e5-4869-b030-a542b42bd461">0.2</ix:nonFraction>)% for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (<ix:nonFraction unitRef="number" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMTc2_47616790-690a-4c81-ae90-bdbdb9ef8855">2.9</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMTgz_2052cb37-7836-4a5f-8b69-e66c3427327f">25.6</ix:nonFraction>%, for the nine months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $<ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="INF" name="mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMjg5_f0d3f05c-1536-4d01-a232-9f932eab2c0a">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMjk2_5db30b36-a36e-4c41-83c2-3d9629605558">11.4</ix:nonFraction> million for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. The discrete items recorded for the nine months ended September&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $<ix:nonFraction unitRef="usd" contextRef="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNTU5_43828414-d9f0-45fa-b837-97868eebfdf7"><ix:nonFraction unitRef="usd" contextRef="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNTU5_5102f87e-7a67-41a8-9a8c-6189f26568be">11.3</ix:nonFraction></ix:nonFraction> million and an income tax benefit of the same amount.  <ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNjYz_ebc88c47-e79d-41fc-8b8c-b4de43c7a12a">No</ix:nonFraction> benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.</span></div></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_70"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RleHRyZWdpb246MWVlYjA3MDRhNmI0NDI2MThmMmE0MDk1NDNjYmNjMDVfMTk4_f6d4aaab-f919-40e9-95a6-d680a24be908" continuedAt="i3e331e30368d4be887b487be291d7447" escape="true">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i3e331e30368d4be887b487be291d7447"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RleHRyZWdpb246MWVlYjA3MDRhNmI0NDI2MThmMmE0MDk1NDNjYmNjMDVfMjAw_7d0a4670-0cf5-416e-92b0-96a92b851475" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:59.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMi0xLTEtMS0x_e221aa2e-f0b9-41b8-9de2-9db792b189a6">3,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMi0zLTEtMS0x_5a1ac8c4-4332-488f-9652-2d41cbd87492">6,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMy0xLTEtMS0x_3ee997c6-4e54-4db7-b3e0-eb2d62e93b8f">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMy0zLTEtMS0x_c584a49a-43d2-48a7-8400-357e786dce37">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:LeaseRightOfUseAssetAndLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNS0xLTEtMS0x_9cc7fe79-6a5a-49c3-aa53-e4b5ffb6bb08">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="mdxg:LeaseRightOfUseAssetAndLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNS0zLTEtMS0x_66b621e1-3e74-4e89-ad91-c3f00c0b9d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:NotesReceivableForSaleOfPropertyAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNi0xLTEtMS0x_e4982dcf-55f9-4ec4-abae-59a9252ff081">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="mdxg:NotesReceivableForSaleOfPropertyAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNi0zLTEtMS0x_8b205bc8-c6d0-45e4-b035-1334a8ca6012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNy0xLTEtMS0x_9df7a5c7-b92f-40bc-b566-83370b4c3fbd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNy0zLTEtMS0x_0e9731b4-6f5f-43fe-9580-39a3ae30e517">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOC0xLTEtMS0x_9a26f5a5-d6d3-46f5-8250-410bbdb08bc6">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOC0zLTEtMS0x_e9c56a5b-5b8a-40d3-818a-226a965d2485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" name="mdxg:TemporaryEquityDeemedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOS0xLTEtMS0x_2df6eced-2b5a-44d2-9689-02bbf731b329">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="mdxg:TemporaryEquityDeemedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOS0zLTEtMS0x_858bdc98-f0a2-44ec-ad9e-a96c12d970ef">31,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:NoncashActivitiesDeferredFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTAtMS0xLTEtMQ_c737e635-3b9f-4f87-9a15-73791efb294e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:NoncashActivitiesDeferredFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTAtMy0xLTEtMQ_52199527-b153-4abd-91ff-8918fa8ecd70">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:StockIssuanceCostsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMS0xLTEtMTM2MA_286b4f02-ea52-4524-a838-d73b498a483e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:StockIssuanceCostsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMy0xLTEtMTM2MA_48ca7b3a-e767-4465-8678-8567630da40d">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="mdxg:NoncashActivitiesDebtInstrumentAmendmentFee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMS0xLTEtMQ_dbc05210-ab7c-4343-b4bc-35a898502aab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" name="mdxg:NoncashActivitiesDebtInstrumentAmendmentFee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMy0xLTEtMQ_11d55d22-11ad-4ac0-879a-6478597492e7">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_73"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        13.  <ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMTMxMzY_f48c4591-47d8-4f70-941d-5d0529cb72fd" continuedAt="idd41174b78f34ba5bcc6c89860959ce9" escape="true">Contractual Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="idd41174b78f34ba5bcc6c89860959ce9" continuedAt="i150098804f6e434fbbb26cba7ca0ffc5"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#8217;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i150098804f6e434fbbb26cba7ca0ffc5" continuedAt="ifa7e7533bac04cbc89921af37cd2cec5"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reasonably estimated. The Company's unaudited condensed consolidated financial statements as of September&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#8217;s legal proceedings, refer to Note 14, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company has accrued $<ix:nonFraction unitRef="usd" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMTc0MA_de924f5e-fa35-450c-813a-068bb5cd07d7">4.0</ix:nonFraction> million related to the legal proceedings. The Company paid, either directly or through its insurance providers, $<ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMjA0Ng_eea0ce57-f9a3-4b0b-bc47-7827b7cb195e">7.7</ix:nonFraction> million toward the resolution of legal matters involving the Company during the nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company received funds from certain director and officer insurance policies for previously-incurred, covered legal expenses. These funds were recognized as a reduction to investigation, restatement, and related expense during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain litigation and regulatory matters:</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating <ix:nonFraction unitRef="securityclassaction" contextRef="i29f9998bd9f949179feb6e677def3f2d_D20190116-20190116" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:ContingencyLossNumberOfSecuritiesClassActions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMjc1OQ_3ccfb905-e8b4-4e21-88f8-f44d0f87c8a4">two</ix:nonFraction> purported securities class actions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MacPhee v. MiMedx Group, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 23, 2018 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Kline v. MiMedx Group, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">CPFI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#8220;Pete&#8221; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp; Holland LLP. The amended complaint (the &#8220;Securities Class Action Complaint&#8221;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#8217; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#8217;s motions and the hearing on the same was held on September 24, 2021. The Court has not yet ruled on the motions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Investigations</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Defense Office of Inspector General Investigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#8217;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#8217;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#8217;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ifa7e7533bac04cbc89921af37cd2cec5"><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Former Employee Litigation and Related Matters</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MiMedx Group, Inc. v. Petit, et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against its former CEO, Parker H. &#8220;Pete&#8221; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#8217;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#8217;s legal expenses. The Company opposed Petit and Taylor&#8217;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation was held on August 11, 2021. Negotiations are ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defamation Claims</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2018, Sparrow Fund Management, LP (&#8220;Sparrow&#8221;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#8217; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#8217;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#8217;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#8217;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#8217;s business, results of operations, financial position or liquidity.</span></div></ix:continuation><div id="ic7c5801de75c41fe8d1189f73f0aadaa_76"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMTM3MA_aa751810-5be0-4163-b3ef-a9a841081084" continuedAt="i4707843536c84793b822f0202f4cde0d" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="i4707843536c84793b822f0202f4cde0d" continuedAt="ia6c51505bff746c7bc0367307154df88"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Product</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has <ix:nonFraction unitRef="product" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:NumberOfProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfNzE_be3a3e9b-8726-400d-81dd-10951be72a6f">two</ix:nonFraction> primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its tissue and cord sheet allograft products, and (2) Section 351 products, consisting of the Company&#8217;s micronized and particulate products, which, prior to the end of Enforcement Discretion were used to treat a variety of patient needs, including both advanced wound care and musculoskeletal applications. Advanced Wound Care is further disaggregated between the Company&#8217;s Tissue/Other and Cord products.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ia6c51505bff746c7bc0367307154df88"><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMTM3Mg_0754409c-2668-4917-b63d-c604171744b8" continuedAt="ic3e4bdfab4b144228293ec0ff95b2e8d" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:29.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a36de01b5ac4820a5ecf7930998772a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy0xLTEtMS0x_beaeba64-2e42-4731-ba12-80b0524ced39">56,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa362db08bef44ea8f60684d8de52387_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy0zLTEtMS0x_485ec92a-39d4-4f4e-8ff2-c4f68506dce3">50,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bdb86d833e4c83b10c73d297c90071_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy01LTEtMS0x_ff857cc4-a756-416d-b7d4-28ba0edb1389">156,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa490c58d174fbe8347c43a9c6d5e5d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy03LTEtMS0x_9814ebf6-9382-49cf-a531-28929f6d4a36">137,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC0xLTEtMS0x_890e4a3f-cde9-4780-97f4-7d2cbdb3037c">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC0zLTEtMS0x_8145da4e-a7cd-4a7d-b8e2-bda0f4e1d6fb">4,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC01LTEtMS0x_9c498096-b75c-478c-9e3c-1ca094a049cb">17,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC03LTEtMS0x_242347c2-d31a-4716-be4f-ec5962386c4c">11,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8eea8c11844b23b19eb0cf0ab5959d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS0xLTEtMS0x_3be66ee5-5476-4e97-808e-c4d72361ea5b">62,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5946e34fb34c6da5e38e11bc904353_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS0zLTEtMS0x_2f9f1188-e80d-49ad-8737-6e0e54464aa6">55,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5c8d9d9bd542fdb5a8db00cdeb2c77_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS01LTEtMS0x_8824fa1d-bc7e-4670-935a-cbf311ea3cb8">173,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bb0ad1ba5b453e958dbe52d1fff145_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS03LTEtMS0x_56cd2587-2cce-475d-b4cd-8877009bab03">149,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi0xLTEtMS0x_3861ce41-d171-4144-bc4f-6a978fe2168d">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi0zLTEtMS0x_925099e1-f2c8-4fb2-ae86-33b5ea724b27">8,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi01LTEtMS0x_dfeb5198-234b-4f3f-846b-8e802f64d53e">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi03LTEtMS0x_2b34395a-cc10-446e-be82-2e1513862461">23,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dc4a45b59b47f188c9741959321706_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy0xLTEtMS0x_99978a48-d423-4ae4-8e81-66483b8edb51">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1522b620767440f3ae5389424e04dfed_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy0zLTEtMS0x_70905546-9573-40ed-8bfc-bb7edb098236">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a8fb5e74c64fb59d625e7756ec9015_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy01LTEtMS0x_bd75ec81-b853-4c86-a2f0-2c84689838c8">914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied33a9c457d644dabec06946c8d55bcf_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy03LTEtMS0x_beb97324-b105-42de-bda9-06ad67ed5866">7,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC0xLTEtMS0x_0541482e-bc0a-425d-a056-3d3b3034930d">63,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC0zLTEtMS0x_fad6562f-54d5-4e64-836c-b9bb7a00be41">64,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC01LTEtMS0x_36db4078-a85a-454e-9cdc-1edf3917398d">191,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC03LTEtMS0x_80c0fa18-7611-4f94-b042-c0028b4de355">179,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;O</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">ther&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div></ix:nonNumeric><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Customer</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has <ix:nonFraction unitRef="distributionchannel" contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfOTUy_83f17da0-13de-401c-8770-c7813d055b8c">two</ix:nonFraction> primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (2) sales through distributors (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><ix:continuation id="ic3e4bdfab4b144228293ec0ff95b2e8d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"></td><td style="width:24.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16ad22774d414f21aed7e4d4af64444c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi0xLTEtMS0x_2b99aed5-491d-4002-af40-ee62e59031cb">61,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48efc9d3e964bcebaec0d6b42ae86ca_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi0zLTEtMS0x_7b8bb601-f95a-4195-b6c2-e105ccce7377">62,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4560a171d344f38b7d85fe0632ce4bf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi01LTEtMS0x_cd443795-d9ae-4245-8d0b-44330ce6f345">184,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3435571269948bfa711c7227cab69bf_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi03LTEtMS0x_f2819008-26ae-4030-b212-883d3ec852fb">175,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e209b570c4940fcbb3cfbb19e1709f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy0xLTEtMS0x_0c3043d5-da45-4b24-8d1b-08a49ffff5f8">1,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5a0b29488b4f5fb8239054f04a74b5_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy0zLTEtMS0x_4fa39ec0-2f45-4636-9a38-b0ebe0878823">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac3427ddcd4497894f4bc23e3e9f0f1_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy01LTEtMS0x_56f82265-b8f8-4663-a18a-eae57688fd5a">6,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9107cfd22f4e39bf4115b0953ea93f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy03LTEtMS0x_0459a261-d2d0-4686-80c5-324538d15afc">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC0xLTEtMS0x_d81b3e12-1436-4b8a-944d-c8724e02e1a1">63,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC0zLTEtMS0x_5bf4be74-b6d9-4cb6-a663-7d0d9ef8244f">64,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC01LTEtMS0x_ba5f54ec-e534-48e6-b98d-1aa5d30a95f8">191,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC03LTEtMS0x_a48d7042-9f4e-4f75-b137-bff64797076a">179,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or nine months ended September&#160;30, 2021 or 2020.</span></div><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMjc0ODc3OTA3NzgyNg_822d11d3-b8bc-4565-85ba-2108b77e8b91" escape="true"><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collections on the Remaining Contracts</span></div><div style="margin-bottom:9pt;margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMjc0ODc3OTA3MTk2Mg_0ad54152-1f41-421f-8203-1f16e53777bd" escape="true"><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi0xLTEtMS0xMzkx_b3ebec48-69bd-4fe1-bf53-d236660c1de8">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi0zLTEtMS0xNDIw_ec517dfc-d0f8-49ee-84cd-f1c47a599e34">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi01LTEtMS0xNDI4_f3943cc5-6e4a-4637-b714-042bb2ffef20">914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi03LTEtMS0xNDQ4_17f9598f-bed6-4050-91fa-e30352c91fe5">7,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy0xLTEtMS0xMzkx_2b77853f-6bac-4d28-81c1-a299357dbd9f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy0zLTEtMS0xNDIw_954d0891-1286-4441-b89b-2cb0d1a1f1fa">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy01LTEtMS0xNDI4_327f818d-833d-42ea-b8cd-8fb3b97a1c87">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy03LTEtMS0xNDQ4_41ba269e-2ae5-4b96-ae05-8ab0e8fc6bc5">1,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC0xLTEtMS0xMzkx_2e45d181-7ea0-4bcd-bc37-31467db7422f">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC0zLTEtMS0xNDAy_b3a45821-5856-40e8-9e99-57d134ba8e83">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC01LTEtMS0xNDI4_ff9a7251-e009-4784-8eb3-18f1127fb7db">786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC03LTEtMS0xNDQ4_f72f21b1-b27c-4066-8ea6-4b5d3f1db01f">6,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_85"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION&#174; process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of our products are regulated by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx is a leading supplier of human placental allografts, which are human tissues that are derived from one person (the donor) and used to produce therapies to treat another person (the recipient). MiMedx has supplied over two million allografts, through both direct and consignment shipments. Our platform technologies include EPIFIX&#174;, AMNIOFIX&#174;, EPICORD&#174;, and AMNIOCORD&#174;. EPIFIX and AMNIOFIX are tissue allografts derived from the amnion and chorion layers of the human placental membrane. EPICORD and AMNIOCORD are tissue allografts derived from human umbilical cord. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our EPIFIX and EPICORD sheet products are marketed for external use, such as in advanced wound care applications, while our AMNIOFIX and AMNIOCORD sheet products are positioned for use in surgical applications, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMNIOFIX Injectable is a micronized configuration of AMNIOFIX and is not currently marketed in the United States. AMNIOFIX Injectable is a lead product candidate for our late-stage pipeline targeted at achieving FDA approval for specific clinical indications, including degenerative musculoskeletal conditions and advanced wound care applications.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two classes of product historically: (1) Advanced Wound Care products, or Section 361 products, consisting of our tissue and cord sheet allograft products, and (2) Section 351 products, consisting of our micronized and particulate products, which, prior to the end of Enforcement Discretion were used to treat a variety of patient needs, including both advanced wound care and musculoskeletal applications. Our Advanced Wound Care business includes two product categories, Tissue/Other and Cord products. We sell product through two distribution channels: (1) direct to customers (healthcare professionals and/or facilities); and (2) sales through distributors.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the FDA&#8217;s decision regarding Enforcement Discretion, we do not currently market our Section 351 products. If and when a BLA is granted by the FDA, we will market these products again. Refer to the section titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of the end of the FDA&#8217;s Enforcement Discretion on our business&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends and Developments Affecting Our Business</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are actively pursuing growth strategies by expanding our geographic reach</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on growth opportunities in the marketplace by expanding our Advanced Wound Care products into international markets. On June 8, 2021, we received regulatory approval from the Japanese Ministry of Health, Labour, and Welfare (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JMHLW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to market our EPIFIX product in Japan. The Company is currently working with JMHLW to establish reimbursement pricing. Once a reimbursement rate is listed, the Company can begin offering EPIFIX to patients and providers in Japan. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We recently reported top-line data from two late-stage musculoskeletal trials, including for the treatment of Knee Osteoarthritis that did not meet primary endpoints, but demonstrated varied efficacy signals between patient cohorts</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In September 2021, we reported top-line data from the results of two late-stage musculoskeletal clinical trials of the Company&#8217;s micronized dehydrated Human Amnion Chorion Membrane (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">mdHACM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) product (AMNIOFIX Injectable), including one from a Phase 2B clinical trial for the treatment of Knee Osteoarthritis.  Results from an interim analysis of the six-month efficacy data for the Phase 2B clinical trial for Knee Osteoarthritis did not meet primary endpoints, but did reveal varied efficacy signals between patient cohorts evaluated pre- and post- a blinded interim analysis performed in mid-2019.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Phase 3 Plantar Fasciitis study did not meet its primary endpoints. The Company plans on a complete review of the full study data, but does not intend to pursue a BLA filing for Plantar Fasciitis at this time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management is examining the findings and reviewing them with the FDA to determine the appropriate path forward toward the initiation of Phase 3 clinical trials in Knee Osteoarthritis.  As previously disclosed, there can be no assurance that we will receive FDA approval, and approval may be delayed due to a variety of factors, including failure of studies to achieve their endpoints; the extra effort and cost required to improve our clinical trials; the impact of the COVID-19 pandemic; the potential that the results of the clinical studies do not merit further investment; and the work required to achieve commercial and manufacturing readiness.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_88"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of the end of the FDA&#8217;s Enforcement Discretion on our business</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The FDA exercised enforcement discretion under limited conditions with respect to Investigative New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. The enforcement discretion period ceased on May 31, 2021. We are not currently marketing these products in the United States.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_91"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect of Covid-19 Pandemic</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outbreak of a novel strain of coronavirus (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covid-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covid-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is still ongoing, the effects on our operations, such as access restrictions to hospitals and difficulties obtaining donor materials, have largely been ameliorated as of September&#160;30, 2021 and did not have a material effect on our operations during the three months ended September&#160;30, 2021. We are continuously monitoring developments with respect to novel variants of the virus and government and societal responses to mitigate continued spread that may impact our operations.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the health and well-being of our employees, we continue to exercise an abundance of caution. We are allowing our non-essential employees to work from home, limiting non-essential travel, and advising all employees to receive a Covid-19 vaccine as soon as reasonably possible. None of these efforts have materially affected the Company&#8217;s operations for the three months ended September&#160;30, 2021. </span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_94"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_97"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2021 Compared to the Three Months Ended September&#160;30, 2020</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:38.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,289</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,339)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We recorded net sales for the three months ended September 30, 2021 of $63.1 million, a $1.2 million, or 1.9%, decrease compared to the three months ended September 30, 2020, in which we recognized revenue of $64.3 million. Net sales for the three months ended September 30, 2021 includes revenue recognized on the Remaining Contracts of $0.3 million, compared to $1.0 million for the three months ended September 30, 2020. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Net Sales, which excludes cash collected on the Remaining Contracts, were $62.8 million for the three months ended September 30, 2021, a decrease of $0.5 million, or 0.8%, compared to $63.3 million for the three months ended September 30, 2020, which included $8.2 million of revenue related to Section 351 products. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding sales of Section 351 products, Adjusted Net Sales increased $7.2 million, or 13.1%, over the prior year. This increase reflects growth in our AMNIOFIX sheet portfolio and sales of our EPICORD Expandable product launched in September 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales and Gross Profit Margin</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the three months ended September 30, 2021 and 2020 was $10.1 million and $10.3 million, respectively, a decrease of $0.2 million or 1.6%. Cost of sales was aided by favorable production variances, year-over-year. This effect was offset by write-downs recorded for discontinued products during the three months ended September 30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the three months ended September 30, 2021 was 83.9% compared to 84.0% for the three months ended September 30, 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended September 30, 2021 decreased $1.8 million, or 3.7%, to $46.3 million compared to $48.0 million for the three months ended September 30, 2020. The decrease in selling, general and administrative expenses during the period was driven by lower professional fees on legal and other matters. These effects were offset by increases in travel expenses over the prior year period, when we implemented travel restrictions in the midst of the Covid-19 Pandemic.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation, Restatement and Related Expenses</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investigation, restatement and related expenses for the three months ended September 30, 2021 were $3.2 million compared to  $12.0 million for the three months ended September 30, 2020. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, we incurred expenses toward the advancement of legal fees of certain former officers and directors of the Company. These expenses were not as significant during the same period in 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain subject to indemnification agreements with certain former officers and directors of the Company (other than Messrs. Petit and Taylor, our former Chief Executive Officer and Chief Operating Officer) for whom legal proceedings are still ongoing, but we expect such expenses to continue to decrease over time.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur some litigation costs moving forward, but we expect a continued reduction in investigation, restatement, and related expenses from 2020, other than costs related to resolution of the securities class action matter, the amount and timing of which are highly uncertain. See Note 13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the unaudited condensed consolidated financial statements for additional details.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses increased approximately $1.0 million, or 29.5%, to $4.4 million for the three months ended September 30, 2021, compared to approximately $3.4 million for the three months ended September 30, 2020. The increase reflects increases in personnel costs, driven by increases in headcount to support clinical research efforts.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have increased our investments in clinical studies, we did not incur as much research and development expense as we had anticipated. This was the result of the delayed timing of our clinical trials. While we expect such costs to increase as we plan and execute clinical trials, the amount and timing of these expenses are dependent on whether our clinical trials merit further investment and other factors. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $0.2 million for the three months ended September 30, 2021, compared to $0.3 million for the three months ended September 30, 2020. The decrease was the result of amortization on customer relationship assets that were impaired during the fourth quarter of 2020.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt was $8.2 million for the three months ended September 30, 2020 as a result of the repayment and termination of our loan agreement with Blue Torch Financial, LLC.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $1.0 million for the three months ended September 30, 2021 compared to $1.5 million for the three months ended September 30, 2020, a decrease of $0.5 million, or 34.6%. The difference was the result of the amortization of deferred financing costs and original issue discount associated with the DD TL under the Hayfin Term Loan Agreement (described below under &#8220;Liquidity and Capital Resources&#8221;). The DD TL commitment period expired on June 30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net, was negligible in each of the three months ended September 30, 2021 and 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Provision Expense</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (14.8)% and (0.2)% for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. There were no material discrete items affecting the effective tax rate in either period. Net operating losses incurred during both periods were offset by a valuation allowance.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_100"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021 Compared to the Nine Months Ended September 30, 2020 </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:38.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded revenue for the nine months ended September 30, 2021 of $191.2 million, a $11.5 million, or 6.4%, increase compared to the nine months ended September 30, 2020, for which we recorded revenue of $179.7 million. Net sales for the nine months ended September 30, 2021 includes collections on the Remaining Contracts of $0.9 million, compared to $7.2 million of revenue for the nine months ended September 30, 2020. </span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Net Sales, which excludes cash collected on the Remaining Contracts, were $190.3 million for the nine months ended September 30, 2021, compared to $172.4 million for the nine months ended September 30, 2020, an increase of $17.8 million or 10.3%. Adjusted Net Sales in these periods included net sales of Section 351 products of $17.2 million and $23.1 million, respectively. Exclusive of Section 351 sales, Adjusted Net Sales increased $23.7 million, or 15.9%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase was primarily the result of an increase in sales volume due to the lessening of access restrictions imposed by hospitals and travel restrictions implemented in the wake of the Covid-19 Pandemic, as well as growth in our AMNIOFIX sheet portfolio and the positive impact of sales of our EPICORD Expandable product launched in September 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales and Gross Profit Margin</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the nine months ended September 30, 2021 was $32.5 million, an increase of $4.0 million, or 14.1%, compared to $28.5 million for the nine months ended September 30, 2020. The increase was primarily driven by year-over-year increases in sales volume. In addition, we recognized inventory write-downs during the nine months ended September 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period, and other products which we are discontinuing. We do not anticipate these write-downs to continue in the future.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the nine months ended September 30, 2021 was 83.0% compared to 84.1% for the nine months ended September 30, 2020. The decrease in gross profit margin was primarily due to write-downs recorded during the nine months ended September 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period. Taken together, these write-downs represented 0.9% of net sales for the period.</span></div><div style="margin-bottom:10pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the nine months ended September 30, 2021 increased $13.0 million, or 9.8%, to $145.3 million, compared to $132.3 million for the nine months ended September 30, 2020. The increase reflects the restoration of full-salary levels and merit increases that were previously restricted during the prior period, along with increased travel costs, which were previously reduced in the midst of the Covid-19 Pandemic. Furthermore, increases in sales commissions resulting from higher sales volumes also contributed to the increase.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation, Restatement and Related Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investigation, restatement and related expenses for the nine months ended September 30, 2021 decreased approximately $30.8 million, or 78.7%, to $8.3 million compared to $39.1 million for the nine months ended September 30, 2020. The decrease was driven by a decrease in expenses toward the restatement of our prior period financial information and the advancement of legal fees of certain former officers and directors of the Company, as described above in the third quarter comparison. In addition, during the nine months ended September 30, 2021, we received funds from certain director and officer insurance policies, as well as negotiated reductions in previously-recognized legal expenses advanced on behalf of certain former members of management.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses increased $4.5 million, or 54.2%, to $12.8 million for the nine months ended September 30, 2021, compared to $8.3 million for the nine months ended September 30, 2020. The increase reflects higher consulting fees, increases in personnel costs, driven both by the reversal of efforts to mitigate the effects of the Covid-19 Pandemic, as well as increases in headcount to support clinical research efforts.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have increased our investments in preclinical studies, we did not incur as much research and development expense as we had anticipated. This was the result of the delayed timing of our clinical trials. While we expect such costs to increase as we plan and execute clinical trials, the amount and timing of these expenses are dependent on whether our clinical trials merit further investment and other factors. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense decreased $0.2 million or 20.9% from the nine months ended September 30, 2020 to the nine months ended September 30, 2021. The decrease was the result of amortization on customer relationship assets that were impaired during the fourth quarter of 2020.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt was $8.2 million for the nine months ended September 30, 2020 as a result of the repayment and termination of our loan agreement with Blue Torch Financial, LLC.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $3.8 million for the nine months ended September 30, 2021 compared to $6.4 million for the nine months ended September 30, 2020. The difference is related to the lower outstanding principal balance, stated interest rate, and amortization of deferred financing costs and original issue discount on our Term Loan and DD TL compared to our previous term loan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was negligible in each of the nine months ended September 30, 2021 and 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Provision (Expense) Benefit</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (2.9)% and 25.6%&#160;for the nine months ended September 30, 2021 and 2020, respectively. The change in effective tax rates was driven by modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount during the nine months ended September 30, 2020. There were no discrete items affecting the effective tax rate for the nine months ended September 30, 2021.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_103"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing financial statements, we follow accounting principles generally accepted in the United States, which require us to make certain estimates and apply judgments that affect its financial position and results of operations. Management regularly reviews our accounting policies and financial information disclosures. A summary of significant accounting policies that require the use of estimates and judgments in preparing the financial statements was provided in our 2020 Form 10-K.&#160;During the quarter covered by this report, there were no material changes to the accounting policies and assumptions previously disclosed, except as disclosed in Note 2 to the unaudited condensed consolidated financial statements contained herein.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_106"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our GAAP results, we provide certain Non-GAAP metrics including Adjusted Net Sales, Earnings Before Interest, Taxes, Depreciation and Amortization (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and Adjusted EBITDA. We believe that the presentation of these measures provides important supplemental information to management and investors regarding our performance. These measurements are not a substitute for GAAP measurements, and the manner in which we calculate such metrics may not be identical to the manner in which other companies calculate and present similar metrics. Company management uses these Non-GAAP measurements as aids in monitoring our ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against comparable companies.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted Net Sales</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net sales between periods, specifically those reported prior to and after the Transition, led to situations where we included revenue recognized on the cash basis and the &#8220;as-shipped&#8221; basis in the same period. Refer to Note 14, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of the unaudited condensed consolidated financial statements and Note 2, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the consolidated financial statements of our 2020 Form 10-K for additional details regarding the Transition. Adjusted Net Sales provides comparative assessments of our revenue and assists in evaluating our sales performance. Adjusted Net Sales consists of GAAP net sales less the effects of the revenue transition and allows the reader to understand the trend in sales irrespective of the change in revenue recognition method.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of GAAP net sales to Adjusted Net Sales is provided in the table below (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:37.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.593%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in revenue recognition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA and Adjusted EBITDA</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA is intended to provide a measure of the Company&#8217;s operating performance as it eliminates the effects of financing and capital expenditures. EBITDA consists of GAAP net loss excluding: (i) depreciation, (ii) amortization of intangibles, (iii) interest expense, net, (iv) loss on extinguishment of debt, and (v) income tax provision. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is intended to provide an enduring, normalized view of EBITDA and our broader business operations that we expect to experience on an ongoing basis by removing certain non-cash items and items which may be irregular, one-time, or non-recurring from EBITDA; most significantly those expenses related to the Audit Committee Investigation and Restatement. This also includes share-based compensation, which is predominantly settled in shares. This enables us to identify underlying trends in our business that could otherwise be masked by such items.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA consists of GAAP net loss excluding: (i) depreciation, (ii) amortization of intangibles, (iii) interest expense, (iv) loss on extinguishment of debt, (v) income tax provision, (vi) costs incurred in connection with Audit Committee Investigation and Restatement, (vii) the effect of the change in revenue recognition on net loss, and (viii) share-based compensation.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management also assesses EBITDA margin and Adjusted EBITDA margin to provide an additional layer of context to the Company&#8217;s profitability; indicating our ability to convert our sales into sustainable operating results. EBITDA margin is calculated as EBITDA divided by GAAP net sales. Similarly, Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by GAAP net sales.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of GAAP net loss to EBITDA and Adjusted EBITDA appears in the table below (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:37.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Net margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(30.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(18.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">EBITDA margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Non-GAAP Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred in connection with Audit Committee Investigation and Restatement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in revenue recognition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA, % of Adjusted Net Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_109"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discussion of Cash Flows</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities during the nine months ended September&#160;30, 2021 was $1.3 million, compared to $20.0 million of cash used for the nine months ended September&#160;30, 2020. The change was primarily the result of decreases in investigation, restatement, and related expenses, particularly those incurred with respect to the restatement of our prior period financial information and the indemnification of certain former officers and directors of the Company. In addition, we received $9.2 million in income tax refunds during the nine months ended September&#160;30, 2021. These effects were offset in part by the reversal of our efforts to mitigate the Covid-19 Pandemic, which caused a year-over-year increase in selling, general and administrative expense, as well as year-over-year increases in research and development expenses.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities during the nine months ended September&#160;30, 2021 was $3.1 million, compared to $2.3 million for the nine months ended September&#160;30, 2020. This increase was the result of a $0.8 million year-over-year increase in capital expenditures, incurred to improve our manufacturing facilities toward CGMP compliance. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $3.4 million during the nine months ended September&#160;30, 2021 compared to cash provided of $62.8 million during the nine months ended September&#160;30, 2020. Activity for the nine months ended September&#160;30, 2020 included proceeds on the sale of our Series B Convertible Preferred Stock of $93.4 million, net of stock issuance costs. In addition, we received $46.7 million of proceeds in connection with the Hayfin Term Loan, net of original issue discount and deferred financing costs. These proceeds were used in combination with one another to repay the remaining principal balance and prepayment premium on our previous Term Loan Agreement of $73.4 million.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining variance was driven by year-over-year increases in cash paid for stock repurchases for tax withholding, offset by year-over-year increases in cash proceeds from the exercise of stock options.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_112"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021, there were no significant changes to the contractual obligations from those disclosed in the section &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results from Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our 2020 Form 10-K.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_115"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business requires capital for our operating activities, including costs associated with the sale of product through direct and indirect sales channels, the conduct of research and development activities, compliance costs, and legal and consulting fees in connection with ongoing litigation and other matters.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had $90.6 million of cash and cash equivalents. We reported total current assets of $141.9 million and total current liabilities of $41.7 million at September&#160;30, 2021, a current ratio of 3.4 as of September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently paying our obligations in the normal course of business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate cash requirements related to the following items within one year of the date of the filing of this Quarterly Report:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investments and expenditures required to achieve necessary regulatory approval and establish operations in new markets deemed strategically important toward the enhancement of our global footprint; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investments and other expenditures required to advance our INDs and BLAs and identify new potential R&amp;D investments;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lawsuits or potential settlements for which we are not able to estimate a loss, or for which our ultimate loss exceeds our estimate. In addition, it is uncertain if we would be entitled to indemnification from our insurance providers for such matters; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">indemnification agreements involving certain former members of our management team.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have analyzed our ability to address aforementioned commitments and potential liabilities for the 12 months extending from the date of the filing of this Quarterly Report. After completing this analysis, which included a review of updated expectations of revenue, margins, and expenses, we believe it is probable that we will meet all obligations as they come due.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an outstanding Loan Agreement with, among others, Hayfin Services, LLP (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), providing us with a senior secured term loan in an aggregate amount of $50 million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan is equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum. If LIBOR is unavailable, the loan will carry interest at the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%, plus the margin of 6.75%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The margin on the interest rate is eligible for a reduction; as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.75% per annum if the Company&#8217;s Total Net Leverage Ratio (as defined in the Hayfin Loan Agreement) is greater than 2.0x,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.5% per annum if the Company&#8217;s Total Net Leverage Ratio is less than 2.0x but greater than or equal to 1.0x, or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the Total Net Leverage Ratio was 2.4x. At issuance, and as of September&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an event of default (as defined by the Hayfin Term Loan Agreement) occurs, an additional 3.0% margin is applied to the interest rate until such event of default is cured. Alternatively, Hayfin may elect to call the Term Loan, requiring us to repay all outstanding principal, applicable prepayment premium, and accrued interest immediately.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan contains financial covenants requiring the Company, on a consolidated basis, to maintain the following:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Maximum Total Net Leverage Ratio of 4.5x through the quarter ending June 30, 2021, further reduced to 4.0x thereafter for the life of the loans, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Minimum Liquidity (as defined in the Hayfin Term Loan Agreement) of $10 million, an at-all-times financial covenant, tested monthly.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan specifies that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, would subject us to a prepayment premium applicable as of the date of the prepayment, as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before July 2, 2022: 2% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2022 but on or before July 2, 2023: 1% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2023: 0% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes certain negative covenants events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. Mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event (as defined in the Hayfin Loan Agreement).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the fiscal year ending December 31, 2021, we are required to prepay the outstanding loans based on the percentage of the Company&#8217;s Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, we issued $100 million of our Series B Convertible Preferred Stock, par value $0.001 per share (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to an affiliate of EW Healthcare Partners and certain funds managed by Hayfin Capital Management LLP (individually, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to a Securities Purchase Agreement with Falcon Fund 2 Holding Company, L.P., an affiliate of EW Healthcare Partners, and to certain funds managed by Hayfin Capital Management LLP, dated as of June 30, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for an aggregate purchase price of $100 million.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends are declared at the sole discretion of our board of directors. Dividends, if declared, are paid in cash at the end of each quarter based on dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend in cash, we may elect to accrue the dividend owed to shareholders. Dividend balances accumulate at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accrued and unpaid dividends, is convertible into our common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accrued and unpaid dividends. The Series B Preferred Stock, including any accrued and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date, provided that the common stock has traded at 200% or more of the conversion price (i) for 20 out of 30 consecutive trading days and (ii) on such date of conversion.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, we will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the Holders of the Series B Preferred Stock in connection with such change in control. If we do not exercise such repurchase right, Holders of the Series B </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock will have the option to (1) require us to repurchase any or all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert their shares of Series B Preferred Stock, including accrued and unpaid dividends into common stock and receive their pro rata consideration thereunder.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not declared or paid any cash dividends on our Series B Convertible Preferred Stock since issuance. Dividends accumulated but not paid as of September&#160;30, 2021 were $5.6 million.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2021, we repurchased 15,354 shares surrendered by employees to satisfy tax withholding obligations upon vesting of restricted stock. Other than these transactions, we did not repurchase any shares of our common stock for the three months ended September 30, 2021. The timing and amount of future repurchases, if any, will depend upon our stock price, economic and market conditions, regulatory requirements, and other corporate considerations. We may initiate, suspend or discontinue purchases at any time.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, to our unaudited condensed consolidated financial statements in Part I, Item 1 herein.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_118"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no off-balance sheet arrangements as of September&#160;30, 2021.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_121"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the effect of recent accounting pronouncements, see Note 2 to the unaudited condensed consolidated financial statements contained herein.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_124"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our lack of market risk sensitive instruments outstanding at September&#160;30, 2021, we have determined that there was no material market risk exposure to our consolidated financial position, results of operations or cash flows as of such date.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_127"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management maintains a set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including our CEO and CFO, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures was performed under the supervision and with the participation of our management, including our CEO and CFO. As a result of this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were not effective as of September 30, 2021 because of certain material weaknesses in internal control over financial reporting, as described in Item 9A, &#8220;Controls and Procedures&#8221; of our 2020 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Remediation Plan and Status</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our remediation efforts previously identified in our Item 9A. Controls and Procedures of our Annual Report on Form 10-K for the year ended December 31, 2020 are ongoing and we continue our initiatives to implement and document policies, procedures and internal controls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This remediation effort has resulted in changes to the design of certain existing controls as well as the development of new controls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are currently in the process of implementing and testing the operating effectiveness of these new and existing controls.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The material weaknesses cannot be considered completely remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under Exchange Act Rules 13a-15(d) and 15d-15(d), management is required to evaluate, with the participation of our principal executive officer and principal financial officer, any changes in internal control over financial reporting that occurred during each fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Other than the ongoing remediation activities noted above, there were no other changes in our internal control over financial reporting during the three months ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitation on the Effectiveness of Internal Controls</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of any system of internal control over financial reporting is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting can only provide reasonable, not absolute, assurance that its objectives will be met. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but we cannot assure that such improvements will be sufficient to provide us with effective internal control over financial reporting in 2021 or future periods.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_133"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are parties to numerous claims and lawsuits arising in the normal course of its business activities, some of which involve claims for substantial amounts. The ultimate outcome of these suits cannot be ascertained at this time. For additional information, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_73">Note&#160;1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_73">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic7c5801de75c41fe8d1189f73f0aadaa_73">, &#8220;Contractual Commitments and Contingencies,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the unaudited condensed consolidated financial statements included in Part I,&#160;Item 1&#160;of this&#160;Quarterly Report, which is incorporated herein by reference.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_136"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s risk factors included in its 2020 Form 10-K other than those set forth in its Form 10-Q for the quarter ended June 30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) None.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) None.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The following table sets forth information regarding the purchases of the Company&#8217;s equity securities made by or on behalf of the Company or any affiliated purchaser (as defined in Exchange Act Rule 10b-18) during the three month period ended&#160;September&#160;30, 2021:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:32.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.752%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of<br/>shares purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid<br/>&#160;per share </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased under publicly announced plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under Plans or Programs</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 - July 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,779&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 - August 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 - September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total for the quarter</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) Shares repurchased during the quarter include shares surrendered by employees to satisfy tax withholding obligations upon vesting of restricted stock.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_142"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_145"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_148"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_151"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-20210930.htm">Certification of Chief Executive Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-20210930.htm">Certification of Chief Financial Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-20210930.htm">Certification of Chief Executive Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-20210930.htm">Certification of Chief Financial Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.157%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="ic7c5801de75c41fe8d1189f73f0aadaa_154"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November&#160;2, 2021</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MIMEDX GROUP, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Principal Financial Officer</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-20210930.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="icf6df487318548e28f608383e633d40f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULES 13a-14(A) AND 15d-14(A)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Timothy R. Wright, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, of MiMedx Group, Inc.&#59;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:6.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-20210930.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i51d10701c90849eeab9a968cd20ea791_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULES 13a-14(A) AND 15d-14(A)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter M. Carlson, certify that&#58;</font></div><div><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, of MiMedx Group, Inc.&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-20210930.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i42402f639a2b463bb11fd2c40e7f8f1f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The undersigned Timothy R. Wright, the Chief Executive Officer of MiMedx Group, Inc. (the &#8220;Company&#8221;), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company&#8217;s Quarterly Report on Form 10-Q for the period ending September 30, 2021 (the &#8220;Report&#8221;). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-20210930.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iae54b3c40c56488faa7f04f2112b1dfe_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The undersigned Peter M. Carlson, the Chief Financial Officer of MiMedx Group, Inc. (the &#8220;Company&#8221;), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company&#8217;s Quarterly Report on Form 10-Q for the period ending September 30, 2021 (the &#8220;Report&#8221;). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mdxg-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdxg="http://mimedx.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mimedx.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://mimedx.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusiness" roleURI="http://mimedx.com/role/NatureofBusiness">
        <link:definition>2101101 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessDetails" roleURI="http://mimedx.com/role/NatureofBusinessDetails">
        <link:definition>2402401 - Disclosure - Nature of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405402 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNet" roleURI="http://mimedx.com/role/AccountsReceivableNet">
        <link:definition>2106103 - Disclosure - Accounts Receivable, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNetTables" roleURI="http://mimedx.com/role/AccountsReceivableNetTables">
        <link:definition>2307301 - Disclosure - Accounts Receivable, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsReceivableNetDetails" roleURI="http://mimedx.com/role/AccountsReceivableNetDetails">
        <link:definition>2408403 - Disclosure - Accounts Receivable, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://mimedx.com/role/Inventory">
        <link:definition>2109104 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://mimedx.com/role/InventoryTables">
        <link:definition>2310302 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://mimedx.com/role/InventoryDetails">
        <link:definition>2411404 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://mimedx.com/role/PropertyandEquipmentNet">
        <link:definition>2112105 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://mimedx.com/role/PropertyandEquipmentNetTables">
        <link:definition>2313303 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" roleURI="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails">
        <link:definition>2414405 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetDepreciationExpenseDetails" roleURI="http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails">
        <link:definition>2415406 - Disclosure - Property and Equipment, Net - Depreciation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://mimedx.com/role/IntangibleAssets">
        <link:definition>2116106 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://mimedx.com/role/IntangibleAssetsTables">
        <link:definition>2317304 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsActivitySummaryDetails" roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails">
        <link:definition>2418407 - Disclosure - Intangible Assets - Activity Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAmortizationExpenseDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails">
        <link:definition>2419408 - Disclosure - Intangible Assets - Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails">
        <link:definition>2420409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://mimedx.com/role/AccruedExpenses">
        <link:definition>2121107 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://mimedx.com/role/AccruedExpensesTables">
        <link:definition>2322305 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://mimedx.com/role/AccruedExpensesDetails">
        <link:definition>2423410 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://mimedx.com/role/LongTermDebt">
        <link:definition>2124108 - Disclosure - Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://mimedx.com/role/LongTermDebtTables">
        <link:definition>2325306 - Disclosure - Long Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails">
        <link:definition>2426411 - Disclosure - Long Term Debt - Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanDebtIssuanceCostsDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails">
        <link:definition>2427412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanBalancesDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails">
        <link:definition>2428413 - Disclosure - Long Term Debt - Term Loan Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanInterestExpenseDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails">
        <link:definition>2429414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanMaturityDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails">
        <link:definition>2430415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShare" roleURI="http://mimedx.com/role/NetLossPerCommonShare">
        <link:definition>2131109 - Disclosure - Net Loss Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareTables" roleURI="http://mimedx.com/role/NetLossPerCommonShareTables">
        <link:definition>2332307 - Disclosure - Net Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareBasicNetLossPerCommonShareDetails" roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails">
        <link:definition>2433416 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails">
        <link:definition>2434417 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://mimedx.com/role/Equity">
        <link:definition>2135110 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityEquityTables" roleURI="http://mimedx.com/role/EquityEquityTables">
        <link:definition>2336308 - Disclosure - Equity Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityNarrativeDetails" roleURI="http://mimedx.com/role/EquityNarrativeDetails">
        <link:definition>2437418 - Disclosure - Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityChangesinSeriesBPreferredStockDetails" roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails">
        <link:definition>2438419 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityRestrictedStockAwardsDetails" roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails">
        <link:definition>2439420 - Disclosure - Equity - Restricted Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockIncentivePlansDetails" roleURI="http://mimedx.com/role/EquityStockIncentivePlansDetails">
        <link:definition>2440421 - Disclosure - Equity - Stock Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://mimedx.com/role/Incometaxes">
        <link:definition>2141111 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesDetails" roleURI="http://mimedx.com/role/IncometaxesDetails">
        <link:definition>2442422 - Disclosure - Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities">
        <link:definition>2143112 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables">
        <link:definition>2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails">
        <link:definition>2445423 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualCommitmentsandContingencies" roleURI="http://mimedx.com/role/ContractualCommitmentsandContingencies">
        <link:definition>2146113 - Disclosure - Contractual Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualCommitmentsandContingenciesNarrativeDetails" roleURI="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails">
        <link:definition>2447424 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://mimedx.com/role/Revenue">
        <link:definition>2148114 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://mimedx.com/role/RevenueTables">
        <link:definition>2349310 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSummaryofRevenuebyProductTypeDetails" roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails">
        <link:definition>2450425 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSummaryofRevenuebyCustomerTypeDetails" roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails">
        <link:definition>2451426 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCollectionsonRemainingContractsDetails" roleURI="http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails">
        <link:definition>2452427 - Disclosure - Revenue - Collections on Remaining Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://mimedx.com/role/SubsequentEvents">
        <link:definition>2153115 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mdxg_AccruedRebates" abstract="false" name="AccruedRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_NumberOfProducts" abstract="false" name="NumberOfProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" abstract="false" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" abstract="true" name="ComputationOfBasicAndDilutedNetLossPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdxg_AdvancedWoundCareTissueAndOtherMember" abstract="true" name="AdvancedWoundCareTissueAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" abstract="false" name="OperatingLeaseAndFinancingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityDividendRatePercentage" abstract="false" name="TemporaryEquityDividendRatePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_CreditFacilitiesMember" abstract="true" name="CreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" abstract="false" name="TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" abstract="false" name="DebtInstrumentUnusedCapacityCommitmentFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_LeaseRightOfUseAssetAndLiability" abstract="false" name="LeaseRightOfUseAssetAndLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" abstract="false" name="AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityAccretedbutUnrecordedDividends" abstract="false" name="TemporaryEquityAccretedbutUnrecordedDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquitySharesIssueduponConversion" abstract="false" name="TemporaryEquitySharesIssueduponConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" abstract="false" name="DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_DebtInstrumentCommitmentFees" abstract="false" name="DebtInstrumentCommitmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_Section351Member" abstract="true" name="Section351Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdTradingDays" abstract="false" name="TemporaryEquityConversionThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_DebtInstrumentDefaultInterestRate" abstract="false" name="DebtInstrumentDefaultInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_StockIssuanceCostsIncurred" abstract="false" name="StockIssuanceCostsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TreasuryStockSharesAdjustment" abstract="false" name="TreasuryStockSharesAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionRatio" abstract="false" name="TemporaryEquityConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mdxg_NotesReceivableForSaleOfPropertyAndEquipment" abstract="false" name="NotesReceivableForSaleOfPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_DebtInstrumentCovenantNetLeverageRatio" abstract="false" name="DebtInstrumentCovenantNetLeverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" abstract="false" name="RevenueFromContractWithCustomerNumberOfDistributionChannels" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" abstract="true" name="HayfinLoanAgreementDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" abstract="true" name="AdvancedWoundCareUmbilicalCordDerivedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" abstract="false" name="ScheduleofDebtIssuanceCostsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_TemporaryEquityThresholdConsecutiveTradingDays" abstract="false" name="TemporaryEquityThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_ScheduleOfDepreciationTableTextBlock" abstract="false" name="ScheduleOfDepreciationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_ContingencyLossNumberOfSecuritiesClassActions" abstract="false" name="ContingencyLossNumberOfSecuritiesClassActions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_DebtInstrumentInterestRateFloorPercentage" abstract="false" name="DebtInstrumentInterestRateFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" abstract="false" name="FairValueOfNonCashConsiderationReceivedForOptionExercise" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_CARESActMember" abstract="true" name="CARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" abstract="false" name="DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_ScheduleofInterestExpenseTableTextBlock" abstract="false" name="ScheduleofInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" abstract="true" name="DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_FinancingTransactionsMember" abstract="true" name="FinancingTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" abstract="false" name="EffectiveIncomeTaxRateReconciliationDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_AssetRetirementCostMember" abstract="true" name="AssetRetirementCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedinPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" abstract="true" name="HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_ProceedsfromIssuanceofTemporaryEquity" abstract="false" name="ProceedsfromIssuanceofTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" abstract="false" name="NoncashActivitiesDebtInstrumentAmendmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_CustomerAndSupplierRelationshipsMember" abstract="true" name="CustomerAndSupplierRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" abstract="true" name="PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_PatentsinProcessMember" abstract="true" name="PatentsinProcessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionPricePerShare" abstract="false" name="TemporaryEquityConversionPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" abstract="false" name="TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_TermLoanAgreementMember" abstract="true" name="TermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" abstract="false" name="NumberofBoardSeatsElectedbyTemporaryEquityHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" abstract="false" name="TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_PaymentsforApplicationCostsPatent" abstract="false" name="PaymentsforApplicationCostsPatent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_DebtCovenantMinimumLiquidity" abstract="false" name="DebtCovenantMinimumLiquidity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityDeemedDividends" abstract="false" name="TemporaryEquityDeemedDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_NoncashActivitiesDeferredFinancingCosts" abstract="false" name="NoncashActivitiesDeferredFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_AccruedClinicalTrialsCurrent" abstract="false" name="AccruedClinicalTrialsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityIncreasingrateDividendFeature" abstract="false" name="TemporaryEquityIncreasingrateDividendFeature" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" abstract="true" name="HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_StockAwardMisstatementsMember" abstract="true" name="StockAwardMisstatementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_InvestigationRestatementandRelated" abstract="false" name="InvestigationRestatementandRelated" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanMember" abstract="true" name="HayfinLoanAgreementTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_RevenueGuidanceTopic606TransitionPeriodMember" abstract="true" name="RevenueGuidanceTopic606TransitionPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" abstract="false" name="TemporaryEquityAccretionofIncreasingrateDividendFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mdxg-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_69e5d447-05dd-4680-86ce-c8e88a76f886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:to="loc_us-gaap_PreferredStockValue_69e5d447-05dd-4680-86ce-c8e88a76f886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fa08e479-3aed-4bab-982f-c4749483b066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:to="loc_us-gaap_CommonStockValue_fa08e479-3aed-4bab-982f-c4749483b066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4d3e9737-e0ed-4a03-9903-b0f9704ab9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4d3e9737-e0ed-4a03-9903-b0f9704ab9c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_79930e85-154f-4ef6-8a9a-d90d8fbabe27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:to="loc_us-gaap_TreasuryStockValue_79930e85-154f-4ef6-8a9a-d90d8fbabe27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b6546ce-453b-4a2f-ae7e-4480b5ec882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6d48304-212b-4d01-b266-deb1a29ca905" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b6546ce-453b-4a2f-ae7e-4480b5ec882b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90bd9a8e-cc09-4626-9c01-77c9a4bb2822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90bd9a8e-cc09-4626-9c01-77c9a4bb2822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ace454c9-cfba-4ee5-8ed2-4e73f75ddecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ace454c9-cfba-4ee5-8ed2-4e73f75ddecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_3ca96e30-2c95-4047-9d66-5d4f3df7f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_IncomeTaxesReceivable_3ca96e30-2c95-4047-9d66-5d4f3df7f85d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f3527955-4c4b-4807-8d84-24bc0e83d015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_InventoryNet_f3527955-4c4b-4807-8d84-24bc0e83d015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db17f054-3ce9-4348-87d6-3f81149870e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db17f054-3ce9-4348-87d6-3f81149870e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ec0d1760-cf9e-4952-a04a-ce40975a5f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5954e8ba-6f0a-4528-9320-82d154f2d063" xlink:to="loc_us-gaap_OtherAssetsCurrent_ec0d1760-cf9e-4952-a04a-ce40975a5f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b83f301-e2f0-4e90-a394-7ed848151304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_us-gaap_AssetsCurrent_3b83f301-e2f0-4e90-a394-7ed848151304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d1b05d31-fdca-4f09-8e91-eb453fd27de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d1b05d31-fdca-4f09-8e91-eb453fd27de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f729bd53-1fc3-4049-a86d-c575c628223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_us-gaap_Goodwill_f729bd53-1fc3-4049-a86d-c575c628223b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9f4e836c-c9f6-4058-91f6-a51fa2b04445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9f4e836c-c9f6-4058-91f6-a51fa2b04445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d53ed54d-5521-4918-825f-5d4fb1f3b096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d53ed54d-5521-4918-825f-5d4fb1f3b096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_e900cfe9-1ecb-49ff-97e5-e0f0a6f9d4bf" xlink:href="mdxg-20210930.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22886655-4edb-48b0-b916-2119f76c501f" xlink:to="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_e900cfe9-1ecb-49ff-97e5-e0f0a6f9d4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_04c1c59c-8771-4ab4-aba2-e0a4fbb8b2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_db53d7a6-84a8-4a72-b3d4-3d322a55ef49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_04c1c59c-8771-4ab4-aba2-e0a4fbb8b2c8" xlink:to="loc_us-gaap_AccountsPayableCurrent_db53d7a6-84a8-4a72-b3d4-3d322a55ef49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f16fe0ae-52bb-4d42-b6a9-25ca5873e09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_04c1c59c-8771-4ab4-aba2-e0a4fbb8b2c8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f16fe0ae-52bb-4d42-b6a9-25ca5873e09f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_80666fc4-8c9f-4511-a539-afe037f42aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_04c1c59c-8771-4ab4-aba2-e0a4fbb8b2c8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_80666fc4-8c9f-4511-a539-afe037f42aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_57b4f47e-6a06-4394-ba7b-3e516169e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_04c1c59c-8771-4ab4-aba2-e0a4fbb8b2c8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_57b4f47e-6a06-4394-ba7b-3e516169e65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_98616a21-a322-4d12-b1cd-e725bee5070f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ea1cf45f-8b0f-4f54-a30e-ff7ef191fc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98616a21-a322-4d12-b1cd-e725bee5070f" xlink:to="loc_us-gaap_Liabilities_ea1cf45f-8b0f-4f54-a30e-ff7ef191fc13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e7d1113-f0fe-4088-b8a5-66d8343f84b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98616a21-a322-4d12-b1cd-e725bee5070f" xlink:to="loc_us-gaap_StockholdersEquity_8e7d1113-f0fe-4088-b8a5-66d8343f84b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8cb3c1a7-61ba-47e6-8f3a-fb7fca59509a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98616a21-a322-4d12-b1cd-e725bee5070f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8cb3c1a7-61ba-47e6-8f3a-fb7fca59509a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5dc2698b-9dcf-476b-94ec-3cf8775f7946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98616a21-a322-4d12-b1cd-e725bee5070f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5dc2698b-9dcf-476b-94ec-3cf8775f7946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c4a10e45-7198-4a58-8cb1-597a64da7e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4fa76e40-1ff9-45dd-8388-f0df09cd301e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c4a10e45-7198-4a58-8cb1-597a64da7e7f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4fa76e40-1ff9-45dd-8388-f0df09cd301e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fe3d637c-5e55-40a5-9709-1c7839de1171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c4a10e45-7198-4a58-8cb1-597a64da7e7f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fe3d637c-5e55-40a5-9709-1c7839de1171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_58e1bafb-3bf5-409d-b3c6-fe6ce9e4e9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c4a10e45-7198-4a58-8cb1-597a64da7e7f" xlink:to="loc_us-gaap_LiabilitiesCurrent_58e1bafb-3bf5-409d-b3c6-fe6ce9e4e9bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fcc5bf54-45e4-4d27-ade0-22aecee1e9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1efe59ff-abfe-449c-b09a-513bd5be472b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fcc5bf54-45e4-4d27-ade0-22aecee1e9b0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1efe59ff-abfe-449c-b09a-513bd5be472b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d6aadad-5cca-43ed-872c-99e2ad12aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fcc5bf54-45e4-4d27-ade0-22aecee1e9b0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d6aadad-5cca-43ed-872c-99e2ad12aa2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e9a96dc-d3ed-4f5b-8c47-7d6208ab9cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4e114094-3067-46cf-9f5b-bbc0cc3e31e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e9a96dc-d3ed-4f5b-8c47-7d6208ab9cba" xlink:to="loc_us-gaap_OperatingIncomeLoss_4e114094-3067-46cf-9f5b-bbc0cc3e31e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_3f9807bb-7e4b-46dc-9e4d-58fa67592608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e9a96dc-d3ed-4f5b-8c47-7d6208ab9cba" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_3f9807bb-7e4b-46dc-9e4d-58fa67592608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c4769e99-6db0-41ee-b951-ffd46f45b8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e9a96dc-d3ed-4f5b-8c47-7d6208ab9cba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c4769e99-6db0-41ee-b951-ffd46f45b8df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d8823665-5a10-457b-83ba-179fa7872466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e9a96dc-d3ed-4f5b-8c47-7d6208ab9cba" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d8823665-5a10-457b-83ba-179fa7872466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated_edcd3b90-9c90-48c6-ae2c-e0850407ddf0" xlink:href="mdxg-20210930.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:to="loc_mdxg_InvestigationRestatementandRelated_edcd3b90-9c90-48c6-ae2c-e0850407ddf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9db6e8ae-3314-45f5-8308-8022abd62264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9db6e8ae-3314-45f5-8308-8022abd62264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6b84947a-8832-4e50-849b-05c1ab869a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6b84947a-8832-4e50-849b-05c1ab869a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37fdb31a-c863-4e0b-a4ed-1b393206f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37fdb31a-c863-4e0b-a4ed-1b393206f13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_691506aa-99f3-4a9f-a9ba-666810993aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d4877220-e9b0-4223-b7fb-f832803ff846" xlink:to="loc_us-gaap_GrossProfit_691506aa-99f3-4a9f-a9ba-666810993aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dc85feb2-0f13-4ae7-aa4d-81899eda8c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30467554-2aa7-403c-97ad-e9a9d137f106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dc85feb2-0f13-4ae7-aa4d-81899eda8c9e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30467554-2aa7-403c-97ad-e9a9d137f106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f1490a5c-8869-4247-b671-5ce02acec11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_dc85feb2-0f13-4ae7-aa4d-81899eda8c9e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f1490a5c-8869-4247-b671-5ce02acec11d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_73db07b0-b31c-4913-96e5-09c5c3d725aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_73db07b0-b31c-4913-96e5-09c5c3d725aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_6a1654a6-917d-485b-aa61-fb01b4b9ef08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_6a1654a6-917d-485b-aa61-fb01b4b9ef08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_fd445a0e-d35a-4011-a849-84beac226791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_fd445a0e-d35a-4011-a849-84beac226791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_1a6fa097-1669-45d8-9209-7a737914ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_1a6fa097-1669-45d8-9209-7a737914ffce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_976efb1d-9354-49de-9594-cc6df0a8eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_976efb1d-9354-49de-9594-cc6df0a8eddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_51c1c286-bab5-4255-b551-caa12a05b07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_51c1c286-bab5-4255-b551-caa12a05b07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_dd1c0df0-bef5-4b49-a455-dd8e39c53450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_ShareBasedCompensation_dd1c0df0-bef5-4b49-a455-dd8e39c53450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_75aa104c-4099-49c2-a268-48ece9ba8a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_75aa104c-4099-49c2-a268-48ece9ba8a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_aaee7537-6d38-4350-a1cd-65bcce7b8ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_aaee7537-6d38-4350-a1cd-65bcce7b8ecc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b627ba39-44fe-432f-9acc-cad1e40e4929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_NetIncomeLoss_b627ba39-44fe-432f-9acc-cad1e40e4929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_44c0919f-eef4-425b-8eea-5024961ac38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_Depreciation_44c0919f-eef4-425b-8eea-5024961ac38a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b08896e3-4309-4895-81b7-b0aae1a96bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b08896e3-4309-4895-81b7-b0aae1a96bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6e484824-5fc6-4e4a-a685-eb521ac1a2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_6e484824-5fc6-4e4a-a685-eb521ac1a2ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_8c407b22-a425-4a6c-b5c8-e613a1d8acce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_8c407b22-a425-4a6c-b5c8-e613a1d8acce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bf9da234-c8e7-488a-9edf-8f28d1efc63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bf9da234-c8e7-488a-9edf-8f28d1efc63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1972cb11-4b53-441a-9dd7-75aa8de7c77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1972cb11-4b53-441a-9dd7-75aa8de7c77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_68bbe04e-1f6d-4645-a671-cc9a9ac941e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_68bbe04e-1f6d-4645-a671-cc9a9ac941e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_590050b6-3838-4e8e-9f90-b8c8c80e5ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b0c8a04f-0450-425b-9737-1c009767836d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_590050b6-3838-4e8e-9f90-b8c8c80e5ea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ee07247-a3ef-4e1b-8c91-58330c104a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_7b2bf528-9ad0-4881-9cac-6a9facab8a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ee07247-a3ef-4e1b-8c91-58330c104a73" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_7b2bf528-9ad0-4881-9cac-6a9facab8a91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent_0cfee5d9-8068-4f44-89e5-3aa9fb7adfe0" xlink:href="mdxg-20210930.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ee07247-a3ef-4e1b-8c91-58330c104a73" xlink:to="loc_mdxg_PaymentsforApplicationCostsPatent_0cfee5d9-8068-4f44-89e5-3aa9fb7adfe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_6c9782dc-d8f3-443f-817f-91a34ee90feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ee07247-a3ef-4e1b-8c91-58330c104a73" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_6c9782dc-d8f3-443f-817f-91a34ee90feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6e22c5e-c824-4ea0-b4c4-bbf57d69424b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8335cdb3-17a1-4708-ae9a-03fe139fc55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6e22c5e-c824-4ea0-b4c4-bbf57d69424b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8335cdb3-17a1-4708-ae9a-03fe139fc55f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f564eb83-473e-4d4f-bc1b-6872ecad1f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6e22c5e-c824-4ea0-b4c4-bbf57d69424b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f564eb83-473e-4d4f-bc1b-6872ecad1f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6314d05-950a-4404-a46b-8dc89879c4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6e22c5e-c824-4ea0-b4c4-bbf57d69424b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6314d05-950a-4404-a46b-8dc89879c4b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_b9b4936f-ccc9-4b9e-a8b0-5f65ba59fecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_b9b4936f-ccc9-4b9e-a8b0-5f65ba59fecf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_f1a8aae8-f7ca-4f77-a268-3da08fc0ad8d" xlink:href="mdxg-20210930.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_f1a8aae8-f7ca-4f77-a268-3da08fc0ad8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56738641-0256-4c69-a6a6-840f41507268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56738641-0256-4c69-a6a6-840f41507268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_ad6b7fcb-6318-4426-96f0-ede76a6bb85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_ad6b7fcb-6318-4426-96f0-ede76a6bb85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8fda7292-359b-47ef-8531-a4a8412be2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8fda7292-359b-47ef-8531-a4a8412be2b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_62b3bc27-940b-47e8-860b-0c890f56e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_62b3bc27-940b-47e8-860b-0c890f56e9a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bfc5d3d1-71ca-4257-9d12-5f0007cf2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_bfc5d3d1-71ca-4257-9d12-5f0007cf2b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8412d7f3-2613-40f9-9f4a-c70da0df99a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8412d7f3-2613-40f9-9f4a-c70da0df99a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_96423c95-1d19-4be7-b476-c9c0c4634969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d85dd183-2648-459b-afd3-e8a5fdee4fe2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_96423c95-1d19-4be7-b476-c9c0c4634969" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccountsReceivableNetDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccountsReceivableNetDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/AccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5f77a6bd-ea63-45ff-ac8a-8d297aaeae0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_77697eea-964e-4069-9545-9e6ffcff704e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5f77a6bd-ea63-45ff-ac8a-8d297aaeae0b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_77697eea-964e-4069-9545-9e6ffcff704e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_9aa6bcc3-1d51-4032-9202-3fa7b111c160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_5f77a6bd-ea63-45ff-ac8a-8d297aaeae0b" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_9aa6bcc3-1d51-4032-9202-3fa7b111c160" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2c721eae-08fe-4654-96bb-fe623aa98b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_74c9a571-4980-4e97-bbe4-83c9efb6aea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2c721eae-08fe-4654-96bb-fe623aa98b4c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_74c9a571-4980-4e97-bbe4-83c9efb6aea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9f9b9cc0-a9e2-479e-b9fd-ef9b9041d2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2c721eae-08fe-4654-96bb-fe623aa98b4c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9f9b9cc0-a9e2-479e-b9fd-ef9b9041d2b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9d8234ae-a5e9-4af1-b07d-ff71dee2bdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_2c721eae-08fe-4654-96bb-fe623aa98b4c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9d8234ae-a5e9-4af1-b07d-ff71dee2bdc3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_55699376-188c-4c42-abe2-cf079b831f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2bbd4939-36a2-4b2a-bf7f-04c72bc8ca28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_55699376-188c-4c42-abe2-cf079b831f33" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2bbd4939-36a2-4b2a-bf7f-04c72bc8ca28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_c815c160-d1fe-4546-aba1-f6505a0fbb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_55699376-188c-4c42-abe2-cf079b831f33" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_c815c160-d1fe-4546-aba1-f6505a0fbb08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aaeb3b8a-b92a-4e89-9858-ac5b17cc57e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_84da821e-7dd1-4773-9b59-d31ad7937c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aaeb3b8a-b92a-4e89-9858-ac5b17cc57e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_84da821e-7dd1-4773-9b59-d31ad7937c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_47566199-1210-452f-9b7e-d7b7be230265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aaeb3b8a-b92a-4e89-9858-ac5b17cc57e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_47566199-1210-452f-9b7e-d7b7be230265" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cd86b093-f21b-48d4-9150-329c4684c954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8ad58419-8dc4-4c00-9540-df3be68de923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cd86b093-f21b-48d4-9150-329c4684c954" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8ad58419-8dc4-4c00-9540-df3be68de923" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e0e6432-9ed7-4082-9d97-1c27863d4734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cd86b093-f21b-48d4-9150-329c4684c954" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e0e6432-9ed7-4082-9d97-1c27863d4734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2883d436-2442-4858-a278-055f8b6f31e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b9dc7c65-cb7e-45b9-8e89-9e3098aa3b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2883d436-2442-4858-a278-055f8b6f31e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b9dc7c65-cb7e-45b9-8e89-9e3098aa3b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_03b0bb65-de0f-4c72-a3b4-57c8861b1024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2883d436-2442-4858-a278-055f8b6f31e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_03b0bb65-de0f-4c72-a3b4-57c8861b1024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0f552774-db91-4f4c-80d9-c0ae93959667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ddd32fd2-ef2e-4e03-968c-21c8b2704c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0f552774-db91-4f4c-80d9-c0ae93959667" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ddd32fd2-ef2e-4e03-968c-21c8b2704c74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d1d0cb65-6843-418f-892b-5f40e073ca31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0f552774-db91-4f4c-80d9-c0ae93959667" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d1d0cb65-6843-418f-892b-5f40e073ca31" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e98325ea-4139-4f0c-bcaf-b30b5c2ea916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e98325ea-4139-4f0c-bcaf-b30b5c2ea916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d111f76e-886c-49a3-bf44-5e6c2e7217e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d111f76e-886c-49a3-bf44-5e6c2e7217e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1ea32da7-8824-45c4-9ef1-48212d76eef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1ea32da7-8824-45c4-9ef1-48212d76eef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c30539-464e-4620-81e0-43121ea1bf69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c30539-464e-4620-81e0-43121ea1bf69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_58be8196-bee0-4940-ad1a-7ddf272f22b0" xlink:href="mdxg-20210930.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_58be8196-bee0-4940-ad1a-7ddf272f22b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_66d1c8c0-f89a-4d19-9d7f-9c38a6a862b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0311e9ff-46ac-4f91-8414-c2a7eac69a90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_66d1c8c0-f89a-4d19-9d7f-9c38a6a862b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a14efbf7-9bda-4048-b6b8-6e9fff5a9b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a14efbf7-9bda-4048-b6b8-6e9fff5a9b28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_c84db45c-916a-454b-bcdb-a7bac1ac86c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_c84db45c-916a-454b-bcdb-a7bac1ac86c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a2d24c39-f13d-40c1-b266-f626b7796ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a2d24c39-f13d-40c1-b266-f626b7796ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_9e9336a6-0a72-4b57-b6c4-6094b19dc6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_9e9336a6-0a72-4b57-b6c4-6094b19dc6d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent_dea4358f-d45e-4bdd-ba95-a82952eaeed3" xlink:href="mdxg-20210930.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_mdxg_AccruedClinicalTrialsCurrent_dea4358f-d45e-4bdd-ba95-a82952eaeed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_919eefc7-602d-4d2d-8ad0-d0f2b5b3b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_919eefc7-602d-4d2d-8ad0-d0f2b5b3b8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates_d9a2e1b0-db0c-41bd-ad15-9f7a5ddc07dc" xlink:href="mdxg-20210930.xsd#mdxg_AccruedRebates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ae650bb6-f195-4e33-9fcc-1ce94a7fc323" xlink:to="loc_mdxg_AccruedRebates_d9a2e1b0-db0c-41bd-ad15-9f7a5ddc07dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a6ffb2d2-eec9-4dd0-ba15-b7cf5b636cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f7e40777-7def-4ef9-9f27-3e12e44aa453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a6ffb2d2-eec9-4dd0-ba15-b7cf5b636cd8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f7e40777-7def-4ef9-9f27-3e12e44aa453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_3c515995-4131-4f95-85c7-16a0b5965cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a6ffb2d2-eec9-4dd0-ba15-b7cf5b636cd8" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_3c515995-4131-4f95-85c7-16a0b5965cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1255852c-7bda-4472-bc34-69d182fac060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a6ffb2d2-eec9-4dd0-ba15-b7cf5b636cd8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1255852c-7bda-4472-bc34-69d182fac060" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_bdb318d6-d46c-4853-bb42-705937fdac22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_dbe14f16-5b4c-4f99-8545-e92f65a3bc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_bdb318d6-d46c-4853-bb42-705937fdac22" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_dbe14f16-5b4c-4f99-8545-e92f65a3bc3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f970bb9c-a0e4-4b9d-89c5-a71cbaeeed53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_bdb318d6-d46c-4853-bb42-705937fdac22" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f970bb9c-a0e4-4b9d-89c5-a71cbaeeed53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_90c033cd-d1be-427d-8c50-b67f9c157f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_bdb318d6-d46c-4853-bb42-705937fdac22" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_90c033cd-d1be-427d-8c50-b67f9c157f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_6697428c-e68b-4873-857b-b1dc9b72b8a2" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_bdb318d6-d46c-4853-bb42-705937fdac22" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_6697428c-e68b-4873-857b-b1dc9b72b8a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanMaturityDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_04352f4c-5b9c-4ade-956f-f4e9f2ff5b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_04352f4c-5b9c-4ade-956f-f4e9f2ff5b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3c9c172b-445f-4ac1-9611-f5f30408c02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3c9c172b-445f-4ac1-9611-f5f30408c02b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_543da551-fa24-4438-a329-71b6c664c905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_543da551-fa24-4438-a329-71b6c664c905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d9b5ec0e-a898-4f50-9652-668c2b470d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d9b5ec0e-a898-4f50-9652-668c2b470d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour_3c54e1d4-7c2c-4aec-9412-72c858cb2633" xlink:href="mdxg-20210930.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_mdxg_LongTermDebtMaturityAfterYearFour_3c54e1d4-7c2c-4aec-9412-72c858cb2633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_659c2e00-52c4-48b2-a265-0edc001b0729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f8cff1df-e5d1-400b-87e4-dc332dfa0649" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_659c2e00-52c4-48b2-a265-0edc001b0729" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareBasicNetLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_34012707-36ed-4cbb-b62d-030ec703268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4e1dee5-fe3e-4528-b756-c70754e0204b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_34012707-36ed-4cbb-b62d-030ec703268c" xlink:to="loc_us-gaap_NetIncomeLoss_c4e1dee5-fe3e-4528-b756-c70754e0204b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d0f99193-77d8-4896-8c33-e66d8c4e6916" xlink:href="mdxg-20210930.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_34012707-36ed-4cbb-b62d-030ec703268c" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d0f99193-77d8-4896-8c33-e66d8c4e6916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_54e3c6c3-9431-4d74-a074-bedae90bc5a9" xlink:href="mdxg-20210930.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_e3326bb7-5d6c-400a-afef-50df3e369b01" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_54e3c6c3-9431-4d74-a074-bedae90bc5a9" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_e3326bb7-5d6c-400a-afef-50df3e369b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_50dc32ff-175c-4ff5-84f4-24a4e6fffc2b" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_54e3c6c3-9431-4d74-a074-bedae90bc5a9" xlink:to="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_50dc32ff-175c-4ff5-84f4-24a4e6fffc2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_3c4b250f-a9d3-421b-9d8f-1e3cfdb3ae30" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_54e3c6c3-9431-4d74-a074-bedae90bc5a9" xlink:to="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_3c4b250f-a9d3-421b-9d8f-1e3cfdb3ae30" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_66a083ef-6d46-4452-adf1-070b47c22f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245dc581-235c-42b1-bbcc-aca3eb9a442a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_66a083ef-6d46-4452-adf1-070b47c22f39" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245dc581-235c-42b1-bbcc-aca3eb9a442a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mdxg-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="extended" id="ic741496115044d58b2f03f6d3bcbd67d_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_35d6a224-1134-44cf-b7ff-d016fec062fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_CommonStockSharesIssued_35d6a224-1134-44cf-b7ff-d016fec062fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6896451-2842-4e44-8986-46da9b864d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockholdersEquity_c6896451-2842-4e44-8986-46da9b864d34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3ff53a4f-3a1a-436b-814a-305deea284b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3ff53a4f-3a1a-436b-814a-305deea284b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_9936ca55-df2b-41d4-94a5-b0814825a785" xlink:href="mdxg-20210930.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_9936ca55-df2b-41d4-94a5-b0814825a785" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4f113884-7cd1-48aa-9bb7-576ff2f0ba43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4f113884-7cd1-48aa-9bb7-576ff2f0ba43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7089fa91-0953-453b-a402-fb042196db17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7089fa91-0953-453b-a402-fb042196db17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_205fdc88-f1ab-4e5a-b751-2f2f9aee937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_205fdc88-f1ab-4e5a-b751-2f2f9aee937a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_edec0604-0dd2-4cae-8624-a1c78fb4ce72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_edec0604-0dd2-4cae-8624-a1c78fb4ce72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c3462df5-2e46-4d22-8bf3-3c47364ec913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c3462df5-2e46-4d22-8bf3-3c47364ec913" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3aa686ba-5376-4373-a091-4ca548a4fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3aa686ba-5376-4373-a091-4ca548a4fcac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e78b195f-ab0f-487d-b41b-81a2f114fb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e78b195f-ab0f-487d-b41b-81a2f114fb99" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3af4ec41-3bf9-4486-b6a2-9fbc1ed2c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3af4ec41-3bf9-4486-b6a2-9fbc1ed2c6d3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_fa986c5c-92b0-4e03-a1de-31f0f71c5fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_fa986c5c-92b0-4e03-a1de-31f0f71c5fad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc464c88-8404-4000-bf91-251dd80d935e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc464c88-8404-4000-bf91-251dd80d935e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b5facbc8-db81-4eda-94cd-285d7bbeface" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b5facbc8-db81-4eda-94cd-285d7bbeface" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_88586cf1-9310-4739-a306-d9884dcf45d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_NetIncomeLoss_88586cf1-9310-4739-a306-d9884dcf45d0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bfe9c76f-982d-4650-bc97-b63bdc27a440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e067cc08-a20d-448f-ae20-407002969f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:to="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4af495c9-93de-4153-9b08-26d4e9888f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_CommonStockMember_4af495c9-93de-4153-9b08-26d4e9888f98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e359ceee-a1b1-458f-9a1b-1613dc8894c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e359ceee-a1b1-458f-9a1b-1613dc8894c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_297ee285-9af5-49ae-a4cf-c32264c862d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_TreasuryStockMember_297ee285-9af5-49ae-a4cf-c32264c862d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f52bb2f5-4a42-4fc7-ae11-9a31c1d9a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_RetainedEarningsMember_f52bb2f5-4a42-4fc7-ae11-9a31c1d9a6b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9f016b1c-7c7c-4e08-aa83-bad93716caa2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:to="loc_srt_RestatementDomain_9f016b1c-7c7c-4e08-aa83-bad93716caa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:to="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_12ba67db-f253-4428-979a-b7a536e21f96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:to="loc_srt_RestatementAdjustmentMember_12ba67db-f253-4428-979a-b7a536e21f96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_76e17bab-35be-4293-afda-5b7b1c017042" xlink:href="mdxg-20210930.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:to="loc_mdxg_StockAwardMisstatementsMember_76e17bab-35be-4293-afda-5b7b1c017042" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NatureofBusinessDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="extended" id="i98ad4ff84b4a479aabbb54e0735dc4a6_NatureofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_499839ca-401a-4cf0-8c42-8063c17286d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_499839ca-401a-4cf0-8c42-8063c17286d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_627dfb8d-1c87-40bc-b30a-864e84c5f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_InventoryNet_627dfb8d-1c87-40bc-b30a-864e84c5f6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1aff2204-7fff-4b13-9c26-176dd5349c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1aff2204-7fff-4b13-9c26-176dd5349c37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9e5d902e-b9c7-4449-a619-51ae50e60587_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:to="loc_srt_ProductsAndServicesDomain_9e5d902e-b9c7-4449-a619-51ae50e60587_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:to="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_c1679660-68a1-47f1-8718-3d989e068170" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:to="loc_mdxg_Section351Member_c1679660-68a1-47f1-8718-3d989e068170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_2d012408-f450-428e-9b1f-739f26fd00ad" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_2d012408-f450-428e-9b1f-739f26fd00ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e72fb00-9edb-4472-9b01-854059b6a5bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:to="loc_us-gaap_EquityComponentDomain_6e72fb00-9edb-4472-9b01-854059b6a5bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:to="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_014f4fd6-c80e-40ca-b1a3-6b4ca12b6497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_014f4fd6-c80e-40ca-b1a3-6b4ca12b6497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9e1d5186-3403-408e-a79f-c9d3700f9f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:to="loc_us-gaap_TreasuryStockMember_9e1d5186-3403-408e-a79f-c9d3700f9f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_7701a5f9-a434-48d5-931d-e3befe25920c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_7701a5f9-a434-48d5-931d-e3befe25920c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_696ac139-72b6-43f5-a599-294f6f6e7464" xlink:href="mdxg-20210930.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:to="loc_mdxg_StockAwardMisstatementsMember_696ac139-72b6-43f5-a599-294f6f6e7464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:to="loc_srt_RestatementDomain_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:to="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_898066fa-1474-44e3-b9d8-b773b27494b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:to="loc_srt_RestatementAdjustmentMember_898066fa-1474-44e3-b9d8-b773b27494b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#InventoryDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended" id="i88393943ad8844bea901f10c1594de04_InventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0eeeeb45-b634-4cb2-8d53-bc0cc075828c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:to="loc_us-gaap_InventoryWriteDown_0eeeeb45-b634-4cb2-8d53-bc0cc075828c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:to="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:to="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d8ef5478-487f-4ca1-9096-392129ce710e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:to="loc_srt_ProductsAndServicesDomain_d8ef5478-487f-4ca1-9096-392129ce710e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:to="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_df06cf0a-2e5c-43ef-9062-3bf6633e76c7" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:to="loc_mdxg_Section351Member_df06cf0a-2e5c-43ef-9062-3bf6633e76c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended" id="i38da4c50838645c38797fd8a76f2ae66_PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5303e709-e3ea-4279-817c-e072e6ffdd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5303e709-e3ea-4279-817c-e072e6ffdd9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2b504d3f-cb6f-478f-a900-59c574781753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2b504d3f-cb6f-478f-a900-59c574781753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9ffa1f49-4223-40db-b1da-3411d78dfa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9ffa1f49-4223-40db-b1da-3411d78dfa4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d8f4f205-618f-42c8-9d7f-6d4f008d224f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d8f4f205-618f-42c8-9d7f-6d4f008d224f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_803b2f89-69f2-42fa-934e-d8a33fc19bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_803b2f89-69f2-42fa-934e-d8a33fc19bcf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_192b5c95-fdb9-4905-af62-17b014a8a403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_192b5c95-fdb9-4905-af62-17b014a8a403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_14215f48-a030-431f-9f85-d96a126601da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_EquipmentMember_14215f48-a030-431f-9f85-d96a126601da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4a9ee0e1-61d9-4a6f-87f8-d541cbf99b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4a9ee0e1-61d9-4a6f-87f8-d541cbf99b3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ef0d1a98-d174-407a-9b3f-f8072499f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_ConstructionInProgressMember_ef0d1a98-d174-407a-9b3f-f8072499f32b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember_1e2b30d1-3ca8-483e-800b-d77bce9c2f41" xlink:href="mdxg-20210930.xsd#mdxg_AssetRetirementCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_mdxg_AssetRetirementCostMember_1e2b30d1-3ca8-483e-800b-d77bce9c2f41" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended" id="i16c5800cfe334d26b8feb9f19c83700c_IntangibleAssetsActivitySummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c00ebaf1-d1f2-49d2-ad96-cd1e3e2e1dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c00ebaf1-d1f2-49d2-ad96-cd1e3e2e1dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ffb355a-f5a9-44c2-a89f-9f1f926eeef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ffb355a-f5a9-44c2-a89f-9f1f926eeef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_939427fe-6677-49dd-b7e9-bec3448b0540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_939427fe-6677-49dd-b7e9-bec3448b0540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a3c8934c-4db6-4c79-895f-6004a90eeeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a3c8934c-4db6-4c79-895f-6004a90eeeb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1eb9ba95-662d-47d8-8bc8-4cc603990c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1eb9ba95-662d-47d8-8bc8-4cc603990c3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_defc8894-e758-4032-99a2-55e7ab112ce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_defc8894-e758-4032-99a2-55e7ab112ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_44d5699d-92f0-49fc-82d1-e7eec948816a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_PatentsMember_44d5699d-92f0-49fc-82d1-e7eec948816a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_75b5f0b0-1115-456c-a9d9-e5531c7ccaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_LicensingAgreementsMember_75b5f0b0-1115-456c-a9d9-e5531c7ccaf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember_0119a69c-5e69-4864-9a16-6797f3fd18f0" xlink:href="mdxg-20210930.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_mdxg_CustomerAndSupplierRelationshipsMember_0119a69c-5e69-4864-9a16-6797f3fd18f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_89b45e1e-4ba9-40c9-baed-2bf70d551225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_89b45e1e-4ba9-40c9-baed-2bf70d551225" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e096107-4730-4a6a-849f-83ef9aa05777_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e096107-4730-4a6a-849f-83ef9aa05777_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7c4c81f-9fdb-434f-b4ab-e52b1f7d52f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7c4c81f-9fdb-434f-b4ab-e52b1f7d52f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_1b4bae4f-d5af-4a13-bcc3-5750db4310d2" xlink:href="mdxg-20210930.xsd#mdxg_PatentsinProcessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:to="loc_mdxg_PatentsinProcessMember_1b4bae4f-d5af-4a13-bcc3-5750db4310d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7507e3f5-c2db-437f-aada-43636ced56d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7507e3f5-c2db-437f-aada-43636ced56d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_84fee58b-7802-4033-b0c2-5de44975eeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_84fee58b-7802-4033-b0c2-5de44975eeb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_84fee58b-7802-4033-b0c2-5de44975eeb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_94356bb4-b149-4b06-bef5-ebbc5d49e5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_024aed14-e9b8-4d14-aff0-aa3edadc41e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_71ee0526-c62f-4303-beb8-b00b6150b84b" xlink:href="mdxg-20210930.xsd#mdxg_PatentsinProcessMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="extended" id="iffdbc0333ff646f89a81c61aec389ddd_LongTermDebtTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f28f96cd-a8d0-4a10-86c7-75c2ebda0409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f28f96cd-a8d0-4a10-86c7-75c2ebda0409" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_13d96e38-3c77-47b9-b9ea-7cd032ad49bf" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_13d96e38-3c77-47b9-b9ea-7cd032ad49bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_255fa9d4-a1d5-4a67-85e7-392759307d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_255fa9d4-a1d5-4a67-85e7-392759307d88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio_e2013a53-9854-40fd-8b19-8cd961c241d3" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCovenantNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio_e2013a53-9854-40fd-8b19-8cd961c241d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate_98ba0961-f7b1-443f-86fa-8ca57044b257" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentDefaultInterestRate_98ba0961-f7b1-443f-86fa-8ca57044b257" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_282a63be-8e20-4af8-9cbf-8b4583bff5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_282a63be-8e20-4af8-9cbf-8b4583bff5f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity_63c9bb44-c6d9-4dc7-ab3d-2fc6cf15213e" xlink:href="mdxg-20210930.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtCovenantMinimumLiquidity_63c9bb44-c6d9-4dc7-ab3d-2fc6cf15213e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_87bfce84-a0a6-4946-9201-dc24c4856ecd" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_87bfce84-a0a6-4946-9201-dc24c4856ecd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_248f2ba9-dddc-4452-97be-32ce346b0bdf" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_248f2ba9-dddc-4452-97be-32ce346b0bdf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_7504f3a7-c7e5-4f86-8dbc-26db2fc376aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_LongTermDebtFairValue_7504f3a7-c7e5-4f86-8dbc-26db2fc376aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_881dda2e-3ed2-426d-8caf-50eb64e755fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_881dda2e-3ed2-426d-8caf-50eb64e755fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_560f92b0-9e59-42f1-92bf-7b967f661533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_560f92b0-9e59-42f1-92bf-7b967f661533" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_368f2e3a-190d-4e5a-8db1-d93ec932089b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:to="loc_srt_RangeMember_368f2e3a-190d-4e5a-8db1-d93ec932089b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:to="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3cf2bead-1060-4e95-8deb-44ae20cc1056" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:to="loc_srt_MinimumMember_3cf2bead-1060-4e95-8deb-44ae20cc1056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_256b7f85-c375-4eb3-a96a-be67efd53801" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:to="loc_srt_MaximumMember_256b7f85-c375-4eb3-a96a-be67efd53801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a3d9df34-6adc-4b6f-9694-c6b50428c719_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a3d9df34-6adc-4b6f-9694-c6b50428c719_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_7cb901a5-9225-4a48-85b9-6518bad40620" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:to="loc_srt_ScenarioForecastMember_7cb901a5-9225-4a48-85b9-6518bad40620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3f88630e-cf12-4100-8027-3f320cfa4908_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3f88630e-cf12-4100-8027-3f320cfa4908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_07d9a5b4-affb-4316-a297-a8eb57891307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_07d9a5b4-affb-4316-a297-a8eb57891307" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab019245-614f-4b77-8826-95e046f9bd6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab019245-614f-4b77-8826-95e046f9bd6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_dcfe4d16-cc6c-450e-b86e-445ae91bbe95" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_dcfe4d16-cc6c-450e-b86e-445ae91bbe95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember_cdd1bd23-b17f-42c1-9105-04f65edba542" xlink:href="mdxg-20210930.xsd#mdxg_FinancingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_FinancingTransactionsMember_cdd1bd23-b17f-42c1-9105-04f65edba542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_bb5697a5-abc2-4a52-b4d6-134e4ec03ee2" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_bb5697a5-abc2-4a52-b4d6-134e4ec03ee2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_06aa06d0-da47-421a-804e-f550f59001e3" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_06aa06d0-da47-421a-804e-f550f59001e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_1d795bfc-e2a3-4b00-a1ed-cb9f69b316a3" xlink:href="mdxg-20210930.xsd#mdxg_CreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_CreditFacilitiesMember_1d795bfc-e2a3-4b00-a1ed-cb9f69b316a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_218a60c3-a0f4-4648-823b-1bcf0085fe06" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_218a60c3-a0f4-4648-823b-1bcf0085fe06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_9d26c7cd-fcbb-4aaa-bdc6-4988aee5e735" xlink:href="mdxg-20210930.xsd#mdxg_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_TermLoanAgreementMember_9d26c7cd-fcbb-4aaa-bdc6-4988aee5e735" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a0407e8e-9699-41a2-8db9-4efa2633806c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:to="loc_us-gaap_VariableRateDomain_a0407e8e-9699-41a2-8db9-4efa2633806c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:to="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8704b270-fef1-4db1-85ff-a9b513a98e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8704b270-fef1-4db1-85ff-a9b513a98e87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_04663272-db09-4d2a-831d-ed57edb9e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_PrimeRateMember_04663272-db09-4d2a-831d-ed57edb9e57e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_bd891cab-4562-4a8d-af24-e817c11d7711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_bd891cab-4562-4a8d-af24-e817c11d7711" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanDebtIssuanceCostsDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="extended" id="ie348a3c7de114deaa52abe31618a39b3_LongTermDebtTermLoanDebtIssuanceCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9048275f-a74d-4e22-a00f-2334b3774a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9048275f-a74d-4e22-a00f-2334b3774a5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_e8b9f512-76a0-4b09-8e1d-7eb018adf549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_e8b9f512-76a0-4b09-8e1d-7eb018adf549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:to="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ad3531cc-95fc-415d-bef2-1468c22e1312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:to="loc_us-gaap_LongTermDebtMember_ad3531cc-95fc-415d-bef2-1468c22e1312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_84972076-0855-4181-bf2c-56e90e21886f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_84972076-0855-4181-bf2c-56e90e21886f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df5951da-7046-4403-92aa-2a4400f6bfc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df5951da-7046-4403-92aa-2a4400f6bfc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_7f34b28d-9ebd-4b56-84fd-6ae738f27ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_7f34b28d-9ebd-4b56-84fd-6ae738f27ba1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_031b206e-7bb1-425d-993a-10276c2ef07c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_031b206e-7bb1-425d-993a-10276c2ef07c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:href="mdxg-20210930.xsd#mdxg_CreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:to="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_badfffad-c39e-44a1-b935-e7d268b9d606" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_badfffad-c39e-44a1-b935-e7d268b9d606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c62bbf1f-f974-4b91-8a39-5eeba76421d2" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c62bbf1f-f974-4b91-8a39-5eeba76421d2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended" id="icc3b65d59eec4a47bf4664a3bbc0af3c_LongTermDebtTermLoanBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_59999266-60ba-44d6-b5d6-fbca93859228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_59999266-60ba-44d6-b5d6-fbca93859228" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_43159c93-ac24-4b22-abcc-9e0b754175b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_43159c93-ac24-4b22-abcc-9e0b754175b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_15ada0ac-d662-4bbd-bcb1-b666fc8229ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_15ada0ac-d662-4bbd-bcb1-b666fc8229ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cb5807d7-61f5-4772-905b-69f7ea631f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_LongTermDebt_cb5807d7-61f5-4772-905b-69f7ea631f0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_47c9bb0b-8d84-4084-baf3-af2f761a0750_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_47c9bb0b-8d84-4084-baf3-af2f761a0750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f6366b0e-ae16-40f4-9188-df5fa009c7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f6366b0e-ae16-40f4-9188-df5fa009c7ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:to="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a53265fb-5a7f-4905-b0da-33c9a08aa8e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a53265fb-5a7f-4905-b0da-33c9a08aa8e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_6672c2b3-9fff-41af-a163-d844e4d2c72a" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_6672c2b3-9fff-41af-a163-d844e4d2c72a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended" id="if625c7bfc0b844d99d97753894da9737_LongTermDebtTermLoanInterestExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_f06c2155-9398-4b36-978f-9d3723e1318b" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_f06c2155-9398-4b36-978f-9d3723e1318b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5abc74d-d092-42bf-905d-251a5147b970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5abc74d-d092-42bf-905d-251a5147b970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_662c10cd-8b06-48be-9e6a-c914587b7f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_662c10cd-8b06-48be-9e6a-c914587b7f5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9b42b74f-231c-4b56-a6e9-a53a6b7c26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9b42b74f-231c-4b56-a6e9-a53a6b7c26b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e1ca6e27-503a-4986-9e4e-1e8ed518a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_InterestExpenseDebt_e1ca6e27-503a-4986-9e4e-1e8ed518a9c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8a81a3e6-5efa-4927-931e-aa43af711543_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8a81a3e6-5efa-4927-931e-aa43af711543_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_4a17169d-6296-48ad-9276-4d23d30e4c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_4a17169d-6296-48ad-9276-4d23d30e4c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:to="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9565eca1-2de4-474d-8a9a-3f6262da4180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9565eca1-2de4-474d-8a9a-3f6262da4180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_32206651-2176-44ae-8748-87ea7c3cb6e0" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_32206651-2176-44ae-8748-87ea7c3cb6e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c523099a-9100-4262-a7f2-3c62e529609d" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c523099a-9100-4262-a7f2-3c62e529609d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended" id="i0ddc51f2656a48a8aacf4d3363d87ea6_NetLossPerCommonShareDilutedNetLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5afcdd6d-77b3-4305-ad73-a79b523f0688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5afcdd6d-77b3-4305-ad73-a79b523f0688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_021c9ec2-2332-4383-81c2-8c254d24501b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_021c9ec2-2332-4383-81c2-8c254d24501b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_69a4a28d-983b-4ece-bf2a-dfc5a99d5a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_69a4a28d-983b-4ece-bf2a-dfc5a99d5a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7fc74c16-92b7-45d6-939f-9e58d94c735d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_RestrictedStockMember_7fc74c16-92b7-45d6-939f-9e58d94c735d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_747cdf48-d2b4-4cb3-9f04-9c023f3f6d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_747cdf48-d2b4-4cb3-9f04-9c023f3f6d3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b0560e58-3a77-4b46-a109-0b2eb485b3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b0560e58-3a77-4b46-a109-0b2eb485b3ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4ac7158a-4d2c-435a-87cf-5c8f6b63a912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_PerformanceSharesMember_4ac7158a-4d2c-435a-87cf-5c8f6b63a912" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="extended" id="i4647106ba91b4a42a1aa69868dcd693a_EquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage_459d4c23-f535-4368-92f2-ad86efb103b0" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityDividendRatePercentage_459d4c23-f535-4368-92f2-ad86efb103b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare_64914ccc-16f2-4862-9153-f5270959758f" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionPricePerShare_64914ccc-16f2-4862-9153-f5270959758f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio_a341019e-de2c-4805-bd80-27611c6ab23a" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionRatio_a341019e-de2c-4805-bd80-27611c6ab23a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_db81dc00-9bfe-4923-887d-f8bc0da1fe7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_db81dc00-9bfe-4923-887d-f8bc0da1fe7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_d57d7154-54fb-4e83-914b-5ce8154b6b7c" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_d57d7154-54fb-4e83-914b-5ce8154b6b7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_3bd7839f-7a52-4d18-858a-d513d4227bac" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_3bd7839f-7a52-4d18-858a-d513d4227bac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_cd703911-ce4c-4c1f-9098-a6423367f5f5" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_cd703911-ce4c-4c1f-9098-a6423367f5f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_aee2b0d6-8262-4219-b907-62f7f89b2e21" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_aee2b0d6-8262-4219-b907-62f7f89b2e21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_64bf3673-abcc-47ce-b123-4e14d8db3566" xlink:href="mdxg-20210930.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_64bf3673-abcc-47ce-b123-4e14d8db3566" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0fc204d0-85d9-448e-be0d-5b358c88ff06" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0fc204d0-85d9-448e-be0d-5b358c88ff06" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_63abe012-1bc5-4da4-9fa2-17ab229f0bf5" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_63abe012-1bc5-4da4-9fa2-17ab229f0bf5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_a676a0de-2c4d-4167-9c9d-dc99fbd58787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_a676a0de-2c4d-4167-9c9d-dc99fbd58787" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_a9f12199-862e-45d8-a5c3-f849fca7dc4a" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_a9f12199-862e-45d8-a5c3-f849fca7dc4a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion_dc19869d-4c72-41d6-b87a-55cd3b592ee1" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquitySharesIssueduponConversion_dc19869d-4c72-41d6-b87a-55cd3b592ee1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a74102e3-b9d3-4ba1-87a0-014637b855ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:to="loc_us-gaap_ClassOfStockDomain_a74102e3-b9d3-4ba1-87a0-014637b855ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:to="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember_463a1ac4-572a-4c84-9a33-adfa06abbdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:to="loc_us-gaap_PreferredClassBMember_463a1ac4-572a-4c84-9a33-adfa06abbdf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_30bf2908-d559-4a85-ae39-d52e22e02ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_30bf2908-d559-4a85-ae39-d52e22e02ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:to="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_3481dce3-c2ea-4756-8491-43b4ef1bc27d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:to="loc_us-gaap_DividendsDomain_3481dce3-c2ea-4756-8491-43b4ef1bc27d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:to="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_51e34073-3dc6-4e23-8bfd-b69b6bb4d2d9" xlink:href="mdxg-20210930.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:to="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_51e34073-3dc6-4e23-8bfd-b69b6bb4d2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_15580d2c-fbff-47af-a406-779ee380eb5a" xlink:href="mdxg-20210930.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:to="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_15580d2c-fbff-47af-a406-779ee380eb5a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityChangesinSeriesBPreferredStockDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="extended" id="i41a99306fa214c0c84be83bf6b0ef535_EquityChangesinSeriesBPreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e335a1fb-4d8a-40ec-9d6f-6c39a63c98f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e335a1fb-4d8a-40ec-9d6f-6c39a63c98f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fc345ec3-26b9-4e89-ab22-d96730c7c09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fc345ec3-26b9-4e89-ab22-d96730c7c09c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_05bf6536-9793-4a3c-8141-5dfa81f2c6be" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_05bf6536-9793-4a3c-8141-5dfa81f2c6be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b2230e03-1d82-4a02-a573-f764a004250f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b2230e03-1d82-4a02-a573-f764a004250f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_efea8aac-b2be-4976-87c5-8bd633ce150e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_efea8aac-b2be-4976-87c5-8bd633ce150e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_947e8eb0-e888-440e-a699-66835406be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c444f3e7-a2d5-4d29-acc2-838b6c9e1f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:to="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_601a5644-b31e-4af1-97c7-e61a1ea4b102_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:to="loc_us-gaap_ClassOfStockDomain_601a5644-b31e-4af1-97c7-e61a1ea4b102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:to="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_b597479d-c892-4676-8fb8-5b6cbfcf63da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_b597479d-c892-4676-8fb8-5b6cbfcf63da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityRestrictedStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="extended" id="i4b5048074a794971b375f4eefdb90181_EquityRestrictedStockAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9bec2637-0bcd-4844-a62c-0941f00332b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9bec2637-0bcd-4844-a62c-0941f00332b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b4dd295-95c6-488b-af02-326351bd16ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b4dd295-95c6-488b-af02-326351bd16ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6c8712f5-8a7d-455e-8936-fc7089ae6981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6c8712f5-8a7d-455e-8936-fc7089ae6981" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a7da3cec-53c6-4818-be46-f9d0b23d96b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a7da3cec-53c6-4818-be46-f9d0b23d96b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9c5690b9-8423-4a5c-8367-7114b6ee5edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f8fb31e0-7f61-4a81-b941-680b83b2637c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f8fb31e0-7f61-4a81-b941-680b83b2637c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a212c08a-b2bd-4033-9e3a-5ed9a530829a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a212c08a-b2bd-4033-9e3a-5ed9a530829a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7aa45ec1-27a4-4059-97fc-56f8525c1688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7aa45ec1-27a4-4059-97fc-56f8525c1688" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_298dc678-c628-46ac-9834-442cefaad7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_298dc678-c628-46ac-9834-442cefaad7fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b8473ad7-df9c-4f82-ae90-fbc163b5abc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:to="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7d4245b-9295-4855-b663-6279f40e6877_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7d4245b-9295-4855-b663-6279f40e6877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_cf8502e8-7f4b-4bb0-a587-cc5573d7fce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_RestrictedStockMember_cf8502e8-7f4b-4bb0-a587-cc5573d7fce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5d4bc38d-e544-49a6-918f-409b400d2ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5d4bc38d-e544-49a6-918f-409b400d2ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_e667f507-424c-4a3f-ae58-a165af42de66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_PerformanceSharesMember_e667f507-424c-4a3f-ae58-a165af42de66" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IncometaxesDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/IncometaxesDetails" xlink:type="extended" id="i1d80ec994b34437a9f30671ff2579c67_IncometaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_904b949f-e865-4b35-8271-e6f2dbb667d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_904b949f-e865-4b35-8271-e6f2dbb667d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e1b60230-5239-4911-b75d-585d3c47d112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e1b60230-5239-4911-b75d-585d3c47d112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_5a122a83-2948-44be-b3cc-dfe47977cc51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_5a122a83-2948-44be-b3cc-dfe47977cc51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember_1cd7bc17-b6bf-4d2c-b89e-87ed410e42c0" xlink:href="mdxg-20210930.xsd#mdxg_CARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:to="loc_mdxg_CARESActMember_1cd7bc17-b6bf-4d2c-b89e-87ed410e42c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueSummaryofRevenuebyProductTypeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="extended" id="i8340028aea2f4748beb1dda00e57f35b_RevenueSummaryofRevenuebyProductTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01c45e26-5dd9-4ee9-a4e1-9e41fa148fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01c45e26-5dd9-4ee9-a4e1-9e41fa148fee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:to="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_85190f0e-3225-4d77-891b-bcaf93060d40_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:to="loc_srt_ProductsAndServicesDomain_85190f0e-3225-4d77-891b-bcaf93060d40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:to="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_9222f813-6c82-4cde-82c7-5970267428af" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:to="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_9222f813-6c82-4cde-82c7-5970267428af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_880d738d-6792-4d50-8bb2-da5d0ad3628c" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_880d738d-6792-4d50-8bb2-da5d0ad3628c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_4c08eeb3-d78e-4d45-8b7e-59e1620a4efd" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_mdxg_Section351Member_4c08eeb3-d78e-4d45-8b7e-59e1620a4efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a2ebf16b-cc44-4c29-8389-27b991f035e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a2ebf16b-cc44-4c29-8389-27b991f035e5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueSummaryofRevenuebyCustomerTypeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="extended" id="i726d4dd11e8c4d4490c2246ad9641ab5_RevenueSummaryofRevenuebyCustomerTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f7a867b-ec0f-473b-a39f-abe1506ad191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f7a867b-ec0f-473b-a39f-abe1506ad191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_8f2f7447-79e9-4c71-ace5-e3e48ae57462" xlink:href="mdxg-20210930.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_8f2f7447-79e9-4c71-ace5-e3e48ae57462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ec20c396-2d96-4033-bed7-2a246e377287_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ec20c396-2d96-4033-bed7-2a246e377287_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_e4173546-6e42-4ab0-87d9-7d79ed302c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_e4173546-6e42-4ab0-87d9-7d79ed302c8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_44e07530-cae6-46be-ba73-2e27391ff15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_44e07530-cae6-46be-ba73-2e27391ff15e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueCollectionsonRemainingContractsDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails" xlink:type="extended" id="i93a0eb60219e48c3a90ec1f6e743ce12_RevenueCollectionsonRemainingContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187be822-67eb-4afa-8b4d-06115115aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187be822-67eb-4afa-8b4d-06115115aa75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_209a53c7-e2f7-499f-aa08-cd70d474bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_209a53c7-e2f7-499f-aa08-cd70d474bcb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_30caa7aa-3861-4b28-bbb4-82543791a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_GrossProfit_30caa7aa-3861-4b28-bbb4-82543791a9f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_eba22072-1093-4e17-9789-ff88c26be855_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_eba22072-1093-4e17-9789-ff88c26be855_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_1002237e-97f3-449e-8e54-86abd15a66dc" xlink:href="mdxg-20210930.xsd#mdxg_RevenueGuidanceTopic606TransitionPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:to="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_1002237e-97f3-449e-8e54-86abd15a66dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3511d8f2-baf8-49ec-84b0-01a7db21de79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3511d8f2-baf8-49ec-84b0-01a7db21de79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_87ad89e3-40b9-4b8a-9f73-41b77867cae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_87ad89e3-40b9-4b8a-9f73-41b77867cae4" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mdxg-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DividendsAxis_1f0514f7-f215-4ecc-a4ec-873596874254_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_10c56867-2c29-419a-917a-781981ef26f3_terseLabel_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021</link:label>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_label_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]</link:label>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_documentation_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:href="mdxg-20210930.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:to="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b49baef6-73ea-4ccb-a373-7b35448e0fdc_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_6c42381a-3cf2-4036-82dd-8ad5c8fb76b8_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradenames and trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_cc27cb05-509b-42b5-8fe0-6621d1bbded2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_697ef86b-e3a3-402a-9f5a-1bf18111d8be_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_503e3264-5fbd-4737-a778-eae14f77ada2_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2acd76ce-94b9-4687-8c5d-a28699bba07a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_c4678a22-7189-4c57-8bab-5825e62ac9ed_terseLabel_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_label_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Deferred Financing Costs</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_documentation_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Deferred Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:href="mdxg-20210930.xsd#mdxg_NoncashActivitiesDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:to="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_21d406de-6e05-41d3-94cf-fa6cbea14514_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, conversion price (in dollars per share)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Price Per Share</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionPricePerShare" xlink:to="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f5feab38-6c2a-42c4-85ce-419713e6ad97_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3c2b2e36-7eee-4daa-a443-f57ebd52016e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_731b70e5-6953-4100-9988-4aa50021fcf0_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2efcde97-b47e-4ed4-bff2-16c3201a71a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_508f3ba8-70d5-4323-b3c5-73c319d64a78_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7bf4b6e8-267d-4626-ac74-3cffd1133808_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Principal Payments for the Term Loan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e1e28cea-8b1c-4e32-907e-6692672b1dab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_37afb9b2-c947-4e22-9e55-e17b8f16cb1a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e5257fba-31fa-4405-a2b0-694444d2f5a5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_d8cc9981-0782-47ab-8b40-c8e1ec43168b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_d657f9c9-ff46-4edf-9ba4-f44ce6954b50_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_ddd7c693-80e6-4a8d-ae06-f75af2dee2c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a8646097-9232-48e6-8a2e-479e4be825dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fd9c46be-b578-4840-9d9d-f8fa86124e82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3bd1bef3-7a2f-4d85-9e21-6c8aedd1c36d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_16c14d37-1b91-4b91-a5c2-0aa8f396abf1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a05c979c-a922-4cb0-8df7-55b4207d08b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (excluding the nine months ended September&#160;30, 2021)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1cebea24-cc3f-438a-81cf-e3616094e690_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a934d27f-331b-49fd-872a-ceace05d18af_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6dd68314-8a0c-408d-8548-1002c52a247c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6ab8afdf-f188-4bb4-9178-376fd3f539dc_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_bd42d7b6-fb90-4521-927d-b787187d688d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_0b0cef40-4a7d-4bde-807e-efb772ff5ab2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_65a7fb51-146d-4790-a2e7-d4f033badce8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3f4ca726-57fc-4d10-a28e-f8ca5865281b_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7607d012-d573-4446-bc68-ac48a5b3eb38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_ecf718da-510a-4069-b523-3205548c3b4d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_9a406aa6-254b-4aca-8aca-980489e1ba00_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, increasing-rate dividend feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_label_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increasing-rate Dividend Feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increasing-rate Dividend Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:to="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_7b699bd2-3686-4c9f-a40c-6214933fce1d_terseLabel_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements</link:label>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_label_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements [Member]</link:label>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_documentation_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember" xlink:href="mdxg-20210930.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_StockAwardMisstatementsMember" xlink:to="lab_mdxg_StockAwardMisstatementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_e3b5c61b-7d7e-41a3-8a13-4a4f0359e23f_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1b68d873-7699-4a14-803f-188ade8eb11b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_d7a0cd13-f4f2-45d9-9395-4313b65a2763_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_159bdd46-e127-476c-b9ec-f557c7a0b850_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_5d95bb75-e397-42a5-a723-aeae071748e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Activity Summary - Indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa38dd9b-0892-4102-bf16-04c37d96b738_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_68aa0877-0cf0-4f2c-8b34-b1f51c0c2da4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_77f0f09a-a1f9-43fc-a938-46b507ecc04e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_41370c9d-98ed-4f3c-8d66-543fec832db4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_11f99270-b767-4cd8-a032-97d720a08fa3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1fd552fe-9c1b-4501-99f5-e09bfeca79a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable options, vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_2fbdebcd-7133-4486-b30e-54851e9794a8_terseLabel_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of out-of-period error (Note 1) (in shares)</link:label>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_label_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Adjustment</link:label>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_documentation_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment" xlink:href="mdxg-20210930.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TreasuryStockSharesAdjustment" xlink:to="lab_mdxg_TreasuryStockSharesAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a3b82af5-2266-49d5-a0f7-cbdc4a68b23d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_3a70eb84-7a54-4d8c-ab86-cb0f9bd8b3e9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a43d4b7e-0998-4149-a3fd-636ab85ef58e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1fa3986f-cd19-4e93-b473-7ca382cd1293_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_2c7ff6b3-66ad-4893-8701-4eebd12b332f_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_889f19ae-f4ee-4741-9f53-01f09e457236_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ffe4e980-dce8-4dd3-b95a-64fb16dd28b1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_ffdfa254-e4ff-4a1f-a763-fe0060a95c0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CARESActMember_07c40b45-e094-4a85-852e-b78a133e284d_terseLabel_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_mdxg_CARESActMember_label_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act [Member]</link:label>
    <link:label id="lab_mdxg_CARESActMember_documentation_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember" xlink:href="mdxg-20210930.xsd#mdxg_CARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CARESActMember" xlink:to="lab_mdxg_CARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_4a16a540-59d6-4ffc-9e67-bee0650ed866_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1f0fe91d-17e2-4a7a-8f5c-06329d2cc1e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_54496085-91de-4773-bf85-ec8ab59ff2b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Antidilutive Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_9c5db0be-8e23-4db1-b996-1a9c0e6c0f33_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_66ebaf50-101b-4882-b7f6-01051fdc4ce4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_eca04504-ecd2-451f-87fd-92714b7ab31c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_91488d60-d8e8-446f-9ac2-0159c1562324_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equipment in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_472de306-5516-4988-87c6-75d8e55d3c7e_terseLabel_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable for sale of property and equipment</link:label>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_label_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable For Sale Of Property And Equipment</link:label>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_documentation_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable For Sale Of Property And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:href="mdxg-20210930.xsd#mdxg_NotesReceivableForSaleOfPropertyAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:to="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_13b51a2c-219c-4dc3-8d1f-2e54ab4ecfdc_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_150f9a83-a97c-4616-b46a-f95843b30496_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5940d186-ac73-4432-b982-ba8e75f3a436_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e02c34e2-0052-4b49-b07d-d3679cf44d64_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_e1e6673e-c943-4be8-9aa0-9435e857cdde_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c17bfac3-90ec-40aa-aa99-857aef9a9402_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_b974324d-90a0-48bd-a5af-b159d5ade8af_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, threshold number of consecutive trading days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:to="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_9266eb75-a98d-468f-b33e-ad890a0fa969_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_0a338951-1184-401a-b8ff-1d56023e14f3_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of beneficial conversion feature</link:label>
    <link:label id="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_label_en-US" xlink:label="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Beneficial Conversion Feature, Amortization</link:label>
    <link:label id="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Beneficial Conversion Feature, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:to="lab_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8c5b461d-a3ca-4b50-9101-13e5d3953902_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_dbbb0927-d8c4-4928-9c88-d0c07bfd0b34_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1071635a-0a28-405a-a873-7808fd4c1b34_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_243cb172-dfd4-414e-b09e-5e5473c202c7_terseLabel_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cord</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_label_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Umbilical Cord-Derived [Member]</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_documentation_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Umbilical Cord-Derived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:to="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4b917365-46f7-48ee-a8b4-b72ffdc1756d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TermLoanAgreementMember_3f824819-da74-4f9e-bf5e-37bb9c896f9e_terseLabel_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BT Term Loan</link:label>
    <link:label id="lab_mdxg_TermLoanAgreementMember_label_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:label id="lab_mdxg_TermLoanAgreementMember_documentation_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember" xlink:href="mdxg-20210930.xsd#mdxg_TermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TermLoanAgreementMember" xlink:to="lab_mdxg_TermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9968b0e8-a88c-4c2b-a6b0-08fb7c0a67b0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6248d7db-05e7-453b-9356-71409a541691_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ad9fd22c-62c4-4086-99d0-40b141d9e1b8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99464090-f9bc-4ca7-8e76-25172388d29d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_b68be431-ea08-4d61-8a84-74f32891ec7c_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_83b10c74-85bc-4a3c-b237-20200253210d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_20086dcc-e41d-4cc5-b83d-e6976ae04720_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9f794e37-89d2-4873-9d68-a43701a758e3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_4d9fe480-0ed2-47cb-9590-f67c46eb6c3c_terseLabel_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate impact of discrete items</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_label_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Discrete Items</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_documentation_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:href="mdxg-20210930.xsd#mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:to="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b0630814-f05e-4373-843f-7b7e74af1a45_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f9300e49-6999-4906-9e97-b2c5fe071a03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for tax withholding</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AssetRetirementCostMember_62c85192-5175-471b-af5b-cb0adc70c423_terseLabel_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement cost</link:label>
    <link:label id="lab_mdxg_AssetRetirementCostMember_label_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Cost [Member]</link:label>
    <link:label id="lab_mdxg_AssetRetirementCostMember_documentation_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember" xlink:href="mdxg-20210930.xsd#mdxg_AssetRetirementCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AssetRetirementCostMember" xlink:to="lab_mdxg_AssetRetirementCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_94f0ce78-b452-446c-b033-01fe89ec8087_terseLabel_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease And Financing Lease, Right-Of-Use-Asset</link:label>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease And Financing Lease, Right-Of-Use-Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:href="mdxg-20210930.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:to="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_b6be930a-590f-4b88-96db-5ec5c3ccb759_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series B Preferred Stock (in shares)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_label_en-US" xlink:label="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued in Period, Shares, New Issues</link:label>
    <link:label id="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued in Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:to="lab_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_Section351Member_b1490f37-f417-4e0d-9466-8284ba889c14_terseLabel_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351</link:label>
    <link:label id="lab_mdxg_Section351Member_label_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351 [Member]</link:label>
    <link:label id="lab_mdxg_Section351Member_documentation_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_Section351Member" xlink:to="lab_mdxg_Section351Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_3a4d9412-1e5a-4266-acab-4614c7381af3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_7293f285-f256-4f90-848d-f69531a4f22a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_f314b04e-3254-4f67-8253-7764391967df_terseLabel_en-US" xlink:label="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Guidance Topic 606 Transition Period</link:label>
    <link:label id="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_label_en-US" xlink:label="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Guidance Topic 606 Transition Period [Member]</link:label>
    <link:label id="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_documentation_en-US" xlink:label="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Guidance Topic 606 Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:href="mdxg-20210930.xsd#mdxg_RevenueGuidanceTopic606TransitionPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:to="lab_mdxg_RevenueGuidanceTopic606TransitionPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a72f619f-603a-4a56-ad4e-ebe02380866d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_29645bbe-4bd2-4013-b7f8-1044d9200e13_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash&#160;flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_46c280b4-f41f-4685-a90b-10543d6d335f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_683360cf-44dd-469a-99f5-7a83875e9ebb_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_8a24888c-7248-416f-b5c1-b6cc5131c135_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_098ba357-1e91-4db8-900e-d56e0679151a_totalLabel_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total adjustments</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_870cb33d-56f8-49e8-bbbe-3df6781f9cdb_terseLabel_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_label_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_documentation_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:href="mdxg-20210930.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:to="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_88a368cb-1f5c-4f82-a6cf-9eacc3c114ad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_11602e84-cf24-437d-9224-cfd9d50d0f80_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7f08d478-72ae-41f6-9f68-52e89c7f9303_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_3b32e1ad-605d-4a91-b852-542aaf650568_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal costs</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_be336bde-16d3-46a5-8cc5-e69286fe96fa_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued GPO fees</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_57a0b539-d860-4a8e-9fc2-b4aedcf536e0_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3934f245-331c-4793-898e-38ae5ba6a0fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_274a8548-8ec3-49cc-ba6c-1fa395748a8e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_36f8ba3b-9597-459d-9fa3-114475e7f1ef_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_29e7391e-34d9-4940-9da1-2d73fd7c87fe_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_093959d1-a1ff-48ef-ab92-c00f4b08dbb5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_75cf826f-0f06-4fd6-88a2-1574e32687f2_terseLabel_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of Series B convertible preferred stock</link:label>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_label_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Temporary Equity</link:label>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_documentation_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:href="mdxg-20210930.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:to="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e4d1b22f-8268-4651-9ba4-17de7efe6228_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_de1de235-c12b-443b-bf2a-97d11dcb8a8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c73885d5-e522-40ea-b5bd-9201e26447b8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_34b90790-41d0-43fd-b172-f243b07f4084_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ff95a8df-e23e-4016-93f7-a8c8c23f99a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e7df493f-97da-4632-959e-aafe6bf3ec82_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_65c4a96f-0734-4245-8701-567318c45f63_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_0360ee6f-0788-4759-acc6-c4dde34c3343_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6c6b7c5e-5572-4ec5-8521-bd28991da430_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_8b4e82f8-21e9-4f70-bd73-45aed52d6a36_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_ab42c833-5928-4422-8123-c6c447e6b404_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_aeb886cf-3189-49d8-a017-f220f093ffaf_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_63bdd5a3-4116-46a6-804b-37f91f3470f2_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b299eaf7-f0a3-4d22-bda7-c6e990100182_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_70c58a3d-8bfa-45b7-873b-39f76117bb40_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_8793afa6-7cb7-4c0b-9e07-be45fe3866b4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_019ed051-de7d-4862-af91-36224514ffe8_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days within consecutive day trading period common stock must exceed trigger conversion price</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Trading Days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_1c561418-52b4-491d-a241-8f97e89d5234_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d908ccd4-f084-422a-bba0-38b0e022473a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_21b2cdd4-d35c-4ef2-94da-60178343cdf0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_93f81948-140a-47d6-921a-3d1cee4fb27d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_b76201ca-6ca2-4179-8ec5-cf94908f9a05_terseLabel_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of non-cash consideration received for option exercise</link:label>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_label_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value Of Non-Cash Consideration Received For Option Exercise</link:label>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_documentation_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value Of Non-Cash Consideration Received For Option Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:href="mdxg-20210930.xsd#mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:to="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AccruedRebates_26e6d0d1-1771-49a6-9e78-03d25ce33c18_terseLabel_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_mdxg_AccruedRebates_label_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates</link:label>
    <link:label id="lab_mdxg_AccruedRebates_documentation_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates" xlink:href="mdxg-20210930.xsd#mdxg_AccruedRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AccruedRebates" xlink:to="lab_mdxg_AccruedRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_01fd3148-c522-4e89-9a5f-42bc8f50ed38_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e8683ca7-3331-4010-929a-54adc4637610_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_a73b8afc-89e4-4d62-882d-3c44325d2a73_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ba8e62aa-1a88-4f94-99ee-6b330d5f20fc_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_66503fd3-f44d-459b-b708-f13960930260_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_4c7ff8d3-9f92-4df5-b0d9-57f18c0210d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_4711f813-0e0b-48d5-970d-24fd2362070e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax refund</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d156f047-0b30-4968-98e3-c8a932e96122_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_fd937f7f-b135-4440-8d91-70402b45fbd4_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c36cf836-ef24-4a40-9ac9-c04c872f0b1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_33285012-88b9-4154-9fc8-c8d6b6a5c9d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_45c370c9-5358-42d0-b184-6d16958602b3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_1ffd86ec-aa7f-4372-bae2-58332ce4ff5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NumberOfProducts_ee995171-4f0b-4a21-8d20-27a8a0913e19_terseLabel_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_mdxg_NumberOfProducts_label_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_mdxg_NumberOfProducts_documentation_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberOfProducts" xlink:href="mdxg-20210930.xsd#mdxg_NumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NumberOfProducts" xlink:to="lab_mdxg_NumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_4772cbf4-cdda-475c-873b-dbb675261b68_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of increasing-rate dividend feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_label_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Increasing-rate Dividend Feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Increasing-rate Dividend Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:to="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_7a623acb-155e-416e-907e-19af7df2a47a_terseLabel_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment fee on BT Term Loan</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_label_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Debt Instrument, Amendment Fee</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_documentation_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Debt Instrument, Amendment Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:href="mdxg-20210930.xsd#mdxg_NoncashActivitiesDebtInstrumentAmendmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:to="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cd3c5bc4-d432-41d3-bd5e-3fb9fa56a003_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,926,898 outstanding at September&#160;30, 2021 and 112,703,926 issued and 110,930,243 outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3af1bd34-fea1-4584-9d10-e3ab25c4c496_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5f432c5a-6940-44cd-b439-7f1450b96c6a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d2597a79-7a33-40ff-adaa-a77d98a140bb_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_26094a48-e8d6-41ac-b687-df20c0c6efbd_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock unit awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_76fc68af-b49a-4bc9-90e7-022eaf67d3d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_8009f4a1-cba0-4a4d-b74b-b8db30822f5e_terseLabel_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and supplier relationships</link:label>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_label_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer And Supplier Relationships [Member]</link:label>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_documentation_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer And Supplier Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember" xlink:href="mdxg-20210930.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CustomerAndSupplierRelationshipsMember" xlink:to="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_141f36c3-9edc-4f15-b67a-fd6b55fd65ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_9c3f6364-651d-4c4f-922f-c7e30d52ad92_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CreditFacilitiesMember_5a250a4e-babe-47bd-8b34-7f23bd30e431_terseLabel_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities</link:label>
    <link:label id="lab_mdxg_CreditFacilitiesMember_label_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities [Member]</link:label>
    <link:label id="lab_mdxg_CreditFacilitiesMember_documentation_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember" xlink:href="mdxg-20210930.xsd#mdxg_CreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CreditFacilitiesMember" xlink:to="lab_mdxg_CreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_156fd3f4-01ee-4622-bd3d-0c322c308fc8_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs</link:label>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleofDebtIssuanceCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:to="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_006173d4-eba1-4898-8d18-3de8f27a2ea9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_98015a08-ed25-4c4d-a2c3-2a79eeec1d45_terseLabel_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, minimum liquidity</link:label>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_label_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Minimum Liquidity</link:label>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_documentation_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Minimum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity" xlink:href="mdxg-20210930.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtCovenantMinimumLiquidity" xlink:to="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_ac4713a9-80af-44a7-a364-76d704b4e43f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_55b513bc-9a59-4413-bbb0-ad1c3dbc3fed_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_label_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</link:label>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:to="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_e0452585-0e1d-4afb-b3fa-f6e1ab699850_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f4725131-d47f-4b87-93f2-5b95dca2e049_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d2b4f11d-f4c0-45f9-9966-75c7c48f26d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_c349b1ec-2c17-424e-9695-9ae8a8e98c1b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bc6205f4-700e-4329-9054-0be86672e95b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FinancingTransactionsMember_479f458c-0675-4453-8b5e-c8626b51573a_terseLabel_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions</link:label>
    <link:label id="lab_mdxg_FinancingTransactionsMember_label_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions [Member]</link:label>
    <link:label id="lab_mdxg_FinancingTransactionsMember_documentation_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember" xlink:href="mdxg-20210930.xsd#mdxg_FinancingTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FinancingTransactionsMember" xlink:to="lab_mdxg_FinancingTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_2d25f83a-9e16-48d6-9d85-0d292819fefe_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_d107cd03-24ef-4af1-9295-9f815ca0aebe_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_5b1eba23-d92b-4630-954e-4e85f676772a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_381b9234-9251-4a5b-92d5-9597be74f1d8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_278a5393-c09f-4c4c-bf2f-b8796850712d_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredClassBMember_32dc8b28-a412-4206-9458-213b20988fbb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Class B Convertible Stock</link:label>
    <link:label id="lab_us-gaap_PreferredClassBMember_label_en-US" xlink:label="lab_us-gaap_PreferredClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredClassBMember" xlink:to="lab_us-gaap_PreferredClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_91b5d895-3049-4f16-a748-13c101847558_negatedTerseLabel_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent application costs</link:label>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_label_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Application Costs, Patent</link:label>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_documentation_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Application Costs, Patent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent" xlink:href="mdxg-20210930.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PaymentsforApplicationCostsPatent" xlink:to="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_62bab5f8-6d08-4efb-9ad8-59001a068e9e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c3c5520f-ac0c-4adc-9dee-e8c225c9f299_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_f3c48c2e-2a6a-4ae9-9b17-4e1b2c12f498_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, ending</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9f4e3149-9bb1-4f2d-a491-619eb4153eda_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_6ad8d255-7573-44f2-a5c0-9a5379f2c85d_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ec9cac84-9997-42d4-8b14-8a7f8d1b5a37_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_60811b8f-aa20-433e-b937-a63e569a29dd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Options, weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_16d8e148-de12-45f6-be9a-45ef9ae1d72c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d3a0e750-9807-451b-9d24-46b8284884d8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net loss available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_8b50e23d-8dd7-4a12-8012-5c0ec807faef_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:to="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f530b78a-7bbb-4530-90ca-92f0f0cc8060_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_971b0bff-9d12-42d8-9f99-3bda93bdf457_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional commitment fee (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:to="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_32f5adf8-dbbf-48d7-9546-f679d9ff536a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_0d76eec4-3cde-4454-980e-9a519c192962_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_190f4afd-cbf3-4cd6-b7ec-57b33c70ef5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_33219a68-b5d6-42a7-880f-6841e34b5cc7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_ff95d99b-26ba-4b85-991d-69d1679373a3_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e3e18a85-504a-4401-97e5-6ba54b7effb3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_789f64ad-5883-49d5-991c-73a84c9f92f6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_29b9227a-4cff-4dff-a2e2-46d1e69f5480_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3c9a639b-0664-4113-814d-f80d938168a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2d6b361b-11d2-4c71-ae69-ab00500b7e2f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b5be2876-a49a-4c30-9ed5-4809bf40656e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2ca2660d-1d50-4b8f-b644-e52d1c785883_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_f5bbac1d-a026-43c8-b2de-9c3a6be78433_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_39c533c6-9f30-4534-a758-add4d8bc6e7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_cb226ac1-2770-498a-bda4-7a293107e540_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_d4da5acc-604a-4acf-85a7-332f1245272f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_12268629-1fb0-4107-820a-b2f7801ade94_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2a13ca8-d78a-43dd-8c71-f14b68513364_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_981f7576-b4f7-425b-9b17-8f7feb37b468_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_8e7dc4e5-5959-4b05-9203-7b76180f81b9_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_a67d7c09-d2ad-49f5-bda8-71aa6372af9c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Customers</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f1963a19-0be9-4718-abc9-ad312829f4a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a17a01e6-f336-4a60-8319-6e16e77d09a3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_b3fd6b27-fe91-4bfa-9fc1-ca79176d43b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_b0f40f5b-3f09-4380-bdd1-9860e701b215_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f24b04d3-e14a-49ae-802a-984c1a905a23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessment of Revenue under ASC 606</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_a0c0d7fc-8131-4183-8452-a8f7c45cedac_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible stock, cumulative dividend (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_label_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate, Percentage</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityDividendRatePercentage" xlink:to="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d0274a4e-c147-473a-8021-804378a6fa63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_b6bf90c7-e4ac-4366-8e4f-4ded9527c0c8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Term Loan</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_92d8303c-eac9-4c2d-a230-d542484f91de_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_a32d5553-07e3-4c57-8e4e-07518e6fad2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_53e07800-703d-4937-a5d9-e38ab67b476f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_92d6c519-99e9-4adb-a425-095f29809476_terseLabel_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of primary distribution channels</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_label_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Distribution Channels</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_documentation_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Distribution Channels</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:href="mdxg-20210930.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:to="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_07384abf-3a5f-41e5-9e05-e04e152ec8dd_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_1f4e88ae-abfd-49e5-b5ec-7766d16d6a96_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PatentsinProcessMember_91ac6ccb-8063-4f34-a0a4-9402723d444e_terseLabel_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in Process</link:label>
    <link:label id="lab_mdxg_PatentsinProcessMember_label_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in Process [Member]</link:label>
    <link:label id="lab_mdxg_PatentsinProcessMember_documentation_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember" xlink:href="mdxg-20210930.xsd#mdxg_PatentsinProcessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PatentsinProcessMember" xlink:to="lab_mdxg_PatentsinProcessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_c1a51935-3845-4642-8059-b821a43871c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium on early repayment of term loan</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_2a7b51a5-76c1-4105-afe1-9934e13dc442_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_74fb4093-9705-4b58-b7ad-c5659b96c28e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_d1e79e42-86b8-49dc-bf98-d60c0a873455_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred convertible stock, shares issuable upon conversion (in shares)</link:label>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_label_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued upon Conversion</link:label>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:to="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2705e217-77dd-4b41-bf19-2e168f507d3e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1e35d06c-2a8d-4a18-9b52-9a69da0d9dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_5fc30ba3-1981-471c-9ac0-07821b403ab0_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_730356f9-20c7-40bd-a4ea-ac9760d650bc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d01f0cb7-47fc-4771-b746-0c1ae934f959_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c80bc389-2e48-4662-9a13-e190e9a5cf69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested options expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5df212a4-bcd4-4604-bbc9-6358acb3b763_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6f2bc55d-478c-4ac7-9a1d-bf4500b3e88d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_06059e24-ac48-4184-a2b0-5098c124d19f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_741da3ce-f2e3-48c2-82df-1f57f1f77ade_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense</link:label>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleofInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:to="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7b7e1e9f-c650-446a-9cf5-b70e0cf900e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d83e0f1c-d9fb-42a6-a56f-75f807afefde_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_41aabe5b-e04a-4413-8cb8-eaa79ecc0e89_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_57a522d8-de98-4b8b-a68b-cb73a33cdf75_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4c17c967-8858-4083-b579-3b8a84bebdc3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8df7e213-a8dc-45b5-8ed5-df30cc92edad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio_aa1449df-f501-47d2-ace0-fc9759a8caf4_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net leverage ratio</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio_label_en-US" xlink:label="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Net Leverage Ratio</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Net Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCovenantNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:to="lab_mdxg_DebtInstrumentCovenantNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4e1a5a86-e95a-4512-9824-435ed1e558d4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_d33e61a1-3a3e-48ce-b470-30e5ba291784_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_85e00573-d79a-49dc-bfb6-872e67fa0d2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_96168718-8be3-408c-af64-d8acaac5a633_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_4e9c0e58-1641-47fd-ad6d-b17abc65c3da_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ef9d785e-6e77-48e4-b0ef-f2084147c9b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d9e0147c-5b47-4e15-a756-50babeff641e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5070594e-262e-4239-bfba-90ef11f7b931_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsAndNontradeReceivableTextBlock_23260650-22a3-416b-9595-5e4aa117f569_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Nontrade Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsAndNontradeReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Nontrade Receivable [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:to="lab_us-gaap_AccountsAndNontradeReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35c51fe0-e144-4b72-9bdb-661b0e92687a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_18a486a2-6081-4cfd-b089-b9fc2a2e86f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_a004dc7e-6f6c-4f61-8634-fdcc6ec74e31_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_022da5f2-5d5d-4acb-b915-fdd2914cef1c_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d3ab363e-912b-4c58-b481-5bea806e1e63_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_37faa618-d840-4546-a2d5-ffbda32523b4_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6755de55-7cb6-4476-9fdd-f11add73c93f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c4f86124-bde9-4d06-95af-c63e6ca1f857_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_11372208-2e99-49e3-8364-1d59ca5a63d8_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0d1025f5-1017-43d1-9e2b-930cb96f4d32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f794fc14-ebde-4ebd-a665-15cb2ac69dba_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_5782d0ef-1ec0-4b38-b3d1-3631d431cbd8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_205de3b8-aa66-416e-8bec-ce738befa0b1_terseLabel_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour" xlink:href="mdxg-20210930.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_LongTermDebtMaturityAfterYearFour" xlink:to="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_83d36cc0-95f9-48dd-8d82-a00b9d540ff7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying value, indefinite lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_8383280d-9adc-4219-9b72-fa982ee301dc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9e7abe61-a683-472a-be6a-8290da2a65a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b4c64f20-9c6a-4d14-aee6-581cc7b788ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_04299095-357a-45f3-8c84-b3637f4390ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (expense) benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_ba04a3ac-dd5f-480d-94f9-ec437703845e_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Depreciation Expense</link:label>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Depreciation [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleOfDepreciationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:to="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8c893041-dc10-4ea6-863e-27f20bb30cc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_12721581-b91e-4d9c-aceb-873f0dad8e7f_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2ac31826-cc39-4795-b4a4-ec33cccb4d56_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_4c02820c-5225-4d22-bc15-53361642ddde_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1eac34c0-6037-4daa-a779-ba428af92531_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c85f236c-69e9-4005-a8ca-1f721efafd4a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8d2998ed-a058-4999-8632-47c112a3ac22_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ccbaed37-8f8f-44d9-91f3-514a63e52249_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_d6418929-c07a-499c-81b2-e29ed8c3255e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_d9d0d298-c556-43a7-918d-dae057992089_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c2cbfe00-d63d-4496-a3fe-cb06882a4e32_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_533e4ad4-7024-4e95-8a4e-b61edacd8e11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b3f77a43-577a-4cc4-8ed7-721ec317ecc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested options expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_52b5f5da-9b68-4d82-8e8c-59563824e5c4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_069de96e-6f58-40a6-91f9-9de1dedcc079_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c6b0663-49a9-4a48-9c5b-28344b168de2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4b8ca4f4-9771-41b7-8cc7-a82606616a5e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7d1d4d17-1f71-4d26-854b-ab5a0f56da8b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_4fa71800-8ef7-4bdf-84f1-e51d08d5715f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_c60ce3a4-7be4-415d-932a-efa4495ecedf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6a97c2ca-ae4c-44f8-ba61-4ae1fcae0a7c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_11638698-ee5a-4bf6-a1c6-f7cd78b310ba_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of original issue discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_ea0f7360-1218-4b97-b272-82a6c78a0373_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_82888ab2-3129-4869-82a4-2f20cddf97d4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1c7a7e35-0321-4cc0-b971-374f031e67ac_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f04442de-8296-40a3-9bfb-cfe9b2508a98_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_707cd41a-feb5-4dd4-a2f4-db57f0aa5681_terseLabel_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue/Other</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_label_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Tissue And Other [Member]</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_documentation_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Tissue And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:to="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_666762aa-3e9a-469f-ba6a-051295f82e29_terseLabel_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued clinical trials</link:label>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_label_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials, Current</link:label>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_documentation_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent" xlink:href="mdxg-20210930.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AccruedClinicalTrialsCurrent" xlink:to="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_93bad1f3-a97d-4e0e-a3ac-4cb576c2e4a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock canceled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_679c2ef8-ae8b-44a2-8699-4ff7af9003fd_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8e244e19-d685-4b86-b9e8-1dc7012e2b18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_983d0742-6353-4cfe-97f5-b5adfc737e11_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation&#160;expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_6357f7af-661c-4fa0-9db0-45c4a75d4bb8_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_e160ff37-3d80-455b-b05d-c66109d66e8f_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ff14815f-c601-4309-a798-d71a76751b31_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_c2c1cad6-b338-4863-960e-7c88b4a6fab5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_102a2db0-beff-400c-9c16-69c2f67afc22_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ce51db8-f738-4c06-bab3-479c08508592_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_4e5f6cf1-77fa-4b09-bde6-ca6b05184eb7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e09f88f-a539-412f-8e38-936c9f12fb5b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_7060cc37-8fb0-498a-8bd2-9e633011b0cc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_de644a62-3650-403b-9085-d4d0fd9e0dfe_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_cfa098b7-8b19-4aad-9379-16b737c013e1_terseLabel_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, restatement and related</link:label>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_label_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, Restatement and Related</link:label>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_documentation_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, Restatement and Related</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated" xlink:href="mdxg-20210930.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_InvestigationRestatementandRelated" xlink:to="lab_mdxg_InvestigationRestatementandRelated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_7e9b2c0f-34af-4984-bd15-2711cdf809c5_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5c7a22ad-da6d-4124-b6f9-a6f367ab9798_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7ab9628f-8b5a-4341-aafb-37d697704bbc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d5eae041-e7e5-4f0e-b81b-3b773bce832f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_8ca6ff85-b318-454e-aec9-d944d8b78bd6_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_032b7d53-9ae0-4cde-be6e-d70c4883c57f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_477d1be2-9734-46a1-8a8f-e1deb49d8af4_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_d7417ec0-4be8-45c8-a81d-c6b763b7bb1b_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio of Series B preferred stock to common stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Ratio</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionRatio" xlink:to="lab_mdxg_TemporaryEquityConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_33e5c16a-724b-40fc-b8d9-3c4715be3642_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3e1f9ec4-15bc-4fd8-a551-46bc3f37677d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_cb790aac-8a1c-4cb1-a900-4c3160acc81f_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care</link:label>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8cbc3320-150e-40ca-96c7-7a8c8d2795f4_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common shareholders (Note 9)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a0418e99-6b4f-4969-9093-b962e4778460_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5c343f7a-7571-4a9e-9cfb-069b6525c70e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_3ede5333-d2cb-44dc-9405-4d5e86318e34_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_275cc0e9-5a22-4d84-868d-353f6168f41c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_1a73c7fb-de0c-4ec0-a3f2-208fe867d932_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ea4f58f-bb05-4e93-8ef1-2a2d1c002853_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_a55aabeb-4c38-439c-a76e-7b5041282091_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated returns</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_13ad0405-3ef8-49bc-b673-af1bb3ea0436_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a277528-8c65-408a-b0f2-2f6199d33bd6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_4d0c5235-f50c-472c-95d6-37030d73d93b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_ff5baaaa-a6f6-4835-b75e-5fe8e17ad612_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_b80afd21-de8f-4af0-921a-b1d0a9d8b750_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2f405dfa-d2ef-4e58-b499-de2b8a67642a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_562fa027-698a-4a96-ae76-5581396bef1d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5c422dbc-cc13-4a56-b1c6-dd153a160446_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fe8c028c-e7d4-495d-9a90-324baeea2594_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_faf2a591-501c-4b9b-b238-1cb616a47aa9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net (loss) income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a1abbe4c-619d-4e6d-983a-28a4f87eaa1a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6da78f68-e4b3-4cae-907f-70aa7697735a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expenses</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_bed84518-6ca3-4eab-9af9-4ad59c73a0bd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_3bb63d10-a45d-4dbd-9c49-6314fe5e6824_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_dbaeb067-bce2-4474-a5cf-05511bb6a42b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ac85a8a-be7f-44fb-afda-4a66fb771370_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_e42c4eaa-fd41-460a-89cb-92c59de0fa52_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c9039c2-8c48-47da-a55b-cbc3fd0e4750_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_1d6c00b6-fcef-4d42-886f-1beb3fe39b1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost; 777,028 shares at September&#160;30, 2021 and 1,773,683 shares at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_StockIssuanceCostsIncurred_f117c323-e447-4832-95a9-368058a0f25e_terseLabel_en-US" xlink:label="lab_mdxg_StockIssuanceCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_mdxg_StockIssuanceCostsIncurred_label_en-US" xlink:label="lab_mdxg_StockIssuanceCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred</link:label>
    <link:label id="lab_mdxg_StockIssuanceCostsIncurred_documentation_en-US" xlink:label="lab_mdxg_StockIssuanceCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockIssuanceCostsIncurred" xlink:href="mdxg-20210930.xsd#mdxg_StockIssuanceCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_StockIssuanceCostsIncurred" xlink:to="lab_mdxg_StockIssuanceCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_41c6c7c4-5237-4b4c-87c5-1a97b0e0eb33_terseLabel_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mdxg-20210930.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_c2a06ffd-23ad-4da0-95ea-2ea914556fec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Awards by Award Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_64ad8190-33c5-48bf-8a89-722b3f441b6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock canceled/forfeited</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7c56e88e-0312-4721-bf67-2d0deb090bff_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_d0dcc863-e90b-4eda-af1b-0229c4955bc0_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e57cc689-f0cc-480c-ab6d-0a13ad9bf049_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_f38ee4c9-0229-46bf-af4f-86bd2cd884cb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (excluding the nine months ended September 30, 2021)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6cd361dd-4b88-4110-97c4-81b859bada84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_988b9957-3f51-45e4-8709-cda568b66457_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6b2a6a72-e6ab-47e2-90bc-abd1cc02d782_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef5f2520-8b49-4027-baf6-68c39de1510e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9d2fc810-05c5-4235-a674-6b16fc1b5fb2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_c69fedb8-1977-4562-8e21-74fa7ae07233_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_d154f22a-aab7-4e46-9dbb-f7073c7a9b43_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_08a2509a-b50a-4085-9514-9a8f11d25cb5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_1382cbd9-5551-4901-90da-ce5afd536f7d_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ab5ec401-530d-47aa-9bc7-cdc154c1fb83_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_2b0fc48c-7ea6-47aa-a7e8-80aef2b96548_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, floor (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_label_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Percentage</link:label>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:to="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_14802725-6d76-4bf0-99fc-38ad88656de0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_039d0dad-de0a-4c16-8c91-598777038bc9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_32ae6576-b1a5-461b-9b58-90a3f46dd7c4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_520976d9-f7ac-4954-85d3-ba5f8f9168f5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f653075f-d21d-4309-81b6-bd0de51f6ee4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_17dcaae1-69c0-4175-99cf-8feb08e1c2c5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9962e8c7-f274-4276-a879-2e748df40f14_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7799479e-18bb-4d32-a10a-f418ea6c7cec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cf3e64d4-3141-44e2-b4f2-37f1e623cced_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Amortization Expense for Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2c24ba4e-09f0-4bb0-9455-8ca0773455bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_11623dbe-0a1c-4ea4-b7de-494cf9dcebce_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_fc2c357d-4b38-407f-9145-711f5b0784fa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_fac202d1-b2d4-4d14-9378-72def5c84f8d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_896522b5-e29c-47f5-b2cb-5dd12857f50f_terseLabel_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of basic and diluted net loss per share [Abstract]</link:label>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_label_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of basic and diluted net loss per share [Abstract]</link:label>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_documentation_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="mdxg-20210930.xsd#mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c4fb8aec-ca61-4310-80b3-b0c39776405b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_34591b3f-a6c5-4d6f-ae98-d49bf11bc462_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityDeemedDividends_ace02e9a-5ea0-4a14-a3b0-5318a931cceb_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityDeemedDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDeemedDividends_label_en-US" xlink:label="lab_mdxg_TemporaryEquityDeemedDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Deemed Dividends</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDeemedDividends_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityDeemedDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Deemed Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDeemedDividends" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityDeemedDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityDeemedDividends" xlink:to="lab_mdxg_TemporaryEquityDeemedDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_d0373cb6-bd48-42d2-9cd8-c432c8fc2c22_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory and clean room equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_2a0af62a-e226-4211-ac88-012d732b8954_terseLabel_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities class actions</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_label_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Securities Class Actions</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_documentation_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Securities Class Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:href="mdxg-20210930.xsd#mdxg_ContingencyLossNumberOfSecuritiesClassActions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:to="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_5e0a62e6-3c69-4e67-835d-e3eec6afc43e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_474c726a-e5be-42ea-adcc-dd147869890a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_95d3042f-ca67-4a02-9d9e-d0e6a770d698_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_19196176-748c-40ef-9446-d5abc09a5565_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_b363582f-96fd-4530-865a-2c39f4d6981b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_e9301aeb-73ea-4369-bebe-cdef574e69ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_080e32ad-62f2-4fd4-81b5-bc5468c2bd22_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_82145dd3-db1e-4ec9-8563-298fa617a7fe_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and know-how</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_2fe1017e-774b-40b2-88c4-e3fb98c86458_terseLabel_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021</link:label>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_label_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]</link:label>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_documentation_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:href="mdxg-20210930.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:to="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_58b6442c-3875-46a5-8874-83fc18e86aae_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c5bef7b3-ce03-4954-8c76-4c983bb8ec5b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_fd323800-06d2-4c6c-9910-04a36dd56da4_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:to="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca01830e-973b-41cc-846a-002446177f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_2c8e4474-7143-4512-8a06-fa2c8b5c9f3b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a0c08897-d377-4dc9-90fa-6a99acfba83c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_41b7ceb4-bb1f-4bfb-af0b-04063fe4e894_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, gross</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_68e64d7d-a475-473e-8ec9-02ec9df746d6_verboseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated dividend on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_7eb3a1f5-6594-4656-84e4-a823e0beea49_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_label_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accreted but Unrecorded Dividends</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accreted but Unrecorded Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:to="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_972eb789-54f5-4b4e-980d-983e8618b381_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_55d1541e-b0b8-4dea-8834-754838af8af9_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_bd0455bd-3011-4587-865b-a15d8f29dedb_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_967ebb30-3e60-4491-a0cf-75e0cc8da45a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on fixed asset disposal</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c38272d-75ca-45ad-bed0-49c6763c8198_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4140961-2b3d-4657-98d7-4b08f5b3e38e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_22a68532-8eb5-472a-9741-4f96a0e43cb0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_b371811c-88de-4098-a2d6-db0e1dd807dc_terseLabel_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right of use asset and liability</link:label>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_label_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right Of Use Asset And Liability</link:label>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_documentation_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right Of Use Asset And Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LeaseRightOfUseAssetAndLiability" xlink:href="mdxg-20210930.xsd#mdxg_LeaseRightOfUseAssetAndLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_LeaseRightOfUseAssetAndLiability" xlink:to="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_886131bc-e945-4bd7-b898-469306540e61_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_05388dd2-e993-486f-9bbd-df3c59ec6714_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_864ad5ab-e59f-4e01-8c59-dca59967ec85_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6c9ef499-c0ea-4d5a-acf0-ca1a4df1129a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Activity Summary - Finite-lived</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_506f65c6-2ece-4244-bdd7-fc40e66f8a6b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2a27dd63-ea0f-46fa-b2d3-a8338b8309f1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_bac1155c-51c6-4659-a2ee-8e2f49db5a34_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments from note receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_f032edbd-9261-4133-957f-80dee3b77552_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a0bc41b4-35ba-4754-a781-4a25e10e20b3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collections on the Remaining Contracts</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e27c2091-9447-4ec0-9522-925bf665172a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6b5847c7-ab3d-44fe-b2b1-3d68122483e3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_08f06a3c-acbf-4711-b463-a7ab18ffd087_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad72d512-6279-4546-a9b6-e3484f191539_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b870a911-632c-49c5-95db-add11e2a9707_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding adjusted for potential common shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a681831e-2f2d-465f-96c8-519b790d68ee_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d5a12f94-42f4-4b4e-9b24-87c382fbf793_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_97df30f0-34ab-46a9-8d5c-494645de1d1c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_dbd2bc99-b51c-4c99-85e2-818e9d290dd9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d169e249-9215-4b36-905e-7a8ad9fd476b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_6d1cf5e9-9da9-4215-99a1-69f3e109ca80_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:to="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_86934cb3-24fc-4cad-8c1d-4e67ecfbffc9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_04db89f7-80bc-472d-a587-586febdeee09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7ac176bc-6078-4619-afe1-b1496c8ad31d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_395dc033-e66a-40f0-9b1e-d7eb9ce5b1f9_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5fd04b3c-8e3a-4efb-9d9e-88fdc7d1ab11_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_884a51a1-1747-4598-bae5-1cf1c3a733e9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b78fcc1-95ad-4d64-9c7d-20a629f750ef_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a64a370b-19a6-49eb-97e9-c05dbfd9f37d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a02c388f-1d5c-401b-81c8-1078b11da792_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash resulting from changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d1b3fef1-89ee-47d4-a112-2a54f65bfdd9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6b030e12-9655-444b-9e95-f050079e1512_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_8a98d839-2243-4e58-a0d0-21240c0e01b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at issuance (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_dd45ae74-d950-4708-9b17-15ebfe711aac_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_f8df1d06-99a5-47e8-a606-ecf56c25210f_terseLabel_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of board seats elected by Series B preferred stockholders</link:label>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_label_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Board Seats Elected by Temporary Equity Holders</link:label>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_documentation_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Board Seats Elected by Temporary Equity Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:href="mdxg-20210930.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:to="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_91c09323-2bcf-41e1-9aad-17e883086d34_terseLabel_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit recognized with respect to net operating loss</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_label_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_documentation_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:href="mdxg-20210930.xsd#mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:to="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_a3c7af77-65a7-45c3-93ae-c9f551b247e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1c750cfe-c2b0-475c-831f-2daf30d0eb36_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_43749f45-320f-4dbc-a825-f68ad35476ca_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_654d569b-36d4-495c-a9a5-a605aadc485e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased for tax withholdings on vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2e934f21-6aab-4af5-a086-2108d85717d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_4eef7c57-b26f-415e-8278-2ecbbe0e443a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions to sales agents</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_97ea37c6-72f2-462a-8bd0-74e5094f5caf_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_label_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fees</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentCommitmentFees" xlink:to="lab_mdxg_DebtInstrumentCommitmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_0c5d6d34-91cb-456a-a441-bf2704d9390b_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Default interest rate (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_label_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate</link:label>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentDefaultInterestRate" xlink:to="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_52a3bfd4-1152-45d7-8a7c-57ab49b21109_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f02dcdcf-b1ff-4637-8378-46b91668a77c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ab4bd2c1-e68a-4786-bc8d-9bc7c4f10428_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_063a8843-8706-4140-8e58-68c94568826c_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5a153bab-c497-48b9-ae3e-94cbbd9f9a11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_6e85be32-e0a3-4ef4-8eda-8d31f42647b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_81f2eaf0-a241-4b8b-b6b1-d8819ced5e9c_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_label_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:to="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_875fb5a7-45e5-4186-99ea-61a93ad8deeb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued and Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ba479c08-3a69-4cea-b2b6-416f194661a0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_a33052d0-f3b2-4b97-88e3-78a5327d8055_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of out-of-period error (Note 1)</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_ab496312-40ec-4678-8195-19b9f4a7acd9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of error</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_66fe59e1-ce4d-47b3-9674-713d1601b9f3_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_e5d8e781-dddb-484e-b5cf-a79df8c04acc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Machinery and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0ccd0d99-c4e0-43b3-bbb4-abd9befb3596_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_61bb9173-3fa7-4661-82f3-de729c657635_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_308ccc97-d777-4436-a653-6be06320e4ed_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8a2a955e-f9a6-4ce0-8a30-518961b7d5f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a49a7b3a-5901-4d59-9a7e-3e76c030e81d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_fef50941-3577-493d-a99c-acab3aebaea0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_6e16fc04-8be6-4f01-9157-bb6f2eb103ad_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_a06c2c80-b215-43c9-8a59-28e17e3407bd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_251b81f0-1fee-4274-844a-b86eaf35a7d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mdxg-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dd7de07c-4c86-4fde-bc42-71e80cce9dc0,g:bebb1759-752a-4b9d-8aee-0bd74cb1611c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mimedx.com/role/Cover" xlink:type="simple" xlink:href="mdxg-20210930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d355903-8caa-499d-a5e2-8529d86e87ed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentType_4d355903-8caa-499d-a5e2-8529d86e87ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_c53c7879-1f08-4c6c-ac4c-1a072c274049" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentQuarterlyReport_c53c7879-1f08-4c6c-ac4c-1a072c274049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8d449ceb-5b31-4e3f-a183-ad0663f40c57" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentPeriodEndDate_8d449ceb-5b31-4e3f-a183-ad0663f40c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4bb850f6-b206-4273-9c7a-518a22e34cd3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentTransitionReport_4bb850f6-b206-4273-9c7a-518a22e34cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f54b99be-8953-4481-8ceb-486dc1a7f41e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityFileNumber_f54b99be-8953-4481-8ceb-486dc1a7f41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_44446fa6-dca0-48b7-aa8e-ab3374fd9a99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityRegistrantName_44446fa6-dca0-48b7-aa8e-ab3374fd9a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e2f9b24f-12d1-43ac-9e68-233308d7b9ad" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e2f9b24f-12d1-43ac-9e68-233308d7b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7a0133e0-8f6a-47c3-86de-7c8ee9b08868" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityTaxIdentificationNumber_7a0133e0-8f6a-47c3-86de-7c8ee9b08868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_230ef8ee-fe71-48cc-a481-28bc8a21ba6a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityAddressAddressLine1_230ef8ee-fe71-48cc-a481-28bc8a21ba6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d174e155-4fbd-45a3-a4ec-3b10c06d5e35" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityAddressCityOrTown_d174e155-4fbd-45a3-a4ec-3b10c06d5e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a4abea81-218d-4205-a168-1a242070bd23" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityAddressStateOrProvince_a4abea81-218d-4205-a168-1a242070bd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ec37a4c5-23d4-4fd8-b378-f75424b6e743" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityAddressPostalZipCode_ec37a4c5-23d4-4fd8-b378-f75424b6e743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_00420c2c-0a6c-4604-8017-6e07d67274ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_CityAreaCode_00420c2c-0a6c-4604-8017-6e07d67274ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_04c38394-9da6-4ff5-b47d-a93991657760" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_LocalPhoneNumber_04c38394-9da6-4ff5-b47d-a93991657760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c908dd94-f2ab-45bf-9cad-0cc1464dbdf5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_Security12bTitle_c908dd94-f2ab-45bf-9cad-0cc1464dbdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0f200a6d-5a75-4c04-886b-a9ca995c0444" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_TradingSymbol_0f200a6d-5a75-4c04-886b-a9ca995c0444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3668b13b-4730-4026-b31b-2a89771fd238" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_SecurityExchangeName_3668b13b-4730-4026-b31b-2a89771fd238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_52a9a579-94b7-4492-bd2d-100bc3255ab5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityCurrentReportingStatus_52a9a579-94b7-4492-bd2d-100bc3255ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4d712213-9356-42ac-9682-257d115c5020" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityInteractiveDataCurrent_4d712213-9356-42ac-9682-257d115c5020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5fc9e5c0-6cb1-473c-8414-91923985d1d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityFilerCategory_5fc9e5c0-6cb1-473c-8414-91923985d1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_7b707227-a5ec-4f11-b9a1-2564e1873ddc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntitySmallBusiness_7b707227-a5ec-4f11-b9a1-2564e1873ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8e0ca836-67d8-4918-97cb-9bbdb29aedb1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityEmergingGrowthCompany_8e0ca836-67d8-4918-97cb-9bbdb29aedb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_886d59cb-a9d7-480d-8f39-a7c3ba1ed625" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityShellCompany_886d59cb-a9d7-480d-8f39-a7c3ba1ed625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1f24f38d-7074-4da4-907d-e2814350ab52" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1f24f38d-7074-4da4-907d-e2814350ab52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf63e27e-9433-400d-8a9d-2fda289c3e27" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_EntityCentralIndexKey_cf63e27e-9433-400d-8a9d-2fda289c3e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3d496ab3-8629-4288-856c-e1382c6e9811" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_CurrentFiscalYearEndDate_3d496ab3-8629-4288-856c-e1382c6e9811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ef8132eb-c7e6-4bc7-88e2-9507ad003cd5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentFiscalYearFocus_ef8132eb-c7e6-4bc7-88e2-9507ad003cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_135edfdf-d98d-46ce-b460-afecf7c02492" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_135edfdf-d98d-46ce-b460-afecf7c02492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6d8e6020-c02b-4134-869e-419289616728" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_95b2ac31-04db-4974-9752-be1bd8fec3c6" xlink:to="loc_dei_AmendmentFlag_6d8e6020-c02b-4134-869e-419289616728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6a5470f7-b023-42a7-a760-dba4d8875189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a5470f7-b023-42a7-a760-dba4d8875189" xlink:to="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_519baabc-4fc1-49ae-8ce4-51c847ca6039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_519baabc-4fc1-49ae-8ce4-51c847ca6039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_94f0bb1a-4de0-46db-8419-124ca6b58cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_94f0bb1a-4de0-46db-8419-124ca6b58cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a91a5030-88b7-4e80-90bb-86311f9c474e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_InventoryNet_a91a5030-88b7-4e80-90bb-86311f9c474e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_715b3d03-1aab-42fe-aa52-062b52685af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_715b3d03-1aab-42fe-aa52-062b52685af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_67cb3fcf-52f4-4594-8cb9-35929691dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_IncomeTaxesReceivable_67cb3fcf-52f4-4594-8cb9-35929691dd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4c86d77b-1073-439a-a4c5-6d84630e3ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_OtherAssetsCurrent_4c86d77b-1073-439a-a4c5-6d84630e3ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_79756537-3a4c-43c4-818a-1130b196f12b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ae456ad0-b402-4309-b66c-32d3cc08ec36" xlink:to="loc_us-gaap_AssetsCurrent_79756537-3a4c-43c4-818a-1130b196f12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_afb43eca-5775-442c-b7d0-fda009c2dfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_afb43eca-5775-442c-b7d0-fda009c2dfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_6f2f2776-3d46-448c-a26a-531c1ac7c20c" xlink:href="mdxg-20210930.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_6f2f2776-3d46-448c-a26a-531c1ac7c20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8bde7075-00dd-4922-8f16-4306b27bf772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_Goodwill_8bde7075-00dd-4922-8f16-4306b27bf772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41007a33-2b43-4244-8e8d-acea7f3de951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41007a33-2b43-4244-8e8d-acea7f3de951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_60c02eed-1052-4f81-954b-38880d568486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_60c02eed-1052-4f81-954b-38880d568486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a0ee56bf-d378-4989-acf1-650245294355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0a41671c-6065-49d6-bcd1-bb9ea31456e1" xlink:to="loc_us-gaap_Assets_a0ee56bf-d378-4989-acf1-650245294355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a5470f7-b023-42a7-a760-dba4d8875189" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3e6d46ad-5916-481c-a744-4fa7fcdab9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:to="loc_us-gaap_AccountsPayableCurrent_3e6d46ad-5916-481c-a744-4fa7fcdab9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d8251130-b195-4a40-8aad-266877dae3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d8251130-b195-4a40-8aad-266877dae3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dcfdd251-d8d6-4eae-8940-e22bbe8872ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dcfdd251-d8d6-4eae-8940-e22bbe8872ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_79f0f980-8f3f-4d1b-9547-0189397f1217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_79f0f980-8f3f-4d1b-9547-0189397f1217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f1663cc1-6ed1-4d62-9dc6-46f0db82b940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4be10ddb-c857-496c-b607-6e44b97bd097" xlink:to="loc_us-gaap_LiabilitiesCurrent_f1663cc1-6ed1-4d62-9dc6-46f0db82b940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_35dfbebf-999f-463c-bc01-c93626c5f651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_35dfbebf-999f-463c-bc01-c93626c5f651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bb827475-3bbc-4cdc-9fc0-595e9635661a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bb827475-3bbc-4cdc-9fc0-595e9635661a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_78cd9185-1bbf-42f2-9506-f5a4450f8691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_Liabilities_78cd9185-1bbf-42f2-9506-f5a4450f8691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_431fdc66-a184-4b05-b92e-62e946b11816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_CommitmentsAndContingencies_431fdc66-a184-4b05-b92e-62e946b11816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_8eb3e1ed-8d89-4ec3-9627-7f34f6f1c692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_8eb3e1ed-8d89-4ec3-9627-7f34f6f1c692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_da9b4496-10bc-4010-8b13-6935b6178621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_PreferredStockValue_da9b4496-10bc-4010-8b13-6935b6178621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_657cb80a-d553-4080-9168-7e6fc062ba58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_CommonStockValue_657cb80a-d553-4080-9168-7e6fc062ba58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d391ba91-e93e-4672-b9ac-4dae4439b882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d391ba91-e93e-4672-b9ac-4dae4439b882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b33ebf04-65a2-4c42-a3a4-b6d6cadad4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_TreasuryStockValue_b33ebf04-65a2-4c42-a3a4-b6d6cadad4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_be1a38ea-c330-457b-b08c-5bfae5768ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_be1a38ea-c330-457b-b08c-5bfae5768ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56439587-9513-4a52-9641-5b84ce1b2663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3846b6d6-20f8-408a-b6fe-fc9e1ce6fe1f" xlink:to="loc_us-gaap_StockholdersEquity_56439587-9513-4a52-9641-5b84ce1b2663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cdc47c68-f34c-402f-90b8-a87b0b2a8ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8a59a857-0e40-4218-86b3-04f4f1df9680" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cdc47c68-f34c-402f-90b8-a87b0b2a8ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_11aefc7b-1423-4dfd-9431-10e709e3cd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_11aefc7b-1423-4dfd-9431-10e709e3cd9c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_84164435-b097-4d8f-bf76-8a4ea269a39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_84164435-b097-4d8f-bf76-8a4ea269a39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_5d338e46-a9dc-49a7-b493-27ea4e39833b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_5d338e46-a9dc-49a7-b493-27ea4e39833b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_a3c8d313-96dc-4e02-a562-7cee610ef054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_a3c8d313-96dc-4e02-a562-7cee610ef054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_83a0ac81-a304-4e42-884a-8b6fd6a0b8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_83a0ac81-a304-4e42-884a-8b6fd6a0b8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b12e1a84-9cfd-4228-a74b-88ab72757573" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_69adb668-888f-4491-b5ea-bb733da85a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_69adb668-888f-4491-b5ea-bb733da85a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e18f4e99-e23d-4782-bc20-0539048b267b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e18f4e99-e23d-4782-bc20-0539048b267b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f1b0e0bf-497c-4a25-9533-d494ec0f1190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f1b0e0bf-497c-4a25-9533-d494ec0f1190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2b6461a9-351f-4bb6-8996-443c5f21efec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2b6461a9-351f-4bb6-8996-443c5f21efec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4308f37-9eb6-4790-a4ae-55bfd79b65f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4308f37-9eb6-4790-a4ae-55bfd79b65f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_529f0325-c3b8-4cc6-a85c-e1f31fe0807a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_529f0325-c3b8-4cc6-a85c-e1f31fe0807a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_924ebd0c-b628-49df-9976-610b3f72d807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_CommonStockSharesIssued_924ebd0c-b628-49df-9976-610b3f72d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d8b8f264-f656-4192-9131-121fcc73ec1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d8b8f264-f656-4192-9131-121fcc73ec1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_5ad3350a-7f78-4b49-9deb-e491cd80dfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d7cfb537-3ee4-4586-8ec5-917029f32ec6" xlink:to="loc_us-gaap_TreasuryStockShares_5ad3350a-7f78-4b49-9deb-e491cd80dfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d02f2bb-c90c-4e60-9bde-bc79a066f218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d02f2bb-c90c-4e60-9bde-bc79a066f218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b52765fb-40c9-400a-938f-c5ff570fedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b52765fb-40c9-400a-938f-c5ff570fedf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_36b409bf-b2e5-4882-a663-0f490b830ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_GrossProfit_36b409bf-b2e5-4882-a663-0f490b830ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9fb5ec76-2986-43b3-8250-3c65dc97f6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9fb5ec76-2986-43b3-8250-3c65dc97f6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated_1a3e484d-be7d-45f6-ac19-41b01b9acc92" xlink:href="mdxg-20210930.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:to="loc_mdxg_InvestigationRestatementandRelated_1a3e484d-be7d-45f6-ac19-41b01b9acc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_19de18c6-92c2-4f20-996c-c00c801a0915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_19de18c6-92c2-4f20-996c-c00c801a0915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dbc29d0f-9b34-4f35-b3ef-b155aaa655c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_053d0d52-4e56-4964-94cf-537e1136c40a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dbc29d0f-9b34-4f35-b3ef-b155aaa655c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71746b0e-5d96-48b5-8197-e8583d33bc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_OperatingIncomeLoss_71746b0e-5d96-48b5-8197-e8583d33bc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1b8fb17c-a15d-4cb2-84c0-0155f843f4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1b8fb17c-a15d-4cb2-84c0-0155f843f4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_01413dab-c86c-4c50-b40e-0ad7fa624f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1b8fb17c-a15d-4cb2-84c0-0155f843f4d8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_01413dab-c86c-4c50-b40e-0ad7fa624f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_0e1a0a0d-bba4-45ac-b75a-67b58bd7e738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1b8fb17c-a15d-4cb2-84c0-0155f843f4d8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_0e1a0a0d-bba4-45ac-b75a-67b58bd7e738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_85d85afa-fabe-4cf0-84ff-fd51868a1ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1b8fb17c-a15d-4cb2-84c0-0155f843f4d8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_85d85afa-fabe-4cf0-84ff-fd51868a1ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c143faff-5c37-4fea-b967-a14d31f801c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c143faff-5c37-4fea-b967-a14d31f801c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_024fe77e-13be-48ca-8b12-b06591e77bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_024fe77e-13be-48ca-8b12-b06591e77bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_910a4e1d-f24b-44e8-ba59-0501e4197abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_NetIncomeLoss_910a4e1d-f24b-44e8-ba59-0501e4197abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7a3387a8-590d-4156-a2bd-ebc1f3d800d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7a3387a8-590d-4156-a2bd-ebc1f3d800d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cb3bd988-1a19-4f04-b176-f9078b0272d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_EarningsPerShareBasic_cb3bd988-1a19-4f04-b176-f9078b0272d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bbdc9612-19f1-4128-a902-12322dd97e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bbdc9612-19f1-4128-a902-12322dd97e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_28ac2f4d-8eca-4a87-a4db-7b083fbee73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_28ac2f4d-8eca-4a87-a4db-7b083fbee73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_902f1d79-315b-4a74-aed9-cfeb38327fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63edd0b2-0616-43f5-8b56-585b8bf39cb4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_902f1d79-315b-4a74-aed9-cfeb38327fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3d0853aa-7aa6-446b-9475-3930819f2a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3d0853aa-7aa6-446b-9475-3930819f2a05" xlink:to="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dc5d5ab8-d1e7-4c8e-ae00-1a9c4406ecd5" xlink:to="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4af495c9-93de-4153-9b08-26d4e9888f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_CommonStockMember_4af495c9-93de-4153-9b08-26d4e9888f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e359ceee-a1b1-458f-9a1b-1613dc8894c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e359ceee-a1b1-458f-9a1b-1613dc8894c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_297ee285-9af5-49ae-a4cf-c32264c862d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_TreasuryStockMember_297ee285-9af5-49ae-a4cf-c32264c862d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f52bb2f5-4a42-4fc7-ae11-9a31c1d9a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_69e12cbc-3c04-4014-a21e-41f80bc73ebb" xlink:to="loc_us-gaap_RetainedEarningsMember_f52bb2f5-4a42-4fc7-ae11-9a31c1d9a6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_9f016b1c-7c7c-4e08-aa83-bad93716caa2" xlink:to="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_12ba67db-f253-4428-979a-b7a536e21f96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_979c71cd-4186-46bf-bbc3-ad4284d5905e" xlink:to="loc_srt_RestatementAdjustmentMember_12ba67db-f253-4428-979a-b7a536e21f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb5a0c5-d390-4b39-bf6b-4146a57bd6f7" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_76e17bab-35be-4293-afda-5b7b1c017042" xlink:href="mdxg-20210930.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_67b8911a-21d2-4638-b149-c7af386e933b" xlink:to="loc_mdxg_StockAwardMisstatementsMember_76e17bab-35be-4293-afda-5b7b1c017042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a61cceb3-e943-46df-a73c-b90214babaaf" xlink:to="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5359c3fc-7f90-4f12-a6f5-8991b1c4d67b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_35d6a224-1134-44cf-b7ff-d016fec062fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_CommonStockSharesIssued_35d6a224-1134-44cf-b7ff-d016fec062fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6896451-2842-4e44-8986-46da9b864d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockholdersEquity_c6896451-2842-4e44-8986-46da9b864d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3ff53a4f-3a1a-436b-814a-305deea284b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_3ff53a4f-3a1a-436b-814a-305deea284b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_9936ca55-df2b-41d4-94a5-b0814825a785" xlink:href="mdxg-20210930.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_9936ca55-df2b-41d4-94a5-b0814825a785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4f113884-7cd1-48aa-9bb7-576ff2f0ba43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4f113884-7cd1-48aa-9bb7-576ff2f0ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7089fa91-0953-453b-a402-fb042196db17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7089fa91-0953-453b-a402-fb042196db17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_205fdc88-f1ab-4e5a-b751-2f2f9aee937a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_205fdc88-f1ab-4e5a-b751-2f2f9aee937a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_edec0604-0dd2-4cae-8624-a1c78fb4ce72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_edec0604-0dd2-4cae-8624-a1c78fb4ce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c3462df5-2e46-4d22-8bf3-3c47364ec913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c3462df5-2e46-4d22-8bf3-3c47364ec913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3aa686ba-5376-4373-a091-4ca548a4fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3aa686ba-5376-4373-a091-4ca548a4fcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e78b195f-ab0f-487d-b41b-81a2f114fb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e78b195f-ab0f-487d-b41b-81a2f114fb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3af4ec41-3bf9-4486-b6a2-9fbc1ed2c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_3af4ec41-3bf9-4486-b6a2-9fbc1ed2c6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_fa986c5c-92b0-4e03-a1de-31f0f71c5fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_fa986c5c-92b0-4e03-a1de-31f0f71c5fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc464c88-8404-4000-bf91-251dd80d935e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc464c88-8404-4000-bf91-251dd80d935e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b5facbc8-db81-4eda-94cd-285d7bbeface" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b5facbc8-db81-4eda-94cd-285d7bbeface" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_88586cf1-9310-4739-a306-d9884dcf45d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_NetIncomeLoss_88586cf1-9310-4739-a306-d9884dcf45d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bfe9c76f-982d-4650-bc97-b63bdc27a440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_CommonStockSharesIssued_bfe9c76f-982d-4650-bc97-b63bdc27a440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e067cc08-a20d-448f-ae20-407002969f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b1f9be2-b749-4041-b2aa-3c311dd55244" xlink:to="loc_us-gaap_StockholdersEquity_e067cc08-a20d-448f-ae20-407002969f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdxg-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c9843613-4da6-4669-90b5-daa1dfc81ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c9843613-4da6-4669-90b5-daa1dfc81ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4074fe9e-5dc5-4a9c-ab48-3377325da8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c9843613-4da6-4669-90b5-daa1dfc81ea6" xlink:to="loc_us-gaap_NetIncomeLoss_4074fe9e-5dc5-4a9c-ab48-3377325da8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c9843613-4da6-4669-90b5-daa1dfc81ea6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5e0c60f3-2731-4c42-b6fe-a2f3b0522b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_ShareBasedCompensation_5e0c60f3-2731-4c42-b6fe-a2f3b0522b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_77b01c77-3da2-435d-be23-8b406443cf68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_Depreciation_77b01c77-3da2-435d-be23-8b406443cf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f0064b94-ecd1-498b-9fe7-52b9cfb32a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f0064b94-ecd1-498b-9fe7-52b9cfb32a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c9e8c0a7-7e84-4c08-8be2-104af5c5fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c9e8c0a7-7e84-4c08-8be2-104af5c5fccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_97eabb01-cc26-4a16-a666-8518059ca93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_97eabb01-cc26-4a16-a666-8518059ca93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_2c479044-d06c-4fe0-beb9-b5cd5471ff9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_2c479044-d06c-4fe0-beb9-b5cd5471ff9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0d29d9cb-106c-4ae7-bf91-27e9c0001352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0d29d9cb-106c-4ae7-bf91-27e9c0001352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c0caeba5-afd9-422f-a3d9-882fbce6269e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c0caeba5-afd9-422f-a3d9-882fbce6269e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d888993-3978-42be-9b43-e86f0a6e7b88" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0ef62a13-8f10-41c4-b9b9-0695a6f3d126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0ef62a13-8f10-41c4-b9b9-0695a6f3d126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b5e46926-ca2d-45c0-8d16-940145a125b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b5e46926-ca2d-45c0-8d16-940145a125b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_cf09380d-a846-4f2c-a606-9166a452f3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_cf09380d-a846-4f2c-a606-9166a452f3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_9305dc1c-64af-4cbe-a4a1-61e455c40894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_9305dc1c-64af-4cbe-a4a1-61e455c40894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_62d8de4f-45af-427b-bd4d-439ff4db4d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_62d8de4f-45af-427b-bd4d-439ff4db4d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3937470f-84a1-4443-adbb-9d9615bc7332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3937470f-84a1-4443-adbb-9d9615bc7332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_db5e75cb-23fe-4a24-94f2-e6fabfffdef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_db5e75cb-23fe-4a24-94f2-e6fabfffdef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cd5f8738-2fe4-4ffa-83da-e4040571e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cd5f8738-2fe4-4ffa-83da-e4040571e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9e599ce0-cef9-4727-9480-9bda41a805c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_89f1ef51-5e0c-4b8d-af31-9f19983ad8ed" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9e599ce0-cef9-4727-9480-9bda41a805c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c589da08-1f4a-48c1-8705-b0b79bd384b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c9843613-4da6-4669-90b5-daa1dfc81ea6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c589da08-1f4a-48c1-8705-b0b79bd384b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_17a3a131-eb87-4bb9-bedb-d75ab252bf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_17a3a131-eb87-4bb9-bedb-d75ab252bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_9d8f3741-0ba3-4b44-812a-b3d7f4922248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_9d8f3741-0ba3-4b44-812a-b3d7f4922248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent_22810e45-68a9-4b4c-973a-6c1ff526e16e" xlink:href="mdxg-20210930.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:to="loc_mdxg_PaymentsforApplicationCostsPatent_22810e45-68a9-4b4c-973a-6c1ff526e16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f5e968f-7602-4828-b217-68a3c94ed846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a3133c0a-f582-410f-adb1-bd8a08e931bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f5e968f-7602-4828-b217-68a3c94ed846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bd4d7415-a548-4019-94c3-9cd1a766cad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bd4d7415-a548-4019-94c3-9cd1a766cad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e1270352-5479-49ff-8cf8-cb677ad38551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e1270352-5479-49ff-8cf8-cb677ad38551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_cf71fbc6-ab6b-4e93-b828-61436c9e988b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_cf71fbc6-ab6b-4e93-b828-61436c9e988b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f11974aa-3069-48a7-9a96-5dd49a9e20dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f11974aa-3069-48a7-9a96-5dd49a9e20dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_01c77116-ced0-4e81-a448-36c3f79be57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_01c77116-ced0-4e81-a448-36c3f79be57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_dde445b5-1015-44bc-8216-c1fdefc0e0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_dde445b5-1015-44bc-8216-c1fdefc0e0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_5f50e994-8fef-407e-ba56-0f841d17be4c" xlink:href="mdxg-20210930.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_5f50e994-8fef-407e-ba56-0f841d17be4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_9ea47438-8bdf-47a8-ab5c-28bda9dd2e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_9ea47438-8bdf-47a8-ab5c-28bda9dd2e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_200247a3-f8bb-4301-a3ef-97a2c2db670b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_200247a3-f8bb-4301-a3ef-97a2c2db670b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d6d028b9-e2fd-4835-8bab-4dba97fb5dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ebdb5b3-e7e4-449e-af11-d56ec03d9ba3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d6d028b9-e2fd-4835-8bab-4dba97fb5dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_785b902d-d7ad-491f-bfb2-ec1ee1b2c196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_785b902d-d7ad-491f-bfb2-ec1ee1b2c196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_04aaf635-8f80-4905-a83d-dcf276a01559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_04aaf635-8f80-4905-a83d-dcf276a01559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb5a541b-9434-4798-bfdd-6806e1a8e959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_55822c71-43b3-4631-bb3a-b0875ea0b2e9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb5a541b-9434-4798-bfdd-6806e1a8e959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusiness" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NatureofBusiness"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9734da47-8a4f-4dff-8854-f874373ec75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_249b0f91-d973-4198-9bda-3eb74280e595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9734da47-8a4f-4dff-8854-f874373ec75b" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_249b0f91-d973-4198-9bda-3eb74280e595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NatureofBusinessDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82aac6ca-a32f-4041-abe6-9906c4290cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82aac6ca-a32f-4041-abe6-9906c4290cd6" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9e5d902e-b9c7-4449-a619-51ae50e60587" xlink:to="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_c1679660-68a1-47f1-8718-3d989e068170" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:to="loc_mdxg_Section351Member_c1679660-68a1-47f1-8718-3d989e068170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_2d012408-f450-428e-9b1f-739f26fd00ad" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d9242548-30f0-4278-b849-32867c4c038d" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_2d012408-f450-428e-9b1f-739f26fd00ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e72fb00-9edb-4472-9b01-854059b6a5bb" xlink:to="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_014f4fd6-c80e-40ca-b1a3-6b4ca12b6497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_014f4fd6-c80e-40ca-b1a3-6b4ca12b6497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9e1d5186-3403-408e-a79f-c9d3700f9f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c0931bef-f405-4a9e-87fa-170645a11864" xlink:to="loc_us-gaap_TreasuryStockMember_9e1d5186-3403-408e-a79f-c9d3700f9f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7701a5f9-a434-48d5-931d-e3befe25920c" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_696ac139-72b6-43f5-a599-294f6f6e7464" xlink:href="mdxg-20210930.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_e1a01a7d-b18f-4d6d-867e-e1ee8c7660d4" xlink:to="loc_mdxg_StockAwardMisstatementsMember_696ac139-72b6-43f5-a599-294f6f6e7464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_e2f2aa67-0b8b-4b73-9f18-09f9dcf66710" xlink:to="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_898066fa-1474-44e3-b9d8-b773b27494b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_9ec0a78e-27a3-450f-8c4f-cf9a4e57848d" xlink:to="loc_srt_RestatementAdjustmentMember_898066fa-1474-44e3-b9d8-b773b27494b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_52058b90-5242-4144-ab33-5a524d37871f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_499839ca-401a-4cf0-8c42-8063c17286d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_499839ca-401a-4cf0-8c42-8063c17286d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_627dfb8d-1c87-40bc-b30a-864e84c5f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_InventoryNet_627dfb8d-1c87-40bc-b30a-864e84c5f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1aff2204-7fff-4b13-9c26-176dd5349c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_c9ae4017-57d0-4239-aaa7-c01136f89b72" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1aff2204-7fff-4b13-9c26-176dd5349c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2888c5bc-a428-4582-a735-040098cf3412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f015244d-087d-4851-a8ee-d7b576490adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2888c5bc-a428-4582-a735-040098cf3412" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f015244d-087d-4851-a8ee-d7b576490adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4daa23cc-9380-4774-b25e-749bd03d66e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4daa23cc-9380-4774-b25e-749bd03d66e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1b267bae-dad8-4f94-ba8a-1434f5453f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_UseOfEstimates_1b267bae-dad8-4f94-ba8a-1434f5453f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8117b35c-2878-463f-ba2b-66c25e1ac4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8117b35c-2878-463f-ba2b-66c25e1ac4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_19099b7b-3a84-4c01-af49-8fffffa3b5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_19099b7b-3a84-4c01-af49-8fffffa3b5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_39970b35-055d-416f-be37-ee671d61bc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_39970b35-055d-416f-be37-ee671d61bc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_544de88b-3aba-4642-8967-1986ffe51741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0dc82a7-7702-4bbc-a27d-eaa43dabf6fe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_544de88b-3aba-4642-8967-1986ffe51741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a8a7f744-ae30-4fbc-800a-9ce2d3278ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_082e4a88-0d66-446a-b56d-8729b407460a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a7f744-ae30-4fbc-800a-9ce2d3278ccd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_082e4a88-0d66-446a-b56d-8729b407460a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccountsReceivableNet" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccountsReceivableNet"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccountsReceivableNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_58893fa5-1b2f-47e3-829d-46c166564275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndNontradeReceivableTextBlock_87250068-31d8-4bbd-859c-334afa36b620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndNontradeReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_58893fa5-1b2f-47e3-829d-46c166564275" xlink:to="loc_us-gaap_AccountsAndNontradeReceivableTextBlock_87250068-31d8-4bbd-859c-334afa36b620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccountsReceivableNetTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccountsReceivableNetTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccountsReceivableNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_09822434-199d-4a58-ad65-c5c09709ba99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8518f474-fcc6-41b1-bf03-1333a580cdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_09822434-199d-4a58-ad65-c5c09709ba99" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_8518f474-fcc6-41b1-bf03-1333a580cdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccountsReceivableNetDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_220c3e55-ee5f-4043-9755-d87a021e2286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_02715b65-d3d8-4f94-9252-366530662ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_220c3e55-ee5f-4043-9755-d87a021e2286" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_02715b65-d3d8-4f94-9252-366530662ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ada0b7a2-200c-4ade-8ff4-b695b9b1c0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_220c3e55-ee5f-4043-9755-d87a021e2286" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ada0b7a2-200c-4ade-8ff4-b695b9b1c0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8e967e1f-ab6f-4585-910c-7318b0ce72b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_220c3e55-ee5f-4043-9755-d87a021e2286" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8e967e1f-ab6f-4585-910c-7318b0ce72b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Inventory" xlink:type="simple" xlink:href="mdxg-20210930.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_38c8375e-3ae5-4559-ab81-027613fa0db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_98294281-764c-400b-896d-487d2523c52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_38c8375e-3ae5-4559-ab81-027613fa0db5" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_98294281-764c-400b-896d-487d2523c52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c0f18401-8e36-4df2-8a00-0627547967da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_487d6157-8877-4b31-a752-63392331a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c0f18401-8e36-4df2-8a00-0627547967da" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_487d6157-8877-4b31-a752-63392331a5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_53a35b53-2a92-42bc-b1eb-e46e632b8a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_53a35b53-2a92-42bc-b1eb-e46e632b8a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_45c2eab9-2f23-4c11-acaa-91fcc6e61e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_45c2eab9-2f23-4c11-acaa-91fcc6e61e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ca992cb0-a465-434c-83a3-f626eb056e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ca992cb0-a465-434c-83a3-f626eb056e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c6be7027-a65e-41d2-a7fa-f3bf34365107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:to="loc_us-gaap_InventoryNet_c6be7027-a65e-41d2-a7fa-f3bf34365107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ae6de5e3-721b-4411-b1b6-41fcbb88ac24" xlink:to="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:to="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d8ef5478-487f-4ca1-9096-392129ce710e" xlink:to="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_df06cf0a-2e5c-43ef-9062-3bf6633e76c7" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b8d4632-97f9-4e8a-bc69-3ad399362162" xlink:to="loc_mdxg_Section351Member_df06cf0a-2e5c-43ef-9062-3bf6633e76c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_e598d4fb-26ea-4394-908c-d93cdd25811e" xlink:to="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0eeeeb45-b634-4cb2-8d53-bc0cc075828c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_ecba6935-3667-4e01-a01b-870c5c8a009b" xlink:to="loc_us-gaap_InventoryWriteDown_0eeeeb45-b634-4cb2-8d53-bc0cc075828c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7e886961-987f-40a1-b1e7-301804274dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8f322930-3281-45b0-bb10-37ec17582963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7e886961-987f-40a1-b1e7-301804274dcf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8f322930-3281-45b0-bb10-37ec17582963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ca89af51-ea75-49c1-80bd-6e20a5285459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_56108c49-3b08-4037-94bb-7d3326f38541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ca89af51-ea75-49c1-80bd-6e20a5285459" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_56108c49-3b08-4037-94bb-7d3326f38541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleOfDepreciationTableTextBlock_b1630617-c1e7-46f9-a712-35eb918914d0" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleOfDepreciationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ca89af51-ea75-49c1-80bd-6e20a5285459" xlink:to="loc_mdxg_ScheduleOfDepreciationTableTextBlock_b1630617-c1e7-46f9-a712-35eb918914d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fb3ed98a-199e-4a6d-bb42-908e7a187ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fb3ed98a-199e-4a6d-bb42-908e7a187ef8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8d856ef6-a8a9-4635-9a6d-44bdd0899eaf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_192b5c95-fdb9-4905-af62-17b014a8a403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_192b5c95-fdb9-4905-af62-17b014a8a403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_14215f48-a030-431f-9f85-d96a126601da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_EquipmentMember_14215f48-a030-431f-9f85-d96a126601da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4a9ee0e1-61d9-4a6f-87f8-d541cbf99b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4a9ee0e1-61d9-4a6f-87f8-d541cbf99b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_ef0d1a98-d174-407a-9b3f-f8072499f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_us-gaap_ConstructionInProgressMember_ef0d1a98-d174-407a-9b3f-f8072499f32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember_1e2b30d1-3ca8-483e-800b-d77bce9c2f41" xlink:href="mdxg-20210930.xsd#mdxg_AssetRetirementCostMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2e2fbb17-3166-4e42-81ff-3d39da015167" xlink:to="loc_mdxg_AssetRetirementCostMember_1e2b30d1-3ca8-483e-800b-d77bce9c2f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a9a75dc1-4072-40bd-a078-f40b9dc2c4e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5303e709-e3ea-4279-817c-e072e6ffdd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5303e709-e3ea-4279-817c-e072e6ffdd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2b504d3f-cb6f-478f-a900-59c574781753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_2b504d3f-cb6f-478f-a900-59c574781753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9ffa1f49-4223-40db-b1da-3411d78dfa4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9ffa1f49-4223-40db-b1da-3411d78dfa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d8f4f205-618f-42c8-9d7f-6d4f008d224f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d8f4f205-618f-42c8-9d7f-6d4f008d224f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_803b2f89-69f2-42fa-934e-d8a33fc19bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e149b9c5-a2a5-4c85-a454-e4816b424f99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_803b2f89-69f2-42fa-934e-d8a33fc19bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#PropertyandEquipmentNetDepreciationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b8c0eb27-a8db-46e4-ba2c-64ed4d41dd13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b3dd11b-e43f-4588-ac45-f5cb8f115d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b8c0eb27-a8db-46e4-ba2c-64ed4d41dd13" xlink:to="loc_us-gaap_Depreciation_3b3dd11b-e43f-4588-ac45-f5cb8f115d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssets" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47715706-3375-4f35-ae8f-743c9e51819a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_18488caf-5d45-4512-8fa1-37f9762a738e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47715706-3375-4f35-ae8f-743c9e51819a" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_18488caf-5d45-4512-8fa1-37f9762a738e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d53114b-e06c-489a-819f-8a9a3531f141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_8583d5f6-b206-4ab8-a83e-b3273521ca53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d53114b-e06c-489a-819f-8a9a3531f141" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_8583d5f6-b206-4ab8-a83e-b3273521ca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6d5d86c8-4934-4b16-8424-42562254fd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d53114b-e06c-489a-819f-8a9a3531f141" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6d5d86c8-4934-4b16-8424-42562254fd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d9e02216-d8a2-4b3c-b22f-61f2f94b61a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d53114b-e06c-489a-819f-8a9a3531f141" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d9e02216-d8a2-4b3c-b22f-61f2f94b61a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5636026-d734-46e0-9c2f-e1cd64fa8cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5636026-d734-46e0-9c2f-e1cd64fa8cb3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_defc8894-e758-4032-99a2-55e7ab112ce0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_44d5699d-92f0-49fc-82d1-e7eec948816a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_PatentsMember_44d5699d-92f0-49fc-82d1-e7eec948816a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_75b5f0b0-1115-456c-a9d9-e5531c7ccaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_LicensingAgreementsMember_75b5f0b0-1115-456c-a9d9-e5531c7ccaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember_0119a69c-5e69-4864-9a16-6797f3fd18f0" xlink:href="mdxg-20210930.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_mdxg_CustomerAndSupplierRelationshipsMember_0119a69c-5e69-4864-9a16-6797f3fd18f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_89b45e1e-4ba9-40c9-baed-2bf70d551225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8abb6e47-d1fe-4352-81cf-b27d1e41223a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_89b45e1e-4ba9-40c9-baed-2bf70d551225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4e096107-4730-4a6a-849f-83ef9aa05777" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7c4c81f-9fdb-434f-b4ab-e52b1f7d52f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7c4c81f-9fdb-434f-b4ab-e52b1f7d52f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_1b4bae4f-d5af-4a13-bcc3-5750db4310d2" xlink:href="mdxg-20210930.xsd#mdxg_PatentsinProcessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9149bd84-df99-42c6-8366-1cf1717d0022" xlink:to="loc_mdxg_PatentsinProcessMember_1b4bae4f-d5af-4a13-bcc3-5750db4310d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f9ca8c39-f6fa-469e-a422-19608ed05fe4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c00ebaf1-d1f2-49d2-ad96-cd1e3e2e1dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c00ebaf1-d1f2-49d2-ad96-cd1e3e2e1dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ffb355a-f5a9-44c2-a89f-9f1f926eeef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ffb355a-f5a9-44c2-a89f-9f1f926eeef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_939427fe-6677-49dd-b7e9-bec3448b0540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_939427fe-6677-49dd-b7e9-bec3448b0540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a3c8934c-4db6-4c79-895f-6004a90eeeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a3c8934c-4db6-4c79-895f-6004a90eeeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1eb9ba95-662d-47d8-8bc8-4cc603990c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a0bcd150-9ce9-4f1a-bfea-71331bdf4397" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1eb9ba95-662d-47d8-8bc8-4cc603990c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5636026-d734-46e0-9c2f-e1cd64fa8cb3" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_84fee58b-7802-4033-b0c2-5de44975eeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_84fee58b-7802-4033-b0c2-5de44975eeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_94356bb4-b149-4b06-bef5-ebbc5d49e5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_024aed14-e9b8-4d14-aff0-aa3edadc41e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_71ee0526-c62f-4303-beb8-b00b6150b84b" xlink:href="mdxg-20210930.xsd#mdxg_PatentsinProcessMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_eae7bc2a-4805-419d-9a00-ebba31af6685" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7507e3f5-c2db-437f-aada-43636ced56d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_280867ac-070a-4ca6-8cb6-f84a762f60bd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7507e3f5-c2db-437f-aada-43636ced56d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c52e4ff0-d131-4484-840b-a9dc26b107f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5636026-d734-46e0-9c2f-e1cd64fa8cb3" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c52e4ff0-d131-4484-840b-a9dc26b107f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6285179b-12fd-460f-97cd-26b24f7f7d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5636026-d734-46e0-9c2f-e1cd64fa8cb3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6285179b-12fd-460f-97cd-26b24f7f7d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_58399360-0a93-49f3-9e2b-af0dd4751c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7b03f47b-6487-48ce-9795-4c387641e3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_58399360-0a93-49f3-9e2b-af0dd4751c26" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7b03f47b-6487-48ce-9795-4c387641e3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_150dd27b-8266-47a1-a57a-c7fca60154d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_150dd27b-8266-47a1-a57a-c7fca60154d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc7801e5-a042-46ee-811d-4809686ca25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_cc7801e5-a042-46ee-811d-4809686ca25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5d7bb6f2-9b2a-41a1-b678-2a7a416c58d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5d7bb6f2-9b2a-41a1-b678-2a7a416c58d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7650488f-3b0f-49a0-a85e-29e891888133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7650488f-3b0f-49a0-a85e-29e891888133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2bd29e88-0128-446a-95af-5b2466159935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2bd29e88-0128-446a-95af-5b2466159935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f3b2ac99-c20f-4e3b-a1bb-177741c6d523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f3b2ac99-c20f-4e3b-a1bb-177741c6d523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d9d708de-9f7c-40a0-9b7f-dcfb1ec04b13" xlink:href="mdxg-20210930.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d9d708de-9f7c-40a0-9b7f-dcfb1ec04b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6b3ff97c-62fd-4d63-bc26-f43f8e2c1420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_3ed48e36-6bec-4cd1-8613-803c1582bf97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6b3ff97c-62fd-4d63-bc26-f43f8e2c1420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7082cbe7-52e3-42d0-a47e-5a39fcd39a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f882c994-976b-457e-8b18-6ca25c3b4226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7082cbe7-52e3-42d0-a47e-5a39fcd39a0c" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f882c994-976b-457e-8b18-6ca25c3b4226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_4ca394dc-e6bf-4a98-9839-87bbc05403f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_bb05823f-c4d6-4396-af46-bb7bb3fad9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4ca394dc-e6bf-4a98-9839-87bbc05403f4" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_bb05823f-c4d6-4396-af46-bb7bb3fad9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_7a4723a8-f555-47b0-a3e7-115b150ac559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_7a4723a8-f555-47b0-a3e7-115b150ac559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_106773d7-9f67-488b-b466-9784833a61dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_106773d7-9f67-488b-b466-9784833a61dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_3aad6b87-f86b-4c8c-b667-2ca0de81500d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_3aad6b87-f86b-4c8c-b667-2ca0de81500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent_53923102-e577-4bd4-89da-4b9ee1fea77f" xlink:href="mdxg-20210930.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_mdxg_AccruedClinicalTrialsCurrent_53923102-e577-4bd4-89da-4b9ee1fea77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fca8d94f-4e2d-43e0-9687-c0867f05efbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fca8d94f-4e2d-43e0-9687-c0867f05efbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates_2892dd12-5673-4ccd-b77b-0894a4ec640d" xlink:href="mdxg-20210930.xsd#mdxg_AccruedRebates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_mdxg_AccruedRebates_2892dd12-5673-4ccd-b77b-0894a4ec640d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_979dab35-6688-42a9-97bd-02890d37b693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_979dab35-6688-42a9-97bd-02890d37b693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_439fa0ca-5701-4c36-a627-01821f7c37c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_215e2def-279a-4803-a2ea-9f292c068866" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_439fa0ca-5701-4c36-a627-01821f7c37c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebt" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2bc831c2-3647-491b-b032-9dd47f3dbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ef7fa25d-7dd5-4332-9a1d-10773520e914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2bc831c2-3647-491b-b032-9dd47f3dbbaa" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ef7fa25d-7dd5-4332-9a1d-10773520e914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_389e0f7c-1651-4d87-8f32-de6eda86d900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_834d13d3-585f-4ec0-8550-d0e1f3d86c65" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleofDebtIssuanceCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_389e0f7c-1651-4d87-8f32-de6eda86d900" xlink:to="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_834d13d3-585f-4ec0-8550-d0e1f3d86c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_735a1e34-16b2-473f-96fc-693592a092c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_389e0f7c-1651-4d87-8f32-de6eda86d900" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_735a1e34-16b2-473f-96fc-693592a092c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofInterestExpenseTableTextBlock_a6935bab-2d37-4a56-a868-7f9fad27b631" xlink:href="mdxg-20210930.xsd#mdxg_ScheduleofInterestExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_389e0f7c-1651-4d87-8f32-de6eda86d900" xlink:to="loc_mdxg_ScheduleofInterestExpenseTableTextBlock_a6935bab-2d37-4a56-a868-7f9fad27b631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6fbc2435-e1dd-4871-bcf9-47b29227d045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_389e0f7c-1651-4d87-8f32-de6eda86d900" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6fbc2435-e1dd-4871-bcf9-47b29227d045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6b583716-f38f-4327-a6cd-84ab32b6899a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6b583716-f38f-4327-a6cd-84ab32b6899a" xlink:to="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_368f2e3a-190d-4e5a-8db1-d93ec932089b" xlink:to="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3cf2bead-1060-4e95-8deb-44ae20cc1056" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:to="loc_srt_MinimumMember_3cf2bead-1060-4e95-8deb-44ae20cc1056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_256b7f85-c375-4eb3-a96a-be67efd53801" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b63c8a69-7ed3-46a4-8ea6-e639556afde1" xlink:to="loc_srt_MaximumMember_256b7f85-c375-4eb3-a96a-be67efd53801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a3d9df34-6adc-4b6f-9694-c6b50428c719" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_7cb901a5-9225-4a48-85b9-6518bad40620" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0c004020-2f69-4eab-a524-fd2adbc72063" xlink:to="loc_srt_ScenarioForecastMember_7cb901a5-9225-4a48-85b9-6518bad40620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3f88630e-cf12-4100-8027-3f320cfa4908" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_07d9a5b4-affb-4316-a297-a8eb57891307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1332e08e-2fa2-47bc-ba0b-17cb14ca45ac" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_07d9a5b4-affb-4316-a297-a8eb57891307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab019245-614f-4b77-8826-95e046f9bd6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_dcfe4d16-cc6c-450e-b86e-445ae91bbe95" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_dcfe4d16-cc6c-450e-b86e-445ae91bbe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember_cdd1bd23-b17f-42c1-9105-04f65edba542" xlink:href="mdxg-20210930.xsd#mdxg_FinancingTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_FinancingTransactionsMember_cdd1bd23-b17f-42c1-9105-04f65edba542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_bb5697a5-abc2-4a52-b4d6-134e4ec03ee2" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_bb5697a5-abc2-4a52-b4d6-134e4ec03ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_06aa06d0-da47-421a-804e-f550f59001e3" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_06aa06d0-da47-421a-804e-f550f59001e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_1d795bfc-e2a3-4b00-a1ed-cb9f69b316a3" xlink:href="mdxg-20210930.xsd#mdxg_CreditFacilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_CreditFacilitiesMember_1d795bfc-e2a3-4b00-a1ed-cb9f69b316a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_218a60c3-a0f4-4648-823b-1bcf0085fe06" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_218a60c3-a0f4-4648-823b-1bcf0085fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_9d26c7cd-fcbb-4aaa-bdc6-4988aee5e735" xlink:href="mdxg-20210930.xsd#mdxg_TermLoanAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c671254-cf01-428e-b59d-761b96598896" xlink:to="loc_mdxg_TermLoanAgreementMember_9d26c7cd-fcbb-4aaa-bdc6-4988aee5e735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a0407e8e-9699-41a2-8db9-4efa2633806c" xlink:to="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8704b270-fef1-4db1-85ff-a9b513a98e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8704b270-fef1-4db1-85ff-a9b513a98e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_04663272-db09-4d2a-831d-ed57edb9e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_PrimeRateMember_04663272-db09-4d2a-831d-ed57edb9e57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_bd891cab-4562-4a8d-af24-e817c11d7711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3d417bf0-d85c-41e0-aac1-f55db878e5c9" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_bd891cab-4562-4a8d-af24-e817c11d7711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76b3cbfe-94ad-4cf9-8657-8801147c400a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f28f96cd-a8d0-4a10-86c7-75c2ebda0409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f28f96cd-a8d0-4a10-86c7-75c2ebda0409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_13d96e38-3c77-47b9-b9ea-7cd032ad49bf" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_13d96e38-3c77-47b9-b9ea-7cd032ad49bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_255fa9d4-a1d5-4a67-85e7-392759307d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_255fa9d4-a1d5-4a67-85e7-392759307d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio_e2013a53-9854-40fd-8b19-8cd961c241d3" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCovenantNetLeverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentCovenantNetLeverageRatio_e2013a53-9854-40fd-8b19-8cd961c241d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate_98ba0961-f7b1-443f-86fa-8ca57044b257" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentDefaultInterestRate_98ba0961-f7b1-443f-86fa-8ca57044b257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_282a63be-8e20-4af8-9cbf-8b4583bff5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_282a63be-8e20-4af8-9cbf-8b4583bff5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity_63c9bb44-c6d9-4dc7-ab3d-2fc6cf15213e" xlink:href="mdxg-20210930.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtCovenantMinimumLiquidity_63c9bb44-c6d9-4dc7-ab3d-2fc6cf15213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_87bfce84-a0a6-4946-9201-dc24c4856ecd" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_87bfce84-a0a6-4946-9201-dc24c4856ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_248f2ba9-dddc-4452-97be-32ce346b0bdf" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_248f2ba9-dddc-4452-97be-32ce346b0bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_7504f3a7-c7e5-4f86-8dbc-26db2fc376aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_LongTermDebtFairValue_7504f3a7-c7e5-4f86-8dbc-26db2fc376aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_881dda2e-3ed2-426d-8caf-50eb64e755fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_881dda2e-3ed2-426d-8caf-50eb64e755fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_560f92b0-9e59-42f1-92bf-7b967f661533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f7ce1da2-0876-4ee7-a747-7f5fffda9581" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_560f92b0-9e59-42f1-92bf-7b967f661533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanDebtIssuanceCostsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6e3dff9-4628-4b04-928d-f7b8cc38061d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6e3dff9-4628-4b04-928d-f7b8cc38061d" xlink:to="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a34b65b-f780-4b0e-ba11-e0cab4f9cc45" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ad3531cc-95fc-415d-bef2-1468c22e1312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:to="loc_us-gaap_LongTermDebtMember_ad3531cc-95fc-415d-bef2-1468c22e1312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_84972076-0855-4181-bf2c-56e90e21886f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d48938ca-2915-459a-9751-267fe555e282" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_84972076-0855-4181-bf2c-56e90e21886f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df5951da-7046-4403-92aa-2a4400f6bfc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_7f34b28d-9ebd-4b56-84fd-6ae738f27ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fff9607d-682c-4bc9-a761-64c51d513589" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_7f34b28d-9ebd-4b56-84fd-6ae738f27ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_031b206e-7bb1-425d-993a-10276c2ef07c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:href="mdxg-20210930.xsd#mdxg_CreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1c9784c7-c168-4fea-910e-11b803ed8229" xlink:to="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_badfffad-c39e-44a1-b935-e7d268b9d606" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_badfffad-c39e-44a1-b935-e7d268b9d606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c62bbf1f-f974-4b91-8a39-5eeba76421d2" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_CreditFacilitiesMember_85b3d7a6-b682-4777-8b6f-35ca58e11863" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c62bbf1f-f974-4b91-8a39-5eeba76421d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99905bfc-0b1f-48c7-b40d-29076914f269" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9048275f-a74d-4e22-a00f-2334b3774a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_9048275f-a74d-4e22-a00f-2334b3774a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_e8b9f512-76a0-4b09-8e1d-7eb018adf549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b77a245a-4e94-462e-b721-fc5df1c94ced" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_e8b9f512-76a0-4b09-8e1d-7eb018adf549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3d9488c8-8462-487a-84de-710d7df7a8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3d9488c8-8462-487a-84de-710d7df7a8d7" xlink:to="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_47c9bb0b-8d84-4084-baf3-af2f761a0750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f6366b0e-ae16-40f4-9188-df5fa009c7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ff2c6961-5c25-4232-b034-cdbabbec9032" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f6366b0e-ae16-40f4-9188-df5fa009c7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:to="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a53265fb-5a7f-4905-b0da-33c9a08aa8e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_6672c2b3-9fff-41af-a163-d844e4d2c72a" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d912144a-818d-417f-bda4-e46b2b3fda0c" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_6672c2b3-9fff-41af-a163-d844e4d2c72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e26dc7e3-118b-4d35-811b-c75d544fd181" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_59999266-60ba-44d6-b5d6-fbca93859228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_59999266-60ba-44d6-b5d6-fbca93859228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_43159c93-ac24-4b22-abcc-9e0b754175b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_43159c93-ac24-4b22-abcc-9e0b754175b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_15ada0ac-d662-4bbd-bcb1-b666fc8229ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_15ada0ac-d662-4bbd-bcb1-b666fc8229ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cb5807d7-61f5-4772-905b-69f7ea631f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f0aafc92-fc25-4f3b-962f-4e04a2d7e958" xlink:to="loc_us-gaap_LongTermDebt_cb5807d7-61f5-4772-905b-69f7ea631f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d1d19cdf-c82d-468c-bd2f-3ddbefe8987d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d1d19cdf-c82d-468c-bd2f-3ddbefe8987d" xlink:to="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a81a3e6-5efa-4927-931e-aa43af711543" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_4a17169d-6296-48ad-9276-4d23d30e4c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da24cbb9-27ff-43af-a1a2-fd7c272bb865" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_4a17169d-6296-48ad-9276-4d23d30e4c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:to="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9565eca1-2de4-474d-8a9a-3f6262da4180" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_32206651-2176-44ae-8748-87ea7c3cb6e0" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_32206651-2176-44ae-8748-87ea7c3cb6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c523099a-9100-4262-a7f2-3c62e529609d" xlink:href="mdxg-20210930.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_91f3aa94-3840-48b6-adc5-ae9e7a72a46b" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_c523099a-9100-4262-a7f2-3c62e529609d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_123897f8-a40a-4b38-8713-bbb5f5894211" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_f06c2155-9398-4b36-978f-9d3723e1318b" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_f06c2155-9398-4b36-978f-9d3723e1318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5abc74d-d092-42bf-905d-251a5147b970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5abc74d-d092-42bf-905d-251a5147b970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_662c10cd-8b06-48be-9e6a-c914587b7f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_662c10cd-8b06-48be-9e6a-c914587b7f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9b42b74f-231c-4b56-a6e9-a53a6b7c26b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9b42b74f-231c-4b56-a6e9-a53a6b7c26b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e1ca6e27-503a-4986-9e4e-1e8ed518a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a15560d-782e-4641-a23b-3f5559f53275" xlink:to="loc_us-gaap_InterestExpenseDebt_e1ca6e27-503a-4986-9e4e-1e8ed518a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#LongTermDebtTermLoanMaturityDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b2be67b4-44a1-472f-9c31-1300b540f8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b2be67b4-44a1-472f-9c31-1300b540f8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0454cde6-5987-49f2-939a-a7a080719b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0454cde6-5987-49f2-939a-a7a080719b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1d24f324-49c2-4784-817a-e87d22aad1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1d24f324-49c2-4784-817a-e87d22aad1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_30e15d83-70dc-4d03-8e53-8e8831a4d4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_30e15d83-70dc-4d03-8e53-8e8831a4d4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1e36c089-af21-4b5e-810b-7413698ff707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1e36c089-af21-4b5e-810b-7413698ff707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour_57940ba6-5a2a-4b17-8c4c-a437b791b3de" xlink:href="mdxg-20210930.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_mdxg_LongTermDebtMaturityAfterYearFour_57940ba6-5a2a-4b17-8c4c-a437b791b3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4ae8ebe3-209d-4f43-af78-e97f7d8f153d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dfda256a-f5c8-4c0d-a0fe-6c39f377cc74" xlink:to="loc_us-gaap_LongTermDebt_4ae8ebe3-209d-4f43-af78-e97f7d8f153d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShare" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98bac2db-8804-4068-ab42-97312d7a5cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_690fd776-0f5c-4d17-93da-0ee6ad682aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98bac2db-8804-4068-ab42-97312d7a5cd3" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_690fd776-0f5c-4d17-93da-0ee6ad682aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5cb765a0-a071-4acd-b0d9-58c040b86c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_cb95a8b3-49dc-4eb3-8dcb-a0980cef21be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5cb765a0-a071-4acd-b0d9-58c040b86c8e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_cb95a8b3-49dc-4eb3-8dcb-a0980cef21be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_8fd5a8b5-4a98-4c87-85b4-34f0730d7b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5cb765a0-a071-4acd-b0d9-58c040b86c8e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_8fd5a8b5-4a98-4c87-85b4-34f0730d7b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2c5d6a4b-eb00-44d0-91c4-b323cddb6220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5cb765a0-a071-4acd-b0d9-58c040b86c8e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2c5d6a4b-eb00-44d0-91c4-b323cddb6220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareBasicNetLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_739c777c-729f-4dc6-92ca-00add9c1064c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_NetIncomeLoss_739c777c-729f-4dc6-92ca-00add9c1064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_5924ea64-b197-4734-b924-6a62f9346f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_5924ea64-b197-4734-b924-6a62f9346f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_73fc586c-d63c-4082-9363-e02877385479" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_5924ea64-b197-4734-b924-6a62f9346f46" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_73fc586c-d63c-4082-9363-e02877385479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_26ebadd8-0078-4c9e-9c4b-e541756d5a8b" xlink:href="mdxg-20210930.xsd#mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_5924ea64-b197-4734-b924-6a62f9346f46" xlink:to="loc_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization_26ebadd8-0078-4c9e-9c4b-e541756d5a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_16088ac2-5d6b-42b9-a7e0-6c0a2942cfc7" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_5924ea64-b197-4734-b924-6a62f9346f46" xlink:to="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_16088ac2-5d6b-42b9-a7e0-6c0a2942cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_308ece1c-0e11-467e-9d2d-5417bdf692f8" xlink:href="mdxg-20210930.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_308ece1c-0e11-467e-9d2d-5417bdf692f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5f881774-ffc0-419d-b6aa-484e6e09ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5f881774-ffc0-419d-b6aa-484e6e09ada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c994e66a-ed43-460d-8cc6-c1c6b4b252bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c994e66a-ed43-460d-8cc6-c1c6b4b252bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29db75d8-cde4-417c-87f9-15ba78b0b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_29db75d8-cde4-417c-87f9-15ba78b0b2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d122d150-7d3a-4da3-a76b-0ff3a31160ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_910164b1-8d49-4202-8fec-ddf9a73633cf" xlink:to="loc_us-gaap_EarningsPerShareBasic_d122d150-7d3a-4da3-a76b-0ff3a31160ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7846d3ac-4f28-4769-b285-65fbf33729dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:href="mdxg-20210930.xsd#mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7846d3ac-4f28-4769-b285-65fbf33729dd" xlink:to="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e1eb436a-0ce9-403a-9d20-04745f0d6a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e1eb436a-0ce9-403a-9d20-04745f0d6a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_2b51fba5-3023-41f2-b7c8-02e1934bc735" xlink:href="mdxg-20210930.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_2b51fba5-3023-41f2-b7c8-02e1934bc735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f0df68d9-72f6-4012-9857-45df08a65757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_662cde46-27e4-4e2c-ba5e-5224aa3e34c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_662cde46-27e4-4e2c-ba5e-5224aa3e34c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_441a7987-0f77-4cbe-82d7-4c3b2b3b685f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_441a7987-0f77-4cbe-82d7-4c3b2b3b685f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acb49b17-acda-450b-8a8b-b39e8b25dbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acb49b17-acda-450b-8a8b-b39e8b25dbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be3ab8a1-4076-49e5-8792-c77792b68af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_bf0622fc-59e6-4709-b916-23efdb5d7794" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be3ab8a1-4076-49e5-8792-c77792b68af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7846d3ac-4f28-4769-b285-65fbf33729dd" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_021c9ec2-2332-4383-81c2-8c254d24501b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_69a4a28d-983b-4ece-bf2a-dfc5a99d5a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_69a4a28d-983b-4ece-bf2a-dfc5a99d5a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7fc74c16-92b7-45d6-939f-9e58d94c735d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_RestrictedStockMember_7fc74c16-92b7-45d6-939f-9e58d94c735d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_747cdf48-d2b4-4cb3-9f04-9c023f3f6d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_747cdf48-d2b4-4cb3-9f04-9c023f3f6d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b0560e58-3a77-4b46-a109-0b2eb485b3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b0560e58-3a77-4b46-a109-0b2eb485b3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4ac7158a-4d2c-435a-87cf-5c8f6b63a912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e60ec12-9fb8-4482-981e-090fa51edbe7" xlink:to="loc_us-gaap_PerformanceSharesMember_4ac7158a-4d2c-435a-87cf-5c8f6b63a912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_219a2b7f-f7b2-42a2-bfb1-46d9476d5326" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5afcdd6d-77b3-4305-ad73-a79b523f0688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96233744-b9bb-4020-a8bb-1e1982cc7eeb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5afcdd6d-77b3-4305-ad73-a79b523f0688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Equity" xlink:type="simple" xlink:href="mdxg-20210930.xsd#Equity"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_131c81a3-d013-447b-8ba3-83f5e8e552ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ffe398b0-4705-474b-a07d-edb0c61c6ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_131c81a3-d013-447b-8ba3-83f5e8e552ee" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ffe398b0-4705-474b-a07d-edb0c61c6ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityEquityTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityEquityTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f15be1e1-0688-46b4-a9c2-eac0e04f6527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_c77764fb-9a91-449a-9915-33b9b5fe60fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f15be1e1-0688-46b4-a9c2-eac0e04f6527" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_c77764fb-9a91-449a-9915-33b9b5fe60fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_fc96855a-13d0-45ad-b30c-e2e98e75473c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f15be1e1-0688-46b4-a9c2-eac0e04f6527" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_fc96855a-13d0-45ad-b30c-e2e98e75473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0c3e338f-a075-4aa3-bfea-36b479fdce67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f15be1e1-0688-46b4-a9c2-eac0e04f6527" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0c3e338f-a075-4aa3-bfea-36b479fdce67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6fadd38e-d7a6-488d-ad1f-e59b5c9fc6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6fadd38e-d7a6-488d-ad1f-e59b5c9fc6cd" xlink:to="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a74102e3-b9d3-4ba1-87a0-014637b855ed" xlink:to="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember_463a1ac4-572a-4c84-9a33-adfa06abbdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:to="loc_us-gaap_PreferredClassBMember_463a1ac4-572a-4c84-9a33-adfa06abbdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_30bf2908-d559-4a85-ae39-d52e22e02ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7c55e21b-1206-40ff-854a-5f59e6b93610" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_30bf2908-d559-4a85-ae39-d52e22e02ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:to="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_3481dce3-c2ea-4756-8491-43b4ef1bc27d" xlink:to="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_51e34073-3dc6-4e23-8bfd-b69b6bb4d2d9" xlink:href="mdxg-20210930.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:to="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_51e34073-3dc6-4e23-8bfd-b69b6bb4d2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_15580d2c-fbff-47af-a406-779ee380eb5a" xlink:href="mdxg-20210930.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_4ce7f58a-15f0-4742-9096-ce62d45790f8" xlink:to="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_15580d2c-fbff-47af-a406-779ee380eb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1d3caf1e-4524-4081-af9c-f8c80c076715" xlink:to="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage_459d4c23-f535-4368-92f2-ad86efb103b0" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityDividendRatePercentage_459d4c23-f535-4368-92f2-ad86efb103b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare_64914ccc-16f2-4862-9153-f5270959758f" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionPricePerShare_64914ccc-16f2-4862-9153-f5270959758f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio_a341019e-de2c-4805-bd80-27611c6ab23a" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionRatio_a341019e-de2c-4805-bd80-27611c6ab23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_db81dc00-9bfe-4923-887d-f8bc0da1fe7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_db81dc00-9bfe-4923-887d-f8bc0da1fe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_d57d7154-54fb-4e83-914b-5ce8154b6b7c" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_d57d7154-54fb-4e83-914b-5ce8154b6b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_3bd7839f-7a52-4d18-858a-d513d4227bac" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_3bd7839f-7a52-4d18-858a-d513d4227bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_cd703911-ce4c-4c1f-9098-a6423367f5f5" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_cd703911-ce4c-4c1f-9098-a6423367f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_aee2b0d6-8262-4219-b907-62f7f89b2e21" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_aee2b0d6-8262-4219-b907-62f7f89b2e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_64bf3673-abcc-47ce-b123-4e14d8db3566" xlink:href="mdxg-20210930.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_64bf3673-abcc-47ce-b123-4e14d8db3566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0fc204d0-85d9-448e-be0d-5b358c88ff06" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0fc204d0-85d9-448e-be0d-5b358c88ff06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_63abe012-1bc5-4da4-9fa2-17ab229f0bf5" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_63abe012-1bc5-4da4-9fa2-17ab229f0bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_a676a0de-2c4d-4167-9c9d-dc99fbd58787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_a676a0de-2c4d-4167-9c9d-dc99fbd58787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_a9f12199-862e-45d8-a5c3-f849fca7dc4a" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_a9f12199-862e-45d8-a5c3-f849fca7dc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion_dc19869d-4c72-41d6-b87a-55cd3b592ee1" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_ae809859-2d24-4d53-ba1a-310f7af55f0c" xlink:to="loc_mdxg_TemporaryEquitySharesIssueduponConversion_dc19869d-4c72-41d6-b87a-55cd3b592ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e519ed3d-45b1-41e7-beb0-7546b7245e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6fadd38e-d7a6-488d-ad1f-e59b5c9fc6cd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e519ed3d-45b1-41e7-beb0-7546b7245e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_39029a93-fdd1-497d-8efe-ff5a34754a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6fadd38e-d7a6-488d-ad1f-e59b5c9fc6cd" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_39029a93-fdd1-497d-8efe-ff5a34754a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityChangesinSeriesBPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_133f11e7-bef6-4f29-9278-ccaca0821284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_133f11e7-bef6-4f29-9278-ccaca0821284" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:to="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_601a5644-b31e-4af1-97c7-e61a1ea4b102" xlink:to="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_b597479d-c892-4676-8fb8-5b6cbfcf63da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_217b724d-2374-42aa-8d1d-4823f8c22570" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_b597479d-c892-4676-8fb8-5b6cbfcf63da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0dbd1b7-0be5-4eb2-91a5-c0657a512f83" xlink:to="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_774b1d8d-9189-43dd-8267-04a4c0270b26" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e335a1fb-4d8a-40ec-9d6f-6c39a63c98f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e335a1fb-4d8a-40ec-9d6f-6c39a63c98f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fc345ec3-26b9-4e89-ab22-d96730c7c09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fc345ec3-26b9-4e89-ab22-d96730c7c09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_05bf6536-9793-4a3c-8141-5dfa81f2c6be" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues_05bf6536-9793-4a3c-8141-5dfa81f2c6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b2230e03-1d82-4a02-a573-f764a004250f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b2230e03-1d82-4a02-a573-f764a004250f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_efea8aac-b2be-4976-87c5-8bd633ce150e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_efea8aac-b2be-4976-87c5-8bd633ce150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_947e8eb0-e888-440e-a699-66835406be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_947e8eb0-e888-440e-a699-66835406be0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c444f3e7-a2d5-4d29-acc2-838b6c9e1f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1278ae2a-13f1-4421-8665-bfee73943f17" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c444f3e7-a2d5-4d29-acc2-838b6c9e1f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityRestrictedStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_30da8d37-2608-4252-84aa-2fa9dd50575f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_30da8d37-2608-4252-84aa-2fa9dd50575f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:to="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a7d4245b-9295-4855-b663-6279f40e6877" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_cf8502e8-7f4b-4bb0-a587-cc5573d7fce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_RestrictedStockMember_cf8502e8-7f4b-4bb0-a587-cc5573d7fce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5d4bc38d-e544-49a6-918f-409b400d2ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5d4bc38d-e544-49a6-918f-409b400d2ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_e667f507-424c-4a3f-ae58-a165af42de66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90982217-2a7f-4a96-8714-dd883c60cc63" xlink:to="loc_us-gaap_PerformanceSharesMember_e667f507-424c-4a3f-ae58-a165af42de66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc89a04-a362-4f32-b5e5-d6da7ef8fd87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9bec2637-0bcd-4844-a62c-0941f00332b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9bec2637-0bcd-4844-a62c-0941f00332b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b4dd295-95c6-488b-af02-326351bd16ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2b4dd295-95c6-488b-af02-326351bd16ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6c8712f5-8a7d-455e-8936-fc7089ae6981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6c8712f5-8a7d-455e-8936-fc7089ae6981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a7da3cec-53c6-4818-be46-f9d0b23d96b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a7da3cec-53c6-4818-be46-f9d0b23d96b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9c5690b9-8423-4a5c-8367-7114b6ee5edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ad2528b-6fdd-4371-860f-d7274a36c148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9c5690b9-8423-4a5c-8367-7114b6ee5edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5348ab63-78b9-42ed-9f6f-dc7ddce77ffc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f8fb31e0-7f61-4a81-b941-680b83b2637c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f8fb31e0-7f61-4a81-b941-680b83b2637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a212c08a-b2bd-4033-9e3a-5ed9a530829a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a212c08a-b2bd-4033-9e3a-5ed9a530829a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7aa45ec1-27a4-4059-97fc-56f8525c1688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7aa45ec1-27a4-4059-97fc-56f8525c1688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_298dc678-c628-46ac-9834-442cefaad7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_298dc678-c628-46ac-9834-442cefaad7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b8473ad7-df9c-4f82-ae90-fbc163b5abc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e88a1312-2935-43d5-b4ec-fbff52a94a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b8473ad7-df9c-4f82-ae90-fbc163b5abc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityStockIncentivePlansDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#EquityStockIncentivePlansDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityStockIncentivePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6d04aad-2895-4f52-9614-67fd4be31e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6d04aad-2895-4f52-9614-67fd4be31e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8abfcd95-6b6e-4237-9771-049dd5bc0cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8abfcd95-6b6e-4237-9771-049dd5bc0cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dfca6046-2626-479e-8041-533fdbd2e50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dfca6046-2626-479e-8041-533fdbd2e50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6123a509-c8d3-4ea8-a659-2252c74cfc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6123a509-c8d3-4ea8-a659-2252c74cfc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_b2555c6d-54b5-4ee7-9feb-867919a50dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_b2555c6d-54b5-4ee7-9feb-867919a50dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85d491a4-4e28-44f5-9cba-21eecb2bd350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1cbbb88c-62bc-4770-a450-6ad8fef2d7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85d491a4-4e28-44f5-9cba-21eecb2bd350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2d31506c-005f-4634-8054-07d084f8df1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2d31506c-005f-4634-8054-07d084f8df1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6e9022a0-b7e6-443b-9c0e-2f22e0bde35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6e9022a0-b7e6-443b-9c0e-2f22e0bde35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_404f40f7-4fda-433c-8a2c-2bd6468950bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_404f40f7-4fda-433c-8a2c-2bd6468950bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e4767aea-42c1-4faa-b97f-7d8d63e2427a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e4767aea-42c1-4faa-b97f-7d8d63e2427a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3568d196-6182-45c8-8f62-55f2002ddc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3568d196-6182-45c8-8f62-55f2002ddc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_41b0e0a5-3401-4301-9362-9cc4ed1bc595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_41b0e0a5-3401-4301-9362-9cc4ed1bc595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4e7cbe7d-dff3-48de-a229-ef236798df79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3378f1c4-ebad-4bd4-9f67-74d0ecf429e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4e7cbe7d-dff3-48de-a229-ef236798df79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_09da3f6d-6874-449c-8a60-3c36c60f8631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_09da3f6d-6874-449c-8a60-3c36c60f8631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a908c23-74d9-4ae5-8d56-c3f6b7f90a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a908c23-74d9-4ae5-8d56-c3f6b7f90a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8d224bb6-3b6e-4b00-b01d-cb53348a0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a908c23-74d9-4ae5-8d56-c3f6b7f90a86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8d224bb6-3b6e-4b00-b01d-cb53348a0b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_442f269b-e0f7-4145-833e-636dc85080b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a908c23-74d9-4ae5-8d56-c3f6b7f90a86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_442f269b-e0f7-4145-833e-636dc85080b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_e343c6d4-3964-4317-b6cf-ec719264dfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d185909-1515-473c-bb7b-8e4318f582d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_e343c6d4-3964-4317-b6cf-ec719264dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_290d7de6-d97b-4ed5-8a6b-09cb061016e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_e343c6d4-3964-4317-b6cf-ec719264dfd3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_290d7de6-d97b-4ed5-8a6b-09cb061016e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5f364b24-0c2e-452e-958d-65ba3ca91cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_e343c6d4-3964-4317-b6cf-ec719264dfd3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5f364b24-0c2e-452e-958d-65ba3ca91cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Incometaxes" xlink:type="simple" xlink:href="mdxg-20210930.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_20ead405-1e1e-4490-8773-00b08f846151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_94126e34-9bec-46b3-85b7-16d751fc9b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_20ead405-1e1e-4490-8773-00b08f846151" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_94126e34-9bec-46b3-85b7-16d751fc9b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#IncometaxesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IncometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_85c882a5-b749-4169-9e15-4322f27449e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_db0603e9-2f61-4180-a0d7-f25b5819955f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85c882a5-b749-4169-9e15-4322f27449e2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_db0603e9-2f61-4180-a0d7-f25b5819955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_f0f5aa50-5c59-46ed-a4c3-798af06742ff" xlink:href="mdxg-20210930.xsd#mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85c882a5-b749-4169-9e15-4322f27449e2" xlink:to="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_f0f5aa50-5c59-46ed-a4c3-798af06742ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85c882a5-b749-4169-9e15-4322f27449e2" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a122a83-2948-44be-b3cc-dfe47977cc51" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember_1cd7bc17-b6bf-4d2c-b89e-87ed410e42c0" xlink:href="mdxg-20210930.xsd#mdxg_CARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_44c6ee97-ceab-4569-9c7b-d6aa15d0a1b4" xlink:to="loc_mdxg_CARESActMember_1cd7bc17-b6bf-4d2c-b89e-87ed410e42c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_125d78fb-14d5-44a7-aee1-7a0142c5bdcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_904b949f-e865-4b35-8271-e6f2dbb667d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_904b949f-e865-4b35-8271-e6f2dbb667d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e1b60230-5239-4911-b75d-585d3c47d112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_e8965c76-8c7f-425a-9eec-9dcdd0a40268" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e1b60230-5239-4911-b75d-585d3c47d112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_2234363d-ffac-4788-8a57-061d645d521d" xlink:href="mdxg-20210930.xsd#mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_85c882a5-b749-4169-9e15-4322f27449e2" xlink:to="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_2234363d-ffac-4788-8a57-061d645d521d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_aab48618-7802-497e-895c-8374f1cea351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_de613c95-b687-4010-acc3-7151bbc799e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_aab48618-7802-497e-895c-8374f1cea351" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_de613c95-b687-4010-acc3-7151bbc799e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_1c9ba0e2-7d05-40e7-b56a-6cce90c6b6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_961a0305-c647-4747-b559-3942e84396b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_1c9ba0e2-7d05-40e7-b56a-6cce90c6b6e4" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_961a0305-c647-4747-b559-3942e84396b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_3973a340-4042-45e1-91dd-a284a24574c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ce087067-409a-4817-962e-9f127892ca93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3973a340-4042-45e1-91dd-a284a24574c1" xlink:to="loc_us-gaap_InterestPaidNet_ce087067-409a-4817-962e-9f127892ca93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_2d3511c2-547e-4970-8d5c-e90a3947502d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3973a340-4042-45e1-91dd-a284a24574c1" xlink:to="loc_us-gaap_IncomeTaxesPaid_2d3511c2-547e-4970-8d5c-e90a3947502d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3973a340-4042-45e1-91dd-a284a24574c1" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LeaseRightOfUseAssetAndLiability_b5c14147-50a3-4bbc-9af7-5ffffe3cda81" xlink:href="mdxg-20210930.xsd#mdxg_LeaseRightOfUseAssetAndLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_LeaseRightOfUseAssetAndLiability_b5c14147-50a3-4bbc-9af7-5ffffe3cda81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_415cac1c-7d1a-45ed-ab2c-5b7641f4f718" xlink:href="mdxg-20210930.xsd#mdxg_NotesReceivableForSaleOfPropertyAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_415cac1c-7d1a-45ed-ab2c-5b7641f4f718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9e9b48b4-281a-467c-8114-a6a108554258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9e9b48b4-281a-467c-8114-a6a108554258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_00d0f92e-3505-4495-90ab-3f1262b3eee0" xlink:href="mdxg-20210930.xsd#mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_00d0f92e-3505-4495-90ab-3f1262b3eee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDeemedDividends_f90bec55-7f8a-4b39-b6f1-6ee4a93fb8a1" xlink:href="mdxg-20210930.xsd#mdxg_TemporaryEquityDeemedDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_TemporaryEquityDeemedDividends_f90bec55-7f8a-4b39-b6f1-6ee4a93fb8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDeferredFinancingCosts_1942fed8-e992-4357-9d74-b1179382ff1d" xlink:href="mdxg-20210930.xsd#mdxg_NoncashActivitiesDeferredFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_NoncashActivitiesDeferredFinancingCosts_1942fed8-e992-4357-9d74-b1179382ff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockIssuanceCostsIncurred_7b3017a5-11cf-4cf7-8dbd-e0c40b681dc6" xlink:href="mdxg-20210930.xsd#mdxg_StockIssuanceCostsIncurred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_StockIssuanceCostsIncurred_7b3017a5-11cf-4cf7-8dbd-e0c40b681dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_30c9d60b-6c6a-4862-8bf6-fd88b3118a28" xlink:href="mdxg-20210930.xsd#mdxg_NoncashActivitiesDebtInstrumentAmendmentFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_31c04569-876f-4f5b-b7ca-a872eca3067c" xlink:to="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_30c9d60b-6c6a-4862-8bf6-fd88b3118a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/ContractualCommitmentsandContingencies" xlink:type="simple" xlink:href="mdxg-20210930.xsd#ContractualCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/ContractualCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98540756-a255-44d2-a8b8-c5230c1d78e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4dbd666e-c548-4ba6-900b-1cec3552f72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98540756-a255-44d2-a8b8-c5230c1d78e4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4dbd666e-c548-4ba6-900b-1cec3552f72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#ContractualCommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7e1a059-ee18-4e54-ab6c-77fe2f014912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_81b9ceee-8939-4138-a46a-84485b31a5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7e1a059-ee18-4e54-ab6c-77fe2f014912" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_81b9ceee-8939-4138-a46a-84485b31a5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_665fa99a-9c7e-49b9-83f5-ed809e9f07be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7e1a059-ee18-4e54-ab6c-77fe2f014912" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_665fa99a-9c7e-49b9-83f5-ed809e9f07be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_f4f6b459-bef0-44be-b0f8-c8e53d718897" xlink:href="mdxg-20210930.xsd#mdxg_ContingencyLossNumberOfSecuritiesClassActions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d7e1a059-ee18-4e54-ab6c-77fe2f014912" xlink:to="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_f4f6b459-bef0-44be-b0f8-c8e53d718897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Revenue" xlink:type="simple" xlink:href="mdxg-20210930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ba126a82-812d-4a2b-91d0-6ad000b1a91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0c12f57f-a48e-48db-9c7c-296150dfeef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba126a82-812d-4a2b-91d0-6ad000b1a91f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0c12f57f-a48e-48db-9c7c-296150dfeef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueTables" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b9ea0f14-2971-43cc-af49-47906d053396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_12672ca5-39ae-4102-86d1-324f95286ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b9ea0f14-2971-43cc-af49-47906d053396" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_12672ca5-39ae-4102-86d1-324f95286ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d9e4d41e-7609-49ff-8935-7a158c38d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b9ea0f14-2971-43cc-af49-47906d053396" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d9e4d41e-7609-49ff-8935-7a158c38d9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueSummaryofRevenuebyProductTypeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0cd546c5-e922-4342-9ab8-be7d3958b7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberOfProducts_7bfe4dbd-4125-4829-a0e4-09cc256b6741" xlink:href="mdxg-20210930.xsd#mdxg_NumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0cd546c5-e922-4342-9ab8-be7d3958b7b6" xlink:to="loc_mdxg_NumberOfProducts_7bfe4dbd-4125-4829-a0e4-09cc256b6741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0cd546c5-e922-4342-9ab8-be7d3958b7b6" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:to="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_85190f0e-3225-4d77-891b-bcaf93060d40" xlink:to="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_9222f813-6c82-4cde-82c7-5970267428af" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:to="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_9222f813-6c82-4cde-82c7-5970267428af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_880d738d-6792-4d50-8bb2-da5d0ad3628c" xlink:href="mdxg-20210930.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareMember_533e86a5-a62c-4d81-97f1-eec37003c311" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_880d738d-6792-4d50-8bb2-da5d0ad3628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_4c08eeb3-d78e-4d45-8b7e-59e1620a4efd" xlink:href="mdxg-20210930.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_mdxg_Section351Member_4c08eeb3-d78e-4d45-8b7e-59e1620a4efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a2ebf16b-cc44-4c29-8389-27b991f035e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1dc226f3-c658-4761-ad52-49102d38d7b8" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a2ebf16b-cc44-4c29-8389-27b991f035e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_796edb32-8450-45c6-9139-414913939a1f" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01c45e26-5dd9-4ee9-a4e1-9e41fa148fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_806c66bd-d0b0-404e-bec9-871ae527bbd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01c45e26-5dd9-4ee9-a4e1-9e41fa148fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueSummaryofRevenuebyCustomerTypeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c7d13655-3510-4dc6-85c0-e153a27bdc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_ca0b7582-841c-44b4-89a0-030be1404bad" xlink:href="mdxg-20210930.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7d13655-3510-4dc6-85c0-e153a27bdc3b" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_ca0b7582-841c-44b4-89a0-030be1404bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7d13655-3510-4dc6-85c0-e153a27bdc3b" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ec20c396-2d96-4033-bed7-2a246e377287" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_e4173546-6e42-4ab0-87d9-7d79ed302c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_e4173546-6e42-4ab0-87d9-7d79ed302c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_44e07530-cae6-46be-ba73-2e27391ff15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_094d6e76-5b0c-4f2c-acc6-7056d88d6a70" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_44e07530-cae6-46be-ba73-2e27391ff15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_f90968b1-1d6e-458a-9829-f7538f6e379d" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f7a867b-ec0f-473b-a39f-abe1506ad191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f7a867b-ec0f-473b-a39f-abe1506ad191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_8f2f7447-79e9-4c71-ace5-e3e48ae57462" xlink:href="mdxg-20210930.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_360f26e4-6e5c-4df3-ad13-4cd1d8e2a1aa" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_8f2f7447-79e9-4c71-ace5-e3e48ae57462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails" xlink:type="simple" xlink:href="mdxg-20210930.xsd#RevenueCollectionsonRemainingContractsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_002c1adb-0a3d-4026-8cf2-239cc53bdc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_002c1adb-0a3d-4026-8cf2-239cc53bdc98" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_eba22072-1093-4e17-9789-ff88c26be855" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_1002237e-97f3-449e-8e54-86abd15a66dc" xlink:href="mdxg-20210930.xsd#mdxg_RevenueGuidanceTopic606TransitionPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_a6856205-4559-4fc4-91f0-a6ef14e1452c" xlink:to="loc_mdxg_RevenueGuidanceTopic606TransitionPeriodMember_1002237e-97f3-449e-8e54-86abd15a66dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3511d8f2-baf8-49ec-84b0-01a7db21de79" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_87ad89e3-40b9-4b8a-9f73-41b77867cae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9409cf91-ca9e-4bc3-ab25-a08df2caaef7" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_87ad89e3-40b9-4b8a-9f73-41b77867cae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8af9d917-ac40-48de-92a4-94242221b281" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187be822-67eb-4afa-8b4d-06115115aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187be822-67eb-4afa-8b4d-06115115aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_209a53c7-e2f7-499f-aa08-cd70d474bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_209a53c7-e2f7-499f-aa08-cd70d474bcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_30caa7aa-3861-4b28-bbb4-82543791a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ea051b8b-150c-4251-9431-94ca6bdbe3ab" xlink:to="loc_us-gaap_GrossProfit_30caa7aa-3861-4b28-bbb4-82543791a9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SubsequentEvents" xlink:type="simple" xlink:href="mdxg-20210930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_be00fb34-a570-43e3-96aa-ff6bf27d50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_23ea6bc3-cfed-41b5-aa9a-2b3e3592bc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_be00fb34-a570-43e3-96aa-ff6bf27d50b2" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_23ea6bc3-cfed-41b5-aa9a-2b3e3592bc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>mdxg-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdxg="http://mimedx.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdxg-20210930.xsd" xlink:type="simple"/>
    <context id="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iddbbfc1062f945efbf07e9ce08fb0ae4_I20211020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-10-20</instant>
        </period>
    </context>
    <context id="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i76db2066b4ab44fb850e9a690cdb64fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i520bd173cc4b40d2961217715f798b5e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i961e59873c934ac892d15eb3961068f2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11539cef14874db9974e274ef191dc3f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if8424268fe0f422699167479e062686d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id7747d8031bb444f8a0d132a76929ab7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i24deb84eee304bf8bd22b8b75a680e8f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4113e96817ee412daf4fb896ba4f907c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6e9879aac5984ce69a94a4be82f2afc7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9d911729a90a4336b491792e0f39a4b1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c1e389a471143e09a8fe973bc129222_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idb9dab3f535941c8a7e99c7f45f0648e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i870ec0719b704056ab5a603cee32bf21_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i00bbd7d8fb234b8b906ba09f5de7f570_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i319b98af263b4cca93e4f38f54ec70de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i436daee9978a4397ad97a4286179a79c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6dbe6f366fa94babbed471b118618949_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ica08a3b681bd4921a6e10b0e732812dc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i73e2569d084d4d16a061c3a2817e4517_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i30ea68f67842422ea554a2c219d5df1f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fff381503ab470cb567487005105042_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48875c6ed61b4455a259bb6c00a985b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4481913816f8495b91664f2c94c198a2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib0527aaa3a4344329744dd834938874f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i907e1ab429324dafb8dede5c9e07fd49_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21b398a86a27463d8c43135cf5d273e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i125daf82d900495c9fe37f9848541647_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91714ed5b0024037979d7567ffba146c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i61389415a5d84a8696dd0a0d0313b5d9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5967a4f404664bef9378ba0366b3c4f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9c93f18d959c4e32bba8d358469e13b7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i81c1fc5c80bb4755a61a11f5bdf75e52_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib194ea304588466d9d6e058e63a66dde_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3f87700978a544fa9d65867f626f385d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia643c1f3ffd5490daba314259b7b5dd8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i30e0382314754873b5d3463a70f2452c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61ac9e9787fd4e5caa1e0fd68f13f431_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i93598c6e79474e738b441aee60fd85fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3d8f37a625b4a6eb4876d23445e7b8f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ieb8fc9cbb62e4e68bf85adfc66a44263_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3efc44c2885e4c7fb8e1a0ea72d8b77f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8d4d540898ae4a45b41a0121cbd3d2bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4cf29e0d1c12430a95941dc867b6c928_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c20ff2657e341d984f4a7abc943473f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5ab18eb20e2647c28d0361be53d48426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i132835a21d9a4d3abe8660919b3bb23a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibf0a4568080142a39217fa3323b53cf4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbac19f0cae14d1db729010e4771ebde_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1353dc3b9164466fae81fcb311283da8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i44d92ee75364420e8e90918b9dc51633_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3a67f851997741fb98d72955463632aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ce4df1ba99d4d4da5aa384183983463_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i1f30e1643e2b457cad73afc68fea533e_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:FinancingTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="ib568475ec03640c79dec4a7823674263_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i5999d39b82454d3485d425e42e44c0ab_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="idf73b93b55dc4376983adc42db197d7d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id816d2b16745481584d1f3ad0216ba99_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2d9d8ddf0424a2ebc54c14f5fb90725_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i07286d413f254827a20487a6cd9f485e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia39e228029734a35b7f629da814e51c1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f8c6ca35468445894a87c3f1396e899_D20210701-20250702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2025-07-02</endDate>
        </period>
    </context>
    <context id="i5fdd3b5337e94c8fa60408bc1abc8f28_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="ib6c60ec647934d8f96e30a1383affd50_D20210703-20220702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-03</startDate>
            <endDate>2022-07-02</endDate>
        </period>
    </context>
    <context id="idee297f90d0f45db8cbb6d3416d3d4ac_D20220703-20230702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-03</startDate>
            <endDate>2023-07-02</endDate>
        </period>
    </context>
    <context id="i25cacd5716404a11aa3833043d143f64_D20230703-20250702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2025-07-02</endDate>
        </period>
    </context>
    <context id="id98ba73abde34242a6ba47a62b0ef574_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i2b87261e163441c1ab6791378bfb180f_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i90ff1eec1ec3433284583249574c58e7_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i33e2f0127c424966a4196fa78dea5252_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i2fb70228ca86484abc1647102df379f3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief91294d01924689b8c5a91709f9113c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i191554e1c310493ca0b9f26eefe399a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i998a9400eb034fb8896247cfa7d4ce64_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie8779dbf56be4207a62a288eb16426e3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5055a550b7f1489bb057050d4eb2e15f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56ff8a9cfc574e8a813ba41191a77909_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3497639dc824203ac3bbc45e1fa7045_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia97c4e39fb2044fd832ec14992093a99_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iddb8825862eb44cba52a62ed12d533bd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaaf86c04cf564e56bba2a505c07e5a27_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8f9bbe152df94574a97c8077e072c43d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id23dbe32c67d4052a1bcc960f0ea1014_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic394f69ff36c4356957ce104b3c4e050_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib09f7d9159dc45a9b65feac3fa5d73f3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8570345d30404e7e9f7c73adbeac5a5b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia49639519ac8451195b5024845ee2aef_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica04d8b2902b463ab11876407debfe02_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib63433c4d26449ff840c826632e10ccc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3be316f6fd1b49e092d2a34cdc59474c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd009bf4fb074bf09897315c7972b8d7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iccc39a1be477444ca4a3b6da11859aaa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ef80048c2e14b599e756caca946ccb2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i213f3703bf564f66b0f66915beb0fe28_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="ifd8876d452174d08a691695fdc40ebc8_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i4155582a666f4b11b948e06e1bb09a77_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d492b0b584d4f269f2f61823174b39e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if09204510e324170b6c22bff3068c0ac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i947487d244a6487686e15b7ebb3df156_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icabc3a726b7540c7ab857df0dbcf05a0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie143cb1da9a04290be81c5d71f845995_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40a77cb321114af080584b94815e9ebe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff503e847be14ec685cb730dc81cca93_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2098fc34c48c488e9b8469ff9bb0d624_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61dd953b6b594540bad6517310eaba17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d8fcc6d51244882af073962e13c8159_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie510c5f07feb4b34b1780b367608d0b9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib9419a5870764efc954e2ea7f11c85ad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29f9998bd9f949179feb6e677def3f2d_D20190116-20190116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2019-01-16</startDate>
            <endDate>2019-01-16</endDate>
        </period>
    </context>
    <context id="i1a36de01b5ac4820a5ecf7930998772a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa362db08bef44ea8f60684d8de52387_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90bdb86d833e4c83b10c73d297c90071_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8aa490c58d174fbe8347c43a9c6d5e5d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ide8eea8c11844b23b19eb0cf0ab5959d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e5946e34fb34c6da5e38e11bc904353_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e5c8d9d9bd542fdb5a8db00cdeb2c77_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2bb0ad1ba5b453e958dbe52d1fff145_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27dc4a45b59b47f188c9741959321706_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1522b620767440f3ae5389424e04dfed_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i78a8fb5e74c64fb59d625e7756ec9015_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ied33a9c457d644dabec06946c8d55bcf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16ad22774d414f21aed7e4d4af64444c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id48efc9d3e964bcebaec0d6b42ae86ca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if4560a171d344f38b7d85fe0632ce4bf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id3435571269948bfa711c7227cab69bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e209b570c4940fcbb3cfbb19e1709f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iff5a0b29488b4f5fb8239054f04a74b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaac3427ddcd4497894f4bc23e3e9f0f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a9107cfd22f4e39bf4115b0953ea93f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic53e6488a3b94530b36da38df1893203_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">mdxg:RevenueGuidanceTopic606TransitionPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>mdxg:day</measure>
    </unit>
    <unit id="director">
        <measure>mdxg:director</measure>
    </unit>
    <unit id="securityclassaction">
        <measure>mdxg:securityClassAction</measure>
    </unit>
    <unit id="product">
        <measure>mdxg:product</measure>
    </unit>
    <unit id="distributionchannel">
        <measure>mdxg:distributionChannel</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF8zLTEtMS0xLTE_31b224cb-827d-416c-b0a9-68616c4140d2">0001376339</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF80LTEtMS0xLTE_3f577da0-201a-4bc0-8ee0-775cabfadd98">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF83LTEtMS0xLTE_32818bfe-f9de-42cb-bdc9-b4f991e68e55">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF84LTEtMS0xLTE_0227a7eb-1cb4-4dd6-8901-cad5316c4cd2">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80L2ZyYWc6MmMxNGQwMzk1YTllNGM1MWFmNTAwZjU3MGE1YjUwZTUvdGFibGU6ZDM3MDk3ZGY5MTc4NGZlZjhjZTIzMWViZjY4NDljYWQvdGFibGVyYW5nZTpkMzcwOTdkZjkxNzg0ZmVmOGNlMjMxZWJmNjg0OWNhZF8xMC0xLTEtMS0x_e0da7c74-7fb5-4a20-beb5-03bc1b0a4ad6">false</dei:AmendmentFlag>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83OS9mcmFnOjBiYzA5MmMyZGFiNTQ3ZDc5OTFlOTQ2M2ZiZmJiOGQ4L3RleHRyZWdpb246MGJjMDkyYzJkYWI1NDdkNzk5MWU5NDYzZmJmYmI4ZDhfMzk_524ea83e-176d-4a7f-aed6-efc886cd340c">Subsequent EventsNone noted.</us-gaap:SubsequentEventsTextBlock>
    <dei:DocumentType
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk2_c4f7df0a-f9eb-4bf7-be24-dce27ca10b28">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6Y2NjMjFhNzNmYjViNGE4YTg1OTRjYWYyZTFmMzg3OGUvdGFibGVyYW5nZTpjY2MyMWE3M2ZiNWI0YThhODU5NGNhZjJlMWYzODc4ZV8wLTAtMS0xLTE_c8f5bc93-cbdb-4f22-ad15-bf2226be0928">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xMjM_7a86b53d-720b-4d4e-9203-410dbdcb55fa">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6MjVhMmViNTMwMmM1NDgwYzllYWI4MDY3Y2E5YzA0OWEvdGFibGVyYW5nZToyNWEyZWI1MzAyYzU0ODBjOWVhYjgwNjdjYTljMDQ5YV8wLTAtMS0xLTE_a1311eda-cc95-4939-9f76-4b95d5d152ce">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk3_3cc10f84-8439-4ded-b85f-d63dc0e9cc54">001-35887</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk4_4f23ed1e-9320-46b3-8e03-a308e12f98ea">MIMEDX GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZWI0ZjM4NWQzOTMxNDc2YWIzODliMjkxYzYzNzRhM2MvdGFibGVyYW5nZTplYjRmMzg1ZDM5MzE0NzZhYjM4OWIyOTFjNjM3NGEzY18wLTAtMS0xLTE_2e51e5f9-b8e1-48df-bc17-0c07142e810d">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZWI0ZjM4NWQzOTMxNDc2YWIzODliMjkxYzYzNzRhM2MvdGFibGVyYW5nZTplYjRmMzg1ZDM5MzE0NzZhYjM4OWIyOTFjNjM3NGEzY18wLTItMS0xLTE_294f353b-bd6e-449a-9fa6-e8ad6c4e1c71">26-2792552</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl80_d4ad8a5b-3c60-4d2f-ad41-a64312106256">1775 West Oak Commons Ct NE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl83_732d7dbd-9719-4fcb-a2d8-6dd502ed9eb3">Marietta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo2YzRiNWNjN2E2Yzg0ODFkOGE2MjljMzIyM2Q3MjRhZl8xMQ_04275597-0920-4ab0-9f26-f182ab56e59d">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NTU3ZWNhZjQ4N2MxNDNmN2JlMDVhYTE0YWVkMDA2NmUvdGFibGVyYW5nZTo1NTdlY2FmNDg3YzE0M2Y3YmUwNWFhMTRhZWQwMDY2ZV8wLTItMS0xLTE_41cfef5b-f950-43a2-a45c-dd4a0d3e9033">30062</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk5_50a9f6a9-420f-4c0c-96fb-2df51a89c8ff">770</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzkz_f874ef68-5013-434b-839e-969b8a6ce637">651-9100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTAtMS0xLTE_34434dd4-0c73-4afa-84ca-6b3d8595d18a">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTEtMS0xLTE_cf4c8170-7d80-4364-b05c-7cfadb980de4">MDXG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6ZjJjYjNiMGViOTRhNGFkY2FjMDcwNzJmZTFkYmMzMzAvdGFibGVyYW5nZTpmMmNiM2IwZWI5NGE0YWRjYWMwNzA3MmZlMWRiYzMzMF8xLTItMS0xLTE_229ba6c9-fe5d-4187-8be9-534404de9ade">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk0_ef7067ea-d3f6-4c43-9633-19e816cb9f0b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xNzk1_d250e2ab-2537-427c-ade8-956f28f6c9f0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTAtMS0xLTEvdGV4dHJlZ2lvbjo1MmViYTkyMmEwNWE0YzdjODA0MDU4ZGExOWRkYmJlZV81_685376e4-b40f-4da0-8c4d-d3a0b3e59ad7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTMtMS0xLTEvdGV4dHJlZ2lvbjpkZmQ3NmIyNzMyZTY0MjRkYTBkNWJiNTRjYjcxNmY2Nl8zMA_5f5da301-3d39-41f2-8e7d-f2287f5338fa">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGFibGU6NDVjZDdlZTU4M2NjNDk5Y2I3ZWVmNGQ1NWY4ZDNkZjYvdGFibGVyYW5nZTo0NWNkN2VlNTgzY2M0OTljYjdlZWY0ZDU1ZjhkM2RmNl8wLTQtMS0xLTEvdGV4dHJlZ2lvbjo4NmIzYWUyMTAzYTU0MmY4OTM4MTAyZDFjNzc4YzkwNV8yOA_dd1d2238-3bbb-402f-95ad-dc413887947a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xODAx_a1775fb6-6e98-4392-b48c-08567a2017d6">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iddbbfc1062f945efbf07e9ce08fb0ae4_I20211020"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xL2ZyYWc6ZmNmYmU5MzQ1MGUxNDgwNmJhZDdkMjM3ODMyZThmMTkvdGV4dHJlZ2lvbjpmY2ZiZTkzNDUwZTE0ODA2YmFkN2QyMzc4MzJlOGYxOV8xMDk5NTExNjI5NTk3_8338fe71-b812-4791-a4ef-ec65c357de62"
      unitRef="shares">112144444</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMy0xLTEtMS0x_e1bdb5ac-b41b-43d9-875b-885cb7e7c5a5"
      unitRef="usd">90607000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMy0zLTEtMS0x_d2f9a6fb-cdfe-41d6-99e4-4d4e5e52c5d7"
      unitRef="usd">95812000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNC0xLTEtMS0x_37c54c7e-0f2a-4d51-94b0-3a6435cee6e2"
      unitRef="usd">36536000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNC0zLTEtMS0x_e575664a-9db0-4b9a-b8e8-eedc662b7509"
      unitRef="usd">35423000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNS0xLTEtMS0x_921ea6ac-fe30-41fb-99d4-e2f6014dd0e5"
      unitRef="usd">11196000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNS0zLTEtMS0x_596bd998-4022-40fc-a0d7-68943c8ee32c"
      unitRef="usd">10361000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNi0xLTEtMS0x_4d2cdbb1-da7a-4ab3-9db2-4ab9da536530"
      unitRef="usd">2078000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNi0zLTEtMS0x_91e9ba63-c7cf-4258-b09f-ad82e84be7e7"
      unitRef="usd">5605000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNy0xLTEtMS0x_0aff3927-c55e-4dce-927a-b91e20711c7e"
      unitRef="usd">625000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNy0zLTEtMS0x_55e1ccc7-a639-4510-ae71-a9620ad921f0"
      unitRef="usd">10045000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOC0xLTEtMS0x_28ff9c32-1c3e-4366-bd58-7315d445d7e5"
      unitRef="usd">860000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOC0zLTEtMS0x_e20b6920-3ee5-46fe-b7b7-a382019fda42"
      unitRef="usd">3371000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOS0xLTEtMS0x_53c4f09a-38b2-4358-948f-766006858178"
      unitRef="usd">141902000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfOS0zLTEtMS0x_56a79750-a118-4a99-bf5b-bca1e24ad987"
      unitRef="usd">160617000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTEtMS0xLTEtMQ_ed65dfc6-e89e-43c7-bdbc-67c937000585"
      unitRef="usd">9856000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTEtMy0xLTEtMQ_426f738c-ba86-40ba-bd2d-f3d9249140dc"
      unitRef="usd">11437000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTItMS0xLTEtMQ_0182d4ed-6bef-48c4-a76a-a94295484772"
      unitRef="usd">2899000</mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset>
    <mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTItMy0xLTEtMQ_a038300d-3da8-45d9-9821-e8696840cb76"
      unitRef="usd">3623000</mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTMtMS0xLTEtMQ_a6951d71-7ab2-4f95-a8cc-e5dc68f9e4ae"
      unitRef="usd">19976000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTMtMy0xLTEtMQ_2f57d99d-8bf9-473a-9877-a4af4ba62aeb"
      unitRef="usd">19976000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTQtMS0xLTEtMQ_61ceee83-ca89-4b1e-9395-9b389e4ff574"
      unitRef="usd">5620000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTQtMy0xLTEtMQ_e72b6563-4ba5-46b3-929b-a6b7f6baa297"
      unitRef="usd">6004000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTYtMS0xLTEtMQ_42a3daea-74f1-4b54-a259-5d7fc5ee8c84"
      unitRef="usd">270000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTYtMy0xLTEtMQ_9bcf7098-f64c-418b-9710-fdaf8737c041"
      unitRef="usd">375000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTctMS0xLTEtMQ_a2c04871-7db3-4186-992b-094deade5977"
      unitRef="usd">180523000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMTctMy0xLTEtMQ_10617667-ff35-49dc-ad25-ad613bab2083"
      unitRef="usd">202032000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjAtMS0xLTEtMQ_d3c386ca-5bd0-4cbf-b915-2f8da998442f"
      unitRef="usd">6881000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjAtMy0xLTEtMQ_1332df83-0805-4bb0-969f-04b2d62f08e6"
      unitRef="usd">8765000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjEtMS0xLTEtMQ_a70e0c44-ae71-4479-a462-222ab48c29dc"
      unitRef="usd">19475000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjEtMy0xLTEtMQ_c8603d9b-4475-43f4-8e8b-5854684d6578"
      unitRef="usd">18467000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjItMS0xLTEtMQ_6fde1f88-5508-415e-a69d-ee3ad893075c"
      unitRef="usd">13692000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjItMy0xLTEtMQ_50749d5a-f1fb-4189-ac3c-3dac6418d92d"
      unitRef="usd">30460000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjctMS0xLTEtMQ_92037952-0c7a-4eb6-8ae1-dcc4c9f46375"
      unitRef="usd">1698000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjctMy0xLTEtMQ_2fc405d1-0ee2-4549-b449-2603b8cdaf42"
      unitRef="usd">1470000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjgtMS0xLTEtMQ_4e7ccfc7-d35a-4aea-99ee-a6551b78e1cc"
      unitRef="usd">41746000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjgtMy0xLTEtMQ_e7eb5191-aeed-4a33-a506-1eafddfd2a25"
      unitRef="usd">59162000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjktMS0xLTEtMQ_bdd8c08b-c290-4591-b766-7afc87096666"
      unitRef="usd">48015000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMjktMy0xLTEtMQ_272afe36-a271-4655-b7eb-cd4705d3d88f"
      unitRef="usd">47697000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzAtMS0xLTEtMQ_b28ecf93-cab0-4163-8a87-60a8cabf4870"
      unitRef="usd">4076000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzAtMy0xLTEtMQ_99b18205-49d1-42df-939e-6cbd1be4cd5e"
      unitRef="usd">3755000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzEtMS0xLTEtMQ_46b7d80f-66e3-440f-b436-18639fc98a63"
      unitRef="usd">93837000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzEtMy0xLTEtMQ_4f4362e7-2545-4a4d-8329-6cbf2c1b5d60"
      unitRef="usd">110614000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzItMS0xLTEtMQ_d671f110-b379-4fe5-86ad-5f68d206211e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzItMy0xLTEtMQ_34485c69-5ac9-4fe0-8959-19e7fd26938b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzQy_73f0a2b0-1e13-4692-bb84-d633c3d95e0e"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzQy_b1e83236-c5f8-4e2d-bc37-b2bbee91e1f6"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_0b6bfa8b-1bfb-463b-811e-050c057e0e4e"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_501eb29d-80f0-4f75-bf34-c5bc470b0c94"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_5a9d9de3-4211-4eb8-b068-b5517da7fa64"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_ba796ff6-6f4e-4aa0-9e60-4f70306d06a9"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_c1d65a47-f036-4d25-acc6-1129f0cbbe44"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjk5OTgyOGMwODhkZjQxODI4ZGQ4YmVkYjdhNDg0N2ZmXzU2_dddabda3-3218-4507-bcc2-ac12c51d3ef4"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMS0xLTEtMQ_c1dc3e7d-119c-425a-85df-945023c0e197"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzMtMy0xLTEtMQ_2a99a3f4-7fdb-486e-902f-424d9ddc82b1"
      unitRef="usd">91568000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzMw_0718e63f-5873-4e01-8e33-6a60e36f5f7b"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzMw_55b1d58e-6c3a-4ca7-a76e-8a1658a1541a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzQ0_adaa3dde-e477-48ac-bc43-eb601be737b4"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzQ0_c869683e-1174-433d-9f22-7f32ecad78f9"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_12672474-0f13-4018-adde-df4760c58157"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_5727be85-af5e-4329-aeaa-a6f1795b2175"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_6d70f179-2125-434b-8b04-247e77605fb8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMC0xLTEtMS90ZXh0cmVnaW9uOjZhMTg2YzJiNzY0NDQzM2M5MWFiOTdhMTdiNjk0ZmQ5XzY2_acde9118-1ed3-48d1-b001-c392159652e6"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMS0xLTEtMQ_2f786f8e-5be3-4893-b911-2a6e2f5ca1bd"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzUtMy0xLTEtMQ_6c3ed203-c271-4a2b-8691-100b7d1873ca"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzE4_0f984b53-16f0-4f92-972c-98fc500bd5d3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzE4_7cb3b26a-d63c-40c9-961c-69b2009f4ec8"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzMy_bb1e1d9b-198d-4045-abb4-3f84a665a2b4"
      unitRef="shares">187500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzU0_39b7a82e-f5f8-4524-bc34-87482db16f4a"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzU0_64f7aff2-7f74-4283-98ad-f466a907e623"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i520bd173cc4b40d2961217715f798b5e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzY4_3c2cadbe-3d40-406c-ac57-332c24a58f09"
      unitRef="shares">111926898</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzkz_39b7a82e-f5f8-4524-bc34-87482db16f4a"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzkz_64f7aff2-7f74-4283-98ad-f466a907e623"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMC0xLTEtMS90ZXh0cmVnaW9uOjY2NTA1MWRjMTY2NDRiYmVhMmMwZDM2ZTJhZjk1NjYyXzEwNw_ac6c373d-8a1d-4ab3-bc1b-3b96dae7a70a"
      unitRef="shares">110930243</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMS0xLTEtMQ_9050ecff-04ee-4aed-b516-a64c31aa73d2"
      unitRef="usd">113000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzYtMy0xLTEtMQ_d00ae9f7-42a7-4cbe-9502-1bf80aede230"
      unitRef="usd">113000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzctMS0xLTEtMQ_56f2edfe-655d-4a58-8a76-8863b6083e45"
      unitRef="usd">162003000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzctMy0xLTEtMQ_8ddc1b16-e6e6-40d7-a131-6fccbd0d8ab9"
      unitRef="usd">158610000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMC0xLTEtMS90ZXh0cmVnaW9uOjZkYTVkZDMxMWY5ODQyYWI5MTcyNjM0NWYzZmQ0NTQ5XzI4_18287571-c8ab-4a37-ac34-8865a85c1329"
      unitRef="shares">777028</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMC0xLTEtMS90ZXh0cmVnaW9uOjZkYTVkZDMxMWY5ODQyYWI5MTcyNjM0NWYzZmQ0NTQ5XzQ4_8ef37fc9-b2fa-4bd5-8d2e-ba0595b4fefc"
      unitRef="shares">1773683</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMS0xLTEtMQ_6a2323e7-8fe4-4271-a0fb-44021111616c"
      unitRef="usd">4000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzgtMy0xLTEtMQ_79b6a662-2a86-4a63-a0da-005126fd6135"
      unitRef="usd">7449000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzktMS0xLTEtMQ_e5434733-bc7a-4c60-bed3-fe98e52eccdd"
      unitRef="usd">-163924000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfMzktMy0xLTEtMQ_b3b0cf87-3734-4676-b5b8-c6dbd0f1f7f1"
      unitRef="usd">-151424000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDAtMS0xLTEtMQ_4ed25ebb-f57a-4de9-b85a-435587c1b149"
      unitRef="usd">-5808000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDAtMy0xLTEtMQ_44b24830-1af7-4fb7-9a9f-1e05fb20dd22"
      unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDEtMS0xLTEtMQ_200c5324-40a6-4551-a821-9d9df221fc66"
      unitRef="usd">180523000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xOS9mcmFnOmRjMDQwOGNjNGUwNjQzOTViY2ExODZmMzNjM2Q2NWMwL3RhYmxlOmE1MThjNDE5MjZmMjQyNzQ5OTQ4NDE0MWQ2ZmM1MDVlL3RhYmxlcmFuZ2U6YTUxOGM0MTkyNmYyNDI3NDk5NDg0MTQxZDZmYzUwNWVfNDEtMy0xLTEtMQ_264fd861-904a-4479-b1a1-496d19866e9b"
      unitRef="usd">202032000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy0xLTEtMS0x_e41e5fae-88a8-4cdd-a962-40917ce0207a"
      unitRef="usd">63074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy0zLTEtMS0x_6869323e-ccf1-43f7-9044-2a4e0ab34927"
      unitRef="usd">64303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy01LTEtMS0x_8a3ba30a-998b-4fbf-9e5a-2b3bd9ae25dc"
      unitRef="usd">191206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMy03LTEtMS0x_9353dda0-03d4-4e37-ab44-32d3e2fd08c9"
      unitRef="usd">179686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC0xLTEtMS0x_97974610-db74-45d7-9d53-aad9965c166d"
      unitRef="usd">10129000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC0zLTEtMS0x_092a8c5e-a0ed-4c45-8987-b5289ddd6430"
      unitRef="usd">10289000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC01LTEtMS0x_138d2eed-520d-4ec9-9885-9a89adc7175d"
      unitRef="usd">32530000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNC03LTEtMS0x_a3564320-2562-40c6-b415-e6a71014e31d"
      unitRef="usd">28513000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS0xLTEtMS0x_a878152a-751d-4598-8f77-6fabf6e39c07"
      unitRef="usd">52945000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS0zLTEtMS0x_a9f76593-7f6d-43b6-b93b-6b0609913dc4"
      unitRef="usd">54014000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS01LTEtMS0x_429d7e60-19d8-47fd-bf2c-14c40189a87a"
      unitRef="usd">158676000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfNS03LTEtMS0x_91e726f4-c21b-4e93-a53b-ab6ef28adc44"
      unitRef="usd">151173000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0xLTEtMS0x_c8a804c4-55c3-4639-9359-2d196711ac8e"
      unitRef="usd">46289000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0zLTEtMS0x_17ea84d2-2bb7-48fa-aada-b62a70df3f44"
      unitRef="usd">48046000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC0zLTEtMS0x_34947376-1347-4fda-9fe8-55a3bbc065c6"
      unitRef="usd">48046000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC01LTEtMS0x_355ae1e3-66c1-49b7-b1b1-a70fac8ff184"
      unitRef="usd">145291000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOC03LTEtMS0x_48b5fd95-ba2d-4f15-9471-4d73d8945a6b"
      unitRef="usd">132316000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0xLTEtMS0x_702a6b03-7218-4d00-9518-2108b63c2328"
      unitRef="usd">3170000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0zLTEtMS0x_47db79a4-1406-45d1-90e2-1be3fa5d3abb"
      unitRef="usd">12027000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS0zLTEtMS0x_fb447a92-454c-4b27-8998-ce223537905a"
      unitRef="usd">12027000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS01LTEtMS0x_8d3ca897-ff19-4b1c-9af8-f2960faa49d4"
      unitRef="usd">8304000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfOS03LTEtMS0x_98c98ce4-8bd5-414f-883f-7c2d2bac7e6a"
      unitRef="usd">39065000</mdxg:InvestigationRestatementandRelated>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMS0xLTEtMQ_f682edc5-9f1f-4915-b9b7-c937545670ed"
      unitRef="usd">4368000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMy0xLTEtMQ_b56e82c6-5bb0-4de3-9473-d28f4b6a51ed"
      unitRef="usd">3372000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtMy0xLTEtMQ_c08eddd8-5958-42de-9694-df5ec8b7a190"
      unitRef="usd">3372000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtNS0xLTEtMQ_2d079301-7be6-4b2e-a360-33d0b8fa20e0"
      unitRef="usd">12770000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTAtNy0xLTEtMQ_796c8b2f-16dd-444f-aff8-4c1a7c93c093"
      unitRef="usd">8281000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMS0xLTEtMQ_4b424d20-948f-4736-b6e1-4c74726937c2"
      unitRef="usd">193000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMy0xLTEtMQ_09c223b1-0ff3-4875-8c27-14e09b89f72e"
      unitRef="usd">276000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtMy0xLTEtMQ_f1d69415-33b7-40e8-814e-60704ec3989c"
      unitRef="usd">276000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtNS0xLTEtMQ_105571a9-27fd-4bbd-8dd7-33f55d05083f"
      unitRef="usd">647000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTEtNy0xLTEtMQ_44cee943-7b6f-4239-956a-0bb55ac89c2b"
      unitRef="usd">818000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtMS0xLTEtMQ_362db3ba-c073-40f5-9b36-d878fbaed920"
      unitRef="usd">-1075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtMy0xLTEtMQ_ee254f90-af41-4289-9b40-020bb4a89bd7"
      unitRef="usd">-9707000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtNS0xLTEtMQ_a225c684-19bb-4e44-a648-ebe90f3aedad"
      unitRef="usd">-8336000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTMtNy0xLTEtMQ_f5276333-0c9a-4cd5-a04b-a5d2f30a5f9a"
      unitRef="usd">-29307000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtMS0xLTEtMQ_239acc6d-b921-4991-960f-219e399ff19d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtMy0xLTEtNTk5_3e342d17-069a-4e70-99dc-99a2f341e4be"
      unitRef="usd">-8201000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtNS0xLTEtMQ_d9a84feb-5c3f-49b0-8a15-efd7cf5411e8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTYtNy0xLTEtMQ_c3cd7251-793d-499a-b50b-7c62498b9466"
      unitRef="usd">-8201000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMS0xLTEtMQ_6600b873-2950-4766-82b3-40efa4bede8a"
      unitRef="usd">-963000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMy0xLTEtMQ_6f848c18-ba3b-4199-a7d8-6f3378a0fdda"
      unitRef="usd">-1472000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctMy0xLTEtMQ_d048d3f6-af07-4697-acdc-3508f4e8eb7f"
      unitRef="usd">-1472000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctNS0xLTEtMQ_af74698f-68e0-4a34-8ce2-9bd9acd13ec5"
      unitRef="usd">-3806000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTctNy0xLTEtMQ_461664cb-0b9f-40c5-bb29-13994ec27f2d"
      unitRef="usd">-6433000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMS0xLTEtMQ_54c4b57c-b8e6-4982-b411-7613446936c9"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMy0xLTEtMQ_ef616fad-483e-49ba-bdbe-a94146abb366"
      unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtMy0xLTEtMQ_f8919c5c-052d-47aa-8f1f-f36c1885fc68"
      unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtNS0xLTEtMQ_ad157549-59c5-471a-b619-4e18497ca391"
      unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTgtNy0xLTEtMQ_36a157f3-e7e4-49a6-87f7-36f54d36b580"
      unitRef="usd">-2000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktMS0xLTEtMQ_111eab87-1f9b-4cfa-b144-e716c4b3fa93"
      unitRef="usd">-2038000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktMy0xLTEtMQ_34560fc9-dce4-4c5f-a201-79fff7bfdee9"
      unitRef="usd">-19379000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktNS0xLTEtMQ_a7ce3956-86c6-470a-b92f-6051505328c8"
      unitRef="usd">-12145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMTktNy0xLTEtMQ_b99c89db-39af-4a2f-96af-d1b62f9c22d3"
      unitRef="usd">-43943000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMS0xLTEtMQ_04257ccc-1832-4abc-bfdf-8153742e609b"
      unitRef="usd">301000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMy0xLTEtMQ_b00d038b-831f-4c45-a77e-2b3a96d5c450"
      unitRef="usd">38000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtMy0xLTEtMQ_e83f1926-e2d0-4b9f-9f81-cf486eefc5f4"
      unitRef="usd">38000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtNS0xLTEtMQ_b3afd829-7ef9-47bb-9c7b-c3fa99d9674b"
      unitRef="usd">355000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjAtNy0xLTEtMQ_dbff85ad-490b-4d79-a7a3-1581c45fa509"
      unitRef="usd">-11239000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtMS0xLTEtMQ_e3a6a1dd-23a0-4eee-a0c5-2b3e7f04b167"
      unitRef="usd">-2339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtMy0xLTEtMQ_59f15f9c-4e5d-410a-a1cc-3541048f39ac"
      unitRef="usd">-19417000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtNS0xLTEtMQ_bc1a1a42-db33-42fc-80e2-7824f086e36b"
      unitRef="usd">-12500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjEtNy0xLTEtMQ_05ca5ece-53dd-4a61-b860-5415216b425c"
      unitRef="usd">-32704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtMS0xLTEtMQ_ee40f574-dc41-4db3-be88-b0862e876dd9"
      unitRef="usd">-3913000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtMy0xLTEtMQ_29baf1a2-db56-4bca-9fb6-fdf7045bc2b5"
      unitRef="usd">-51982000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtNS0xLTEtMQ_6aa708a3-97f8-44da-a25e-f12eb8d9a032"
      unitRef="usd">-17039000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjMtNy0xLTEtMQ_c8344bfb-6785-44dc-8e2b-379803ba3037"
      unitRef="usd">-65269000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtMS0xLTEtMQ_5d907682-666a-45c1-8e68-426d8e971e2d"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtMy0xLTEtMQ_5bc84fa4-27fc-4834-9b5b-8c01b0a2c481"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtNS0xLTEtMQ_2c300bb4-fefe-42f1-973d-f44c047ed4d9"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjUtNy0xLTEtMQ_0dda7691-8f20-4854-b105-083142bb5b1d"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtMS0xLTEtMQ_be7d997c-e498-4a5e-99c0-36baab7cda12"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtMy0xLTEtMQ_ae993c2d-ccaa-4616-8438-35b472d52327"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtNS0xLTEtMQ_8a5958ac-482a-4989-9dab-84e0c3509fea"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjYtNy0xLTEtMQ_95704cff-00c3-4097-9444-397b68d53411"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtMS0xLTEtMQ_54fde61d-a944-454d-a18e-9127a4b20b06"
      unitRef="shares">110717073</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtMy0xLTEtMQ_c99b9c57-4803-4f7c-84cb-933ffd4884da"
      unitRef="shares">108493208</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtNS0xLTEtMQ_7284e7ce-2ddb-4800-9b9b-dab08a47daa3"
      unitRef="shares">110136517</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjgtNy0xLTEtMQ_4bde1d0c-3d6c-4828-a13b-c51c534472ae"
      unitRef="shares">108222419</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktMS0xLTEtMQ_fcb0d94f-9f7f-4b72-a5db-3ac09d58375e"
      unitRef="shares">110717073</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktMy0xLTEtMQ_c37ff979-8ac0-4206-9406-19cc21fa70b7"
      unitRef="shares">108493208</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktNS0xLTEtMQ_056a6dab-b5e2-40f1-8692-0311ebf4b180"
      unitRef="shares">110136517</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yMi9mcmFnOmQzMDIwZWRhMzJmNzQwNjhiMjYwOWIyYTllODY3MzBmL3RhYmxlOmI0M2JlODRhYTQ0MjQ0MzA4Nzk0OWYyNDE4ZjhiYTg3L3RhYmxlcmFuZ2U6YjQzYmU4NGFhNDQyNDQzMDg3OTQ5ZjI0MThmOGJhODdfMjktNy0xLTEtMQ_e58aac32-c1bd-49ff-ba87-685c48ed0c49"
      unitRef="shares">108222419</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if8424268fe0f422699167479e062686d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0xLTEtMS0x_ff84b4e7-1e46-44b3-a710-87b42890e57e"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if8424268fe0f422699167479e062686d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0yLTEtMS0x_99638af3-a8ad-43c2-8583-29ad79d43c9b"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7747d8031bb444f8a0d132a76929ab7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi0zLTEtMS0x_70dcf76c-5bc7-4d1c-bf91-cd4b47c12739"
      unitRef="usd">158720000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi00LTEtMS0x_21e7c4b2-2e50-41d8-970c-dfa7e051c4fe"
      unitRef="shares">821988</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i765dd0ccb0c7463c978f5c98b0bc890b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi01LTEtMS0x_2389d3ea-fa8b-45f0-a341-9415c88c5fc5"
      unitRef="usd">-4385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24deb84eee304bf8bd22b8b75a680e8f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi02LTEtMS0x_f9efc6a2-e1e8-46b6-9b9b-81833b8f3da1"
      unitRef="usd">-161585000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i520bd173cc4b40d2961217715f798b5e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMi03LTEtMS0x_7e778710-f296-4381-96dc-423b217c2021"
      unitRef="usd">-7137000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNS0zLTEtMS0x_1770a88d-2059-475c-8957-3d6e9c2614b5"
      unitRef="usd">3811000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNS03LTEtMS0x_35af59f9-78e2-469a-8df6-89f847f2e06f"
      unitRef="usd">3811000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy0zLTEtMS0x_a1d6feaa-d0f8-498a-87aa-b164ce5bb921"
      unitRef="usd">-250000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy00LTEtMS0x_8d94a437-358b-4263-b3d9-c67eff29bfb6"
      unitRef="shares">30032</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy01LTEtMS0x_af0fdb1d-86d6-44f7-8630-f34d51e8c501"
      unitRef="usd">295000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfNy03LTEtMS0x_7104a95e-7808-48a3-ad2e-363e0e007665"
      unitRef="usd">45000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS0zLTEtMS0x_4e913115-eb99-4f8b-b973-1a541d533c6a"
      unitRef="usd">-477000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS00LTEtMS0x_97a9b96e-98e9-4e3d-85b4-4c31b00104fa"
      unitRef="shares">48630</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS01LTEtMS0x_01b62a72-bd88-442a-bcf6-d7c504984266"
      unitRef="usd">477000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfOS03LTEtMS0x_005996cc-d07d-4b88-af63-80104fd14531"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i16a5c6a3126446408d113e5a08e8d063_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtMy0xLTEtMQ_71df1443-406a-4352-8d65-91376cbadee5"
      unitRef="usd">-199000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNC0xLTEtMQ_f9b5e19c-f055-491a-9e96-cf5b738a71ee"
      unitRef="shares">18348</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNS0xLTEtMQ_30f1a33b-90b4-4d75-9a9f-5ec8b1fd3cc8"
      unitRef="usd">199000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTAtNy0xLTEtMQ_133d353e-00b3-4d4f-9366-2f8a89524a21"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNC0xLTEtMQ_8101ae1a-2184-4014-b6d2-966288151ef9"
      unitRef="shares">15354</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2c540d6beef74016a6ae00afd809f5f7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNS0xLTEtMQ_7bcf6b7c-b6ce-4310-aa29-c2a0f38709f8"
      unitRef="usd">188000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTMtNy0xLTEtMQ_b6fe2f37-dd25-465e-b404-b49a21fd8096"
      unitRef="usd">188000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i4113e96817ee412daf4fb896ba4f907c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTQtNi0xLTEtMQ_eb6c7515-c2b2-4632-8b90-6569e545a22e"
      unitRef="usd">-2339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTQtNy0xLTEtMQ_d0f0dba9-726e-4daf-8530-0541616cbb5c"
      unitRef="usd">-2339000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMS0xLTEtMQ_587bc419-0d80-4515-bac4-e748a7c6a0c3"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMi0xLTEtMQ_aced27d6-3ee1-47cc-ac5b-eda22fd1a1c8"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e9879aac5984ce69a94a4be82f2afc7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtMy0xLTEtMQ_47b29edc-19b1-48f1-a5bb-08183b64f6c3"
      unitRef="usd">162003000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNC0xLTEtMQ_2bb39d3a-2859-4a67-9b79-509befa5d471"
      unitRef="shares">777028</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNS0xLTEtMQ_e74b956f-e42b-4ce4-b97b-b3217da7a343"
      unitRef="usd">-4000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d911729a90a4336b491792e0f39a4b1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNi0xLTEtMQ_cff5a3e5-29a5-485f-87a3-780e73b4e5c2"
      unitRef="usd">-163924000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjQ4MTE4NDlkOTgzOTRiZWI4Yzc4MWE3YTI5YjJmYWE3L3RhYmxlcmFuZ2U6NDgxMTg0OWQ5ODM5NGJlYjhjNzgxYTdhMjliMmZhYTdfMTUtNy0xLTEtMQ_339d0cb4-d5db-458f-a5bc-cdc01cd4036a"
      unitRef="usd">-5808000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2c1e389a471143e09a8fe973bc129222_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0xLTEtMS0x_3ea6dffd-8630-477b-b705-de544e3779a0"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2c1e389a471143e09a8fe973bc129222_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0yLTEtMS0x_a691ee83-9ff3-4724-ac57-036e091ea64d"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb9dab3f535941c8a7e99c7f45f0648e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi0zLTEtMS0x_d343069a-ddb7-46f5-ac54-a2d6c1da8afb"
      unitRef="usd">151625000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i870ec0719b704056ab5a603cee32bf21_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi00LTEtMS0x_12d230be-d2a9-4808-a2bb-5e3bc89b7901"
      unitRef="shares">2412522</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i870ec0719b704056ab5a603cee32bf21_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi01LTEtMS0x_f136f6a4-cd40-4d57-a055-c31298ba75d2"
      unitRef="usd">-13451000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00bbd7d8fb234b8b906ba09f5de7f570_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi02LTEtMS0x_cd1433cf-e00c-4309-803b-ed4e75c8f1f9"
      unitRef="usd">-115427000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i319b98af263b4cca93e4f38f54ec70de_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMi03LTEtMS0x_d2dba78d-03b8-4e07-a508-b490b4cb8c9b"
      unitRef="usd">22860000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy0zLTEtMS0zMDAzNA_7339453e-3ffd-4185-9e48-d41a4cdbf3e0"
      unitRef="usd">32954000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy03LTEtMS0zMDA0OQ_24ca5ec7-6ebd-4573-bd66-aeacf347bf9b"
      unitRef="usd">32954000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNC0zLTEtMS0zMDAzNA_e27f26b1-882e-4e41-9e34-56ad7fbe19dc"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNC03LTEtMS0zMDA0OQ_cc108811-c779-4609-9cc3-487affcef724"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy0zLTEtMS0x_7f8ea6b3-5216-482b-8af9-4010e60eefc6"
      unitRef="usd">8048000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMy03LTEtMS0x_cf189052-3aeb-466b-9c41-4a89d26c4fc6"
      unitRef="usd">8048000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi0zLTEtMS0zMDA3OA_54e96db5-b951-4b85-a842-f14aeea3620c"
      unitRef="usd">-328000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi00LTEtMS0zMDA3OA_07017f66-440a-4ff9-b417-711ab8de0753"
      unitRef="shares">45000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi01LTEtMS0zMDA3OA_d53df6f5-ff65-4d8a-84e6-1f9beb253350"
      unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi03LTEtMS0zMDA3OA_6258977a-5b70-4cf3-a7cc-deeafcd86fd8"
      unitRef="usd">72000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS0zLTEtMS0x_3b60037c-f5cf-48c6-b608-e1ba782b8160"
      unitRef="usd">-2939000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS00LTEtMS0x_8ad1eb20-b67a-4f38-866d-b4bf72548891"
      unitRef="shares">328894</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS01LTEtMS0x_8ae55b02-acfc-4062-8c10-d8ce17871f35"
      unitRef="usd">2939000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNS03LTEtMS0x_5b526d19-4bbf-444a-9484-9d832400c00a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6ac2313621d74307849ad9e91742e45a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi0zLTEtMS0x_3acce249-9fb6-4731-8410-cb362751881b"
      unitRef="usd">-526000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi00LTEtMS0x_9e1a25b4-6332-4b0e-9ee3-1718a452e5cf"
      unitRef="shares">59441</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi01LTEtMS0x_ec53c923-dfa3-43c2-83d5-53df3a66fc58"
      unitRef="usd">526000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfNi03LTEtMS0x_fdb3914f-80ef-4f00-9c66-b65a39ea7dc3"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS00LTEtMS0x_9b21f293-1d83-4a54-b74c-ad97b3fba10a"
      unitRef="shares">14123</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i436daee9978a4397ad97a4286179a79c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS01LTEtMS0x_c1856c8e-c810-4e00-b665-6ca6dc717647"
      unitRef="usd">79000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfOS03LTEtMS0x_efdebb8b-0d6b-4585-b790-cb95a90cf187"
      unitRef="usd">79000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i6dbe6f366fa94babbed471b118618949_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTAtNi0xLTEtMQ_dca02f60-9827-476e-b94a-f339c6d110b9"
      unitRef="usd">-19417000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTAtNy0xLTEtMQ_86e5891b-e1bf-4078-8c73-7eece651be16"
      unitRef="usd">-19417000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMS0xLTEtMQ_12ae7bb6-571e-467e-9855-69d479aff1d9"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMi0xLTEtMQ_42f3e8d9-e43c-4c05-8485-967cbf8c0921"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica08a3b681bd4921a6e10b0e732812dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtMy0xLTEtMQ_536c0198-4365-4e05-92d5-4d3bc1e2fc55"
      unitRef="usd">158318000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNC0xLTEtMQ_660daf5d-ff6d-42a9-bc11-f8d486a370cc"
      unitRef="shares">2112192</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNS0xLTEtMQ_e2b5854d-2d0d-438e-89a9-cb09e7855047"
      unitRef="usd">-10717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNi0xLTEtMQ_b34137de-6716-42c4-a22d-37fdab93d632"
      unitRef="usd">-134844000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjU3ODhhNjYxYzFmNDQ4ZGNiYzM2NWM0Y2E4MThlMDliL3RhYmxlcmFuZ2U6NTc4OGE2NjFjMWY0NDhkY2JjMzY1YzRjYTgxOGUwOWJfMTEtNy0xLTEtMQ_ab2dd3b2-66d0-4904-8fa6-63dd45a45334"
      unitRef="usd">12870000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0xLTEtMS0x_39b2e251-2f3e-400d-be7b-c00e5e69fed2"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2d9f4e6f7b3f4214a02ff0398689b0d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0yLTEtMS0x_10efbcb7-e9c6-426f-9e4c-a735625db080"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fff381503ab470cb567487005105042_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi0zLTEtMS0x_e04d9064-3320-4996-8228-6c5673de7fd5"
      unitRef="usd">158610000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi00LTEtMS0x_d716078c-329a-433a-9070-c7ede15f089c"
      unitRef="shares">1773683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib0628426cc9a4c5ba1c5e754edf2a423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi01LTEtMS0x_48b8f124-18c7-44be-a442-c9893483850d"
      unitRef="usd">-7449000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48875c6ed61b4455a259bb6c00a985b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi02LTEtMS0x_60dac2c7-93c2-4cb1-a1fe-c651cb0b622f"
      unitRef="usd">-151424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMi03LTEtMS0x_69881b0c-4cc9-4c3d-8a8b-6587c6ef8c96"
      unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i4481913816f8495b91664f2c94c198a2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy0zLTEtMS0x_4376669f-b0e6-4dc0-b88a-0d0a186b0f45"
      unitRef="usd">-2009000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <mdxg:TreasuryStockSharesAdjustment
      contextRef="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy00LTEtMS0x_2eb18899-c798-409e-b658-79979bc7dc06"
      unitRef="shares">-239502</mdxg:TreasuryStockSharesAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i761d607344cf4ea79a6dc1e3c868ad2d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy01LTEtMS0x_ba513794-fa95-4677-9b2c-99e253433557"
      unitRef="usd">2009000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ib0527aaa3a4344329744dd834938874f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMy03LTEtMS0x_ecb46417-dc89-4224-94d1-6424c8b87c0b"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNC0zLTEtMS0x_3d067466-889f-4b42-91e7-92861a3d421e"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNC03LTEtMS0x_e8b4e48f-e4b8-4ab4-a23c-3e2b3c406a2f"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNS0zLTEtMS0x_935c5523-baaa-44d3-909e-129eeb4fad53"
      unitRef="usd">11115000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNS03LTEtMS0x_7dec0a15-f40a-4203-925c-7c8bb44f6898"
      unitRef="usd">11115000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi0zLTEtMS0x_c339023a-7cb0-425e-81dd-9cdc861a5787"
      unitRef="usd">-1184000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi00LTEtMS0x_2df6ee3f-b8c3-439e-8825-cee2e03432d5"
      unitRef="shares">482361</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi01LTEtMS0x_97e17d1d-8aea-48f9-a786-f29a08997817"
      unitRef="usd">2588000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNi03LTEtMS0x_9eced3c0-2604-4c06-ab94-83c6d2f6e3bb"
      unitRef="usd">1404000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy0zLTEtMS0x_c4864b4d-4f6f-4c88-be54-4c7cb4808547"
      unitRef="usd">-4053000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy00LTEtMS0x_7fe40c41-8a9c-49ae-b38d-e9b36dd6e9fd"
      unitRef="shares">810405</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy01LTEtMS0x_cf28ad5e-68bb-4c76-b221-45bd8c02be95"
      unitRef="usd">4053000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfNy03LTEtMS0x_67f570bb-d378-4ea1-8f52-fc7dec347b3e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="iabecddc935164519aab66d2c8cd067a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC0zLTEtMS0x_b091b05e-45c6-488c-9513-c0d863ef91ad"
      unitRef="usd">-450000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC00LTEtMS0x_4855925b-bab7-4a68-8b9e-11fb7435d4ca"
      unitRef="shares">66374</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC01LTEtMS0x_ca62ab22-d36d-4431-a83c-9cea85e6e25b"
      unitRef="usd">450000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOC03LTEtMS0x_47bea69c-8b83-448e-9fff-9d609e636a27"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS00LTEtMS0x_3bd61d5c-ea2f-4c33-973f-e40153255f01"
      unitRef="shares">469239</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0bf3749702ab4f9ba5df2da295787d5f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS01LTEtMS0x_ab78d4df-cbd1-46ee-ad67-f365a33037d9"
      unitRef="usd">4751000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfOS03LTEtMS0x_f976d52f-f4ba-40a7-89c3-fd12299888db"
      unitRef="usd">4751000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i907e1ab429324dafb8dede5c9e07fd49_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTAtNi0xLTEtMQ_e15eb60e-e02a-4752-ad81-2f8a6fda97be"
      unitRef="usd">-12500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTAtNy0xLTEtMQ_8abbcb9b-ff7e-4b64-8ac7-e4a16445cef3"
      unitRef="usd">-12500000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMS0xLTEtMQ_d4cd6b37-8e84-44ea-8440-e7dc5dae1137"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i53fdc83dfd0149eaac0de8eaa5a7eabf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMi0xLTEtMQ_22f829a5-8ed3-4802-b74e-3f3e5bf5d035"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e9879aac5984ce69a94a4be82f2afc7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtMy0xLTEtMQ_4f4d26c4-2253-4cfb-bd4e-1cc774f032cc"
      unitRef="usd">162003000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNC0xLTEtMQ_723804c4-6ac9-4010-bc94-7ede398df869"
      unitRef="shares">777028</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9af38df7e7e045dbb7e10b3f35a85c3d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNS0xLTEtMQ_a0af8752-a5a0-492c-b997-c7ac35890b18"
      unitRef="usd">-4000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d911729a90a4336b491792e0f39a4b1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNi0xLTEtMQ_2f92449e-7938-4d8d-bdd3-b4a4d0511238"
      unitRef="usd">-163924000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOmY1ZWFhOWM3Y2Y0MjQ2NzliY2VjYjhmMWE3YTRkNmE3L3RhYmxlcmFuZ2U6ZjVlYWE5YzdjZjQyNDY3OWJjZWNiOGYxYTdhNGQ2YTdfMTEtNy0xLTEtMQ_8746db73-b6e7-47b5-8c75-58116eccaa6b"
      unitRef="usd">-5808000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i21b398a86a27463d8c43135cf5d273e1_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0xLTEtMS0x_8f8344c8-7fea-44d8-bf46-e11cac14203f"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i21b398a86a27463d8c43135cf5d273e1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0yLTEtMS0x_f5f830cb-4dc0-47d7-a27f-b70dade9a1a2"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i125daf82d900495c9fe37f9848541647_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi0zLTEtMS0x_0bea1067-6da9-4ad2-820d-910c767829a3"
      unitRef="usd">147231000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i91714ed5b0024037979d7567ffba146c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi00LTEtMS0x_669b0041-30cc-4431-beaa-8a21ff3c9a8d"
      unitRef="shares">1885277</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i91714ed5b0024037979d7567ffba146c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi01LTEtMS0x_ff8748ab-e710-476e-9ddc-0b1254730d2d"
      unitRef="usd">-10806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61389415a5d84a8696dd0a0d0313b5d9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi02LTEtMS0x_bfa2889a-6a9b-47cf-8498-e46f9934e549"
      unitRef="usd">-102140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5967a4f404664bef9378ba0366b3c4f2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMi03LTEtMS0x_a5675d8a-3824-46cc-99c1-d8a130aa81dc"
      unitRef="usd">34398000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMy0zLTEtMS0zMDEwNw_b282697f-a387-4df1-9d09-37f87e533044"
      unitRef="usd">32954000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMy03LTEtMS0zMDEwNw_1c30ddc9-2b8c-4b88-84a2-29624b9c1031"
      unitRef="usd">32954000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC0zLTEtMS0zMDEwNw_9bce87a9-a3a4-45d8-8fdf-98b7b4d3d47c"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC03LTEtMS0zMDEwNw_187d9dd4-6b3d-44ae-92d4-a8b52dba556e"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC0zLTEtMS0x_7313eba9-75f2-42b9-921e-e3c0c9f7f97f"
      unitRef="usd">11829000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNC03LTEtMS0x_a0055901-9404-4340-9c88-95a578f3422f"
      unitRef="usd">11829000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS0zLTEtMS0x_4324f622-43bd-4595-a1b1-273ade0a4d76"
      unitRef="usd">-1986000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS00LTEtMS0x_230c7ba7-6558-4805-ac65-f5752683029c"
      unitRef="shares">265300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS01LTEtMS0x_927e2d03-7100-4abd-b8ea-3286949726dc"
      unitRef="usd">2356000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNS03LTEtMS0x_a84b535b-bcee-418b-a332-c5edfd7915cb"
      unitRef="usd">370000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi0zLTEtMS0x_3b1ef36e-9c92-446f-b405-b51c09a8d7d2"
      unitRef="usd">-2939000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi00LTEtMS0x_7732746b-7086-4041-8e12-162a0bba7a67"
      unitRef="shares">328894</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi01LTEtMS0x_9facc633-f1b7-4ac0-bc40-f39604bac02c"
      unitRef="usd">2939000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNi03LTEtMS0x_f19c231f-93e3-4937-8878-417f2ac425d3"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy0zLTEtMS0x_236bce20-a536-41ee-b15c-5f2660585e1e"
      unitRef="usd">-2650000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy00LTEtMS0x_63d57309-d44f-43b8-8466-b30cc49a6ccd"
      unitRef="shares">345052</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy01LTEtMS0x_a446bc1e-2741-40cb-bc9b-23c8990106f5"
      unitRef="usd">2650000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfNy03LTEtMS0x_bc6ac9fe-21c7-4427-8eeb-20697093e968"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if8186633d97948528d65f2fa51dcafbe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC0zLTEtMS0x_d0c8e06e-f191-46e7-aa2d-addb84c5e585"
      unitRef="usd">-147000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC00LTEtMS0x_5e364eae-cfe0-4c90-95d1-670f8e285e4e"
      unitRef="shares">476057</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i244933eea60b47a196d7376e82eb8e38_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC01LTEtMS0x_475c99dd-1968-4e10-962b-3e7b94460744"
      unitRef="usd">2556000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOC03LTEtMS0x_16d2b85d-8c13-4260-a5a5-5234b8ea7bfe"
      unitRef="usd">2409000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i9c93f18d959c4e32bba8d358469e13b7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOS02LTEtMS0x_d8b55032-13d9-49ca-9710-dc4cac6c7785"
      unitRef="usd">-32704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfOS03LTEtMS0x_27ddc898-d8c8-4380-8387-dc7eb8b24637"
      unitRef="usd">-32704000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMS0xLTEtMQ_76b6df55-1ac4-45ee-b838-1879bc69e3e3"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0d748ab4e8b043cc9ad7f61d152dcaa1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMi0xLTEtMQ_5914a0c1-9bb2-4d1b-80fe-6949519cdb76"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica08a3b681bd4921a6e10b0e732812dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtMy0xLTEtMQ_249394c1-3392-4b78-b858-3bcc820d760e"
      unitRef="usd">158318000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNC0xLTEtMQ_091355e9-513f-431c-84e0-bae045836d9f"
      unitRef="shares">2112192</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i73e2569d084d4d16a061c3a2817e4517_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNS0xLTEtMQ_ce7c30a4-4977-4ecb-850b-733ff53514e6"
      unitRef="usd">-10717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec9abfb48a3b43d5ad2350cce64d4d7b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNi0xLTEtMQ_a08b588b-053a-40ff-bc4d-9e1a1a05a3cb"
      unitRef="usd">-134844000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yNS9mcmFnOjk1ZjA5NzBmNjVkZjQwMDA4NjQ1ODQ4NjQ5MTAwMzM5L3RhYmxlOjZhNWVjNGRkNDE1MjQzZGViMzRmNDFlNDE2MDgwZjIxL3RhYmxlcmFuZ2U6NmE1ZWM0ZGQ0MTUyNDNkZWIzNGY0MWU0MTYwODBmMjFfMTAtNy0xLTEtMQ_9e458af9-3ae1-403a-aca9-a8d760864dd0"
      unitRef="usd">12870000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMy0xLTEtMS0x_5ec123e4-c926-4a75-ae50-a1d6d625676b"
      unitRef="usd">-12500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMy0zLTEtMS0x_52d71fd2-57ab-4bcc-b91f-f15220c6369f"
      unitRef="usd">-32704000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNS0xLTEtMS0x_d19e3f8c-deef-45bb-9115-4bc91d00f183"
      unitRef="usd">11115000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNS0zLTEtMS0x_2de677c3-9761-4a27-b50e-a9146eb99fb1"
      unitRef="usd">11452000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNi0xLTEtMS0x_eee998c7-ead0-4315-bce0-acc294c421f6"
      unitRef="usd">3390000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNi0zLTEtMS0x_bee69492-0415-45ef-99fc-8e42d21f2424"
      unitRef="usd">4494000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNy0xLTEtMS0x_3b495783-f421-40fa-a57a-182c326761b1"
      unitRef="usd">647000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNy0zLTEtMS0x_844673e4-374b-4c9f-a305-424fb231a2a7"
      unitRef="usd">818000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOC0xLTEtMS0x_c7aac087-427f-4540-abd9-d9bcd006f8b2"
      unitRef="usd">943000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOC0zLTEtMS0x_4ecac232-da9f-4be8-8497-4c7d18c2daf5"
      unitRef="usd">1811000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOS0xLTEtMS0x_8f6dc529-6c05-486e-b16f-4514ddadb163"
      unitRef="usd">724000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfOS0zLTEtMS0x_8e370851-f7bf-4f52-99f2-3db15397d205"
      unitRef="usd">702000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTAtMS0xLTEtMQ_aa3cb79f-7fe4-43a5-8d7d-10961a186b73"
      unitRef="usd">57000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTAtMy0xLTEtMQ_c17009aa-fb12-41ce-aae7-2357cb704f49"
      unitRef="usd">0</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTEtMS0xLTEtMQ_20e27f00-9895-4c13-9c82-4a2702cdaeab"
      unitRef="usd">-236000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTEtMy0xLTEtMQ_3cba4fcb-503f-4593-ac01-8fe8bc55bc1d"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTMtMS0xLTEtMQ_ea1facd5-db65-4c82-9fbf-694deea17bbb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTMtMy0xLTEtMQ_997622ca-c35c-4b3f-955f-4e2a535ee22d"
      unitRef="usd">-8201000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTUtMS0xLTEtMQ_b63e044a-529f-4bef-8373-24dd927dbe1f"
      unitRef="usd">1113000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTUtMy0xLTEtMQ_95b3c18f-12fa-470a-b659-f635ca2d4c91"
      unitRef="usd">715000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTYtMS0xLTEtMQ_da124f9a-1d74-499b-96b0-9d719a35416e"
      unitRef="usd">835000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTYtMy0xLTEtMQ_9ff60504-a451-4c62-b7aa-ba40cd36a299"
      unitRef="usd">1919000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTctMS0xLTEtMQ_f66a35d2-0b07-403c-aa33-41c7cb498e6f"
      unitRef="usd">-3527000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTctMy0xLTEtMQ_4c29a9a6-c0c9-469b-8843-6be2cca4b753"
      unitRef="usd">-5177000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTgtMS0xLTEtMQ_78e8dd66-0f06-4fce-aeb2-956712015da0"
      unitRef="usd">-9420000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTgtMy0xLTEtMQ_56407df8-a6b5-45fa-b20e-63c6f608210f"
      unitRef="usd">10835000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTktMS0xLTEtMQ_45830ab4-2c4e-4967-bff8-72b0b4c010f6"
      unitRef="usd">-1990000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMTktMy0xLTEtMQ_9a69a107-7d1c-44ea-b9a6-5b1590678b8e"
      unitRef="usd">-1633000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjAtMS0xLTEtMQ_586dfbba-9325-45ae-a6b8-61569632b237"
      unitRef="usd">-828000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjAtMy0xLTEtMQ_205c8b86-df8a-4de4-a5bf-367ee632a500"
      unitRef="usd">339000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjEtMS0xLTEtMQ_f83fe2f4-0fa5-4d28-9d44-28f4922cdf5c"
      unitRef="usd">2085000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjEtMy0xLTEtMQ_5bbc2739-61ad-441b-9f28-a6a57c6dd206"
      unitRef="usd">-2775000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjItMS0xLTEtMQ_24fdc56b-4573-42ac-a1be-38767188d88c"
      unitRef="usd">-16768000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjItMy0xLTEtMQ_7f931dc8-2b63-4d77-8248-b8493a0dd338"
      unitRef="usd">-4835000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjMtMS0xLTEtMQ_eb45c59f-03bb-4cf8-aab1-19ddb356ed70"
      unitRef="usd">-840000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjMtMy0xLTEtMQ_6aca4061-1f17-4a68-9050-d254183bcb92"
      unitRef="usd">-840000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjQtMS0xLTEtMQ_00c116ab-94cb-4e72-8a4d-365a653c2d6b"
      unitRef="usd">1250000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjQtMy0xLTEtMQ_7dc76874-947b-41a2-b289-3e6bfc448479"
      unitRef="usd">-19996000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjctMS0xLTEtMQ_d90e6826-657f-4644-b368-5da071b98b86"
      unitRef="usd">2893000</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjctMy0xLTEtMQ_20668f96-89dd-47e5-bfc3-9a9d6c9a3cbe"
      unitRef="usd">2073000</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjgtMS0xLTEtMQ_51726f52-ad34-447c-a96a-bb24b389eee4"
      unitRef="usd">75000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMjgtMy0xLTEtMQ_e43a8cee-0c5d-48d3-bbc2-db8c9ebc8ef9"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <mdxg:PaymentsforApplicationCostsPatent
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzAtMS0xLTEtMQ_d1a6786b-c374-4c3d-9533-6bc70bef241a"
      unitRef="usd">263000</mdxg:PaymentsforApplicationCostsPatent>
    <mdxg:PaymentsforApplicationCostsPatent
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzAtMy0xLTEtMQ_ad57e797-9eb9-430d-a8e8-86329df95cc2"
      unitRef="usd">209000</mdxg:PaymentsforApplicationCostsPatent>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzEtMS0xLTEtMQ_7195777f-34cb-456f-b178-d2377e0b74d5"
      unitRef="usd">-3081000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzEtMy0xLTEtMQ_c1568293-7246-47de-9f59-e78b177fd452"
      unitRef="usd">-2282000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzQtMS0xLTEtMQ_8577068d-e4ab-4e5b-bfbc-db8c920a9d19"
      unitRef="usd">1404000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzQtMy0xLTEtMQ_25a49c0a-1984-41c8-8df2-d685150721d6"
      unitRef="usd">370000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzUtMS0xLTEtMQ_de48c0ff-eb87-4cdb-a2c0-382a819f7628"
      unitRef="usd">4751000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzUtMy0xLTEtMQ_40ab03d9-c105-4ab2-942c-e2802b96c140"
      unitRef="usd">2409000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzYtMS0xLTEtMQ_09a25b46-3630-4d90-b14f-001686300565"
      unitRef="usd">27000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzYtMy0xLTEtMQ_bd6e952c-270e-475c-b25c-df1f5f0d1b34"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzctMS0xLTEtMQ_98999670-d891-49e2-88ef-2d86410cf514"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzctMy0xLTEtMQ_452cbefc-b65e-4943-9538-cdff8d84bef3"
      unitRef="usd">2782000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzgtMS0xLTEtMQ_b8dbbf41-32fb-4c10-a746-17bc11a2a451"
      unitRef="usd">0</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzgtMy0xLTEtMQ_b0198c30-0ba3-41de-9dd2-cccbdb9a259c"
      unitRef="usd">83872000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzktMS0xLTEtMQ_74b2f0f2-9042-4c24-8944-bbb696759b5f"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfMzktMy0xLTEtMQ_95474cda-22aa-4d91-871a-23881016c36e"
      unitRef="usd">59500000</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <mdxg:ProceedsfromIssuanceofTemporaryEquity
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMS0xLTEtMzA0OTA_254e183a-eb58-4d35-bf7a-8b053450cbe5"
      unitRef="usd">0</mdxg:ProceedsfromIssuanceofTemporaryEquity>
    <mdxg:ProceedsfromIssuanceofTemporaryEquity
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMy0xLTEtMzA0OTc_49b1846c-2590-4a8c-ad79-6e1aa86e9c5a"
      unitRef="usd">100000000</mdxg:ProceedsfromIssuanceofTemporaryEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDEtMS0xLTEtMzA0OTA_8c484414-7840-4d8d-8075-1d366bc6ee46"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDEtMy0xLTEtMzA0OTc_e2741791-f015-4393-a33f-b35ffc7e9fdd"
      unitRef="usd">6564000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMS0xLTEtMzA0OTA_174c9cad-b9f2-47c5-8eb4-86e04c31f9a6"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMy0xLTEtMzA0OTc_77f1f5d7-43dd-435f-aa60-0d0ded4647bb"
      unitRef="usd">1439000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMS0xLTEtMQ_df781bfa-0d63-4843-a2c4-44c23f3edc87"
      unitRef="usd">-3374000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDAtMy0xLTEtMQ_6e39fd8f-677a-4a37-8090-9f7000fc71c6"
      unitRef="usd">62804000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMS0xLTEtMQ_a5c4023a-2d41-41d5-8eff-9d3831338282"
      unitRef="usd">-5205000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDItMy0xLTEtMQ_7d69ccf4-4198-4943-b62c-0f08d40687ed"
      unitRef="usd">40526000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDQtMS0xLTEtMQ_0595cc0c-7b3c-44b0-ac42-76d66c82a557"
      unitRef="usd">95812000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5967a4f404664bef9378ba0366b3c4f2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDQtMy0xLTEtMQ_358e44a3-46ef-4714-99d5-9e74276584d0"
      unitRef="usd">69069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDUtMS0xLTEtMQ_93fa485c-e07f-4659-871e-4a4a6798c4e4"
      unitRef="usd">90607000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i30ea68f67842422ea554a2c219d5df1f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8yOC9mcmFnOjFiMTM0MDliMmJjMDQ1YmNiNGNkNzZhYzkwZmMzYmYyL3RhYmxlOjFjMGNjYWMwMDllZDQ1NTI4Y2QyOTQwMGEwOGJiNzAzL3RhYmxlcmFuZ2U6MWMwY2NhYzAwOWVkNDU1MjhjZDI5NDAwYTA4YmI3MDNfNDUtMy0xLTEtMQ_23dfffc2-3017-4acf-8f26-d244fe091603"
      unitRef="usd">109595000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDg3Ng_f1f4f9a7-7f10-403a-8326-d307ccb2fbc1">Nature of Business&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MiMedx&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; or the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#xae; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United States Food and Drug Administration (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FDA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business model is focused primarily on the United States of America, but the Company is pursuing opportunities for international expansion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Enforcement Discretion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#x2019;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FDA exercised enforcement discretion with respect to Investigational New Drug (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products in the United States and is precluded from marketing such products until a Biologics License Application (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BLA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) is granted. If and when the FDA approves a BLA, the Company expects to be allowed to market its Section 351 products in the United States, but only for specific indications as permitted by the FDA. Sales of the Company&#x2019;s Section 351 products were $0.5 million and $8.2 million for the three months ended September&#160;30, 2021 and 2020, respectively, and $17.2 million and $23.1 million for the nine months ended September&#160;30, 2021 and 2020, respectively. Sales of Section 351 product during the three months ended September&#160;30, 2021 were derived from sales outside of the United States of America..&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently markets EPICORD&#xae; and AMNIOCOR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;D&#xae; tissue products derived from human umbilical cord as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#x2019;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#x2019;s revenue, business, financial condition, and results of operations. Net sales of the Company&#x2019;s umbilical cord-derived products were $6.2 million and $4.2 million for the three months ended September&#160;30, 2021 and 2020, respectively, and $17.1 million and $11.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#x2019;s cord inventory, which would be at risk for write-down in the case of such a determination, was $1.5 million as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Out-of-Period Adjustment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#x2019;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#x2019;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#x2019;s reported consolidated balance sheets and consolidated statements of stockholders&#x2019; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#x2019; (deficit) equity or earnings per share in any period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded an out-of-period adjustment during the nine months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which resulted in a decrease of $2.0 million to the balance of additional paid-in capital for the nine months ended September&#160;30, 2020, respectively, and an increase of $2.0&#160;million to the balance of treasury stock during those same periods.&lt;/span&gt;&lt;/div&gt;The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjYzMQ_ecac833f-96b6-4a10-8311-aad9379968ee"
      unitRef="usd">500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjYzOA_42162848-763c-4de6-8c5f-e52bde4d9b82"
      unitRef="usd">8200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjY5Nw_f1364675-16c1-4783-9045-d58473225ffb"
      unitRef="usd">17200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMjcwNA_5e3a468d-18b7-4ef5-8368-a4d4759fea90"
      unitRef="usd">23100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzM1MA_3f914133-14e2-42d7-b698-7a821d914abd"
      unitRef="usd">6200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzM1Nw_cd36ad4b-e13f-45d2-80a8-9ea74cbb2f73"
      unitRef="usd">4200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzQxNg_59c2550d-80ce-4341-b7b4-5102df601d97"
      unitRef="usd">17100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzQyMw_bf960f2d-bc21-4b78-b033-4d3fac73fbd9"
      unitRef="usd">11400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryNet
      contextRef="i81c1fc5c80bb4755a61a11f5bdf75e52_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfMzU1NQ_4d834128-a492-4aeb-b4d6-f01b517b079b"
      unitRef="usd">1500000</us-gaap:InventoryNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i4481913816f8495b91664f2c94c198a2_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDQzNg_56bae51b-fb8b-467e-a1fd-87630dcf9b5e"
      unitRef="usd">-2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ib194ea304588466d9d6e058e63a66dde_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNC9mcmFnOmRkZDEyYTRiNzc5MjQzOTdiMTQ5MmFkMTY2ZTc4OTUwL3RleHRyZWdpb246ZGRkMTJhNGI3NzkyNDM5N2IxNDkyYWQxNjZlNzg5NTBfNDU1MA_ae01c50d-8720-4d17-9d62-11ffbca913fe"
      unitRef="usd">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMDc_570a5016-b04c-4b3c-bdb6-09f748e7270d">Significant Accounting Policies&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please see Note 2 to the Company&#x2019;s Consolidated Financial Statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SEC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) on March 8, 2021 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Form 10-K&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) for a description of all significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and nine months ended September&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#x2019;s assessment of the Company&#x2019;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#x2019;s period of Enforcement Discretion and other regulatory factors with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#x2019;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in Annual Goodwill Impairment Testing Date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#x2019;s available resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020. As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded no impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) 2020-06, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, this ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under Accounting Standards Codification (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LIBOR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of September&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other ASUs issued and not yet effective for the nine months ended September 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMjg_10f66a92-2da5-45cc-8ef9-7722fa09e771">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and nine months ended September&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMDY_d712d32d-8987-49c3-8453-17062e1dc8b8">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#x2019;s assessment of the Company&#x2019;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#x2019;s period of Enforcement Discretion and other regulatory factors with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#x2019;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMTU_8ce35a56-7522-4b74-b430-ae974d510e21">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMjk_cd62a5af-227e-42bd-82b6-888a91830294">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in Annual Goodwill Impairment Testing Date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#x2019;s available resources. &lt;/span&gt;&lt;/div&gt;Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3f87700978a544fa9d65867f626f385d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfNjg3NQ_3f9f6da4-7d37-4234-b928-be3f821a177f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8zNy9mcmFnOmE1OWMzYWJlNDg0NzRmNjRiY2E5MmI1YWNiMTYwZmUyL3RleHRyZWdpb246YTU5YzNhYmU0ODQ3NGY2NGJjYTkyYjVhY2IxNjBmZTJfMTYxMTA_365a7cf8-f39b-4e86-9b71-0ac8465f2ca9">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) 2020-06, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, this ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under Accounting Standards Codification (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LIBOR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of September&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other ASUs issued and not yet effective for the nine months ended September 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsAndNontradeReceivableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGV4dHJlZ2lvbjowYjAxMWE5M2IzOTc0NThkODkwZDBlYThiMWY5ZmVkYV8yNzQ4Nzc5MDY5NjM1_e56b2a68-a857-4917-8a5e-f428290672e5">Accounts Receivable, Net&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGV4dHJlZ2lvbjowYjAxMWE5M2IzOTc0NThkODkwZDBlYThiMWY5ZmVkYV8yNzQ4Nzc5MDY5NjM2_4e0c3c93-9cfe-4c09-946f-e106b0a3c784">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18xLTEtMS0xLTEwNw_2bd94874-6845-4e9d-8a6d-b59f8f249751"
      unitRef="usd">37403000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18xLTMtMS0xLTExMQ_64b40dfa-2e53-4a39-bd72-321ff95594bb"
      unitRef="usd">36160000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18yLTEtMS0xLTEwNw_ac1f1bf8-8a6b-4d80-9121-65cbe7d8b45c"
      unitRef="usd">867000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18yLTMtMS0xLTExMQ_f42e730d-e7fe-477f-9d8f-1bd9d7522164"
      unitRef="usd">737000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18zLTEtMS0xLTEwNw_ddcb1a31-6791-4e23-8085-7bce713d72b7"
      unitRef="usd">36536000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV8xMjcwL2ZyYWc6MGIwMTFhOTNiMzk3NDU4ZDg5MGQwZWE4YjFmOWZlZGEvdGFibGU6ZjZiNzZlYjdmZGZjNDU0ZmFhYTc1MzhmNmNlODJkZDMvdGFibGVyYW5nZTpmNmI3NmViN2ZkZmM0NTRmYWFhNzUzOGY2Y2U4MmRkM18zLTMtMS0xLTExMQ_ab0318c5-b78e-48c4-b33b-88492e75682f"
      unitRef="usd">35423000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMzk0_64e400ae-74d6-4f03-bf0c-9742b2a8f2cb">Inventory&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the conclusion of the FDA&#x2019;s period of Enforcement Discretion on May 31, 2021, the Company wrote down $1.0 million of its Section 351 product inventory during the nine months ended September&#160;30, 2021. In addition, during the three and nine months ended September&#160;30, 2021, the Company reserved $0.5&#160;million and $0.7 million, respectively, for inventory related to product lines which have been discontinued. These amounts are included as part of cost of sales on the unaudited condensed consolidated statements of operations for those period.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfNDAw_88e176c3-db71-49a1-818d-855fcad46532">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMS0xLTEtMS0x_c7db972c-5d1b-456a-bef7-fe1e8bb049b5"
      unitRef="usd">416000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMS0zLTEtMS0x_4832ca16-042c-4714-946b-ca8984f50b71"
      unitRef="usd">314000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMi0xLTEtMS0x_4795fdd7-75d5-4081-a10c-3e37cea1b220"
      unitRef="usd">6064000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMi0zLTEtMS0x_23190888-64a5-4ec6-b017-d77d296b4f2d"
      unitRef="usd">4316000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMy0xLTEtMS0x_0e8e51fc-a71c-4efb-ab05-191ee1bf533c"
      unitRef="usd">4716000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfMy0zLTEtMS0x_39adc14e-f4c1-44ff-980f-76f819fd6c7a"
      unitRef="usd">5731000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfNi0xLTEtMS0x_96c8d5ac-6b97-4538-8049-9135b7df0cd9"
      unitRef="usd">11196000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RhYmxlOjllZjgyMGVkNTE0ZjQzMWZiMWNlNmE0YzljOTc4ZTkxL3RhYmxlcmFuZ2U6OWVmODIwZWQ1MTRmNDMxZmIxY2U2YTRjOWM5NzhlOTFfNi0zLTEtMS0x_79cc8ac0-d1f6-4394-8d15-65f325469c68"
      unitRef="usd">10361000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMTkw_05b619f5-9a0d-4b57-90cb-bcfd400dd383"
      unitRef="usd">1000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMjc0ODc3OTA3MDU4OA_9ff1e982-0810-4947-aa6d-47e23e54998c"
      unitRef="usd">500000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80My9mcmFnOmNjMmNmZTlmMTI4ZDQxNmJhYTE2MjAyNjU0NzUwZGVhL3RleHRyZWdpb246Y2MyY2ZlOWYxMjhkNDE2YmFhMTYyMDI2NTQ3NTBkZWFfMTA5OTUxMTYyODI2Ng_dfd0ecee-d46a-4b80-9ee1-99eb8adf3e96"
      unitRef="usd">700000</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDE3_6bc09718-480a-4635-9e88-fd894f2f5ddd">Property and Equipment, Net&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and clean room equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset retirement cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for each of the three and nine months ended September&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is allocated amongst cost of sales, research and development expense, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDI5_a1372576-5e97-4926-98eb-4595f4cdc629">&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and clean room equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset retirement cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,076)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia643c1f3ffd5490daba314259b7b5dd8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMS0xLTEtMS0x_f513da49-3c96-46a9-9f02-95ecf440b4a6"
      unitRef="usd">8745000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i30e0382314754873b5d3463a70f2452c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMS0zLTEtMS0x_ed413ba3-8641-4de7-9e03-db529a5e6be3"
      unitRef="usd">6010000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i61ac9e9787fd4e5caa1e0fd68f13f431_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMi0xLTEtMS0x_92aa562b-1c9f-4db8-a68e-0347391eed9b"
      unitRef="usd">16497000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i93598c6e79474e738b441aee60fd85fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMi0zLTEtMS0x_d45f9e6f-90d7-4f7c-b556-5b023eb69c71"
      unitRef="usd">15524000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib3d8f37a625b4a6eb4876d23445e7b8f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMy0xLTEtMS0x_bace15d2-69b6-4fe1-9f09-e5ff952183b2"
      unitRef="usd">14944000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ieb8fc9cbb62e4e68bf85adfc66a44263_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfMy0zLTEtMS0x_bcfec5be-07ec-43a4-89f4-0227a029949d"
      unitRef="usd">15295000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3efc44c2885e4c7fb8e1a0ea72d8b77f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNC0xLTEtMS0x_d92e848b-1eb1-450f-a9e5-f65e2df712d3"
      unitRef="usd">677000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8d4d540898ae4a45b41a0121cbd3d2bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNC0zLTEtMS0x_2b5983f4-17a9-4108-87f0-9a4890014316"
      unitRef="usd">3321000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4cf29e0d1c12430a95941dc867b6c928_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNS0xLTEtMS0x_49c2b4bb-4846-4e91-801c-cf1d82ca3a83"
      unitRef="usd">880000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2c20ff2657e341d984f4a7abc943473f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNS0zLTEtMS0x_8875ea1a-04aa-412a-9db9-61b7b9b59609"
      unitRef="usd">785000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNi0xLTEtMS0x_a97527a0-aa76-4412-a84a-c6d4236d9014"
      unitRef="usd">189000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNi0zLTEtMS0x_f61dfbe3-4112-4b52-8c40-0fde795f4e23"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNy0xLTEtMS0x_2ef3d976-87c3-4f94-908f-2c4e4ec5db4c"
      unitRef="usd">41932000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfNy0zLTEtMS0x_f7fe3853-207a-4931-9a27-968713dd03e5"
      unitRef="usd">40935000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOC0xLTEtMS0x_cbd63475-38b5-4b8b-8210-0da391ac2e5a"
      unitRef="usd">32076000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOC0zLTEtMS0x_255095d4-02a8-4503-bc74-b3ff52308560"
      unitRef="usd">29498000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOS0xLTEtMS0x_abbc79f5-753f-485c-aafb-9c7f1b1fc9b7"
      unitRef="usd">9856000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmY0YjI3YTkzZjQ1ODQ0ODQ4NDZmZGZkZmI2NDZlNDYzL3RhYmxlcmFuZ2U6ZjRiMjdhOTNmNDU4NDQ4NDg0NmZkZmRmYjY0NmU0NjNfOS0zLTEtMS0x_2f8104b4-c384-49d1-96ce-f8318cd14877"
      unitRef="usd">11437000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <mdxg:ScheduleOfDepreciationTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RleHRyZWdpb246NjBkYWQ3NDAyMjMxNDQ5MmE0MjMzMWZiMjczM2Y2MjhfNDIz_329d1a6d-4c0e-4f7f-abf1-cf60487b8560">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for each of the three and nine months ended September&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdxg:ScheduleOfDepreciationTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi0xLTEtMS0x_110fd109-d785-432d-b3f5-65d58396aa3f"
      unitRef="usd">923000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi0zLTEtMS0x_b77702b0-695a-43d7-b24c-35b3a814764e"
      unitRef="usd">1566000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi01LTEtMS0x_efd14751-f9ef-47da-a0fc-12ddfef2e95d"
      unitRef="usd">3390000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV80Ni9mcmFnOjYwZGFkNzQwMjIzMTQ0OTJhNDIzMzFmYjI3MzNmNjI4L3RhYmxlOmIyMGM4ODRlMjFlNDRhZDliNTRhMWYyOTc1NzgyZWY1L3RhYmxlcmFuZ2U6YjIwYzg4NGUyMWU0NGFkOWI1NGExZjI5NzU3ODJlZjVfMi03LTEtMS0x_a37b17b0-d85e-4f73-8bb1-bcef9d2d1d9b"
      unitRef="usd">4494000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzE0_f9c3e8f5-74e8-4b4e-9d42-645645b4e788">Intangible Assets&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Intangible Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradenames and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in Process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three and nine months ended September 30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization of intangible assets as of September&#160;30, 2021, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated&lt;br/&gt;Amortization &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the nine months ended September 30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzAz_9c6886f0-934e-4ff8-98d7-97df53eb9dee">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Intangible Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradenames and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in Process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three and nine months ended September 30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzA5_b4316a91-c5cf-488c-9b84-536781e28951">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Intangible Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradenames and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in Process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0xLTEtMS0x_6b4cd9ae-c048-4f9f-af4d-f41fdd10e0b7"
      unitRef="usd">9568000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0yLTEtMS0x_061f058a-851f-495d-b418-00aeb92583a4"
      unitRef="usd">6238000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie869b0abc2b24f28af7ccb3c78813ccd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy0zLTEtMS0x_0923c0b9-1c23-4f75-9057-4e9f28e6cd82"
      unitRef="usd">3330000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy01LTEtMS0x_7d5b484c-3260-48ca-bd8f-5569b0bc8360"
      unitRef="usd">9510000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy02LTEtMS0x_2adb09ba-420a-45fd-a09a-ed35672bbaca"
      unitRef="usd">5730000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5ab18eb20e2647c28d0361be53d48426_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMy03LTEtMS0x_0dc72663-6db3-4474-93cb-d880aabb8743"
      unitRef="usd">3780000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0xLTEtMS0x_47717e94-0767-49a4-a6b2-a971164d1fe6"
      unitRef="usd">1414000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0yLTEtMS0x_ea520a04-8813-4455-9fb6-f8b031ddda7c"
      unitRef="usd">1414000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i132835a21d9a4d3abe8660919b3bb23a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC0zLTEtMS0x_6324d946-c085-45b7-865e-6da787345943"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC01LTEtMS0x_347d97bd-5494-4e2c-bbe4-55bcffb69930"
      unitRef="usd">1414000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC02LTEtMS0x_a6c7a9c3-69eb-481c-96b8-d4d65ba79690"
      unitRef="usd">1334000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibf0a4568080142a39217fa3323b53cf4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNC03LTEtMS0x_7292331e-6ac1-429b-847f-c97829c6b64e"
      unitRef="usd">80000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0xLTEtMS0x_a45cfd53-5b84-49f9-90f5-d9ccc579a446"
      unitRef="usd">241000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0yLTEtMS0x_1d1fb6a3-c58f-4cbd-ab7a-a45f015b9ec8"
      unitRef="usd">185000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icbac19f0cae14d1db729010e4771ebde_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS0zLTEtMS0x_d799fb62-1f03-45dc-a04e-07fc011d090f"
      unitRef="usd">56000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS01LTEtMS0x_0f2932fd-0ada-433f-b2ee-88ee72ae5fdb"
      unitRef="usd">241000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS02LTEtMS0x_44abd17d-f504-475c-b111-4703ea20fd93"
      unitRef="usd">172000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i75ccd2d4d0064e9eb1e23f246cdb6814_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNS03LTEtMS0x_e776765c-6d42-4986-b8f4-3df92bee5e8f"
      unitRef="usd">69000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0xLTEtMS0x_469852b4-ece0-4f33-b63c-77d80a0d030d"
      unitRef="usd">120000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0yLTEtMS0x_154417ea-a592-4827-8bb2-08d96c7dd126"
      unitRef="usd">120000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1353dc3b9164466fae81fcb311283da8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi0zLTEtMS0x_7c60d645-bdbb-4bc0-8fda-7bc4d7b0f198"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi01LTEtMS0x_8c076daf-d901-415c-a306-adaa74569e80"
      unitRef="usd">120000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi02LTEtMS0x_3b8cfb98-a5a4-4b7e-a2ba-5438f3ac10bd"
      unitRef="usd">98000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i44d92ee75364420e8e90918b9dc51633_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNi03LTEtMS0x_4f24a686-fb66-4e0b-b97a-d4585287f2fe"
      unitRef="usd">22000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0xLTEtMS0x_ffda948b-609a-4023-8bc5-777a4ba999a7"
      unitRef="usd">11343000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0yLTEtMS0x_de25bf56-5516-4526-a9fe-2a29320689a1"
      unitRef="usd">7957000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy0zLTEtMS0x_3cb7fd25-5e3b-457e-847b-5e088dab951c"
      unitRef="usd">3386000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy01LTEtMS0x_878cd872-54e9-4600-b93d-37d0fcdc8552"
      unitRef="usd">11285000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy02LTEtMS0x_08a6d98f-5600-4202-aecb-9d719bcc3b20"
      unitRef="usd">7334000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfNy03LTEtMS0x_1a2b8c7c-2b8e-44f5-84c9-9ead2cbd8fec"
      unitRef="usd">3951000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtMS0xLTEtMQ_5a9a0a64-fc4a-4d66-b6da-163a4650c92b"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0f60b68bd2004e37a8c8dddba9dd324c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtMy0xLTEtMQ_478a3577-26fb-4ce3-a7ea-7cb028ea89da"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3a67f851997741fb98d72955463632aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtNS0xLTEtMQ_af4fbb32-5513-477d-bfd1-41ae02ed9b92"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3a67f851997741fb98d72955463632aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTAtNy0xLTEtMQ_f2d16a29-fb5f-4039-9086-5089389895f0"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7ce4df1ba99d4d4da5aa384183983463_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtMS0xLTEtMQ_91220f0a-0874-4c60-bbbe-c593e3b8ffb0"
      unitRef="usd">1226000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7ce4df1ba99d4d4da5aa384183983463_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtMy0xLTEtMQ_95c966f0-59c4-45c9-9eb7-9fc53e54dcbb"
      unitRef="usd">1226000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtNS0xLTEtMQ_350a9a3e-1f77-4fe0-a6f8-d86ab3026c5a"
      unitRef="usd">1045000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic4dcabec842a4c0c985e20ad5fdf944e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTEtNy0xLTEtMQ_d2f11986-d1f4-46dd-9b9b-b83ec12c6a5d"
      unitRef="usd">1045000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItMS0xLTEtMQ_192ca969-4e0f-4163-96be-475710822bc6"
      unitRef="usd">13577000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItMy0xLTEtMQ_327c2a6d-d0f5-4aff-b607-ed7f8edb4816"
      unitRef="usd">5620000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItNS0xLTEtMQ_152dcf30-78ef-402f-965a-5c5372f6c612"
      unitRef="usd">13338000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjI4MzAzZTdhZTVhNTRhZGU4OTU5MTU3YjY1Mzk5MTU5L3RhYmxlcmFuZ2U6MjgzMDNlN2FlNWE1NGFkZTg5NTkxNTdiNjUzOTkxNTlfMTItNy0xLTEtMQ_361c0766-4b25-4cec-bf03-21b53d9dc0c2"
      unitRef="usd">6004000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0xLTEtMS0x_4b424d20-948f-4736-b6e1-4c74726937c2"
      unitRef="usd">193000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0zLTEtMS0x_09c223b1-0ff3-4875-8c27-14e09b89f72e"
      unitRef="usd">276000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi0zLTEtMS0x_f1d69415-33b7-40e8-814e-60704ec3989c"
      unitRef="usd">276000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi01LTEtMS0x_105571a9-27fd-4bbd-8dd7-33f55d05083f"
      unitRef="usd">647000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOjhkZmE3YTljYTEzMjRmYTRhMjJkMmExZDE1MmNhZmRjL3RhYmxlcmFuZ2U6OGRmYTdhOWNhMTMyNGZhNGEyMmQyYTFkMTUyY2FmZGNfMi03LTEtMS0x_44cee943-7b6f-4239-956a-0bb55ac89c2b"
      unitRef="usd">818000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RleHRyZWdpb246Zjg4ZjJlMjNlMGI2NDY0MDlmZDg3ODE5NTk3ZDVlODJfMzEx_2bfa411c-36c4-41b8-834d-8a7edd2a2616">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization of intangible assets as of September&#160;30, 2021, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated&lt;br/&gt;Amortization &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the nine months ended September 30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMS0xLTEtMS0x_2c8c5129-d5f8-40b4-8f97-9c5ba7f2eb71"
      unitRef="usd">174000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMi0xLTEtMS0x_febea814-0dfb-4c99-98a5-a23211461e95"
      unitRef="usd">695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfMy0xLTEtMS0x_7bd62720-7866-4a99-8c1d-fc23315f3fa8"
      unitRef="usd">695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNC0xLTEtMS0x_74359017-3007-4ad3-b76e-d0007d6b2e91"
      unitRef="usd">695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNS0xLTEtMS0x_ea106e23-a21c-447a-98bd-10dc2bbb62b6"
      unitRef="usd">283000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNi0xLTEtMS0x_9e7a5a1a-911b-4d29-9eda-9e50754774b1"
      unitRef="usd">844000</mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81Mi9mcmFnOmY4OGYyZTIzZTBiNjQ2NDA5ZmQ4NzgxOTU5N2Q1ZTgyL3RhYmxlOmU0NTYzZmJiZDZhMjQ3ZDE4ZTM5NjUyMjRiOWUwNzcxL3RhYmxlcmFuZ2U6ZTQ1NjNmYmJkNmEyNDdkMThlMzk2NTIyNGI5ZTA3NzFfNy0xLTEtMS0x_763329fc-867e-4164-aa02-d7aec5173250"
      unitRef="usd">3386000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RleHRyZWdpb246Zjg5MWVlYjRmODBiNGUwOGIwZDk3MGRkNDNiYmNiYmZfOTA_4f163cba-2b7f-401a-90ba-4a91701c800a">Accrued Expenses&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&#160;consisted of the following&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions to sales agents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued GPO fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accrual for settlement costs, which was presented separately in previously-issued financial statements, is included as part of legal costs in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RleHRyZWdpb246Zjg5MWVlYjRmODBiNGUwOGIwZDk3MGRkNDNiYmNiYmZfODk_644a6ade-8e6f-40df-8c04-98e64ca7299f">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&#160;consisted of the following&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions to sales agents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued GPO fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMS0xLTEtMS0x_7136a4ba-1fc3-43ce-899b-d3696df309a4"
      unitRef="usd">8102000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMS0zLTEtMS0x_828c0e00-2154-47c6-8d8e-51a1f46fbf50"
      unitRef="usd">24797000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMy0xLTEtMS0x_65068986-ef7c-47af-b062-b7d3411f1277"
      unitRef="usd">1809000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfMy0zLTEtMS0x_221f22fc-752b-4bea-8a0c-ca192442484c"
      unitRef="usd">2141000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNC0xLTEtMS0x_19b48b36-6c8d-420b-8c9a-429dc8763d1f"
      unitRef="usd">797000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNC0zLTEtMS0x_58aa4f29-fa34-4291-87ff-e7565954ff1f"
      unitRef="usd">688000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <mdxg:AccruedClinicalTrialsCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNS0xLTEtMS0x_b46c3f7e-c96b-45ba-8170-88a0da9f9498"
      unitRef="usd">792000</mdxg:AccruedClinicalTrialsCurrent>
    <mdxg:AccruedClinicalTrialsCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNS0zLTEtMS0x_8ced6cbd-f425-4f8c-90cd-925f0ab41dad"
      unitRef="usd">651000</mdxg:AccruedClinicalTrialsCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNi0xLTEtMS0x_6949ea3e-2c68-4b8d-8162-4066e162a3c0"
      unitRef="usd">496000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNi0zLTEtMS0x_5981112c-ad11-4552-9435-ac8605777d93"
      unitRef="usd">554000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mdxg:AccruedRebates
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNy0xLTEtMS0x_6a84dd1b-5951-4280-8c94-daa34bc47636"
      unitRef="usd">584000</mdxg:AccruedRebates>
    <mdxg:AccruedRebates
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfNy0zLTEtMS0x_1bdb093c-2fa3-43d5-8379-262b04419353"
      unitRef="usd">886000</mdxg:AccruedRebates>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOC0xLTEtMS0x_4bb4d935-26d8-46bf-be12-2b06d2faf9c3"
      unitRef="usd">1112000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOC0zLTEtMS0x_27fe58bd-ed2c-4d77-94e0-f438d36a6568"
      unitRef="usd">743000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOS0xLTEtMS0x_5620991e-4b5c-43a5-bb82-b771e9f8fc32"
      unitRef="usd">13692000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81NS9mcmFnOmY4OTFlZWI0ZjgwYjRlMDhiMGQ5NzBkZDQzYmJjYmJmL3RhYmxlOjYwZDI0NTUzNTIwNzQ4NTI5NTRkOTAyYTQ1ZmJhYjJhL3RhYmxlcmFuZ2U6NjBkMjQ1NTM1MjA3NDg1Mjk1NGQ5MDJhNDVmYmFiMmFfOS0zLTEtMS0x_e67eecbb-ab3d-4b20-bdb1-c4aaabddf409"
      unitRef="usd">30460000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTY_27377ff8-7e6c-4d95-bf2e-6db35f036f66">Long Term Debt&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), an affiliate of Hayfin Capital Management LLP (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Loan Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), which Hayfin funded (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Loan Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) on July 2, 2020 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Closing Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), providing  the Company with a senior secured term loan in an aggregate amount of $50 million (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The Term Loan matures on June 30, 2025 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Maturity Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Hayfin Loan Agreement also provided the Company an option to draw on an additional delayed draw term loan (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DD TL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; collectively with the Term Loan, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in the form of a committed but undrawn facility until June 30, 2021. The Company did not exercise the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#x2019;s Series B Convertible Preferred Stock (as defined and described in Note 10, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in an aggregate amount of up to $100 million (collectively, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financing Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in order to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Refinancing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BT Term Loan Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), among the Company, the lenders thereunder and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). If LIBOR is unavailable, the Term Loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%. The Margin is eligible for a reduction depending on the Company&#x2019;s Total Net Leverage Ratio  (as defined in the Hayfin Loan Agreement) for the quarter; as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;6.5% per annum if the Total Net Leverage Ratio is less than 2.0x but greater than or equal to 1.0x, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional 3.0% margin is applied to the interest rate in the event of a default as defined by the Hayfin Loan Agreement. At issuance and as of September&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities contain financial covenants (as defined in the Hayfin Loan Agreement) requiring the Company, on a consolidated basis, to maintain the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A Maximum Total Net Leverage Ratio of 4.0x, required to be calculated on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A Minimum Liquidity of $10 million, an at-all-times financial covenant tested monthly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On or before July 2, 2022: 2% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;After July 2, 2022 and on or before July 2, 2023: 1% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;After July 2, 2023: 0% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#x2019; commitments terminated. Mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event (as defined in the Hayfin Loan Agreement). Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Company&#x2019;s Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. No such prepayments have been required as of September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hayfin maintains a first-priority security interest in substantially all of the Company&#x2019;s assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock (described below in Note 10) and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD TL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of September&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of 1% per annum of the amount undrawn, which is recognized as interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balances of the Term Loan as of September&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stated interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;`&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of principal payments due on the Term Loan, by year, from September&#160;30, 2021 through maturity are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the nine months ended September&#160;30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of September&#160;30, 2021, the fair value of the Term Loan was determined to be $51.3&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. The remaining cash flows associated with the Term Loan were discounted to September&#160;30, 2021 using this discount rate</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNDIw_df787ed5-83e7-4192-8db0-2256bd129c03"
      unitRef="usd">50000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1f30e1643e2b457cad73afc68fea533e_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTMyNg_813f49da-91e2-43b8-bc15-67c4b23b0abc"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <mdxg:DebtInstrumentInterestRateFloorPercentage
      contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTk5MA_871a9b25-3248-4862-b7ed-09262537a820"
      unitRef="number">0.015</mdxg:DebtInstrumentInterestRateFloorPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjAxMQ_a7a19fd0-e490-4cae-91f8-7db4bdb1ad53"
      unitRef="number">0.0675</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib568475ec03640c79dec4a7823674263_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjE3Mw_e094e9d9-6a2e-473a-a640-36733fd2e9dc"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5999d39b82454d3485d425e42e44c0ab_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjE5MQ_fdb86488-90ca-4d31-b1c9-d61060278db7"
      unitRef="number">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idf73b93b55dc4376983adc42db197d7d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjMwNg_8ea756ef-b218-4245-8cd1-b9b2d19e9e6b"
      unitRef="number">0.065</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mdxg:DebtInstrumentCovenantNetLeverageRatio
      contextRef="id816d2b16745481584d1f3ad0216ba99_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQwNg_020faee4-0e43-4017-a3ed-9fb3b9c107f6"
      unitRef="number">2.0</mdxg:DebtInstrumentCovenantNetLeverageRatio>
    <mdxg:DebtInstrumentCovenantNetLeverageRatio
      contextRef="ie2d9d8ddf0424a2ebc54c14f5fb90725_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQzOQ_6b06b15a-0077-4b36-a29c-49dd5f81de52"
      unitRef="number">1.0</mdxg:DebtInstrumentCovenantNetLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i07286d413f254827a20487a6cd9f485e_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjQ0Nw_c7867bbf-60c9-4a6f-a3d6-9296d0013e9a"
      unitRef="number">0.060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mdxg:DebtInstrumentCovenantNetLeverageRatio
      contextRef="i07286d413f254827a20487a6cd9f485e_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjUwNQ_6d4e0e29-7434-41b3-b8cb-6b588b0abdf4"
      unitRef="number">1.0</mdxg:DebtInstrumentCovenantNetLeverageRatio>
    <mdxg:DebtInstrumentDefaultInterestRate
      contextRef="ic101508fb7804350bf1f3f6f6af89b84_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjUyNA_1db6fe5f-5bc2-42bb-89ea-c2bf623a452e"
      unitRef="number">0.030</mdxg:DebtInstrumentDefaultInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia39e228029734a35b7f629da814e51c1_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjY5OQ_9c614de6-fe06-4a89-b922-2deef607f16c"
      unitRef="number">0.083</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <mdxg:DebtInstrumentCovenantNetLeverageRatio
      contextRef="i2f8c6ca35468445894a87c3f1396e899_D20210701-20250702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMjkxMQ_512c69cb-eaf3-496c-8f39-0d66f0c3438e"
      unitRef="number">4.0</mdxg:DebtInstrumentCovenantNetLeverageRatio>
    <mdxg:DebtCovenantMinimumLiquidity
      contextRef="i5fdd3b5337e94c8fa60408bc1abc8f28_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzA2NA_ed831bf6-3a20-4d76-8308-8c7a0638b533"
      unitRef="usd">10000000</mdxg:DebtCovenantMinimumLiquidity>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="ib6c60ec647934d8f96e30a1383affd50_D20210703-20220702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzg0NQ_fefc3984-b45b-488d-955b-02f8ff256df6"
      unitRef="number">0.02</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="idee297f90d0f45db8cbb6d3416d3d4ac_D20220703-20230702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMzkzMQ_33ff56d2-c007-4bfc-8497-4d19f9eba561"
      unitRef="number">0.01</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="i25cacd5716404a11aa3833043d143f64_D20230703-20250702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNDAxNg_fb79d4f5-a469-4a58-90eb-6989b0d2c6be"
      unitRef="number">0</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:ScheduleofDebtIssuanceCostsTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTk_62285356-bcb1-435d-9791-c540268f1f5d">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD TL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mdxg:ScheduleofDebtIssuanceCostsTableTextBlock>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id98ba73abde34242a6ba47a62b0ef574_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy0xLTEtMS0x_d97e71f0-632f-4b6f-8d30-475984ee83ec"
      unitRef="usd">333000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2b87261e163441c1ab6791378bfb180f_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy0zLTEtMS0x_9d1a55cb-1d75-43a6-9317-31466068afa5"
      unitRef="usd">167000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i90ff1eec1ec3433284583249574c58e7_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfMy01LTEtMS0x_02930902-4c36-4fd1-9c5e-40b6e705878d"
      unitRef="usd">500000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="id98ba73abde34242a6ba47a62b0ef574_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC0xLTEtMS0x_979698a1-9f6d-4ebe-8f7e-79eed8afdf54"
      unitRef="usd">2169000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2b87261e163441c1ab6791378bfb180f_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC0zLTEtMS0x_328c8649-b828-490b-a6f4-4b30ec80c626"
      unitRef="usd">1084000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i90ff1eec1ec3433284583249574c58e7_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmJkZGQ3NGEwNDUyMDQ0ODk5NTA2MjRiYTM3N2VmYzUzL3RhYmxlcmFuZ2U6YmRkZDc0YTA0NTIwNDQ4OTk1MDYyNGJhMzc3ZWZjNTNfNC01LTEtMS0x_d218834c-5908-4967-827c-bea19aa42569"
      unitRef="usd">3253000</us-gaap:DeferredFinanceCostsGross>
    <mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage
      contextRef="i33e2f0127c424966a4196fa78dea5252_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNjgzMw_a7e4e80d-2889-4dbc-b139-640a8787dc72"
      unitRef="number">0.01</mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTI_4a0d12aa-704e-4626-826c-f09a72a954bf">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balances of the Term Loan as of September&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2fb70228ca86484abc1647102df379f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMS0xLTEtMS0x_dd587171-00df-4373-ae24-b772a2390bd9"
      unitRef="usd">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ief91294d01924689b8c5a91709f9113c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMS0zLTEtMS0x_dc989915-ff3d-4e9d-beaa-990eca52c928"
      unitRef="usd">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2fb70228ca86484abc1647102df379f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMi0xLTEtMS0x_dfc7097a-4cca-4433-ad8c-ca86231b62ee"
      unitRef="usd">1721000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ief91294d01924689b8c5a91709f9113c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMi0zLTEtMS0x_5f76cd14-2b72-4a16-bc87-45687ea2ead7"
      unitRef="usd">1996000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2fb70228ca86484abc1647102df379f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMy0xLTEtMS0x_bb441782-6cdd-4f93-9ca1-818b73588331"
      unitRef="usd">264000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ief91294d01924689b8c5a91709f9113c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfMy0zLTEtMS0x_18b30fe3-6b55-44d1-9ee5-01a1cdc38a27"
      unitRef="usd">307000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i2fb70228ca86484abc1647102df379f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfNC0xLTEtMS0x_3febeef6-bf90-411a-9c7e-ba318f7d3d25"
      unitRef="usd">48015000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ief91294d01924689b8c5a91709f9113c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOjNiY2ZjZGU0ZjlkNTQyYTI5Nzc0YzZjOWU1ZjhlNGZhL3RhYmxlcmFuZ2U6M2JjZmNkZTRmOWQ1NDJhMjk3NzRjNmM5ZTVmOGU0ZmFfNC0zLTEtMS0x_29ee734c-ed3d-4630-8449-ddd914383294"
      unitRef="usd">47697000</us-gaap:LongTermDebt>
    <mdxg:ScheduleofInterestExpenseTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MTM_8bc7a925-4b53-495f-90d7-2cd7ae8494a6">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stated interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;`&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdxg:ScheduleofInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0xLTEtMS0x_ea2999fb-7aba-4a78-9fc1-300c6657c52f"
      unitRef="usd">1054000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0zLTEtMS0xMjAz_2dc4c1f2-be88-498d-a60f-d73ec868d51a"
      unitRef="usd">1031000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi0zLTEtMS0x_67c02a9b-2cd9-4b10-98f0-ea15ce3860b6"
      unitRef="usd">3116000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMi03LTEtMS0xMjEy_f2a80b11-9903-40ce-9295-45def7159a50"
      unitRef="usd">1031000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0xLTEtMS0x_7f9c0c4f-2ee6-449f-bae5-4a21353bdda9"
      unitRef="usd">95000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0zLTEtMS0xMjAz_8bf0c6c1-4c31-4729-82e1-82f10dcb8072"
      unitRef="usd">90000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy0zLTEtMS0x_31f9be71-5cc6-4c0b-bd47-ba2020409aae"
      unitRef="usd">276000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfMy03LTEtMS0xMjEy_2692c710-5081-43df-bfb7-82d5b861f09a"
      unitRef="usd">90000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0xLTEtMS0x_02fa5db1-58da-4443-a5e7-d84f6f3d486a"
      unitRef="usd">15000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0zLTEtMS0xMjAz_53a11123-6709-4ae8-ac4b-f55b67741c8a"
      unitRef="usd">38000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC0zLTEtMS0x_c898526a-2d9c-43a7-96ad-ca081b10d078"
      unitRef="usd">42000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNC03LTEtMS0xMjEy_8a38a31b-118a-4a04-bc8e-eaeb0ed41fec"
      unitRef="usd">38000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0xLTEtMS0x_1b97a643-db03-4c9c-9337-e47bdeb3ecb8"
      unitRef="usd">1164000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ie2f2da63a0254a5ca59b014209cf8063_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0zLTEtMS0xMjAz_28a93db9-e37e-482f-bec7-604c6b65dd88"
      unitRef="usd">1159000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i4ef98c199c2a4049ab8c4fb8f08b5cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS0zLTEtMS0x_42b67ee0-1ecd-48bd-8980-a6eb027427d8"
      unitRef="usd">3434000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6e9ba772cc2344e383beb5e6a9710b37_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmRkNDc2MDkxODIxNjQ2ZGE5YmRhZGZmNDlmZGEyYTczL3RhYmxlcmFuZ2U6ZGQ0NzYwOTE4MjE2NDZkYTliZGFkZmY0OWZkYTJhNzNfNS03LTEtMS0xMjEy_40d36e0c-c450-49ad-b599-ac1b46dcdd59"
      unitRef="usd">1159000</us-gaap:InterestExpenseDebt>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0xLTEtMS0x_22cd2a37-dd4d-4ccd-b230-f38c431dcb4e"
      unitRef="usd">0</mdxg:DebtInstrumentCommitmentFees>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0zLTEtMS0xMjI0_c0322def-787c-4ae8-abaf-28fae7141a6c"
      unitRef="usd">64000</mdxg:DebtInstrumentCommitmentFees>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi0zLTEtMS0x_61f82452-0293-42ce-a0a9-5a9cb11a0fc1"
      unitRef="usd">126000</mdxg:DebtInstrumentCommitmentFees>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMi01LTEtMS0x_3fcfcabe-7af9-4a6c-98d7-e19de719773b"
      unitRef="usd">64000</mdxg:DebtInstrumentCommitmentFees>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0xLTEtMS0x_54c8923d-274b-4229-b907-50ddee83d132"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0zLTEtMS0xMjI0_6dbfcc1b-bb28-486b-a2eb-60d62e8b5131"
      unitRef="usd">106000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy0zLTEtMS0x_8fa42e1e-241c-44ec-adaa-ba9edeaa53de"
      unitRef="usd">542000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfMy01LTEtMS0x_c8367151-0e04-4497-aa9c-35513acc6199"
      unitRef="usd">106000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0xLTEtMS0x_3a13bcf2-026a-4eda-850c-74436bd299af"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0zLTEtMS0xMjI0_e86f9035-43d0-4fcc-b758-bfc8d1b3aada"
      unitRef="usd">125000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC0zLTEtMS0x_7cc40045-faef-49c4-805e-9da833f6a09c"
      unitRef="usd">83000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNC01LTEtMS0x_dbdcd6c0-fe30-4940-b4e5-072b0f3455a8"
      unitRef="usd">125000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="i1f4eab402c9a4c4f800d8f2ce7411a00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0xLTEtMS0x_d57a0a12-ef98-4b01-a01f-79fbf6b99ce6"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i063e7cb15e82450ca8a0180a631a3b83_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0zLTEtMS0xMjI0_e4ca9039-2ccc-4661-8e08-ac0fe05b6c2d"
      unitRef="usd">295000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i473a6a6d31cb4126ae1b9df26760c73b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS0zLTEtMS0x_e39f73b9-9a34-4d44-985f-5e3e782f7136"
      unitRef="usd">751000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibd59521a59af4e52b5e0cafa0b995658_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmYyZjUwMzQ3MzY1MjQ3ODE4MDUzNGMzZDBhMjkzZThhL3RhYmxlcmFuZ2U6ZjJmNTAzNDczNjUyNDc4MTgwNTM0YzNkMGEyOTNlOGFfNS01LTEtMS0x_14dca226-a69e-4321-b9f9-bcc46ab39cc6"
      unitRef="usd">295000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfMTA1MDg_a63ff06c-feee-48dd-bf1a-780edb75de28">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of principal payments due on the Term Loan, by year, from September&#160;30, 2021 through maturity are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the nine months ended September&#160;30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMS0xLTEtMS0x_946d3cf3-a8b7-40d6-895f-923583612dc2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMi0xLTEtMS0x_8587eccb-e5b0-434c-b7a0-7842b3b12467"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfMy0xLTEtMS0x_5843efd0-972b-485f-a35b-e8965c774b82"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNC0xLTEtMS0x_78428814-e78e-4c5c-8963-9d82cf46f391"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNS0xLTEtMS0x_a658fb3b-e794-4016-b89c-a07ba5846fb6"
      unitRef="usd">50000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <mdxg:LongTermDebtMaturityAfterYearFour
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNi0xLTEtMS0x_49578fec-1294-4ce1-96d6-ca381341e476"
      unitRef="usd">0</mdxg:LongTermDebtMaturityAfterYearFour>
    <us-gaap:LongTermDebt
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RhYmxlOmI2OWNhOTI2OGJmOTQzMjZhOWZjNjNhMmMxZWQ3Nzc5L3RhYmxlcmFuZ2U6YjY5Y2E5MjY4YmY5NDMyNmE5ZmM2M2EyYzFlZDc3NzlfNy0xLTEtMS0x_cb2e6ce1-974c-4463-b75e-a997608f6a17"
      unitRef="usd">50000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i191554e1c310493ca0b9f26eefe399a4_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV81OC9mcmFnOjk4NzRmYjM0MDdmMDQ5YzM4MmNiZGE0MTZkM2JjOGM1L3RleHRyZWdpb246OTg3NGZiMzQwN2YwNDljMzgyY2JkYTQxNmQzYmM4YzVfNzUzMw_76e122da-b2c2-48df-9962-a4218d75d8b2"
      unitRef="usd">51300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwMA_5da4c347-f24e-4151-9f43-be7c17661a75">Net Loss Per Common Share&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per common share is calculated using two methods: basic and diluted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basic Net Loss Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#x2019;s Series B Convertible Preferred Stock during the period, (ii) periodic amortization of the beneficial conversion feature, and (iii) periodic accretion of the increasing-rate dividend feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and nine months ended September&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile to net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated dividend on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of beneficial conversion feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of increasing-rate dividend feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#x2019;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back periodic accrued or deemed dividends on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company&#x2019;s Series B Convertible Preferred Stock, and assumes conversion as of the later of the beginning of the period and the original transaction date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive or does not reduce net loss per common share, the effect is excluded from the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,185,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,032,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding adjusted for potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,027,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,691,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,626,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,185,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,032,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwMw_abe5a6ca-cf6c-4c3d-be21-9aabc98cb9ea">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and nine months ended September&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile to net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated dividend on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of beneficial conversion feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of increasing-rate dividend feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi0xLTEtMS0x_458cc4ad-349c-4998-bd06-9b76a396e2b6"
      unitRef="usd">-2339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi0zLTEtMS0x_c849406d-cfee-46fd-a80a-85d13c235fcd"
      unitRef="usd">-19417000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi01LTEtMS0x_bc1a1a42-db33-42fc-80e2-7824f086e36b"
      unitRef="usd">-12500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMi03LTEtMS0x_c295b5a9-b9c3-4a9c-80cb-23874ac1460a"
      unitRef="usd">-32704000</us-gaap:NetIncomeLoss>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC0xLTEtMS0x_f2fcc5bf-dfac-4c46-bb51-d09f68c08835"
      unitRef="usd">1574000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC0zLTEtMS0x_f475adcb-d585-47d2-854d-26f9a5880578"
      unitRef="usd">997000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC01LTEtMS0x_52fe8018-7dde-4ea9-bdd9-aa72cb673847"
      unitRef="usd">3613000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNC03LTEtMS0x_3a3d0964-ced1-4618-be1b-590ff2162f3e"
      unitRef="usd">997000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS0xLTEtMS0x_7eb8020e-aa66-4821-96c0-8b18a7d23aa3"
      unitRef="usd">0</mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization>
    <mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS0zLTEtMS0x_017c6415-5806-4191-9978-402ed131dc4f"
      unitRef="usd">31110000</mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization>
    <mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS01LTEtMS0x_2f799e87-da19-40ff-81bc-0c0b6eed7c03"
      unitRef="usd">0</mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization>
    <mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNS03LTEtMS0x_f8143ab1-6895-49a0-aa56-9e217f9c9718"
      unitRef="usd">31110000</mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi0xLTEtMS0x_c2018194-c46d-4299-8bbe-784a67d7778f"
      unitRef="usd">0</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi0zLTEtMS0x_bc6b8635-e28f-4166-afcb-058efbf5be5e"
      unitRef="usd">458000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi01LTEtMS0x_6ab20f1a-ada7-4b48-901e-be83e685e801"
      unitRef="usd">926000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNi03LTEtMS0x_9b70ecf3-4938-43b4-80eb-bb19cab38f1a"
      unitRef="usd">458000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy0xLTEtMS0x_ab29448d-9dad-490b-864c-1baef9206878"
      unitRef="usd">1574000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy0zLTEtMS0x_7d955775-3177-4108-915c-bbd054d881d0"
      unitRef="usd">32565000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy01LTEtMS0x_a2c3fe16-c77e-48b4-be4f-5d4c8444ccdc"
      unitRef="usd">4539000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfNy03LTEtMS0x_fc5b27d3-3c2a-4b5d-9697-9a5a35483044"
      unitRef="usd">32565000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC0xLTEtMS0x_324ae521-f241-45b9-8e56-ce6bfd23b73d"
      unitRef="usd">-3913000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC0zLTEtMS0x_f739b91d-d7cf-47a9-95b9-7ecf77ff89e6"
      unitRef="usd">-51982000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC01LTEtMS0x_6aa708a3-97f8-44da-a25e-f12eb8d9a032"
      unitRef="usd">-17039000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOC03LTEtMS0x_c8344bfb-6785-44dc-8e2b-379803ba3037"
      unitRef="usd">-65269000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS0xLTEtMS0x_54fde61d-a944-454d-a18e-9127a4b20b06"
      unitRef="shares">110717073</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS0zLTEtMS0x_c99b9c57-4803-4f7c-84cb-933ffd4884da"
      unitRef="shares">108493208</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS01LTEtMS0x_7284e7ce-2ddb-4800-9b9b-dab08a47daa3"
      unitRef="shares">110136517</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfOS03LTEtMS0x_4bde1d0c-3d6c-4828-a13b-c51c534472ae"
      unitRef="shares">108222419</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtMS0xLTEtMQ_63e65c29-996b-4c0a-95a0-ce455f8a226d"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtMy0xLTEtMQ_cdfb0189-eb63-4312-aa9a-b614fdb2e333"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtNS0xLTEtMQ_e25da0af-af61-40d5-b436-cfc019a04540"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjlkYmQyNDAxMDkzMDRiNzY4YzU3NzIxYjM3ZTc4MWVkL3RhYmxlcmFuZ2U6OWRiZDI0MDEwOTMwNGI3NjhjNTc3MjFiMzdlNzgxZWRfMTAtNy0xLTEtMQ_fcc4bd4d-c1a1-4da8-ab96-3567d3debbcb"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjUwNQ_5e078cb0-0f1b-4ce6-a923-112951b52030">&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,185,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,032,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding adjusted for potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,717,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,493,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,136,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,222,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,027,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,691,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,626,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,185,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,032,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi0xLTEtMS0x_598a7fae-f469-4733-aaaf-9f05cde9361e"
      unitRef="usd">-3913000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi0zLTEtMS0x_f739b91d-d7cf-47a9-95b9-7ecf77ff89e6"
      unitRef="usd">-51982000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi01LTEtMS0x_6aa708a3-97f8-44da-a25e-f12eb8d9a032"
      unitRef="usd">-17039000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMi03LTEtMS0x_c8344bfb-6785-44dc-8e2b-379803ba3037"
      unitRef="usd">-65269000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy0xLTEtMS0x_402b5960-d51e-48d0-adb8-c9d371ca24b8"
      unitRef="usd">1574000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy0zLTEtMS0x_7d955775-3177-4108-915c-bbd054d881d0"
      unitRef="usd">32565000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy01LTEtMS0x_a2c3fe16-c77e-48b4-be4f-5d4c8444ccdc"
      unitRef="usd">4539000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfMy03LTEtMS0x_fc5b27d3-3c2a-4b5d-9697-9a5a35483044"
      unitRef="usd">32565000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC0xLTEtMS0x_846422e1-4e76-454f-a5fb-4e5772d6691e"
      unitRef="usd">-3913000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC0zLTEtMS0x_0ec1a2c3-6bbf-456a-963b-656f994f414d"
      unitRef="usd">-51982000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC01LTEtMS0x_670aa2f0-1e91-4d9b-8df8-fbb63996d290"
      unitRef="usd">-17039000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNC03LTEtMS0x_b3074cff-d363-4222-9834-5ba02fdbbbb7"
      unitRef="usd">-65269000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS0xLTEtMS0x_0ac4f409-745b-4d24-bee8-fd6815c54a19"
      unitRef="shares">110717073</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS0zLTEtMS0x_d6aa7397-810e-47a6-85d5-783cd83bc5a9"
      unitRef="shares">108493208</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS01LTEtMS0x_8bf5b030-2264-4944-ba0b-6bd2110fca80"
      unitRef="shares">110136517</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNS03LTEtMS0x_6546e8af-c639-4982-9da4-da19c0371f18"
      unitRef="shares">108222419</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi0xLTEtMS0x_c2bf84f4-4578-404e-8c20-9e5d93f65022"
      unitRef="shares">30658193</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi0zLTEtMS0x_b17a7ecb-d877-463a-8b0f-6aca0a0d4718"
      unitRef="shares">28625684</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi01LTEtMS0x_97208fe1-57bb-4beb-9425-12ae061487f5"
      unitRef="shares">30185813</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNi03LTEtMS0x_1e50b4b8-752d-4d96-9a94-bf50c8234405"
      unitRef="shares">11032820</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy0xLTEtMS0x_fcb0d94f-9f7f-4b72-a5db-3ac09d58375e"
      unitRef="shares">110717073</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy0zLTEtMS0x_c37ff979-8ac0-4206-9406-19cc21fa70b7"
      unitRef="shares">108493208</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy01LTEtMS0x_056a6dab-b5e2-40f1-8692-0311ebf4b180"
      unitRef="shares">110136517</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfNy03LTEtMS0x_e58aac32-c1bd-49ff-ba87-685c48ed0c49"
      unitRef="shares">108222419</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC0xLTEtMS0x_55d64409-e017-4036-971b-fbc4282c4885"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC0zLTEtMS0x_c93dd1ee-1f43-4a65-914a-1bcd3175f496"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC01LTEtMS0x_4d75a471-23b6-451a-a6f0-8280bdeed81a"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOjY3NzhjY2RmODZlNTQwOThiNGMxMjhlZTE0ODAzMzgxL3RhYmxlcmFuZ2U6Njc3OGNjZGY4NmU1NDA5OGI0YzEyOGVlMTQ4MDMzODFfOC03LTEtMS0x_c8c02d08-59e1-4188-b2f1-e3ad35c396d5"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RleHRyZWdpb246ZjYwNmUzNDY0MWI1NGI5N2I2NDA0NTQyYzc2N2U0M2NfMjc0ODc3OTA3MjI5NQ_43f20a5f-8781-4d4a-abfe-272730ce1465">The effect of each of these adjustments on the calculation is presented in the table below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,027,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,691,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,626,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,625,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,185,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,032,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i998a9400eb034fb8896247cfa7d4ce64_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi0xLTEtMS0x_91771997-39d7-48c2-8aa3-681842e2852c"
      unitRef="shares">27027252</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie8779dbf56be4207a62a288eb16426e3_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi0zLTEtMS0x_9b601593-939c-40ab-b8e2-0e972e351959"
      unitRef="shares">25691700</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5055a550b7f1489bb057050d4eb2e15f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi01LTEtMS0x_87f8fbd8-f500-4664-9a1c-02d8b6ad8bc7"
      unitRef="shares">26497570</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i56ff8a9cfc574e8a813ba41191a77909_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMi03LTEtMS0x_dc33f017-727a-4cd4-9537-c90d096732a1"
      unitRef="shares">8626410</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib3497639dc824203ac3bbc45e1fa7045_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy0xLTEtMS0x_72ed4d31-07bc-44ae-b5b8-a4af95ac2bc1"
      unitRef="shares">974687</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia97c4e39fb2044fd832ec14992093a99_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy0zLTEtMS0x_99b07f68-7a1f-49c9-9a3d-64de9f7a0ba4"
      unitRef="shares">1203853</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iddb8825862eb44cba52a62ed12d533bd_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy01LTEtMS0x_2fa1c016-2498-4b3e-ba3b-ce5e518d82d8"
      unitRef="shares">1287635</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaaf86c04cf564e56bba2a505c07e5a27_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfMy03LTEtMS0x_445e6499-4e33-40bc-8690-538c693b8f86"
      unitRef="shares">1281635</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8f9bbe152df94574a97c8077e072c43d_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC0xLTEtMS0x_0e922265-7152-49ee-807e-a2719a9658be"
      unitRef="shares">1840483</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id23dbe32c67d4052a1bcc960f0ea1014_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC0zLTEtMS0x_2de3d220-5ee8-468f-ae5f-11d032e1c8d8"
      unitRef="shares">919233</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic394f69ff36c4356957ce104b3c4e050_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC01LTEtMS0x_2751466c-4c6c-4c52-a8d0-079142baffb3"
      unitRef="shares">1500674</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib09f7d9159dc45a9b65feac3fa5d73f3_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNC03LTEtMS0x_3d7a0be2-bc54-48c5-a8db-0820d5c258fc"
      unitRef="shares">359103</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8570345d30404e7e9f7c73adbeac5a5b_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS0xLTEtMS0x_6e0d0f8e-b6a2-43db-b20b-d4b6c8ec6e78"
      unitRef="shares">805437</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia49639519ac8451195b5024845ee2aef_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS0zLTEtMS0x_17e08992-618f-4fef-ae3d-1c66d87bd261"
      unitRef="shares">772967</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ica04d8b2902b463ab11876407debfe02_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS01LTEtMS0x_5144fed1-862f-4033-9b9d-cdad25dd7766"
      unitRef="shares">875714</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib63433c4d26449ff840c826632e10ccc_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNS03LTEtMS0x_fcdd843c-b173-4a57-b4b0-41b4a5d8517e"
      unitRef="shares">739937</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3be316f6fd1b49e092d2a34cdc59474c_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi0xLTEtMS0x_6a17ecca-6a01-4e45-8de7-9049a110830b"
      unitRef="shares">10334</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icd009bf4fb074bf09897315c7972b8d7_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi0zLTEtMS0x_b15aad7e-0cd8-49c3-bbdf-bb7689ab0dde"
      unitRef="shares">37931</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iccc39a1be477444ca4a3b6da11859aaa_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi01LTEtMS0x_a8999126-a522-4cea-b4a5-70e1eef1a834"
      unitRef="shares">24220</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ef80048c2e14b599e756caca946ccb2_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNi03LTEtMS0x_af43f6a6-07a0-47db-a5a4-527ba54549f4"
      unitRef="shares">25735</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy0xLTEtMS0x_c2bf84f4-4578-404e-8c20-9e5d93f65022"
      unitRef="shares">30658193</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy0zLTEtMS0x_b17a7ecb-d877-463a-8b0f-6aca0a0d4718"
      unitRef="shares">28625684</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy01LTEtMS0x_6a0b4cc6-552c-44ca-9387-5c63d4038281"
      unitRef="shares">30185813</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82MS9mcmFnOmY2MDZlMzQ2NDFiNTRiOTdiNjQwNDU0MmM3NjdlNDNjL3RhYmxlOmU0MWI0YTczYTBkYzRiNjg5ZWE4Nzk1MjUwNzljZmNiL3RhYmxlcmFuZ2U6ZTQxYjRhNzNhMGRjNGI2ODllYTg3OTUyNTA3OWNmY2JfNy03LTEtMS0x_1e50b4b8-752d-4d96-9a94-bf50c8234405"
      unitRef="shares">11032820</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3MQ_36effd3c-5b59-4ac7-accd-a7451ac64dc2">Equity&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Convertible Preferred Stock of the Company (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends, if declared, are paid in cash at the end of each quarter based on dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into the Company&#x2019;s common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date (July 2, 2023 for the 100,000 shares currently outstanding), provided that the common stock has traded at 200% or more of the conversion price for 20 out of the preceding 30 consecutive trading days and on the trading date immediately prior to the date of conversion, the common stock traded at 200% or more of the conversion price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect two members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#x2019;s shareholders on an as-converted basis as a single class with the common stock not to exceed 19.9% of the total voting stock of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $1.8 million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and nine months ended September&#160;30, 2021, the Company recognized $0 and $0.9 million of deemed dividends related to the amortization of the increasing rate dividend feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends, into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#x2019;s control, the Series B Preferred Stock is classified as temporary equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2020 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2020 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends accumulated but not paid as of September&#160;30, 2021 was $5.6 million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on accumulated dividends as of September&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of 27,435,993 shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued several classes of restricted stock awards to employees: restricted stock (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSAs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), restricted stock unit awards (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), and performance stock unit awards (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The following is summary information for restricted stock awards for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, there was $28.2&#160;million of unrecognized share-based compensation expense related to restricted stock awards. This expense is expected to be recognized over a weighted-average period of 2.21 years, which approximates the remaining vesting period of these grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through September&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of September&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(975,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the nine months ended September 30, 2021 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested options expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mdxg:TemporaryEquityDividendRatePercentage
      contextRef="i213f3703bf564f66b0f66915beb0fe28_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNzE0_d3cd1e30-1e1d-403f-a57e-4e8bd8138c19"
      unitRef="number">0.040</mdxg:TemporaryEquityDividendRatePercentage>
    <mdxg:TemporaryEquityDividendRatePercentage
      contextRef="ifd8876d452174d08a691695fdc40ebc8_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfODIz_7e3797f2-f6f4-4561-b721-8a749ed66123"
      unitRef="number">0.060</mdxg:TemporaryEquityDividendRatePercentage>
    <mdxg:TemporaryEquityConversionPricePerShare
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTU1NA_332efc4d-a936-4373-ace8-60d86008cc82"
      unitRef="usdPerShare">3.85</mdxg:TemporaryEquityConversionPricePerShare>
    <mdxg:TemporaryEquityConversionRatio
      contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNzE0NjgyNTU4ODYxNg_14681477-9cfa-4e9c-b95c-19343ad3be0e"
      unitRef="number">259.74</mdxg:TemporaryEquityConversionRatio>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjc0ODc3OTA3NzUyNg_275c56ae-200f-4b51-bc89-addb5781b943"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTkxMQ_913f1a80-b807-4cb6-87a1-d27ea083b9bd"
      unitRef="number">2</mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger>
    <mdxg:TemporaryEquityConversionThresholdTradingDays
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTk1MA_c98e779e-2a1a-4dde-85d5-f021e3499fea"
      unitRef="day">20</mdxg:TemporaryEquityConversionThresholdTradingDays>
    <mdxg:TemporaryEquityThresholdConsecutiveTradingDays
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMTk2MA_7654cba5-2f6b-4abb-a17b-2bd45066abbf"
      unitRef="day">30</mdxg:TemporaryEquityThresholdConsecutiveTradingDays>
    <mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjA1MA_d2bb5ec1-bcb0-47c1-ae32-d6f4148ed49a"
      unitRef="number">2</mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion>
    <mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjE3OA_d447295f-f642-4bd9-9ed1-df29c05fa1ba"
      unitRef="director">2</mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders>
    <mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis
      contextRef="if888b7f728934af48aaa3fc34c496a0a_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMjQxNg_6bd4366c-a8d5-45da-a2c8-4f36e933344c"
      unitRef="number">0.199</mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis>
    <mdxg:TemporaryEquityIncreasingrateDividendFeature
      contextRef="i4155582a666f4b11b948e06e1bb09a77_I20200702"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzI0NA_3dbcfac7-e128-43c7-a104-f5afe946ae7a"
      unitRef="usd">1800000</mdxg:TemporaryEquityIncreasingrateDividendFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzQ3Mg_4c706f24-1c20-4716-92ce-a38c940909c9"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfMzQ3OQ_4ce5be1f-6f09-40e8-af70-8125ca6428e8"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3Mw_b3804922-102d-4c0b-aeb4-10688c402151">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2020 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2020 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.725%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0d492b0b584d4f269f2f61823174b39e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMi0xLTEtMS0x_6cb6f98f-cc7f-491e-bd39-6f1c00ac09f4"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i0d492b0b584d4f269f2f61823174b39e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMi0zLTEtMS0x_3862de77-3639-448b-94b1-e64fa046c2fc"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i8251e35f7cf24a95ac52c2654088a177_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfMy0zLTEtMS0x_0653d1be-a4bd-404e-ac0c-fff11f65cee7"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfNC0xLTEtMS0x_94dd26dd-e830-4495-9315-11be26e1eda7"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmM5ZWM2ZTRlNDU4ODQ1YjE5OWQ4NjhjNGU2YzAzMmNkL3RhYmxlcmFuZ2U6YzllYzZlNGU0NTg4NDViMTk5ZDg2OGM0ZTZjMDMyY2RfNC0zLTEtMS0x_a9ce1e1e-e73d-4b8f-8e8d-49e4948b0c49"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="if09204510e324170b6c22bff3068c0ac_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMi0xLTEtMS00NDU_5039a1b9-de31-426d-a62a-b30c0eb8fe2c"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="if09204510e324170b6c22bff3068c0ac_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMi0zLTEtMS00NDU_6d0f5366-5670-4c07-8bd5-12a69c41023d"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues
      contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0xLTEtMS01Njc_746cbe91-a75d-404e-a552-77b5f76d0e0f"
      unitRef="shares">100000</mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0zLTEtMS01NzE_23a445be-3f24-48ce-aad6-1d0a0ced11fe"
      unitRef="usd">59540000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i947487d244a6487686e15b7ebb3df156_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfMy0zLTEtMS00NDU_7fe569f3-8844-4493-85d5-ca053c9b48c2"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfNS0xLTEtMS0xMjc2_7cc59056-c207-44e5-8398-ada3c2deceef"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmUwYmQxNDU3ZGIwZTRhMjVhYjJjNWU4Yzk4ZTM2ZmY4L3RhYmxlcmFuZ2U6ZTBiZDE0NTdkYjBlNGEyNWFiMmM1ZThjOThlMzZmZjhfNS0zLTEtMS0xMjc2_c342fb2d-9b66-4921-9437-e14afd8275af"
      unitRef="usd">91108000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie143cb1da9a04290be81c5d71f845995_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMi0xLTEtMS0x_8364687b-cdeb-4113-890c-1f863768d451"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie143cb1da9a04290be81c5d71f845995_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMi0zLTEtMS0x_efda7d98-75ba-46ae-b968-3dcac576296d"
      unitRef="usd">91568000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfMy0zLTEtMS0x_623b9b84-132a-4f33-9bfb-869fca16869f"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfNC0xLTEtMS0x_f60a32fd-10ea-4a66-9bc3-0357e8975c55"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjkwMzJhZmE5MDQzMDQ4NGQ5ZmI2ZTdmYWM0NTZiMWZhL3RhYmxlcmFuZ2U6OTAzMmFmYTkwNDMwNDg0ZDlmYjZlN2ZhYzQ1NmIxZmFfNC0zLTEtMS0x_54347366-0846-4dc2-b1b5-d48117c51d34"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i40a77cb321114af080584b94815e9ebe_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMi0xLTEtMS01MzA_6ac32584-0eb1-4818-b209-c326fca65e95"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i40a77cb321114af080584b94815e9ebe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMi0zLTEtMS01MzU_578d19d3-5787-4ee4-95c0-f8f97d838d29"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues
      contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMy0xLTEtMS01NDY_e41a50a7-7bbc-4b18-9548-5d823e1ef186"
      unitRef="shares">100000</mdxg:TemporaryEquityStockIssuedinPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfMy0zLTEtMS01NTA_4b9632e5-0ec2-4e49-8514-a8e168d19db2"
      unitRef="usd">59540000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="iff503e847be14ec685cb730dc81cca93_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNC0zLTEtMS01NTg_763ec5ba-582f-4fa4-b089-cea6e77e4a36"
      unitRef="usd">31568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNS0xLTEtMS0xMzQ4_3c105bde-79a6-4ed7-a8a2-02ce8da0fc1e"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icabc3a726b7540c7ab857df0dbcf05a0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjgzODM5NTZiMzA5ZDRjNzQ4NGE1OTYyMzc1ZjlmMjkzL3RhYmxlcmFuZ2U6ODM4Mzk1NmIzMDlkNGM3NDg0YTU5NjIzNzVmOWYyOTNfNS0zLTEtMS0xMzQ4_fccec487-d55b-4f0f-9234-caa3faba9df9"
      unitRef="usd">91108000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i0f6b4375ddd2400db0cb46bd68919b38_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTAzMA_d5b35e22-4763-48fa-b064-6f198164fcf5"
      unitRef="usd">5600000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquitySharesIssueduponConversion
      contextRef="ifa06137eede743e69cd1ac1b25b0a0c8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTI5Nw_6e8d9675-f409-4fe4-8623-dee1747176c3"
      unitRef="shares">27435993</mdxg:TemporaryEquitySharesIssueduponConversion>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTY0OQ_ac7b2ad3-1b4b-4d27-b619-c3f12112730e"
      unitRef="usd">28200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNTgxMw_f931b329-2795-4f4e-8b9a-e72c901374fe">P2Y2M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI2OQ_989133b7-45bd-412f-9516-0cd0676a6d78">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through September&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of September&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,991,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(975,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi0xLTEtMS0x_ebd945f2-0d91-4441-92dd-2aacb3954973"
      unitRef="shares">2175859</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi0yLTEtMS0x_19769a59-1684-4554-98b2-759b1289f162"
      unitRef="usdPerShare">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2098fc34c48c488e9b8469ff9bb0d624_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi00LTEtMS0x_20012ef9-c658-4f78-b077-c9a99af24fa0"
      unitRef="shares">2325273</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2098fc34c48c488e9b8469ff9bb0d624_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi01LTEtMS0x_62dd74bc-0004-4c82-ada0-c7148cef2111"
      unitRef="usdPerShare">5.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i61dd953b6b594540bad6517310eaba17_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi03LTEtMS0x_4659f429-990a-49c2-b17a-c67faefb4881"
      unitRef="shares">35212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i61dd953b6b594540bad6517310eaba17_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMi04LTEtMS0x_03f9bc19-e67a-41a5-8778-436eff9a63d7"
      unitRef="usdPerShare">7.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy0xLTEtMS0x_f269b951-128f-4096-8ebc-073a07a373c0"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy0yLTEtMS0x_ffad5f43-19aa-447b-9efc-b1d9c087fc1b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy00LTEtMS0x_f7cefe1f-2366-48ac-b2e4-a86cdf32a873"
      unitRef="shares">2991137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy01LTEtMS0x_2de08f0c-672f-4e7e-959c-f960c4db2bea"
      unitRef="usdPerShare">10.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy03LTEtMS0x_a77fa648-55c7-4a66-8210-339e7c789911"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfMy04LTEtMS0x_1f61810e-aa52-426c-bfbf-55f8b6a43147"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC0xLTEtMS0x_8b34aded-d65a-4b57-a70b-3180e1bab3d3"
      unitRef="shares">975259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC0yLTEtMS0x_cf235a7b-e19c-4ef5-9d64-e0f5d43513e5"
      unitRef="usdPerShare">4.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC00LTEtMS0x_234e70ae-784a-4d0a-a823-5725f92b94d6"
      unitRef="shares">775193</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC01LTEtMS0x_724123e1-e0b0-459e-8213-e0ebb724bfd8"
      unitRef="usdPerShare">5.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC03LTEtMS0x_f6136b71-b4c5-4f56-9da6-15a49037bcba"
      unitRef="shares">35212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNC04LTEtMS0x_27a9c827-349a-40fa-bc40-9e5863599bb5"
      unitRef="usdPerShare">7.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS0xLTEtMS0x_769c6cac-0b66-4745-9cac-e69527b83377"
      unitRef="shares">66374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8b3d039d18324a4ea91880e16c1dce3a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS0yLTEtMS0x_a8d04b10-85c7-43d2-957f-61947e20a90a"
      unitRef="usdPerShare">3.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS00LTEtMS0x_c00666d5-1efa-4731-9572-7cbc4bf3e31e"
      unitRef="shares">252486</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ieaf5b89981494a6d8103a76cca5abd36_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS01LTEtMS0x_25e751a8-5c0a-4607-8354-51e4cac7f722"
      unitRef="usdPerShare">8.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS03LTEtMS0x_050e1d6c-f797-4040-bd50-002ff5621d74"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i882d9d76bc6142988b4f6f5169ad82a2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNS04LTEtMS0x_87d8c6da-7d71-4897-8d23-34a653ed41b1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2d8fcc6d51244882af073962e13c8159_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi0xLTEtMS0x_6e1ef917-3f53-41e1-95fc-2e3e7f595c59"
      unitRef="shares">1134226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2d8fcc6d51244882af073962e13c8159_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi0yLTEtMS0x_385a6c36-362c-4391-b6d9-c98c4f01984b"
      unitRef="usdPerShare">4.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie510c5f07feb4b34b1780b367608d0b9_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi00LTEtMS0x_dd8ea1a9-6619-45cd-80ed-78bc5fb981e2"
      unitRef="shares">4288731</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie510c5f07feb4b34b1780b367608d0b9_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi01LTEtMS0x_669f196c-09e9-4644-8ec8-682a79fbf535"
      unitRef="usdPerShare">8.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib9419a5870764efc954e2ea7f11c85ad_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi03LTEtMS0x_d9a51d8d-77bd-4278-acd9-502712e6f776"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib9419a5870764efc954e2ea7f11c85ad_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOmFkNWYyZmRhYzJjZDQ3NjM5YTRhODhmOGYzZjc3Mjc5L3RhYmxlcmFuZ2U6YWQ1ZjJmZGFjMmNkNDc2MzlhNGE4OGY4ZjNmNzcyNzlfNi04LTEtMS0x_f6128f08-57cf-4d23-bb88-f1966c901e62"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RleHRyZWdpb246YzBiMzMxNGJlY2IyNDRhYWFlYjYzNTYwZDJiMWQwNzNfNjI3MA_68ba0cab-5209-4bda-93a5-ae6a46ec6be8">A summary of stock option activity for the nine months ended September 30, 2021 is presented below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested options expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,451,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMS0xLTEtMS0x_7acb1336-ce24-47b6-8f46-f96f604cb707"
      unitRef="shares">2025683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i76db2066b4ab44fb850e9a690cdb64fb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMS0zLTEtMS0x_5f95f5ca-59d3-4ecb-9164-70eeff9fd35e"
      unitRef="usdPerShare">4.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMi0xLTEtMS0x_3a9c108f-528f-429c-b053-0eaf1b0163ee"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMi0zLTEtMS0x_5edd79b1-e8f4-4c09-b447-2b1495fc2a0f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMy0xLTEtMS0x_89e7e2e9-f016-4844-a4bb-a7e72e3e4a30"
      unitRef="shares">524171</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfMy0zLTEtMS0x_6c1187ac-1cfe-4a61-8f3d-93b5fe7ee440"
      unitRef="usdPerShare">3.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNC0xLTEtMS0x_26fb7852-841e-4c13-bff6-91cb8015ecf3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNC0zLTEtMS0x_ad057bd1-3ed5-476a-bb56-a634da937170"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNS0xLTEtMS0x_8d45b4b2-3142-487f-b924-8cd5752b1f07"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNS0zLTEtMS0x_a52d7e6e-199a-40b4-ac36-bed10f04df15"
      unitRef="usdPerShare">1.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi0xLTEtMS0x_d1348d2c-f5b1-4c5e-984b-a0a45dea0762"
      unitRef="shares">1451512</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi0zLTEtMS0x_c9452272-bf39-43a9-8e9f-e50be5c1331c"
      unitRef="usdPerShare">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi01LTEtMS0x_c9727a32-ca1a-4ce9-ab28-d7947c29c6da">P1Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNi03LTEtMS0x_33247ac5-1732-4ace-8627-e3c412b62db8"
      unitRef="usd">1982949</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy0xLTEtMS0x_32089a8c-e1c1-45f6-9c67-2ec010592516"
      unitRef="shares">1451212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy0zLTEtMS0x_a3767348-a469-4b6f-a3f2-54d2c5bb9b6d"
      unitRef="usdPerShare">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy01LTEtMS0x_acbd4118-56c9-4287-9b64-560be3d7b7b5">P1Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82NC9mcmFnOmMwYjMzMTRiZWNiMjQ0YWFhZWI2MzU2MGQyYjFkMDczL3RhYmxlOjAxY2E0NzA2MWZjNjQwOTg4NmMzNzkyMTMyYWQ4MzRiL3RhYmxlcmFuZ2U6MDFjYTQ3MDYxZmM2NDA5ODg2YzM3OTIxMzJhZDgzNGJfNy03LTEtMS0x_4c4204a4-03f4-402e-9d89-f77fda03a90f"
      unitRef="usd">1982949</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNzg4_eb7a5081-3d0b-4bc5-9556-d9b63d43df1c">Income Taxes&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the Company were (14.8)% and (0.2)% for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the Company were (2.9)% and 25.6%, for the nine months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $0 and $11.4 million for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. The discrete items recorded for the nine months ended September&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount.  No benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNjg_e9707e7d-7cf7-43b6-96a5-848308568264"
      unitRef="number">-0.148</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNzU_3c1696ec-70e5-4869-b030-a542b42bd461"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMTc2_47616790-690a-4c81-ae90-bdbdb9ef8855"
      unitRef="number">-0.029</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMTgz_2052cb37-7836-4a5f-8b69-e66c3427327f"
      unitRef="number">0.256</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMjg5_f0d3f05c-1536-4d01-a232-9f932eab2c0a"
      unitRef="usd">0</mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems>
    <mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfMjk2_5db30b36-a36e-4c41-83c2-3d9629605558"
      unitRef="usd">11400000</mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNTU5_43828414-d9f0-45fa-b837-97868eebfdf7"
      unitRef="usd">11300000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ied330f3e6aa84ca6b4000cb2d87be340_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNTU5_5102f87e-7a67-41a8-9a8c-6189f26568be"
      unitRef="usd">-11300000</us-gaap:IncomeTaxExpenseBenefit>
    <mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV82Ny9mcmFnOmExNmI2ZDdiMTVkOTQyY2RhODI2YzNkZDY1ZGQxY2VlL3RleHRyZWdpb246YTE2YjZkN2IxNWQ5NDJjZGE4MjZjM2RkNjVkZDFjZWVfNjYz_ebc88c47-e79d-41fc-8b8c-b4de43c7a12a"
      unitRef="usd">0</mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RleHRyZWdpb246MWVlYjA3MDRhNmI0NDI2MThmMmE0MDk1NDNjYmNjMDVfMTk4_f6d4aaab-f919-40e9-95a6-d680a24be908">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected cash payments, receipts, and non-cash activities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right of use asset and liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable for sale of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of equipment in accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of non-cash consideration received for option exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendment fee on BT Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RleHRyZWdpb246MWVlYjA3MDRhNmI0NDI2MThmMmE0MDk1NDNjYmNjMDVfMjAw_7d0a4670-0cf5-416e-92b0-96a92b851475">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected cash payments, receipts, and non-cash activities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right of use asset and liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable for sale of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of equipment in accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of non-cash consideration received for option exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendment fee on BT Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMi0xLTEtMS0x_e221aa2e-f0b9-41b8-9de2-9db792b189a6"
      unitRef="usd">3269000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMi0zLTEtMS0x_5a1ac8c4-4332-488f-9652-2d41cbd87492"
      unitRef="usd">6308000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMy0xLTEtMS0x_3ee997c6-4e54-4db7-b3e0-eb2d62e93b8f"
      unitRef="usd">157000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMy0zLTEtMS0x_c584a49a-43d2-48a7-8400-357e786dce37"
      unitRef="usd">213000</us-gaap:IncomeTaxesPaid>
    <mdxg:LeaseRightOfUseAssetAndLiability
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNS0xLTEtMS0x_9cc7fe79-6a5a-49c3-aa53-e4b5ffb6bb08"
      unitRef="usd">189000</mdxg:LeaseRightOfUseAssetAndLiability>
    <mdxg:LeaseRightOfUseAssetAndLiability
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNS0zLTEtMS0x_66b621e1-3e74-4e89-ad91-c3f00c0b9d4d"
      unitRef="usd">0</mdxg:LeaseRightOfUseAssetAndLiability>
    <mdxg:NotesReceivableForSaleOfPropertyAndEquipment
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNi0xLTEtMS0x_e4982dcf-55f9-4ec4-abae-59a9252ff081"
      unitRef="usd">75000</mdxg:NotesReceivableForSaleOfPropertyAndEquipment>
    <mdxg:NotesReceivableForSaleOfPropertyAndEquipment
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNi0zLTEtMS0x_8b205bc8-c6d0-45e4-b035-1334a8ca6012"
      unitRef="usd">0</mdxg:NotesReceivableForSaleOfPropertyAndEquipment>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNy0xLTEtMS0x_9df7a5c7-b92f-40bc-b566-83370b4c3fbd"
      unitRef="usd">6000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfNy0zLTEtMS0x_0e9731b4-6f5f-43fe-9580-39a3ae30e517"
      unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOC0xLTEtMS0x_9a26f5a5-d6d3-46f5-8250-410bbdb08bc6"
      unitRef="usd">380000</mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise>
    <mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOC0zLTEtMS0x_e9c56a5b-5b8a-40d3-818a-226a965d2485"
      unitRef="usd">0</mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise>
    <mdxg:TemporaryEquityDeemedDividends
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOS0xLTEtMS0x_2df6eced-2b5a-44d2-9689-02bbf731b329"
      unitRef="usd">926000</mdxg:TemporaryEquityDeemedDividends>
    <mdxg:TemporaryEquityDeemedDividends
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfOS0zLTEtMS0x_858bdc98-f0a2-44ec-ad9e-a96c12d970ef"
      unitRef="usd">31568000</mdxg:TemporaryEquityDeemedDividends>
    <mdxg:NoncashActivitiesDeferredFinancingCosts
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTAtMS0xLTEtMQ_c737e635-3b9f-4f87-9a15-73791efb294e"
      unitRef="usd">0</mdxg:NoncashActivitiesDeferredFinancingCosts>
    <mdxg:NoncashActivitiesDeferredFinancingCosts
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTAtMy0xLTEtMQ_52199527-b153-4abd-91ff-8918fa8ecd70"
      unitRef="usd">471000</mdxg:NoncashActivitiesDeferredFinancingCosts>
    <mdxg:StockIssuanceCostsIncurred
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMS0xLTEtMTM2MA_286b4f02-ea52-4524-a838-d73b498a483e"
      unitRef="usd">0</mdxg:StockIssuanceCostsIncurred>
    <mdxg:StockIssuanceCostsIncurred
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMy0xLTEtMTM2MA_48ca7b3a-e767-4465-8678-8567630da40d"
      unitRef="usd">942000</mdxg:StockIssuanceCostsIncurred>
    <mdxg:NoncashActivitiesDebtInstrumentAmendmentFee
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMS0xLTEtMQ_dbc05210-ab7c-4343-b4bc-35a898502aab"
      unitRef="usd">0</mdxg:NoncashActivitiesDebtInstrumentAmendmentFee>
    <mdxg:NoncashActivitiesDebtInstrumentAmendmentFee
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83MC9mcmFnOjFlZWIwNzA0YTZiNDQyNjE4ZjJhNDA5NTQzY2JjYzA1L3RhYmxlOmUyMDA4ZjMzYzcwNTQ3YTI4ZDVmNjVkMTJkNTE2MjVmL3RhYmxlcmFuZ2U6ZTIwMDhmMzNjNzA1NDdhMjhkNWY2NWQxMmQ1MTYyNWZfMTEtMy0xLTEtMQ_11d55d22-11ad-4ac0-879a-6478597492e7"
      unitRef="usd">722000</mdxg:NoncashActivitiesDebtInstrumentAmendmentFee>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMTMxMzY_f48c4591-47d8-4f70-941d-5d0529cb72fd">Contractual Commitments and Contingencies&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#x2019;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reasonably estimated. The Company's unaudited condensed consolidated financial statements as of September&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#x2019;s legal proceedings, refer to Note 14, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company has accrued $4.0 million related to the legal proceedings. The Company paid, either directly or through its insurance providers, $7.7 million toward the resolution of legal matters involving the Company during the nine months ended September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company received funds from certain director and officer insurance policies for previously-incurred, covered legal expenses. These funds were recognized as a reduction to investigation, restatement, and related expense during the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain litigation and regulatory matters:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating two purported securities class actions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;MacPhee v. MiMedx Group, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; filed February 23, 2018 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Kline v. MiMedx Group, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;CPFI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x201d;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#x201c;Pete&#x201d; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp;amp; Holland LLP. The amended complaint (the &#x201c;Securities Class Action Complaint&#x201d;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp;amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#x2019; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#x2019;s motions and the hearing on the same was held on September 24, 2021. The Court has not yet ruled on the motions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Defense Office of Inspector General Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#x2019;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#x2019;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#x2019;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Former Employee Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;MiMedx Group, Inc. v. Petit, et. al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) against its former CEO, Parker H. &#x201c;Pete&#x201d; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#x2019;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#x2019;s legal expenses. The Company opposed Petit and Taylor&#x2019;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation was held on August 11, 2021. Negotiations are ongoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defamation Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 4, 2018, Sparrow Fund Management, LP (&#x201c;Sparrow&#x201d;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#x2019; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#x2019;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#x2019;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#x2019;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#x2019;s business, results of operations, financial position or liquidity.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMTc0MA_de924f5e-fa35-450c-813a-068bb5cd07d7"
      unitRef="usd">4000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMjA0Ng_eea0ce57-f9a3-4b0b-bc47-7827b7cb195e"
      unitRef="usd">7700000</us-gaap:PaymentsForLegalSettlements>
    <mdxg:ContingencyLossNumberOfSecuritiesClassActions
      contextRef="i29f9998bd9f949179feb6e677def3f2d_D20190116-20190116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83My9mcmFnOmFlNThhMDg2NDU0NTRlNjliZWQxNzY3MTg5NGYyNGU4L3RleHRyZWdpb246YWU1OGEwODY0NTQ1NGU2OWJlZDE3NjcxODk0ZjI0ZThfMjc1OQ_3ccfb905-e8b4-4e21-88f8-f44d0f87c8a4"
      unitRef="securityclassaction">2</mdxg:ContingencyLossNumberOfSecuritiesClassActions>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMTM3MA_aa751810-5be0-4163-b3ef-a9a841081084">Revenue&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue by Product&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx has two primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its tissue and cord sheet allograft products, and (2) Section 351 products, consisting of the Company&#x2019;s micronized and particulate products, which, prior to the end of Enforcement Discretion were used to treat a variety of patient needs, including both advanced wound care and musculoskeletal applications. Advanced Wound Care is further disaggregated between the Company&#x2019;s Tissue/Other and Cord products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each class of product (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tissue/Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Cord&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1) &#x201c;O&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;ther&#x201d; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue by Customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx has two primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), and (2) sales through distributors (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each customer type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct Customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or nine months ended September&#160;30, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collections on the Remaining Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:13.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of shipment and that such criteria would not be met until collection of such sales (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). This was in accordance with the change in the Company&#x2019;s revenue recognition pattern beginning September 30, 2019 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September&#160;30, 2021 and 2020 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <mdxg:NumberOfProducts
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfNzE_be3a3e9b-8726-400d-81dd-10951be72a6f"
      unitRef="product">2</mdxg:NumberOfProducts>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMTM3Mg_0754409c-2668-4917-b63d-c604171744b8">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each class of product (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tissue/Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Cord&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1) &#x201c;O&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;ther&#x201d; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each customer type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct Customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a36de01b5ac4820a5ecf7930998772a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy0xLTEtMS0x_beaeba64-2e42-4731-ba12-80b0524ced39"
      unitRef="usd">56035000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa362db08bef44ea8f60684d8de52387_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy0zLTEtMS0x_485ec92a-39d4-4f4e-8ff2-c4f68506dce3"
      unitRef="usd">50842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90bdb86d833e4c83b10c73d297c90071_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy01LTEtMS0x_ff857cc4-a756-416d-b7d4-28ba0edb1389"
      unitRef="usd">156012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aa490c58d174fbe8347c43a9c6d5e5d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfMy03LTEtMS0x_9814ebf6-9382-49cf-a531-28929f6d4a36"
      unitRef="usd">137975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2667744585bb48c09af4f59d88bfd890_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC0xLTEtMS0x_890e4a3f-cde9-4780-97f4-7d2cbdb3037c"
      unitRef="usd">6247000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20a5a122a9d7469e9cc716aa6f322b5f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC0zLTEtMS0x_8145da4e-a7cd-4a7d-b8e2-bda0f4e1d6fb"
      unitRef="usd">4227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i452c359c7dd4480697d2aea6a112b046_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC01LTEtMS0x_9c498096-b75c-478c-9e3c-1ca094a049cb"
      unitRef="usd">17093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a775e47d6fa4df9b4671433b8264357_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNC03LTEtMS0x_242347c2-d31a-4716-be4f-ec5962386c4c"
      unitRef="usd">11387000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide8eea8c11844b23b19eb0cf0ab5959d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS0xLTEtMS0x_3be66ee5-5476-4e97-808e-c4d72361ea5b"
      unitRef="usd">62282000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e5946e34fb34c6da5e38e11bc904353_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS0zLTEtMS0x_2f9f1188-e80d-49ad-8737-6e0e54464aa6"
      unitRef="usd">55069000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e5c8d9d9bd542fdb5a8db00cdeb2c77_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS01LTEtMS0x_8824fa1d-bc7e-4670-935a-cbf311ea3cb8"
      unitRef="usd">173105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2bb0ad1ba5b453e958dbe52d1fff145_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNS03LTEtMS0x_56cd2587-2cce-475d-b4cd-8877009bab03"
      unitRef="usd">149362000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a2891421a794a799dfb95815a0ca8dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi0xLTEtMS0x_3861ce41-d171-4144-bc4f-6a978fe2168d"
      unitRef="usd">489000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie08a5f6990c84ab39b8acba02e6a017d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi0zLTEtMS0x_925099e1-f2c8-4fb2-ae86-33b5ea724b27"
      unitRef="usd">8195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a16463d10404e52bb4af574f1559d05_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi01LTEtMS0x_dfeb5198-234b-4f3f-846b-8e802f64d53e"
      unitRef="usd">17187000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cb632f826914c31aee1ccad29420e4c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNi03LTEtMS0x_2b34395a-cc10-446e-be82-2e1513862461"
      unitRef="usd">23084000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27dc4a45b59b47f188c9741959321706_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy0xLTEtMS0x_99978a48-d423-4ae4-8e81-66483b8edb51"
      unitRef="usd">303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1522b620767440f3ae5389424e04dfed_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy0zLTEtMS0x_70905546-9573-40ed-8bfc-bb7edb098236"
      unitRef="usd">1039000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78a8fb5e74c64fb59d625e7756ec9015_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy01LTEtMS0x_bd75ec81-b853-4c86-a2f0-2c84689838c8"
      unitRef="usd">914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied33a9c457d644dabec06946c8d55bcf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfNy03LTEtMS0x_beb97324-b105-42de-bda9-06ad67ed5866"
      unitRef="usd">7240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC0xLTEtMS0x_0541482e-bc0a-425d-a056-3d3b3034930d"
      unitRef="usd">63074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC0zLTEtMS0x_fad6562f-54d5-4e64-836c-b9bb7a00be41"
      unitRef="usd">64303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC01LTEtMS0x_36db4078-a85a-454e-9cdc-1edf3917398d"
      unitRef="usd">191206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjE2NzZjMjQ2NDYwMjQ2NTdiNTliOThmOWNkOWUxZTIwL3RhYmxlcmFuZ2U6MTY3NmMyNDY0NjAyNDY1N2I1OWI5OGY5Y2Q5ZTFlMjBfOC03LTEtMS0x_80c0fa18-7611-4f94-b042-c0028b4de355"
      unitRef="usd">179686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels
      contextRef="i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfOTUy_83f17da0-13de-401c-8770-c7813d055b8c"
      unitRef="distributionchannel">2</mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16ad22774d414f21aed7e4d4af64444c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi0xLTEtMS0x_2b99aed5-491d-4002-af40-ee62e59031cb"
      unitRef="usd">61087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id48efc9d3e964bcebaec0d6b42ae86ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi0zLTEtMS0x_7b8bb601-f95a-4195-b6c2-e105ccce7377"
      unitRef="usd">62409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4560a171d344f38b7d85fe0632ce4bf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi01LTEtMS0x_cd443795-d9ae-4245-8d0b-44330ce6f345"
      unitRef="usd">184706000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3435571269948bfa711c7227cab69bf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMi03LTEtMS0x_f2819008-26ae-4030-b212-883d3ec852fb"
      unitRef="usd">175060000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e209b570c4940fcbb3cfbb19e1709f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy0xLTEtMS0x_0c3043d5-da45-4b24-8d1b-08a49ffff5f8"
      unitRef="usd">1987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff5a0b29488b4f5fb8239054f04a74b5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy0zLTEtMS0x_4fa39ec0-2f45-4636-9a38-b0ebe0878823"
      unitRef="usd">1894000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaac3427ddcd4497894f4bc23e3e9f0f1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy01LTEtMS0x_56f82265-b8f8-4663-a18a-eae57688fd5a"
      unitRef="usd">6500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9107cfd22f4e39bf4115b0953ea93f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfMy03LTEtMS0x_0459a261-d2d0-4686-80c5-324538d15afc"
      unitRef="usd">4626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i057fe79e33fc4177befb72654ccf4378_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC0xLTEtMS0x_d81b3e12-1436-4b8a-944d-c8724e02e1a1"
      unitRef="usd">63074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i961e59873c934ac892d15eb3961068f2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC0zLTEtMS0x_5bf4be74-b6d9-4cb6-a663-7d0d9ef8244f"
      unitRef="usd">64303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC01LTEtMS0x_ba5f54ec-e534-48e6-b98d-1aa5d30a95f8"
      unitRef="usd">191206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11539cef14874db9974e274ef191dc3f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOjkxMGMxZTlkOGMwNTQ4NmZiNjFkNzRhYmI2ZmY0NjY5L3RhYmxlcmFuZ2U6OTEwYzFlOWQ4YzA1NDg2ZmI2MWQ3NGFiYjZmZjQ2NjlfNC03LTEtMS0x_a48d7042-9f4e-4f75-b137-bff64797076a"
      unitRef="usd">179686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMjc0ODc3OTA3NzgyNg_822d11d3-b8bc-4565-85ba-2108b77e8b91">&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collections on the Remaining Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:13.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of shipment and that such criteria would not be met until collection of such sales (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). This was in accordance with the change in the Company&#x2019;s revenue recognition pattern beginning September 30, 2019 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ib059f33b4d88402dbe59f1461265db41_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RleHRyZWdpb246ZGFiN2M1NWY3MDAxNGQ2NjhlYjc5ZmNhNmRmMjIwNmNfMjc0ODc3OTA3MTk2Mg_0ad54152-1f41-421f-8203-1f16e53777bd">&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September&#160;30, 2021 and 2020 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi0xLTEtMS0xMzkx_b3ebec48-69bd-4fe1-bf53-d236660c1de8"
      unitRef="usd">303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi0zLTEtMS0xNDIw_ec517dfc-d0f8-49ee-84cd-f1c47a599e34"
      unitRef="usd">1039000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi01LTEtMS0xNDI4_f3943cc5-6e4a-4637-b714-042bb2ffef20"
      unitRef="usd">914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMi03LTEtMS0xNDQ4_17f9598f-bed6-4050-91fa-e30352c91fe5"
      unitRef="usd">7240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy0xLTEtMS0xMzkx_2b77853f-6bac-4d28-81c1-a299357dbd9f"
      unitRef="usd">42000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy0zLTEtMS0xNDIw_954d0891-1286-4441-b89b-2cb0d1a1f1fa"
      unitRef="usd">146000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy01LTEtMS0xNDI4_327f818d-833d-42ea-b8cd-8fb3b97a1c87"
      unitRef="usd">128000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfMy03LTEtMS0xNDQ4_41ba269e-2ae5-4b96-ae05-8ab0e8fc6bc5"
      unitRef="usd">1014000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i1831204c1854475a8c1a996ca37bc586_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC0xLTEtMS0xMzkx_2e45d181-7ea0-4bcd-bc37-31467db7422f"
      unitRef="usd">261000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic53e6488a3b94530b36da38df1893203_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC0zLTEtMS0xNDAy_b3a45821-5856-40e8-9e99-57d134ba8e83"
      unitRef="usd">893000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie2c64f8eeb924c6b8ae6b22176511e72_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC01LTEtMS0xNDI4_ff9a7251-e009-4784-8eb3-18f1127fb7db"
      unitRef="usd">786000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id0bdc29fa6fc4056979bf83a48b68d0f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM3YzU4MDFkZTc1YzQxZmU4ZDExODlmNzNmMGFhZGFhL3NlYzpjN2M1ODAxZGU3NWM0MWZlOGQxMTg5ZjczZjBhYWRhYV83Ni9mcmFnOmRhYjdjNTVmNzAwMTRkNjY4ZWI3OWZjYTZkZjIyMDZjL3RhYmxlOmQxZGZlMDFjZjEzOTQ4ZjM4YmI0YTlkNmVhMTU3YjQ5L3RhYmxlcmFuZ2U6ZDFkZmUwMWNmMTM5NDhmMzhiYjRhOWQ2ZWExNTdiNDlfNC03LTEtMS0xNDQ4_f72f21b1-b27c-4066-8ea6-4b5d3f1db01f"
      unitRef="usd">6226000</us-gaap:GrossProfit>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471186872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 20, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MIMEDX GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2792552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1775 West Oak Commons Ct NE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marietta<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-9100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDXG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,144,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001376339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470737496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 90,607<span></span>
</td>
<td class="nump">$ 95,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">36,536<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">11,196<span></span>
</td>
<td class="nump">10,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses</a></td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">5,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">10,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">860<span></span>
</td>
<td class="nump">3,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">141,902<span></span>
</td>
<td class="nump">160,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">9,856<span></span>
</td>
<td class="nump">11,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">2,899<span></span>
</td>
<td class="nump">3,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">19,976<span></span>
</td>
<td class="nump">19,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">5,620<span></span>
</td>
<td class="nump">6,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">180,523<span></span>
</td>
<td class="nump">202,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,881<span></span>
</td>
<td class="nump">8,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">19,475<span></span>
</td>
<td class="nump">18,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">13,692<span></span>
</td>
<td class="nump">30,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">41,746<span></span>
</td>
<td class="nump">59,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt, net</a></td>
<td class="nump">48,015<span></span>
</td>
<td class="nump">47,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">4,076<span></span>
</td>
<td class="nump">3,755<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">93,837<span></span>
</td>
<td class="nump">110,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">92,494<span></span>
</td>
<td class="nump">91,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,926,898 outstanding at September&#160;30, 2021 and 112,703,926 issued and 110,930,243 outstanding at December&#160;31, 2020</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">162,003<span></span>
</td>
<td class="nump">158,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost; 777,028 shares at September&#160;30, 2021 and 1,773,683 shares at December&#160;31, 2020</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">(7,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(163,924)<span></span>
</td>
<td class="num">(151,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(5,808)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</a></td>
<td class="nump">$ 180,523<span></span>
</td>
<td class="nump">$ 202,032<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease And Financing Lease, Right-Of-Use-Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955475244232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series B convertible preferred stock par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Series B convertible preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Series B convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">187,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,926,898<span></span>
</td>
<td class="nump">110,930,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">777,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,773,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470090408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 63,074<span></span>
</td>
<td class="nump">$ 64,303<span></span>
</td>
<td class="nump">$ 191,206<span></span>
</td>
<td class="nump">$ 179,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">10,129<span></span>
</td>
<td class="nump">10,289<span></span>
</td>
<td class="nump">32,530<span></span>
</td>
<td class="nump">28,513<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">52,945<span></span>
</td>
<td class="nump">54,014<span></span>
</td>
<td class="nump">158,676<span></span>
</td>
<td class="nump">151,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">46,289<span></span>
</td>
<td class="nump">48,046<span></span>
</td>
<td class="nump">145,291<span></span>
</td>
<td class="nump">132,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_InvestigationRestatementandRelated', window );">Investigation, restatement and related</a></td>
<td class="nump">3,170<span></span>
</td>
<td class="nump">12,027<span></span>
</td>
<td class="nump">8,304<span></span>
</td>
<td class="nump">39,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,368<span></span>
</td>
<td class="nump">3,372<span></span>
</td>
<td class="nump">12,770<span></span>
</td>
<td class="nump">8,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(1,075)<span></span>
</td>
<td class="num">(9,707)<span></span>
</td>
<td class="num">(8,336)<span></span>
</td>
<td class="num">(29,307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,201)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(1,472)<span></span>
</td>
<td class="num">(3,806)<span></span>
</td>
<td class="num">(6,433)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax provision</a></td>
<td class="num">(2,038)<span></span>
</td>
<td class="num">(19,379)<span></span>
</td>
<td class="num">(12,145)<span></span>
</td>
<td class="num">(43,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (expense) benefit</a></td>
<td class="num">(301)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="nump">11,239<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,339)<span></span>
</td>
<td class="num">(19,417)<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
<td class="num">(32,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common shareholders (Note 9)</a></td>
<td class="num">$ (3,913)<span></span>
</td>
<td class="num">$ (51,982)<span></span>
</td>
<td class="num">$ (17,039)<span></span>
</td>
<td class="num">$ (65,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_InvestigationRestatementandRelated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investigation, Restatement and Related</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_InvestigationRestatementandRelated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470166984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Revision of Prior Period, Adjustment</div></th>
<th class="th"><div>Common Stock Issued</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Treasury Stock </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,885,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 34,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 147,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,806)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (102,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Convertible Preferred Stock</a></td>
<td class="nump">32,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="num">(31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">11,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(265,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(328,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(2,409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,704)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,112,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2020</a></td>
<td class="nump">12,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,844)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,412,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Jun. 30, 2020</a></td>
<td class="nump">22,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">151,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Convertible Preferred Stock</a></td>
<td class="nump">32,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="num">(31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">8,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(328,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(19,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,417)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,112,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2020</a></td>
<td class="nump">$ 12,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,844)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,773,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2020</a></td>
<td class="num">$ (150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of out-of-period error (Note 1) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">821,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2021</a></td>
<td class="num">$ (7,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161,585)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,773,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2020</a></td>
<td class="num">$ (150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of out-of-period error (Note 1) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TreasuryStockSharesAdjustment', window );">Correction of out-of-period error (Note 1) (in shares) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="num">(926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">11,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="num">(524,171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(482,361)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(810,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(4,751)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,751)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Sep. 30, 2021</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2021</a></td>
<td class="num">$ (5,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">162,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,924)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">821,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Jun. 30, 2021</a></td>
<td class="num">(7,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">158,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161,585)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">3,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,032)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,339)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Sep. 30, 2021</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Sep. 30, 2021</a></td>
<td class="num">$ (5,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 162,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (163,924)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TreasuryStockSharesAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TreasuryStockSharesAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471652360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,500)<span></span>
</td>
<td class="num">$ (32,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">11,115<span></span>
</td>
<td class="nump">11,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3,390<span></span>
</td>
<td class="nump">4,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expenses</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of asset retirement obligation</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on fixed asset disposal</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash resulting from changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,113)<span></span>
</td>
<td class="num">(715)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(835)<span></span>
</td>
<td class="num">(1,919)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">3,527<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes</a></td>
<td class="nump">9,420<span></span>
</td>
<td class="num">(10,835)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">1,990<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(828)<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued compensation</a></td>
<td class="nump">2,085<span></span>
</td>
<td class="num">(2,775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(16,768)<span></span>
</td>
<td class="num">(4,835)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(840)<span></span>
</td>
<td class="num">(840)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows provided by (used in) operating activities</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="num">(19,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash&#160;flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Purchases of equipment</a></td>
<td class="num">(2,893)<span></span>
</td>
<td class="num">(2,073)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Principal payments from note receivable</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_PaymentsforApplicationCostsPatent', window );">Patent application costs</a></td>
<td class="num">(263)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(2,282)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Stock repurchased for tax withholdings on vesting of restricted stock</a></td>
<td class="num">(4,751)<span></span>
</td>
<td class="num">(2,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance lease</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,782)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Repayment of term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(83,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes', window );">Proceeds from term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ProceedsfromIssuanceofTemporaryEquity', window );">Proceeds from sale of Series B convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Prepayment premium on early repayment of term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,439)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows (used in) provided by financing activities</a></td>
<td class="num">(3,374)<span></span>
</td>
<td class="nump">62,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="num">(5,205)<span></span>
</td>
<td class="nump">40,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">95,812<span></span>
</td>
<td class="nump">69,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 90,607<span></span>
</td>
<td class="nump">$ 109,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_PaymentsforApplicationCostsPatent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Application Costs, Patent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_PaymentsforApplicationCostsPatent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ProceedsfromIssuanceofTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance of Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ProceedsfromIssuanceofTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467919992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#174; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model is focused primarily on the United States of America, but the Company is pursuing opportunities for international expansion.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enforcement Discretion</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA exercised enforcement discretion with respect to Investigational New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products in the United States and is precluded from marketing such products until a Biologics License Application (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is granted. If and when the FDA approves a BLA, the Company expects to be allowed to market its Section 351 products in the United States, but only for specific indications as permitted by the FDA. Sales of the Company&#8217;s Section 351 products were $0.5 million and $8.2 million for the three months ended September&#160;30, 2021 and 2020, respectively, and $17.2 million and $23.1 million for the nine months ended September&#160;30, 2021 and 2020, respectively. Sales of Section 351 product during the three months ended September&#160;30, 2021 were derived from sales outside of the United States of America..</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently markets EPICORD&#174; and AMNIOCOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D&#174; tissue products derived from human umbilical cord as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#8217;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#8217;s revenue, business, financial condition, and results of operations. Net sales of the Company&#8217;s umbilical cord-derived products were $6.2 million and $4.2 million for the three months ended September&#160;30, 2021 and 2020, respectively, and $17.1 million and $11.4 million for the nine months ended September&#160;30, 2021 and 2020, respectively. The Company&#8217;s cord inventory, which would be at risk for write-down in the case of such a determination, was $1.5 million as of September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-of-Period Adjustment</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#8217;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#8217;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#8217;s reported consolidated balance sheets and consolidated statements of stockholders&#8217; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#8217; (deficit) equity or earnings per share in any period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an out-of-period adjustment during the nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which resulted in a decrease of $2.0 million to the balance of additional paid-in capital for the nine months ended September&#160;30, 2020, respectively, and an increase of $2.0&#160;million to the balance of treasury stock during those same periods.</span></div>The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469864664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Note 2 to the Company&#8217;s Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for a description of all significant accounting policies.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and nine months ended September&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion and other regulatory factors with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020. As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded no impairment.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, this ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under Accounting Standards Codification (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</span></div><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of September&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the nine months ended September 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469760680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndNontradeReceivableTextBlock', window );">Accounts and Nontrade Receivable</a></td>
<td class="text">Accounts Receivable, Net<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndNontradeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI http://asc.fasb.org/topic&amp;trid=2196771<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -URI http://asc.fasb.org/topic&amp;trid=82887179<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndNontradeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469882520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the conclusion of the FDA&#8217;s period of Enforcement Discretion on May 31, 2021, the Company wrote down $1.0 million of its Section 351 product inventory during the nine months ended September&#160;30, 2021. In addition, during the three and nine months ended September&#160;30, 2021, the Company reserved $0.5&#160;million and $0.7 million, respectively, for inventory related to product lines which have been discontinued. These amounts are included as part of cost of sales on the unaudited condensed consolidated statements of operations for those period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467840664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for each of the three and nine months ended September&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is allocated amongst cost of sales, research and development expense, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469046792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know-how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,957)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Intangible Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in Process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and nine months ended September 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of September&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469760680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:53.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accrual for settlement costs, which was presented separately in previously-issued financial statements, is included as part of legal costs in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467649208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long Term Debt</a></td>
<td class="text">Long Term Debt<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Term Loan Agreement</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), providing  the Company with a senior secured term loan in an aggregate amount of $50 million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hayfin Loan Agreement also provided the Company an option to draw on an additional delayed draw term loan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD TL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively with the Term Loan, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the form of a committed but undrawn facility until June 30, 2021. The Company did not exercise the option.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#8217;s Series B Convertible Preferred Stock (as defined and described in Note 10, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in an aggregate amount of up to $100 million (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in order to:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Refinancing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the lenders thereunder and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). If LIBOR is unavailable, the Term Loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%. The Margin is eligible for a reduction depending on the Company&#8217;s Total Net Leverage Ratio  (as defined in the Hayfin Loan Agreement) for the quarter; as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.5% per annum if the Total Net Leverage Ratio is less than 2.0x but greater than or equal to 1.0x, or</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional 3.0% margin is applied to the interest rate in the event of a default as defined by the Hayfin Loan Agreement. At issuance and as of September&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain financial covenants (as defined in the Hayfin Loan Agreement) requiring the Company, on a consolidated basis, to maintain the following:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Maximum Total Net Leverage Ratio of 4.0x, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Minimum Liquidity of $10 million, an at-all-times financial covenant tested monthly.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before July 2, 2022: 2% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2022 and on or before July 2, 2023: 1% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After July 2, 2023: 0% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. Mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event (as defined in the Hayfin Loan Agreement). Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Company&#8217;s Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. No such prepayments have been required as of September 30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayfin maintains a first-priority security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock (described below in Note 10) and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"/><td style="width:24.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of September&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of 1% per annum of the amount undrawn, which is recognized as interest expense.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of September&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:33.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"/><td style="width:33.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.774%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">`</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:34.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of principal payments due on the Term Loan, by year, from September&#160;30, 2021 through maturity are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of September&#160;30, 2021, the fair value of the Term Loan was determined to be $51.3&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. The remaining cash flows associated with the Term Loan were discounted to September&#160;30, 2021 using this discount rate<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469370744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text">Net Loss Per Common Share<div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per common share is calculated using two methods: basic and diluted.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#8217;s Series B Convertible Preferred Stock during the period, (ii) periodic amortization of the beneficial conversion feature, and (iii) periodic accretion of the increasing-rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and nine months ended September&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net loss available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of beneficial conversion feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#8217;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back periodic accrued or deemed dividends on the </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s Series B Convertible Preferred Stock, and assumes conversion as of the later of the beginning of the period and the original transaction date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive or does not reduce net loss per common share, the effect is excluded from the calculation.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,032,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,027,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,691,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,032,820&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469375224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Convertible Preferred Stock of the Company (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends, if declared, are paid in cash at the end of each quarter based on dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into the Company&#8217;s common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date (July 2, 2023 for the 100,000 shares currently outstanding), provided that the common stock has traded at 200% or more of the conversion price for 20 out of the preceding 30 consecutive trading days and on the trading date immediately prior to the date of conversion, the common stock traded at 200% or more of the conversion price.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect two members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#8217;s shareholders on an as-converted basis as a single class with the common stock not to exceed 19.9% of the total voting stock of the Company. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $1.8 million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and nine months ended September&#160;30, 2021, the Company recognized $0 and $0.9 million of deemed dividends related to the amortization of the increasing rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends, into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#8217;s control, the Series B Preferred Stock is classified as temporary equity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"><tr><td style="width:1.0%"/><td style="width:48.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.529%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends accumulated but not paid as of September&#160;30, 2021 was $5.6 million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of September&#160;30, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on accumulated dividends as of September&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of 27,435,993 shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued several classes of restricted stock awards to employees: restricted stock (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), restricted stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and performance stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The following is summary information for restricted stock awards for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, there was $28.2&#160;million of unrecognized share-based compensation expense related to restricted stock awards. This expense is expected to be recognized over a weighted-average period of 2.21 years, which approximates the remaining vesting period of these grants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through September&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of September&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:31.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(975,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,288,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the nine months ended September 30, 2021 is presented below:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:48.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469370744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (14.8)% and (0.2)% for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (2.9)% and 25.6%, for the nine months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $0 and $11.4 million for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. The discrete items recorded for the nine months ended September&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount.  No benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467672440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</a></td>
<td class="text">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467881400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contractual Commitments and Contingencies</a></td>
<td class="text">Contractual Commitments and Contingencies<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#8217;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reasonably estimated. The Company's unaudited condensed consolidated financial statements as of September&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#8217;s legal proceedings, refer to Note 14, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company has accrued $4.0 million related to the legal proceedings. The Company paid, either directly or through its insurance providers, $7.7 million toward the resolution of legal matters involving the Company during the nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company received funds from certain director and officer insurance policies for previously-incurred, covered legal expenses. These funds were recognized as a reduction to investigation, restatement, and related expense during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain litigation and regulatory matters:</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating two purported securities class actions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MacPhee v. MiMedx Group, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 23, 2018 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Kline v. MiMedx Group, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">CPFI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#8220;Pete&#8221; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp; Holland LLP. The amended complaint (the &#8220;Securities Class Action Complaint&#8221;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#8217; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#8217;s motions and the hearing on the same was held on September 24, 2021. The Court has not yet ruled on the motions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Investigations</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Defense Office of Inspector General Investigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#8217;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#8217;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#8217;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Former Employee Litigation and Related Matters</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MiMedx Group, Inc. v. Petit, et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against its former CEO, Parker H. &#8220;Pete&#8221; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#8217;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#8217;s legal expenses. The Company opposed Petit and Taylor&#8217;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation was held on August 11, 2021. Negotiations are ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defamation Claims</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2018, Sparrow Fund Management, LP (&#8220;Sparrow&#8221;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#8217; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#8217;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#8217;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#8217;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#8217;s business, results of operations, financial position or liquidity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467672440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Product</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has two primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its tissue and cord sheet allograft products, and (2) Section 351 products, consisting of the Company&#8217;s micronized and particulate products, which, prior to the end of Enforcement Discretion were used to treat a variety of patient needs, including both advanced wound care and musculoskeletal applications. Advanced Wound Care is further disaggregated between the Company&#8217;s Tissue/Other and Cord products.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;O</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">ther&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Customer</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has two primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (2) sales through distributors (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:24.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or nine months ended September&#160;30, 2021 or 2020.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collections on the Remaining Contracts</span></div><div style="margin-bottom:9pt;margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469081688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsNone noted.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955466357128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and nine months ended September&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion and other regulatory factors with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div>Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, this ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under Accounting Standards Codification (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Topic 815 and removing the requirement to account for beneficial conversion features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</span></div><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of September&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the nine months ended September 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Collections on the Remaining Contracts</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collections on the Remaining Contracts</span></div><div style="margin-bottom:9pt;margin-top:13.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955573365016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467657656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467833688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleOfDepreciationTableTextBlock', window );">Schedule of Depreciation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for each of the three and nine months ended September&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleOfDepreciationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleOfDepreciationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955466363928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets Activity Summary - Indefinite-lived</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know-how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,957)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Intangible Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in Process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets Activity Summary - Finite-lived</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know-how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,957)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Intangible Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in Process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and nine months ended September 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Future Amortization Expense for Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of September&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955466759992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:53.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955474070040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock', window );">Schedule of Debt Issuance Costs</a></td>
<td class="text">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"/><td style="width:24.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of September&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:33.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleofInterestExpenseTableTextBlock', window );">Schedule of Interest Expense</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"/><td style="width:33.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.774%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">`</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:34.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Future Principal Payments for the Term Loan</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of principal payments due on the Term Loan, by year, from September&#160;30, 2021 through maturity are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the nine months ended September&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Issuance Costs [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleofDebtIssuanceCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleofInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Interest Expense [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleofInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955557894936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Basic</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and nine months ended September&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net loss available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of beneficial conversion feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,982)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,032,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,717,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,493,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,136,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,222,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,027,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,691,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,032,820&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The effect of each of these adjustments on the calculation is presented in the table below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,027,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,691,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,625,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,032,820&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on basic earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955469409544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Series B Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the nine months ended September&#160;30, 2020 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"><tr><td style="width:1.0%"/><td style="width:48.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.529%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Awards by Award Type</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through September&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of September&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of September&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:31.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(975,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,288,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Activity</a></td>
<td class="text">A summary of stock option activity for the nine months ended September 30, 2021 is presented below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:48.160%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467965608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471003576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;O</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">ther&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:24.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,303&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Assessment of Revenue under ASC 606</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470105496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 63,074<span></span>
</td>
<td class="nump">$ 64,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,206<span></span>
</td>
<td class="nump">$ 179,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">11,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember', window );">Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital | Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock | Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">8,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
<td class="nump">23,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember', window );">Cord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">$ 4,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,093<span></span>
</td>
<td class="nump">$ 11,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467934216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955474806920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">$ 37,403<span></span>
</td>
<td class="nump">$ 36,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(867)<span></span>
</td>
<td class="num">(737)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 36,536<span></span>
</td>
<td class="nump">$ 35,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550150808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">6,064<span></span>
</td>
<td class="nump">6,064<span></span>
</td>
<td class="nump">4,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">4,716<span></span>
</td>
<td class="nump">4,716<span></span>
</td>
<td class="nump">5,731<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">11,196<span></span>
</td>
<td class="nump">11,196<span></span>
</td>
<td class="nump">$ 10,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471106632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance lease assets</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">41,932<span></span>
</td>
<td class="nump">40,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation</a></td>
<td class="num">(32,076)<span></span>
</td>
<td class="num">(29,498)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">9,856<span></span>
</td>
<td class="nump">11,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,745<span></span>
</td>
<td class="nump">6,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory and clean room equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">16,497<span></span>
</td>
<td class="nump">15,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">14,944<span></span>
</td>
<td class="nump">15,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">3,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember', window );">Asset retirement cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 880<span></span>
</td>
<td class="nump">$ 785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467716472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Depreciation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="nump">$ 3,390<span></span>
</td>
<td class="nump">$ 4,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470770648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Activity Summary (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 11,343<span></span>
</td>
<td class="nump">$ 11,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,957)<span></span>
</td>
<td class="num">(7,334)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,386<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">5,620<span></span>
</td>
<td class="nump">6,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross carrying amount</a></td>
<td class="nump">13,577<span></span>
</td>
<td class="nump">13,338<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net carrying amount</a></td>
<td class="nump">5,620<span></span>
</td>
<td class="nump">6,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Tradenames and trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember', window );">Patents in Process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents and know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">9,568<span></span>
</td>
<td class="nump">9,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,238)<span></span>
</td>
<td class="num">(5,730)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">3,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,414)<span></span>
</td>
<td class="num">(1,334)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember', window );">Customer and supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955467727160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955560590696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2021 (excluding the nine months ended September 30, 2021)</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,386<span></span>
</td>
<td class="nump">$ 3,951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955551094856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Legal costs</a></td>
<td class="nump">$ 8,102<span></span>
</td>
<td class="nump">$ 24,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions to sales agents</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Estimated returns</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AccruedClinicalTrialsCurrent', window );">Accrued clinical trials</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Accrued GPO fees</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AccruedRebates', window );">Accrued rebates</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 13,692<span></span>
</td>
<td class="nump">$ 30,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AccruedClinicalTrialsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Trials, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AccruedClinicalTrialsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AccruedRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AccruedRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471044952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Term Loan (Details) - Term loan<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 02, 2023</div></th>
<th class="th"><div>Jul. 02, 2022</div></th>
<th class="th"><div>Jul. 02, 2025</div></th>
<th class="th"><div>Jul. 02, 2025</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal issued</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentInterestRateFloorPercentage', window );">Debt instrument, interest rate, floor (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentDefaultInterestRate', window );">Default interest rate (percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate at issuance (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Financing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal issued</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtCovenantMinimumLiquidity', window );">Debt covenant, minimum liquidity</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="nump">$ 3,253,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage', window );">Additional commitment fee (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">BT Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of the Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCovenantNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCovenantNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent', window );">Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Hayfin Loan Agreement Term Loan | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCovenantNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Hayfin Loan Agreement Term Loan | Fed Funds Effective Rate Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCovenantNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtCovenantMinimumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Minimum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtCovenantMinimumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentCovenantNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentCovenantNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentDefaultInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Default Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentDefaultInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentInterestRateFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Floor Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentInterestRateFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unused Capacity, Commitment Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_FinancingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_FinancingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471609720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Debt Issuance Costs (Details) - Term loan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 02, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long term debt | Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets | Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,084<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955475117032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(1,721)<span></span>
</td>
<td class="num">(1,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 48,015<span></span>
</td>
<td class="nump">$ 47,697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550286024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Interest Expense (Details) - Term loan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Stated interest</a></td>
<td class="nump">$ 1,054<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="nump">$ 3,116<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of original issue discount</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">1,164<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">3,434<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCommitmentFees', window );">Commitment fee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of original issue discount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 751<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentCommitmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Commitment Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentCommitmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955466037992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021 (excluding the nine months ended September&#160;30, 2021)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471078472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Basic Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,339)<span></span>
</td>
<td class="num">$ (19,417)<span></span>
</td>
<td class="num">$ (12,500)<span></span>
</td>
<td class="num">$ (32,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Adjustments to reconcile to net loss available to common stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Accumulated dividend on Series B Convertible Preferred Stock</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="nump">3,613<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization', window );">Amortization of beneficial conversion feature</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,110<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature', window );">Accretion of increasing-rate dividend feature</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders', window );">Total adjustments</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">32,565<span></span>
</td>
<td class="nump">4,539<span></span>
</td>
<td class="nump">32,565<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
<td class="num">$ (3,913)<span></span>
</td>
<td class="num">$ (51,982)<span></span>
</td>
<td class="num">$ (17,039)<span></span>
</td>
<td class="num">$ (65,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Beneficial Conversion Feature, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accreted but Unrecorded Dividends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretedbutUnrecordedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accretion of Increasing-rate Dividend Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550446328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
<td class="num">$ (3,913)<span></span>
</td>
<td class="num">$ (51,982)<span></span>
</td>
<td class="num">$ (17,039)<span></span>
</td>
<td class="num">$ (65,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders', window );">Dividends on Series B Convertible Preferred Stock</a></td>
<td class="nump">$ 1,574<span></span>
</td>
<td class="nump">$ 32,565<span></span>
</td>
<td class="nump">$ 4,539<span></span>
</td>
<td class="nump">$ 32,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">30,658,193<span></span>
</td>
<td class="nump">28,625,684<span></span>
</td>
<td class="nump">30,185,813<span></span>
</td>
<td class="nump">11,032,820<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding adjusted for potential common shares</a></td>
<td class="nump">110,717,073<span></span>
</td>
<td class="nump">108,493,208<span></span>
</td>
<td class="nump">110,136,517<span></span>
</td>
<td class="nump">108,222,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per common share (in dollars per share)</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">30,658,193<span></span>
</td>
<td class="nump">28,625,684<span></span>
</td>
<td class="nump">30,185,813<span></span>
</td>
<td class="nump">11,032,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">27,027,252<span></span>
</td>
<td class="nump">25,691,700<span></span>
</td>
<td class="nump">26,497,570<span></span>
</td>
<td class="nump">8,626,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">27,027,252<span></span>
</td>
<td class="nump">25,691,700<span></span>
</td>
<td class="nump">26,497,570<span></span>
</td>
<td class="nump">8,626,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">974,687<span></span>
</td>
<td class="nump">1,203,853<span></span>
</td>
<td class="nump">1,287,635<span></span>
</td>
<td class="nump">1,281,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">974,687<span></span>
</td>
<td class="nump">1,203,853<span></span>
</td>
<td class="nump">1,287,635<span></span>
</td>
<td class="nump">1,281,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">1,840,483<span></span>
</td>
<td class="nump">919,233<span></span>
</td>
<td class="nump">1,500,674<span></span>
</td>
<td class="nump">359,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,840,483<span></span>
</td>
<td class="nump">919,233<span></span>
</td>
<td class="nump">1,500,674<span></span>
</td>
<td class="nump">359,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">805,437<span></span>
</td>
<td class="nump">772,967<span></span>
</td>
<td class="nump">875,714<span></span>
</td>
<td class="nump">739,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">805,437<span></span>
</td>
<td class="nump">772,967<span></span>
</td>
<td class="nump">875,714<span></span>
</td>
<td class="nump">739,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential common shares</a></td>
<td class="nump">10,334<span></span>
</td>
<td class="nump">37,931<span></span>
</td>
<td class="nump">24,220<span></span>
</td>
<td class="nump">25,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">10,334<span></span>
</td>
<td class="nump">37,931<span></span>
</td>
<td class="nump">24,220<span></span>
</td>
<td class="nump">25,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955551161736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 02, 2020 </div>
<div>USD ($) </div>
<div>day </div>
<div>director </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B convertible preferred stock, shares outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,568)<span></span>
</td>
<td class="num">$ (926)<span></span>
</td>
<td class="num">$ (31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,574<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">3,613<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Outstanding Options, weighted average remaining contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionPricePerShare', window );">Series B preferred stock, conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionRatio', window );">Conversion ratio of Series B preferred stock to common stock</a></td>
<td class="nump">259.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B convertible preferred stock, shares outstanding (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger', window );">Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdTradingDays', window );">Number of trading days within consecutive day trading period common stock must exceed trigger conversion price | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityThresholdConsecutiveTradingDays', window );">Series B preferred stock, threshold number of consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion', window );">Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders', window );">Number of board seats elected by Series B preferred stockholders | director</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis', window );">Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)</a></td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityIncreasingrateDividendFeature', window );">Series B preferred stock, increasing-rate dividend feature</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock | Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityDividendRatePercentage', window );">Series B convertible stock, cumulative dividend (percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock | Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityDividendRatePercentage', window );">Series B convertible stock, cumulative dividend (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B convertible preferred stock, shares outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (31,568)<span></span>
</td>
<td class="num">$ (926)<span></span>
</td>
<td class="num">$ (31,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquitySharesIssueduponConversion', window );">Series B Preferred convertible stock, shares issuable upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,435,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,435,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Board Seats Elected by Temporary Equity Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accreted but Unrecorded Dividends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretedbutUnrecordedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Dividend Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityIncreasingrateDividendFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increasing-rate Dividend Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityIncreasingrateDividendFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquitySharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares Issued upon Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquitySharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550255864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Changes in Series B Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, beginning (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,568<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 31,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, ending (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, ending</a></td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, beginning (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, beginning</a></td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 91,568<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues', window );">Issuance of Series B Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 31,568<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 31,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, ending (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, ending</a></td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="nump">$ 91,108<span></span>
</td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="nump">$ 91,108<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued in Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550790856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Restricted Stock Awards (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">2,175,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(975,259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(66,374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">1,134,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">4.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">3.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">2,325,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2,991,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(775,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(252,486)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">4,288,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">10.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">5.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">8.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">35,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(35,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">7.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550897592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Incentive Plans (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">2,025,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(524,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Unvested options forfeited (in shares)</a></td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Vested options expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">1,451,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable options, vested and expected to vest (in shares)</a></td>
<td class="nump">1,451,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 4.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Unvested options forfeited (in dollars per share)</a></td>
<td class="nump">1.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Vested options expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share)</a></td>
<td class="nump">5.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 5.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">1 year 9 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable (in years)</a></td>
<td class="text">1 year 9 months 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 1,982,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 1,982,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471470104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(14.80%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
<td class="nump">25.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems', window );">Effective income tax rate impact of discrete items</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (expense) benefit</a></td>
<td class="num">(301,000)<span></span>
</td>
<td class="num">$ (38,000)<span></span>
</td>
<td class="num">$ (355,000)<span></span>
</td>
<td class="nump">$ 11,239,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward', window );">Tax benefit recognized with respect to net operating loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember', window );">CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (expense) benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Federal tax refund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470299640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 3,269<span></span>
</td>
<td class="nump">$ 6,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_LeaseRightOfUseAssetAndLiability', window );">Lease right of use asset and liability</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NotesReceivableForSaleOfPropertyAndEquipment', window );">Note receivable for sale of property and equipment</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of equipment in accounts payable</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise', window );">Fair value of non-cash consideration received for option exercise</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityDeemedDividends', window );">Deemed dividends on Series B Convertible Preferred Stock</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">31,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NoncashActivitiesDeferredFinancingCosts', window );">Deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_StockIssuanceCostsIncurred', window );">Stock issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee', window );">Amendment fee on BT Term Loan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value Of Non-Cash Consideration Received For Option Exercise</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_LeaseRightOfUseAssetAndLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right Of Use Asset And Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_LeaseRightOfUseAssetAndLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Activities, Debt Instrument, Amendment Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NoncashActivitiesDebtInstrumentAmendmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NoncashActivitiesDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Activities, Deferred Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NoncashActivitiesDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NotesReceivableForSaleOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable For Sale Of Property And Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NotesReceivableForSaleOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_StockIssuanceCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_StockIssuanceCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityDeemedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Deemed Dividends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityDeemedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955474848472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Commitments and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 16, 2019 </div>
<div>securityClassAction</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ContingencyLossNumberOfSecuritiesClassActions', window );">Number of securities class actions | securityClassAction</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ContingencyLossNumberOfSecuritiesClassActions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingency Loss, Number Of Securities Class Actions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ContingencyLossNumberOfSecuritiesClassActions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955550252376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Revenue by Product Type (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>product</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>product</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NumberOfProducts', window );">Number Of Products | product</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 63,074<span></span>
</td>
<td class="nump">$ 64,303<span></span>
</td>
<td class="nump">$ 191,206<span></span>
</td>
<td class="nump">$ 179,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember', window );">Advanced Wound Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">62,282<span></span>
</td>
<td class="nump">55,069<span></span>
</td>
<td class="nump">173,105<span></span>
</td>
<td class="nump">149,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember', window );">Tissue/Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">56,035<span></span>
</td>
<td class="nump">50,842<span></span>
</td>
<td class="nump">156,012<span></span>
</td>
<td class="nump">137,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember', window );">Cord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">4,227<span></span>
</td>
<td class="nump">17,093<span></span>
</td>
<td class="nump">11,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">8,195<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
<td class="nump">23,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">$ 914<span></span>
</td>
<td class="nump">$ 7,240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955471629080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Revenue by Customer Type (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>distributionChannel</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>distributionChannel</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels', window );">Number of primary distribution channels | distributionChannel</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 63,074<span></span>
</td>
<td class="nump">$ 64,303<span></span>
</td>
<td class="nump">$ 191,206<span></span>
</td>
<td class="nump">$ 179,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels', window );">Number of primary distribution channels | distributionChannel</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 61,087<span></span>
</td>
<td class="nump">62,409<span></span>
</td>
<td class="nump">$ 184,706<span></span>
</td>
<td class="nump">175,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,987<span></span>
</td>
<td class="nump">$ 1,894<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="nump">$ 4,626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Number Of Distribution Channels</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139955470710984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Collections on Remaining Contracts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 63,074<span></span>
</td>
<td class="nump">$ 64,303<span></span>
</td>
<td class="nump">$ 191,206<span></span>
</td>
<td class="nump">$ 179,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">10,129<span></span>
</td>
<td class="nump">10,289<span></span>
</td>
<td class="nump">32,530<span></span>
</td>
<td class="nump">28,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">52,945<span></span>
</td>
<td class="nump">54,014<span></span>
</td>
<td class="nump">158,676<span></span>
</td>
<td class="nump">151,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=mdxg_RevenueGuidanceTopic606TransitionPeriodMember', window );">Revenue Guidance Topic 606 Transition Period | Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">914<span></span>
</td>
<td class="nump">7,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">$ 261<span></span>
</td>
<td class="nump">$ 893<span></span>
</td>
<td class="nump">$ 786<span></span>
</td>
<td class="nump">$ 6,226<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=mdxg_RevenueGuidanceTopic606TransitionPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=mdxg_RevenueGuidanceTopic606TransitionPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>71
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M).':0#U?,R9?)KKCR%O2_D]02P,$%     @ I85B4\/'J,0L!@  :!D  !@
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MAP]EMJM_[_LQ*\ML4[]=R42)K@J@_GZ;9>6W#]5/B \_K+_X'U!+ P04
M" "EA6)3[7QL '4'  #G'@  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;)V9;6_;.!+'OPKA6QQ:8%U+I&1)O21 'EIL@;8)ZN[M:UFB8UXET4O2>;A/
M?T-),1WQP>WU12/)0^K/X<S\2.KLD8L?<DNI0D]MT\GSV5:IW?O%0E9;VI;R
M'=_1#G[9<-&6"F[%_4+N!"WKOE';+' 4+1=MR;K9Q5G_[$Y<G/&]:EA'[P22
M^[8MQ?,5;?CC^2R>O3SXQNZW2C]87)SMRGNZHNK/W9V N\6AEYJUM).,=TC0
MS?GL,GY_G1#=H+?X-Z./\N@:Z:&L.?^A;S[5Y[-(*Z(-K93NHH0_#_2:-HWN
M"73\/78Z.[Q3-SR^?NG]8S]X&,RZE/2:-W^Q6FW/9_D,U713[AOUC3_^0<<!
MI;J_BC>R_Q\]CK;1#%5[J7@[-@8%+>N&O^73Z(BC!M"/NP$>&^!I@\33@(P-
M>L\M!F7]L&Y*55Z<"?Z(A+:&WO1%[YN^-8R&=7H:5TK KPS:J8OKVZ\W'[ZN
M/MP@N%K=?OYT<_D=;E;?X<^7#U^_K]#M1W1]N?H#??Q\^]<*S=&?JQOTYK>W
MZ#?$.O1]R_>R[&IYME"@1O>YJ,8W7PUOQIXW%^@+[]16H@]=3>O7[1<PBL-0
M\,M0KG"PPQ7=O4,D^AWA",<./=<_WSP*R"$'SY*^/^+S;"FW: -I(M%&\!9!
MYHE2L>Y^"%VF&)7O ^])#N])^O<DGO=\A5QON'3.P-!RV;?4"?UP,8]Q&L'P
M'HX=XS C.(N2@]DK8>E!6!ITP&7]'XA?2'DED>*0\Q7O*M90U(V*]5-]71E/
M[01_8! .:/V,WNPE7+#N[2^[;GE0N RZ;K4M!9WK*E"CBK=0&F6IBXO+E4-/
MZ9&/8OB73CSILDI2['9D=I"9!67>4*C0%?-*RZR7$E),Y]@V2I+",\/Y05@>
M%';9<J'8?WMAB&]@KE39W;,US'$I)57.F,PM(<LDFXBU;?(X=VLM#EJ+7](*
MI9X* 1._85T)<0G!57'IEEQ8<HJ$3"3;-G$>QV[-<62J<Q1.;M[-^_1H*$0I
MHD\Z1JF[VD:6@@PG$Y4NH\@3GO$10^*P;ZM*T!?']C./]+V@.OD17S?LWAN\
M8]?'BM)I.#AL(H]F;#3CH.;/N@"!X@U[@B 81-=,[K@L&Z=.;&G 9#D5:AOY
MA!J,Q.2GA-(G70'W3&X'K^H07BNG5!)0,0JU37(<^<+5H"A.@B7_4P>!H /U
M34V'J[=ZE=!'L* 2EE8ZSWH<5ELH%53"SZ%*'AO8Q.FI&.1[C1HHE90]E%"$
MG+Y)K8'/H8Y/L]EEEAU5^]<B#6_B,' ^=0\P=UP\.Z79\)CG9$H8EU5<Q(5'
MFF%,'(;,G:"[DM7A$N,@38JM;+6MTCC+/ (-:^(P;""V>$N1*I\\XFQH% FV
M M^VFL?1L9M?RS-XB<-\N55;*@+8BQV *"Q*NZR6A+C%88,1',;((3EVY;,O
M,["-AGF.\XE AQ4L-CSZ#$#P:8#L?V(1AFT0X"B?IHC#:HZSS#/%V" #AY'Q
MHC*4(M@FP#Q>9DO+CPZ[Q!N&V- "AVDQA&'#RC5K^G6R4Z1=_>=Y,HW%4U:O
M%1I&X-/[E?]KQ>\<26+G"VQPIB.QK:!F%L72,Q8#'1S>XN@]WC__$2^C?QUM
M]!@4>?D+NQ5L\('#^+C;"\ F1)ZF/_U[SW9Z*>#TBX,2."^FF'.:19FOWAB8
MX%,P8;"DWI6-+CC##K!W3<<5/0%H;-,CLQ+<MO&%I<$+#N/EKE1Z657N=@VK
MAEV"=S^ '1#!2\NY+JO(5RL-:' 8-)/\&5/&&75.[39AYB3*XZEXAQG&N6>K
M0 R)2/1+IR)F]_5SR4(,4TB8*7>"5Y36XWOH$Q45@Y4I9(Y4O/H!)49/LM-'
MQ 9(G$33O93#BF2>."0&,B0,F54O#A9C8Z[#!I4+O>I!CTQMM[RIP5G]AN!E
MOF%$L+96@E4*K/O!.0?E(DZ63B?>98837]B2H].P,)@<):'??>GII\/VUJG:
M 2%KQ>DP\LV#P10)8^K&?3[@U&CC94H@APD,PYM.!D DO.OY1D=OZBA05+2H
MX:4GJ.TMC:72L>O)29[Y9!IPD1/@>I6+)W3:3+)TVB9I<7RL^5JFP18YA:UC
MF;)L^G*QH@**$KJ"^8<:*U1_OK43+_'A3[@0I<:!V"9QI/]Y1F)H1L(T&ZH(
MDW+?IY>79,1FE*71@;%ENO0<'1+#,1+F6+_A'&(7G-FR?=N?<I2B>4;"&=;.
M =B<L@;@0%F<^#8MB4%9<N)L[C6(S>+U>$GKXIOSI-ZQ^R(DFS+'8;;$N>^D
M/C&P3,*P[,?2G\B\G-<X13HV5BF.ILLSAUD2I=BSVDX,&I,P&ONU0]G5@]?U
M^O<!4A1(\CM:TWO6=2,-8>_ >.T<@ VW(LUC/!V ;;8LHJ4O8@P#DS # P.@
M\#0LG5@?:4!2-$6APRR."JB.$^V+HT^&+17W_9=4B?IC@N&3V^'IX6OM9?^-
M<O+\*GY_/7QS-=T,GX"_E (F10+;-]!E]"X#?XKAJ^IPH_BN_S"YYDKQMK_<
MTK*F0AO [QL.VX7Q1K_@\&W[XG]02P,$%     @ I85B4U'Z]T2K"0  U!@
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MUHAZ)$<HNI"K62F,MHQ)=D&J-AEV7:V"=XB@\VZ?#*.-:]\Z#;$T+\FAVK)
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M%Z^D7-KQ.-G7N3SUKH C$7KB.3)42<RFR>"@[CN16#_U9)SGW#;O4/YN'6\
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MJ)T#G1=*V?W&)1CNU_5?4$L#!!0    ( *6%8E/-H#T56P,  #4'   9
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M+IY[9Z*3Q[Q#W?B19<@@965XUZ?3:2I>#</@A_@P4C\PW7!IJ.9WI!I?S(L
M]#"FAHU5>S\:MLK2H/&?+4UVU$Z [G=*V>/&.9C^*ZS_ 5!+ P04    " "E
MA6)3-U854 @$  "]"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RM
M%FMOVS;PKQRT8G  -WK;<F8;<)*N*[ &09-N&(9]H*6S340259*JT_[ZW5&R
MX[R, ML'B<=[W_'NR.E6Z3NS0;1P7Y6UF7D;:YLSWS?Y!BMA3E6#-5%62E?"
MTE:O?=-H%(43JDH_"H*17PE9>_.IPUWK^52UMI0U7FLP;54)_>T<2[6=>:&W
M0WR2ZXUEA#^?-F*--V@_-]>:=OY>2R$KK(U4-6A<S;Q%>':>,+]C^$/BUAS
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M]SM:;\#ZVA@Z7WR \1]C\S=02P,$%     @ I85B4]Y\%?<P#   HR4  !D
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MV4C8]@+>OGA3ATLO!GB03WC$@0I^9 %\WQKC^Q?>X/!?D,?? 5!+ P04
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M9^4<Q8'17Y5A1/$"*0@WOHTY7-[9'R>E73GI>9>3GN_,*!=]R0Q?GG5'/M
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MJ;*D4V^6]#"B=@%T7BBZ^F[C"O1/[>H?4$L#!!0    ( *6%8E.ZP"V.9@(
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MUE+@ND(+\'RA8>0XH /6'X2._@%02P,$%     @ I85B4XA T8#V!   8Q
M !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULS5AM;]LV$/XK!Z\88D"3
M]6+94IH8<-IN:X&N0=R7#\,^T-+9(BJ)*DG%R7[]CI2M>*FLM<#6]4M$TKSG
MGCL^QY=<[(3\J')$#7=E4:G+4:YU?3Z9J#3'DBE7U%C1+QLA2Z:I*[<354MD
MF34JBTG@>;-)R7@U6ES8L6NYN!"-+GB%UQ)44Y9,WE]A(7:7(W]T&+CAVUR;
M@<GBHF9;7*%^5U]+ZDTZE(R76"DN*I"XN1PM_?.KF9EO)[SGN%-';3"1K(7X
M:#HOL\N19PAA@:DV"(P^M_@,B\( $8U/>\Q1Y](8'K</Z#_;V"F6-5/X3!0?
M>*;SRU$\@@PWK"GTC=C]BOMX(H.7BD+9O[!KYTZ3$:2-TJ+<&Q.#DE?ME]WM
M\W!D$'LG#(*]06!YMXXLR^=,L\6%%#N09C:AF88-U5H3.5Z915EI2;]RLM.+
M%Y\:KN]A_SE[R]8%JO'%1!.VF3%)]SA7+4YP B>!UZ+2N8(758;9W^TGQ*DC
M%AR(706#@"NL70@]!P(O\ ?PPB[0T.*%PX'^OEPK+4D+?PQ@3CO,J<6<GN)(
M)9(U!8+8P HE1P57<$VR0BDQ@Y46Z<>^5 ZBFC(\5S5+\7)$=:90WN)H\39'
M6)L2 FV6"'A1-"8033[3G%5;^O(*-$U[)LJ:5?<__A '_ORI(M$6K$H'20)5
MM[75N42$LEU*-$M)-K7&<HVR6PTXLYY$HUB5*0?P+J4YH'(F$5@IFDJK\?EI
M9RLS4<'2SH2K/3VFX553X8,7W_,<S_/@"22!,TVF\!RQ))",W_*,N"FP(09/
MN^\15 _KS_"^HYQZWR2G7I>I)UWKI5+-/X9R2%V4.-'4.[T0H>]$LWAP';SC
M=? =WXN_U3I45&?_F[2?8[KWY/>EP63M9%:38/:=2OL+4OK?*?M12OWD^U3W
MP#D3=>=,-'S.M#<F$\0-TC+R5'?DESLFB>/ZOFW!V_L:^\Z<00]?=N:T%S?^
M)R717J;,>4J4FNJ62!$A^<!-66ZLXV9;H(D;;*0HX16K&A.1OQ<P[9&BV>8]
MVG;AW0'_9K4\0%;"#+3DC(YXE1:-T1]IC=.:4XO4!G0+59H:O-I"*DI2ZH&9
M:A7QV)L#NYQ3J,V#SW?*0EW;!KDBUWWNJ"*^VIMK0R(7!AU^:^R/-/.#O4MB
M]M/R%B5=C>$7R4C[=,'#?W56EUES3CQ:D<#QYY$31PDI>>K.8QH(@\@)YB$-
M1&[B04@]/Z#>W/6]%I:@'I_)@9.80@CG5!FN[W_V^_N6P5E"WH(H&9,SVK_.
MYM3UDW!,KN($SEI?X]857<<WR*W5;.:$\^D80C>,X2R(:/>+9V.(W5GXF:?C
M:/OV4"(Y=0+::VW (5 GCIUYZ-,  <Y[MI>!VIYUM3W[TMIN"_I-;9XKM.'M
M2ZROF <A^XMY>7AW&4^M+$7]\# RM?Q5!R578,&KKA#/^U1WU%INMQ*W1G=O
MC@JE5WH>*6T6AW8E9L%);;VX0YER9800!5,2K&^40%MXM]1BG\Q-)YD3^CM,
MQ+N:2PMHM_$Q^&X0/B;<JYYI1,<#U4/D^C%9S4GP3A*3_*?)@:C=18?LVWIZ
M0'ARA-&GM<G1PZ]$N;7/6SKAS5'9O@&[T>X%O6P?C@_3V^?W:R:WG!)0X(9,
M/7=.!X9LG[1M1XO:/B/70M.CU#9S9!E*,X%^WPC:D_<=XZ#[O\+B+U!+ P04
M    " "EA6)3HXQOQ6L#  !R!P  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6RM5=MNXS80_96!6A1=P(UD^>[:!NQD@RZPNS#6:?M0](&6QA81BM22
ME)W\?6<H6<X6VR /?9'(X5S.G!D.%V=C'UV!Z.&I5-HMH\+[:A['+BNP%.[&
M5*CIY&!L*3QM[3%VE461!Z-2Q6F2C.-22!VM%D&VM:N%J;V2&K<67%V6PCYO
M4)GS,NI'%\$7>2P\"^+5HA)'W*'_O=I:VL6=EUR6J)TT&BP>EM&Z/]\,63\H
M_"'Q[%ZL@3/9&_/(FP_Y,DH8$"K,/'L0]#OA+2K%C@C&U]9GU(5DPY?KB_?[
MD#OELA<.;XWZ4^:^6$;3"'(\B%KY+^;\&[;YC-A?9I0+7SBWNDD$6>V\*5MC
M0E!*W?S%4\O#6PS2UB -N)M  >6=\&*UL.8,EK7)&R]"JL&:P$G-1=EY2Z>2
M[/QJ5U>50F+9"P5WTF7*N-HBF /<"E? /54-A,[AL]&_!,D'?4+GI3X&\;W4
M0F>\6S._TDMT\/.#V"MT[Q:Q)X@<*,Y:.)L&3OH?<&;PR6A?.'BO<\R_M8\I
MM2Z_])+?)GW5X0ZK&Q@D/4B3M/^*OT''UR#X&[R%KRM#[QN9@[_6>^<M]=K?
MKP0;=L&&(=CP_RA.]K;B?*\FKZ+@L3!WE<AP&=&]=VA/&!&O?*\PAQ"V$L\A
M_1[=TPQEQ2L&H"^XQ+4Y!"4@'!R,(O34*U*#+TSM2-^]F\-GBOY-$P"5T&.Y
M1]O5D3])0T$E9$Z^+$CMD=!Y^!$&O70\H_^X-TBF1$EF2@0OGBAX4.^/)I#V
M!U?6KNCF\!'ICH/ER\P\UX[1.IJ.G(^28B^5],_0G\[@IQ^F:3_]E?QX;!(_
M<=\'.$ZH4*?*TORT9,#F^+66%1,%DU%GO:UM5E!,Q^I7#<D3*S,U-Q71&QR/
M.Z-[(2V<A*I#D([FS-"TS-$*W\Q,AH0-/Z8*,GQ"FTE*:C!-.F]W2$V60TXD
MY$AE %+<H>5J;>#64$]9+QG ED8F6LM%\29[A%DZAD&_-QI/R4=[<NB:+C..
MP%^"#"?]UDHZ5Y,*_DMA-DQA3;GG(?\#(L/8/, #VA(^&J$[S4F:PO>N5_QB
M#I9HCV':.P@L-B.QDW8/RKJ9HU?UYC7Z).Q1:@<*#V2:W$Q&4=,4EXTW59BJ
M>^-I1H=E08\B6E:@\X.AKF@W'*![9E?_ %!+ P04    " "EA6)3#]S) <D$
M  !."P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6R]5MMNVS@0_96!
M-UBD@!#K9EE*$P..L[>'MD&2W3XL]H&6QA91B51)*F[^?F<HV747B=%]Z8O%
MR\SA<.;,,:]VVGRR-:*#+VVC[/6D=JZ[G$YM66,K[(7N4-'.1IM6.)J:[=1V
M!D7EG=IF&H=A-FV%5)/%E5^[,XLKW;M&*KPS8/NV%>;Y!AN]NYY$D_W"O=S6
MCA>FBZM.;/$!W9_=G:'9](!2R1:5E5J!P<WU9!E=WLS8WAO\)7%GC\; -UEK
M_8DG?U37DY #P@9+QPB"/D^XPJ9A( KC\X@Y.1S)CL?C/?JO_NYTE[6PN-+-
M1UFY^GJ23Z#"C>@;=Z]WO^-X'Q]@J1OK?V$WV";9!,K>.MV.SA1!*]7P%5_&
M/!PYY.$K#O'H$/NXAX-\E+?"B<65T3LP;$UH//!7]=X4G%1<E =G:%>2GUO<
MXQ.J'N'\4:P;M&^NIHY0>6]:C@@W T+\"D(![[1RM85?5(75M_Y3BN804KP/
MZ28^"?B W04D80!Q&$<G\)+#%1./E[R*MR46.;C'3ALGU1;^7JZM,T2(?T[
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M=L)H8J%:TM7T=CT/\3'@NX#.G:U)J&1OS%,POI9+F@1!(*' @,#][PAW(&4
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M"P V!/C]RA@\&8%@?%/ROU!+ P04    " "EA6)3^GC63E "  ##!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R55-%NFS 4_14+]:&5VD @D"HB
M2&FB:9.V*4K6[6':@X&;8-78S#9)]_>S#6$T(MGV K[V/<?G7+@W/G+Q(@L
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MPO;)PBA\RI!GTKG"EE/FB5!1D-E]PVIL G-&OF*+OB<98//EC+IW.GO$YM1
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M_$YW"PITO)BEHOP+-EO;" U O!:293MGI2!+\NTG^;5+1,T!CCH<T,X!]77
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MT8T(VFZ@]:52^#:Q3;>Y8\=_ %!+ P04    " "EA6)3F/'7LN,"  "A"
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MNSU3X  K<)ZU9+B"7(29@_!PGKLV67JD>KV6L/<NPB^3.[( <*+U.F&3?G:
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MUR];>X;NO5:F><^0NF<?ME]5>\>_9. ?:J]W<&*7'"I_HG(%607"EX!QN@,
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M:'"$&>AFA&HV5JW\4'&M+(XH?KG$L1.T,\#W<Z7L_<;-*=T@._T#4$L#!!0
M   ( *6%8E.?CY#ZM0(  *('   9    >&PO=V]R:W-H965T<R]S:&5E=#0U
M+GAM;+5574_;,!3]*U:T!Y &^6B;M"BM!*TFD)B&*&P/TQ[<Y+:U<.S,=BA(
M^_&[=D)4((TV3>M#XX][SCWW^"O=2?6@MP"&/!5<Z*FW-:8\\WV=;:&@^E26
M('!F+55!#7;5QM>E IH[4,']* ABOZ!,>+/4C=VH62HKPYF &T5T5114/5\
ME[NI%WHO [=LLS5VP)^E)=W $LQ]>:.PY[<L.2M :"8%4;">>N?AV7QBXUW
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ML3($9 DEL94AB"7HCQ\&:?1E5^-9WQZUO-3SW*%YRJ,L?.JQ..HLCHY9C/M
M;59R')1TH.08:-@'2MX+2CM0>@PTZ@.E[P6-.]#X&"CI XU?@9+(_OIADPXV
M>1-V7X%MG"L$W8><O+>V:8>;OHGS9QO=>2[M >E#3E^]B7U5AGOMQ77J&ZK7
M3!K"867SHO.Q]:S;[M<&J&K?<98*;?_RP\I^,$"[!?;^2BG<!:Z)=9^@_!]0
M2P,$%     @ I85B4Z 6O]EE!   QP\  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#@N>&ULK5=;C^(V%/XK%MJ'&6EG$N<&&3%(PZ5JI=UJM.QT'ZH^F,2
M.XE-;0/;_OH>)R% 8@*]O$#L?.?8W^?CDW.&>R'?U9I2C;[G&5?/O;76FR?'
M4<F:YD0]B@WE\&8I9$XT#.7*41M)25H8Y9GCN6[DY(3QWFA8S+W*T5!L=<8X
M?95(;?.<R#_'-!/[YQ[N'2:^L-5:FPEG--R0%9U3_;9YE3!R:B\IRRE73' D
MZ?*Y]X*?9M@W!@7B%T;WZN09&2H+(=[-X*?TN>>:'=&,)MJX(/"WHQ.:9<83
M[../RFFO7M,8GCX?O/]0D <R"Z+H1&3?6*K7S[U!#Z5T2;:9_B+V/]**4&C\
M)2)3Q2_:5UBWAY*MTB*OC&$'.>/E/_E>"7%B '[L!EYEX#4-@@L&?F7@W[I"
M4!D$MZX05@8%=:?D7@@W)9J,AE+LD31H\&8>"O4+:]"+<1,H<RWA+0,[/?H9
M8O&34 J]4HDF(L_A\.9K(BEZ0&.B6((N(^ZF5!.6J7O OLVGZ.[#/?J '*3,
M6X481V^<:?41)N'YZUIL%>&I&CH:-FZ6=Y)JD^-RD]Z%3?KHL^!ZK=",IS2U
MV$^[[>,.>P<$JU7S#JJ-O4Z'<[IY1+[[$7FNARW[F=QN[MKH_+?59_]Z]3,Q
M_#J$_,*??\'?C$C.^*H,D#(R?GU9*"TA"?S6X3^H_0>%_Z C1#,(0%O<E)91
M86ERXF[TX/E^/'1VIZ=A0>$XP/USV-0&\T+7/8?-+##?Z[M!#3MC&=8LPTX5
M7]+?X;9#"M8*:0$Y.!$\81DU UXI@,@.[AM9E+-)>1<A123O:Y&E5*H.M:-Z
M'U&GVB])LLVW&=$T12G;L93R%)DK3R6#2SV&%,!W5&IF=O$*69U*"="YV87M
MA,K5PA.U<-@/&@?4!L5Q\W3:&#_"?N-LNAV="=*O!>EW"Y(+8/L7*;YK8HD6
ME-,E2QC)X 2,%,4W<TF)WDIJ4Z#?VE,CHB9MA(\Q;J"F5_W,KODYXS^H^0^N
M!82D!_*,PP ^"WSU("%$CA'2P7]PE7\;$82#!OLV)O:B!O]N/V?LXYI]W,G^
MJ]!PT.1X.6T,XUMBO WRO3 *&S3;J"!LYK/9-5=G3+%[+ 7<FQ+M/TPSU1?<
MM:3%N'E!)S98B..!U]#!AL-]MR6%#1>%7A1?$..D+L*=8GPK2DS(; 2N.)3,
MM0YE<0,UM])0S<!-@.HG9=G68._8 7!OU0BW P6[?>#5;^ED@;J#(/8]MWDS
M[%ZQ'X7-+]S,[M7SO !?$LP["N;]?X(MBM+RFES>[7)9H)?DLGJURV7UVBG7
ML6C"?J=<97%=?]DW4#N="E9HDXHL([)\6<S:92H7&IQ> ??1;>8?.RQHR6.%
MX; IC146-51Q3AJ3G,I5T1$J(+KENBPPZ]FZZWPI>JW&_!@_3;!E?FJZU*(1
M.KHO6]S/1*X85RBC2UC*?>S#*<JR:RP'6FR*MF@A-#19Q>,:.FTJ#0#>+X70
MAX%9H.[=1W\#4$L#!!0    ( *6%8E.*SFY,,@8  -8@   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0Y+GAM;,U:76_;-A3]*X2QAP1H(Y'49^ $2&(/*]!N
M0;.N#\4>%(N)M4JB1]%Q]^]W*2FF+%TKR5HL?FDL^?"2//?C7)J=;J3Z6BV%
MT.1;D9?5V62I]>K4<:K%4A1)=2)7HH1O[J0J$@V/ZMZI5DHD:3VHR!WFNH%3
M)%DY.9_6[Z[5^52N=9Z5XEJ1:ET4B?KG4N1R<S:AD\<7'[/[I38OG//I*KD7
M-T)_6ETK>'*V5M*L$&65R9(H<7<VN:"G<QZ8 37BCTQLJLYG8K9R*^57\_ N
M/9NX9D4B%PMM3"3PYT%<B3PWEF =?[=&)]LYS<#NYT?K/]>;A\W<)I6XDOGG
M+-7+LTDT(:FX2]:Y_B@WOXAV0[ZQMY!Y5?]+-BW6G9#%NM*R: ?#"HJL;/XF
MWUHB.@/ #CZ M0-8?X"W9P!O!_#GSN"U [SGSN"W ^JM.\W>:^)FB4[.ITIN
MB#)HL&8^U.S7HX&OK#2!<J,5?)O!.'W^*\3B>UE5Y%HH<B6+ IQWLTR4(&_)
M+,O76J1D/^9H)G22Y=4QH#_=S,C13\?D)^*0RGQ;D:PDG\I,5V_@)7S^?2G7
M55*FU=31L'2S &?1+O.R62;;LTQ./LA2+RLR+U.1(N-GX^/CD?$.4+;EC3WR
M=LE&#=Z(U0GA[AO"7$:1]5P]?[B+;>?[9I__Y]EWR.#;(.*U/;[''L3$:JV3
M.O/EG4G<;$' T21M(ZB$",I-!*T@@NK@(%\N;BNMH$[\.;( ;[L KUZ -Q+%
MM?WD <(QN<T%T9(LFE"%'%I\7<H\%0J-O,9T4)LV=?7A_"V/*9\Z#UU_(BB?
MQA';A<T0& U='N_"Y@@L\%E@83LT^%L:_%$:9ME#E@I(,&(R5*@,<O 2,K9\
M$$IGAI5K*,-"*7#)C6$%H\,?+(WZH==C8PCBS _\'AE#E.</J'C*U X3P9:)
M8)2)S[5 P#83V#H(WF-% JFL-$1F5MZ3(RA)S>MCC(=F K_+ W5#<&;8#PT$
MZ49>S)D;]0A!;5(>^#3LL8+:9(QY=$^,A%MFPE%FKJ46I<Z2?)L>-048 ^%@
M#=P-_(C&?0*&0!8%X,2H%S8SS"*-P&3/XGP(!*(XBTRYPG8?;7<??7=<).E?
MH+N @3:,K)Y/5_3L@$&0>P(&M8D&#&IS+&#B+67Q$T7%UO C4V2/0<N!#%$7
M\RXK=4:E,L\3U:GT:'(U4T;=^N>>N/TJ@Z*\/D<HBO9JT1Q%!3@UU+7=DSNJ
M?!<0&[7(0;<+%7>Q5IDV57?^;9&O4Q-#2A:DIX_S1)40:$T_U3127]Z#8?).
MBZ(:TT/::>OHJ-=V%E;9A8F=A2UV%R8>%V9E^HDBV:[B&34"0>XI$JA-M$H@
MR/$R09GECXWR]W+UW)W(MD[TE7HG:ILG.MX]O4 26DL[7@Q=%C*?]?V-(/T@
MAG+H]OV-( ,O#OW0[?M[B(00"CRZS]VV<:+^0>6Q[6/H>"/S?^7QL-_8YU<$
MN<>O"'*/7X?(<;_:9H>.=SL?!21*MC!Y5!\#2+))5/\ NFO;MA(T>J7,M=),
MQ[7Y)9D;#SB.0R^(PKY_ASC*7![YO.]>#!B% >\K+PZD7>#N$=RJ+SLH]656
M?=E!J"\;ZA_J4P2'^Q0%8C[%@2,^M<++QH5WD+'K,M-/IRVS@LM>27"9%5SV
MPP27#26/1I[K1?W^"@'&-&9\X&+$H.^Z0?^(/T> W(^AO=KC8:NU[*"TEEFM
M90>AM0PYV^,N'0)QER(&<9<.@:,NM3++QF7VM\[QN<E:N3($C6:L%5KV2D++
MK-"R'R:T;"AWD>M[?%"4A[@P9'$0]KV+V(,>B@Z<B]CC<=R9=_>W7:NR_*!4
MEEN5Y0>ALGRH=:A#$1SJ4,P>YE#,WIA#K<3R<8D%E]0WC.5"O$AC>><^X)4T
MEEN-Y3],8SDBB2[G_5^C$!@/8T[[[D6.LQYC_3,/!O/#??T3M^K*#TI=N557
M?A#JRK%?SA%G(E*(.1,YPV+.Q [%0V<ZG7O:0JC[^H*\@CVO2]W<MFW?;B_A
M+^JKY][[2WIZ19'W,WHZ;Z[8K?GFQO]#HNZSLB*YN(.IW),0UJJ:2_3F0<M5
M?4M\*[661?UQ*9)4* . [^\D)%3[8";8_E>&\W\!4$L#!!0    ( *6%8E,!
MB\];: 8  "0=   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;,59;6_;
M-A#^*X31 0G0V!)EV5:1!%CBI$G0M5G3;A^&?6 DVA8JB2Y)Y67HC]]1DO5B
M2117)%@0V))\[\\=[T@=/S+^36PHE>@ICA)Q,MI(N7TWF0A_0V,BQFQ+$_AE
MQ7A,)-SR]41L.25!QA1'$VQ9LTE,PF1T>IP]N^6GQRR549C06XY$&L>$/Y_1
MB#V>C.S1[L'G<+V1ZL'D]'A+UO2.RJ_;6PYWDU)*$,8T$2%+$*>KD]&O]KL;
M)V/(*/X(Z:.H72/ERCUCW]3-=7 RLI1%-**^5"((?#W0<QI%2A+8\;T0.BIU
M*L;Z]4[Z9>8\.'-/!#UGT9]A(#<GH\4(!71%TDA^9H]7M'#(5?)\%HGL$ST6
MM-8(^:F0+"Z8P8(X3/)O\E0$HL8P7?0PX((![S'@>0^#4S XI@S3@F%JRN 6
M#*XIPZQ@F.TS]$5I7C#,31D6!</"E,$K&#Q3!MO:(6=E&91#GN7+DDAR>LS9
M(^**'N2IBRSI,GY(DS!1]7$G.?P: I\\O?B>AO(9':&/A'.B<A4=+*DD820.
MT1LT06)#.!4H3-#7))3B+3R$ZR\;E@J2!.)X(L$*)6OB%QK/<HVX1^--&HV1
MA=\B;&'KZ]T2';PY#,AS$'(H&<8KG?EGAX)SO8([NATCQ\H4V(6"7EE+<UG6
MD*R+%[3K\@7M>C\$2%+9U2OD2B]D27T08N<&]0JY-K>D7\B-L26VUR5D B52
MU@DNZP1G4IT^J>%#&%!(>'1+GLE]1-%?'X $74L:B[\U"IQ2@9,IF/8BRD.H
MLS/DL^2!<ADJ'=#R5I1S&B!8"OQO;W?5"(U.2"B_,%FC RC'_/$A^H'ZBR97
M[V;J5==\.+4M]7<\>:CGL!G9U2!9(PC3,@A3;1"6E,;@;+ +=E?!YA)F-<U'
MCNW.%GM^=)!Y>-8DNAR4U?#"+;UPS:"\+>&K@WJ70UDZ"3."SU,@ND\E2IB$
ML<-G/( ',/X@N8$T ($LZ +5;3E@N_-IT\MEF\CSYGOA<EMX.C/;V0N77E C
M5K,R5C-MK+XP22*4)LKG=1+^D\4JANE/D&Q^HD_JFG;Y/FM9@Q>XE<]#5 VK
MYZ75<ZW5GVKU]VFK#(7&^)C-8N   :AAM@0<U8"J: !^R6$43,%727F<%>TS
M)5P<=O41O7*<<R*,8A"[$<AV$310W2JW*/U::$57"7L>$:%2^'P_<35:O%*+
M]SIKJ6U54XUE5H*M%32OQ&R\W_+0IQD4 8LB%5(HM'P%54MI-8ET#CFY 8MZ
MQ8P7;G=>V;5QS-8:?EZ9I\8QAM@*]3F#)%/% EF0WW>:F:OSZOGO>N/:&M$T
MM.J'-OY?^]59H=^TQ=A5H[4-.VW+6IBPPSB-51KX-)&JAB'\M8S)PY[G#01?
M\G"]AI2I41P4O%UU?39@&"Q+8\OZ15< 52.U]9WT8QK?@V5@/BP\6=S5$@';
M"[F!^(/!@OII-N[#\Y(F;S2-I$(Q;$-@&?8IQ*G#X3P8/Y283I>G+11Q'X)5
M?[4-&VP+0;F!;-JP*$!)&8"ZLXU@]!O=T0W[C*X:G:WO="^4=BRI_Q(020=R
M3F^50<Y53='6-Z8JY^X9X> >)5*@["A$33?/O0N9 @P<4H 4N\!.3^;M5.H!
MI>IWMK[A:4 A3QDH#TRJA"D@J"&4( +_XJA8_Y2'1(1B  V].;8W]O1@5#W6
M]G[2LS#Q.053D_415^FS&T31"O!*>=>L=58H:PR:B[ZE&%=M&NO;M,&\ 4FQ
M#(7/TD2%>#<ZH,_*<J@(-2$S]'M*  $>/5<$,%K$@ *B>=<!N&!W2=7N4FUS
M=3O"JE=C^W7F&%S;=?Y$E]U-,FF<1OF130FA-OD&=$T'%@)<=5BL;V1FL-Y2
MOJ792-Q$E:P RO\&*1K"M.J;>/I*F%;="QMVKQ?!5*]K-H1IU;ZP8?NJ0UD!
M/;0WP%47P?-70J!:];'AJO]:9RV%_J%3E*4AW84AW:4AW7M#NBM#NNL.NCV2
M&RU)$\>JQV%]CS,X+CK'[<[50J%-TGFDU$77/E,:EM8\'ZR:I6.XIWWU8Z6+
MPI*Z#^ZLK]T[5<-T])O; 0^:=1<*D6;EGVZ;,Z_Q@:?=GA?G4\?U/&?_S-.
M,G=Y4GO3HMX?_D;X.DP$BN@*6*WQ'&3P_)5<?B/9-GOY<L^D9'%VN:$$IEU%
M +^O&).[&_4^IWPQ>OHO4$L#!!0    ( *6%8E.M\#,(R0,  .\0   9
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MCY_3CO(Q>A*+>S_N1T]B1UG PS+DRL+P%Y\R;QUE)1B=AH$K/F.6.LK4</'
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M4UX!U/LU8_*XJ!RT_T_,?@%02P,$%     @ I85B4Q K\AL= P  +A(   T
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M IE?P\_W^3* 3!'(]!TA.Y',$,CL/2&3 /(4@3REA5QR5QO!]):=UU8J86W
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M[CV?#7^R7+T"4$L! A0#%     @ I85B4P=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "EA6)3*)A(
M!N\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " "EA6)3F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *6%8E/'W(-+. 4  &85
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " "EA6)3?\C!1X0&  ![&@  &               @(%\#0
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ I85B4SC6^.NZ
M P  G@X  !@              ("!-A0  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( *6%8E/#QZC$+ 8  &@9   8              "
M@288  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "EA6)3
MRXB^C[8*  !D/P  &               @(&('@  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ I85B4^U\; !U!P  YQX  !@
M     ("!="D  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M *6%8E-1^O=$JPD  -08   8              " @1\Q  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " "EA6)3\)9GJ*T+   N'P  &
M            @($ .P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ I85B4UG7W,UP @  :P4  !@              ("!XT8  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *6%8E/-H#T56P,  #4'
M   9              " @8E)  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ I85B4_$J'+^L P  -P@  !D              ("!&TT
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "EA6)3-U85
M4 @$  "]"0  &0              @('^4   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( *6%8E/@*8K'" ,  #T&   9
M  " @3U5  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
MI85B4]Y\%?<P#   HR4  !D              ("!?%@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " "EA6)3#X<G+C8'  "X%0  &0
M            @('C9   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( *6%8E-%,FAN,0L  +4C   9              " @5!L  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ I85B4T5..@(F P
MNP<  !D              ("!N'<  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " "EA6)3G>_5?V(#  "^!P  &0              @($5
M>P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( *6%8E.X
M=?+9@P\  !DI   9              " @:Y^  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ I85B4^Z6GO;P!@  $1$  !D
M     ("!:(X  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *6%8E/VAIYZA ,  !P(   9              "
M@2RI  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ I85B
M4U(]L!YC!   70X  !D              ("!YZP  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " "EA6)3GOIM=, "  "G!0  &0
M        @(&!L0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( *6%8E.F"V@IMP0  -,-   9              " @7BT  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ I85B4SOC/:*W!0  '!(
M !D              ("!9KD  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " "EA6)3B$#1@/8$  !C$   &0              @(%4OP
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *6%8E.CC&_%
M:P,  '('   9              " @8'$  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ I85B4P_<R0')!   3@L  !D
M ("!(\@  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "E
MA6)3^]*AEA,$   3$0  &0              @($CS0  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *6%8E-EE31-$ (  %\$   9
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M970S."YX;6Q02P$"% ,4    " "EA6)3629'%=$$  ",&   &0
M    @('PWP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M *6%8E,<FN-8>P(  +(&   9              " @?CD  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ I85B4Y)UE*6P @  ;P<  !D
M             ("!JN<  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " "EA6)3F/'7LN,"  "A"   &0              @(&1Z@  >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( *6%8E,>D4EQY 4
M #D?   9              " @:OM  !X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ I85B4_U*[0@C P  U H  !D              ("!
MQO,  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "EA6)3
MGX^0^K4"  "B!P  &0              @($@]P  >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( *6%8E.]SFBDN@,  ' .   9
M      " @0SZ  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ I85B4^>R'LUO @  C@8  !D              ("!_?T  'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "EA6)3H!:_V64$  #'#P
M&0              @(&C  $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( *6%8E.*SFY,,@8  -8@   9              " @3\% 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ I85B4P&+SUMH
M!@  )!T  !D              ("!J L! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " "EA6)3K? S",D#  #O$   &0
M@(%'$@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( *6%
M8E.P?7%#G00  '<8   9              " @4<6 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ I85B4Q3>NY'I P  -0\  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( *6%8E,J+VW26@,   P,   9
M  " @=HM 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
MI85B4UM2,CBB P  6PP  !D              ("!:S$! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " "EA6)3$"OR&QT#   N$@  #0
M            @ %$-0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *6%8E.7
MBKL<P    !,"   +              "  8PX 0!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( *6%8E.]5H*ZZ@0  -PF   /              "  74Y 0!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " "EA6)3678!^/4!   X(P  &@
M        @ &,/@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " "EA6)3%\C,&]L!  #1(@  $P              @ &Y0 $ 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     0P!# $P2  #%0@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>182</ContextCount>
  <ElementCount>362</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>55</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NatureofBusiness</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Accounts Receivable, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccountsReceivableNet</Role>
      <ShortName>Accounts Receivable, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2109104 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112105 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Long Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebt</Role>
      <ShortName>Long Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - Net Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShare</Role>
      <ShortName>Net Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2146113 - Disclosure - Contractual Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/ContractualCommitmentsandContingencies</Role>
      <ShortName>Contractual Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148114 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2153115 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mimedx.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Accounts Receivable, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccountsReceivableNetTables</Role>
      <ShortName>Accounts Receivable, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccountsReceivableNet</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/Inventory</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/IntangibleAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccruedExpenses</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - Long Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTables</Role>
      <ShortName>Long Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/LongTermDebt</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2332307 - Disclosure - Net Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareTables</Role>
      <ShortName>Net Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/NetLossPerCommonShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Equity Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityEquityTables</Role>
      <ShortName>Equity Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2349310 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/Revenue</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NatureofBusinessDetails</Role>
      <ShortName>Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/NatureofBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Accounts Receivable, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccountsReceivableNetDetails</Role>
      <ShortName>Accounts Receivable, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccountsReceivableNetTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/InventoryTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Property and Equipment, Net - Depreciation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails</Role>
      <ShortName>Property and Equipment, Net - Depreciation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Intangible Assets - Activity Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails</Role>
      <ShortName>Intangible Assets - Activity Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - Intangible Assets - Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccruedExpensesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - Long Term Debt - Term Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanDetails</Role>
      <ShortName>Long Term Debt - Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails</Role>
      <ShortName>Long Term Debt - Term Loan Debt Issuance Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - Long Term Debt - Term Loan Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails</Role>
      <ShortName>Long Term Debt - Term Loan Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails</Role>
      <ShortName>Long Term Debt - Term Loan Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails</Role>
      <ShortName>Long Term Debt - Term Loan Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails</Role>
      <ShortName>Equity - Changes in Series B Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Equity - Restricted Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityRestrictedStockAwardsDetails</Role>
      <ShortName>Equity - Restricted Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Equity - Stock Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityStockIncentivePlansDetails</Role>
      <ShortName>Equity - Stock Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IncometaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/Incometaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Contractual Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2450425 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails</Role>
      <ShortName>Revenue - Summary of Revenue by Product Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails</Role>
      <ShortName>Revenue - Summary of Revenue by Customer Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mdxg-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2452427 - Disclosure - Revenue - Collections on Remaining Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails</Role>
      <ShortName>Revenue - Collections on Remaining Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mdxg-20210930.htm">mdxg-20210930.htm</File>
    <File>exhibit311-20210930.htm</File>
    <File>exhibit312-20210930.htm</File>
    <File>exhibit321-20210930.htm</File>
    <File>exhibit322-20210930.htm</File>
    <File>mdxg-20210930.xsd</File>
    <File>mdxg-20210930_cal.xml</File>
    <File>mdxg-20210930_def.xml</File>
    <File>mdxg-20210930_lab.xml</File>
    <File>mdxg-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>77
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mdxg-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 182,
   "dts": {
    "calculationLink": {
     "local": [
      "mdxg-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdxg-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mdxg-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mdxg-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdxg-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mdxg-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 458,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 6
   },
   "keyCustom": 47,
   "keyStandard": 315,
   "memberCustom": 18,
   "memberStandard": 33,
   "nsprefix": "mdxg",
   "nsuri": "http://mimedx.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://mimedx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109104 - Disclosure - Inventory",
     "role": "http://mimedx.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112105 - Disclosure - Property and Equipment, Net",
     "role": "http://mimedx.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Intangible Assets",
     "role": "http://mimedx.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Accrued Expenses",
     "role": "http://mimedx.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Long Term Debt",
     "role": "http://mimedx.com/role/LongTermDebt",
     "shortName": "Long Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - Net Loss Per Common Share",
     "role": "http://mimedx.com/role/NetLossPerCommonShare",
     "shortName": "Net Loss Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Equity",
     "role": "http://mimedx.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - Income taxes",
     "role": "http://mimedx.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146113 - Disclosure - Contractual Commitments and Contingencies",
     "role": "http://mimedx.com/role/ContractualCommitmentsandContingencies",
     "shortName": "Contractual Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148114 - Disclosure - Revenue",
     "role": "http://mimedx.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153115 - Disclosure - Subsequent Events",
     "role": "http://mimedx.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Accounts Receivable, Net (Tables)",
     "role": "http://mimedx.com/role/AccountsReceivableNetTables",
     "shortName": "Accounts Receivable, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Inventory (Tables)",
     "role": "http://mimedx.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://mimedx.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Intangible Assets (Tables)",
     "role": "http://mimedx.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://mimedx.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - Long Term Debt (Tables)",
     "role": "http://mimedx.com/role/LongTermDebtTables",
     "shortName": "Long Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332307 - Disclosure - Net Loss Per Common Share (Tables)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareTables",
     "shortName": "Net Loss Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Equity Equity (Tables)",
     "role": "http://mimedx.com/role/EquityEquityTables",
     "shortName": "Equity Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349310 - Disclosure - Revenue (Tables)",
     "role": "http://mimedx.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Nature of Business (Details)",
     "role": "http://mimedx.com/role/NatureofBusinessDetails",
     "shortName": "Nature of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i3f87700978a544fa9d65867f626f385d_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i3f87700978a544fa9d65867f626f385d_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Accounts Receivable, Net (Details)",
     "role": "http://mimedx.com/role/AccountsReceivableNetDetails",
     "shortName": "Accounts Receivable, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Inventory (Details)",
     "role": "http://mimedx.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i76db2066b4ab44fb850e9a690cdb64fb_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "role": "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdxg:ScheduleOfDepreciationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Property and Equipment, Net - Depreciation Expense (Details)",
     "role": "http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails",
     "shortName": "Property and Equipment, Net - Depreciation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Intangible Assets - Activity Summary (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
     "shortName": "Intangible Assets - Activity Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - Intangible Assets - Amortization Expense (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Accrued Expenses (Details)",
     "role": "http://mimedx.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - Long Term Debt - Term Loan (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanDetails",
     "shortName": "Long Term Debt - Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ie6396b4bafc24fa88ac9bbc69e29cf10_I20200702",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i90ff1eec1ec3433284583249574c58e7_I20200702",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
     "shortName": "Long Term Debt - Term Loan Debt Issuance Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "id98ba73abde34242a6ba47a62b0ef574_I20200702",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - Long Term Debt - Term Loan Balances (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
     "shortName": "Long Term Debt - Term Loan Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i2fb70228ca86484abc1647102df379f3_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdxg:ScheduleofInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails",
     "shortName": "Long Term Debt - Term Loan Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdxg:ScheduleofInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i52fb0f0a9a04458cb47b0acbc4dde172_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails",
     "shortName": "Long Term Debt - Term Loan Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "mdxg:DebtInstrumentConvertibleBeneficialConversionFeatureAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i21b398a86a27463d8c43135cf5d273e1_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i21b398a86a27463d8c43135cf5d273e1_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesAuthorized",
       "us-gaap:TemporaryEquitySharesIssued",
       "us-gaap:TemporaryEquitySharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - Equity - Narrative (Details)",
     "role": "http://mimedx.com/role/EquityNarrativeDetails",
     "shortName": "Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesIssued",
       "us-gaap:TemporaryEquitySharesOutstanding",
       "us-gaap:TemporaryEquitySharesAuthorized",
       "us-gaap:TemporaryEquitySharesIssued",
       "us-gaap:TemporaryEquitySharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i76db2066b4ab44fb850e9a690cdb64fb_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)",
     "role": "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
     "shortName": "Equity - Changes in Series B Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i0d492b0b584d4f269f2f61823174b39e_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Equity - Restricted Stock Awards (Details)",
     "role": "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
     "shortName": "Equity - Restricted Stock Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i4ff4439fdb9b485aa8d27be3a6e253c7_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i76db2066b4ab44fb850e9a690cdb64fb_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Equity - Stock Incentive Plans (Details)",
     "role": "http://mimedx.com/role/EquityStockIncentivePlansDetails",
     "shortName": "Equity - Stock Incentive Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i76db2066b4ab44fb850e9a690cdb64fb_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Income taxes (Details)",
     "role": "http://mimedx.com/role/IncometaxesDetails",
     "shortName": "Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)",
     "role": "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails",
     "shortName": "Contractual Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mdxg:NumberOfProducts",
      "reportCount": 1,
      "unitRef": "product",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450425 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)",
     "role": "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails",
     "shortName": "Revenue - Summary of Revenue by Product Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ide8eea8c11844b23b19eb0cf0ab5959d_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i8e4a2c8b62af46b5b27eb6cb036e56ab_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels",
      "reportCount": 1,
      "unitRef": "distributionchannel",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)",
     "role": "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
     "shortName": "Revenue - Summary of Revenue by Customer Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i16ad22774d414f21aed7e4d4af64444c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i057fe79e33fc4177befb72654ccf4378_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452427 - Disclosure - Revenue - Collections on Remaining Contracts (Details)",
     "role": "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails",
     "shortName": "Revenue - Collections on Remaining Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "i1831204c1854475a8c1a996ca37bc586_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Nature of Business",
     "role": "http://mimedx.com/role/NatureofBusiness",
     "shortName": "Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Significant Accounting Policies",
     "role": "http://mimedx.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Accounts Receivable, Net",
     "role": "http://mimedx.com/role/AccountsReceivableNet",
     "shortName": "Accounts Receivable, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210930.htm",
      "contextRef": "ib059f33b4d88402dbe59f1461265db41_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsAndNontradeReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 55,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mdxg_AccruedClinicalTrialsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Clinical Trials, Current",
        "label": "Accrued Clinical Trials, Current",
        "terseLabel": "Accrued clinical trials"
       }
      }
     },
     "localname": "AccruedClinicalTrialsCurrent",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AccruedRebates": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates",
        "label": "Accrued Rebates",
        "terseLabel": "Accrued rebates"
       }
      }
     },
     "localname": "AccruedRebates",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
        "label": "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
        "terseLabel": "Dividends on Series B Convertible Preferred Stock",
        "totalLabel": "Total adjustments"
       }
      }
     },
     "localname": "AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AdvancedWoundCareTissueAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Wound Care, Tissue And Other",
        "label": "Advanced Wound Care, Tissue And Other [Member]",
        "terseLabel": "Tissue/Other"
       }
      }
     },
     "localname": "AdvancedWoundCareTissueAndOtherMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_AdvancedWoundCareUmbilicalCordDerivedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Wound Care, Umbilical Cord-Derived",
        "label": "Advanced Wound Care, Umbilical Cord-Derived [Member]",
        "terseLabel": "Cord"
       }
      }
     },
     "localname": "AdvancedWoundCareUmbilicalCordDerivedMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_AssetRetirementCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Cost [Member]",
        "label": "Asset Retirement Cost [Member]",
        "terseLabel": "Asset retirement cost"
       }
      }
     },
     "localname": "AssetRetirementCostMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_CARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act",
        "label": "CARES Act [Member]",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "CARESActMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Computation of basic and diluted net loss per share [Abstract]",
        "terseLabel": "Computation of basic and diluted net loss per share [Abstract]"
       }
      }
     },
     "localname": "ComputationOfBasicAndDilutedNetLossPerShareAbstract",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdxg_ContingencyLossNumberOfSecuritiesClassActions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingency Loss, Number Of Securities Class Actions",
        "label": "Contingency Loss, Number Of Securities Class Actions",
        "terseLabel": "Number of securities class actions"
       }
      }
     },
     "localname": "ContingencyLossNumberOfSecuritiesClassActions",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_CreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facilities [Member]",
        "label": "Credit Facilities [Member]",
        "terseLabel": "Credit Facilities"
       }
      }
     },
     "localname": "CreditFacilitiesMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_CustomerAndSupplierRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer And Supplier Relationships",
        "label": "Customer And Supplier Relationships [Member]",
        "terseLabel": "Customer and supplier relationships"
       }
      }
     },
     "localname": "CustomerAndSupplierRelationshipsMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_DebtCovenantMinimumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Minimum Liquidity",
        "label": "Debt Covenant, Minimum Liquidity",
        "terseLabel": "Debt covenant, minimum liquidity"
       }
      }
     },
     "localname": "DebtCovenantMinimumLiquidity",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_DebtInstrumentCommitmentFees": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Commitment Fees",
        "label": "Debt Instrument, Commitment Fees",
        "terseLabel": "Commitment fee"
       }
      }
     },
     "localname": "DebtInstrumentCommitmentFees",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_DebtInstrumentConvertibleBeneficialConversionFeatureAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Beneficial Conversion Feature, Amortization",
        "label": "Debt Instrument, Convertible, Beneficial Conversion Feature, Amortization",
        "terseLabel": "Amortization of beneficial conversion feature"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleBeneficialConversionFeatureAmortization",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_DebtInstrumentCovenantNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Net Leverage Ratio",
        "label": "Debt Instrument, Covenant, Net Leverage Ratio",
        "terseLabel": "Total net leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantNetLeverageRatio",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mdxg_DebtInstrumentDefaultInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Default Interest Rate",
        "label": "Debt Instrument, Default Interest Rate",
        "terseLabel": "Default interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentDefaultInterestRate",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentInterestRateFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Floor Percentage",
        "label": "Debt Instrument, Interest Rate, Floor Percentage",
        "terseLabel": "Debt instrument, interest rate, floor (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFloorPercentage",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
        "label": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
        "terseLabel": "Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
        "label": "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Additional commitment fee (percent)"
       }
      }
     },
     "localname": "DebtInstrumentUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
        "label": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
        "terseLabel": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021"
       }
      }
     },
     "localname": "DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Discrete Items",
        "label": "Effective Income Tax Rate Reconciliation, Discrete Items",
        "terseLabel": "Effective income tax rate impact of discrete items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDiscreteItems",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
        "label": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
        "terseLabel": "Tax benefit recognized with respect to net operating loss"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value Of Non-Cash Consideration Received For Option Exercise",
        "label": "Fair value Of Non-Cash Consideration Received For Option Exercise",
        "terseLabel": "Fair value of non-cash consideration received for option exercise"
       }
      }
     },
     "localname": "FairValueOfNonCashConsiderationReceivedForOptionExercise",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_FinancingTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Transactions [Member]",
        "label": "Financing Transactions [Member]",
        "terseLabel": "Financing Transactions"
       }
      }
     },
     "localname": "FinancingTransactionsMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
        "label": "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
        "terseLabel": "Hayfin Loan Agreement Delayed Draw Term Loan"
       }
      }
     },
     "localname": "HayfinLoanAgreementDelayedDrawTermLoanMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan [Member]",
        "label": "Hayfin Loan Agreement Term Loan [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
        "label": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
        "label": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_InvestigationRestatementandRelated": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investigation, Restatement and Related",
        "label": "Investigation, Restatement and Related",
        "terseLabel": "Investigation, restatement and related"
       }
      }
     },
     "localname": "InvestigationRestatementandRelated",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_LeaseRightOfUseAssetAndLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right Of Use Asset And Liability",
        "label": "Lease, Right Of Use Asset And Liability",
        "terseLabel": "Lease right of use asset and liability"
       }
      }
     },
     "localname": "LeaseRightOfUseAssetAndLiability",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Four",
        "label": "Long-Term Debt, Maturity, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NoncashActivitiesDebtInstrumentAmendmentFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Activities, Debt Instrument, Amendment Fee",
        "label": "Non-cash Activities, Debt Instrument, Amendment Fee",
        "terseLabel": "Amendment fee on BT Term Loan"
       }
      }
     },
     "localname": "NoncashActivitiesDebtInstrumentAmendmentFee",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NoncashActivitiesDeferredFinancingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Activities, Deferred Financing Costs",
        "label": "Non-cash Activities, Deferred Financing Costs",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "NoncashActivitiesDeferredFinancingCosts",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NotesReceivableForSaleOfPropertyAndEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable For Sale Of Property And Equipment",
        "label": "Notes Receivable For Sale Of Property And Equipment",
        "terseLabel": "Note receivable for sale of property and equipment"
       }
      }
     },
     "localname": "NotesReceivableForSaleOfPropertyAndEquipment",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Products",
        "label": "Number Of Products",
        "terseLabel": "Number Of Products"
       }
      }
     },
     "localname": "NumberOfProducts",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Board Seats Elected by Temporary Equity Holders",
        "label": "Number of Board Seats Elected by Temporary Equity Holders",
        "terseLabel": "Number of board seats elected by Series B preferred stockholders"
       }
      }
     },
     "localname": "NumberofBoardSeatsElectedbyTemporaryEquityHolders",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease And Financing Lease, Right-Of-Use-Asset",
        "label": "Operating Lease And Financing Lease, Right-Of-Use-Asset",
        "terseLabel": "Right of use asset"
       }
      }
     },
     "localname": "OperatingLeaseAndFinancingLeaseRightOfUseAsset",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_PatentsinProcessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents in Process",
        "label": "Patents in Process [Member]",
        "terseLabel": "Patents in Process"
       }
      }
     },
     "localname": "PatentsinProcessMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_PaymentsforApplicationCostsPatent": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Application Costs, Patent",
        "label": "Payments for Application Costs, Patent",
        "negatedTerseLabel": "Patent application costs"
       }
      }
     },
     "localname": "PaymentsforApplicationCostsPatent",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
        "label": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
        "terseLabel": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021"
       }
      }
     },
     "localname": "PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_ProceedsfromIssuanceofTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Issuance of Temporary Equity",
        "label": "Proceeds from Issuance of Temporary Equity",
        "terseLabel": "Proceeds from sale of Series B convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsfromIssuanceofTemporaryEquity",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Number Of Distribution Channels",
        "label": "Revenue From Contract With Customer, Number Of Distribution Channels",
        "terseLabel": "Number of primary distribution channels"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerNumberOfDistributionChannels",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_RevenueGuidanceTopic606TransitionPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Guidance Topic 606 Transition Period",
        "label": "Revenue Guidance Topic 606 Transition Period [Member]",
        "terseLabel": "Revenue Guidance Topic 606 Transition Period"
       }
      }
     },
     "localname": "RevenueGuidanceTopic606TransitionPeriodMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_ScheduleOfDepreciationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Depreciation",
        "label": "Schedule Of Depreciation [Table Text Block]",
        "terseLabel": "Schedule of Depreciation Expense"
       }
      }
     },
     "localname": "ScheduleOfDepreciationTableTextBlock",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_ScheduleofDebtIssuanceCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Issuance Costs [Table Text Block]",
        "label": "Schedule of Debt Issuance Costs [Table Text Block]",
        "terseLabel": "Schedule of Debt Issuance Costs"
       }
      }
     },
     "localname": "ScheduleofDebtIssuanceCostsTableTextBlock",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_ScheduleofInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Interest Expense [Table Text Block]",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of Interest Expense"
       }
      }
     },
     "localname": "ScheduleofInterestExpenseTableTextBlock",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_Section351Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Section 351",
        "label": "Section 351 [Member]",
        "terseLabel": "Section 351"
       }
      }
     },
     "localname": "Section351Member",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_StockAwardMisstatementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Award Misstatements",
        "label": "Stock Award Misstatements [Member]",
        "terseLabel": "Stock Award Misstatements"
       }
      }
     },
     "localname": "StockAwardMisstatementsMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_StockIssuanceCostsIncurred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuance Costs Incurred",
        "label": "Stock Issuance Costs Incurred",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "StockIssuanceCostsIncurred",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityAccretedbutUnrecordedDividends": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Accreted but Unrecorded Dividends",
        "label": "Temporary Equity, Accreted but Unrecorded Dividends",
        "terseLabel": "Series B Preferred convertible Stock, dividends accrued but not recorded for the period",
        "verboseLabel": "Accumulated dividend on Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityAccretedbutUnrecordedDividends",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 3.0,
       "parentTag": "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
        "label": "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
        "terseLabel": "Accretion of increasing-rate dividend feature"
       }
      }
     },
     "localname": "TemporaryEquityAccretionofIncreasingrateDividendFeature",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityConversionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion Price Per Share",
        "label": "Temporary Equity, Conversion Price Per Share",
        "terseLabel": "Series B preferred stock, conversion price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityConversionPricePerShare",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mdxg_TemporaryEquityConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion Ratio",
        "label": "Temporary Equity, Conversion Ratio",
        "terseLabel": "Conversion ratio of Series B preferred stock to common stock"
       }
      }
     },
     "localname": "TemporaryEquityConversionRatio",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
        "label": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdPercentageofStockPriceTrigger",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
        "label": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
        "terseLabel": "Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Trading Days",
        "label": "Temporary Equity, Conversion, Threshold Trading Days",
        "terseLabel": "Number of trading days within consecutive day trading period common stock must exceed trigger conversion price"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdTradingDays",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_TemporaryEquityDeemedDividends": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Deemed Dividends",
        "label": "Temporary Equity, Deemed Dividends",
        "terseLabel": "Deemed dividends on Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityDeemedDividends",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityDividendRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Dividend Rate, Percentage",
        "label": "Temporary Equity, Dividend Rate, Percentage",
        "terseLabel": "Series B convertible stock, cumulative dividend (percent)"
       }
      }
     },
     "localname": "TemporaryEquityDividendRatePercentage",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityIncreasingrateDividendFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increasing-rate Dividend Feature",
        "label": "Temporary Equity, Increasing-rate Dividend Feature",
        "terseLabel": "Series B preferred stock, increasing-rate dividend feature"
       }
      }
     },
     "localname": "TemporaryEquityIncreasingrateDividendFeature",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
        "label": "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
        "terseLabel": "Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)"
       }
      }
     },
     "localname": "TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquitySharesIssueduponConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares Issued upon Conversion",
        "label": "Temporary Equity, Shares Issued upon Conversion",
        "terseLabel": "Series B Preferred convertible stock, shares issuable upon conversion (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssueduponConversion",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mdxg_TemporaryEquityStockIssuedinPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued in Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued in Period, Shares, New Issues",
        "terseLabel": "Issuance of Series B Preferred Stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedinPeriodSharesNewIssues",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mdxg_TemporaryEquityThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Threshold Consecutive Trading Days",
        "label": "Temporary Equity, Threshold Consecutive Trading Days",
        "terseLabel": "Series B preferred stock, threshold number of consecutive trading days"
       }
      }
     },
     "localname": "TemporaryEquityThresholdConsecutiveTradingDays",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_TermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement [Member]",
        "label": "Term Loan Agreement [Member]",
        "terseLabel": "BT Term Loan"
       }
      }
     },
     "localname": "TermLoanAgreementMember",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_TreasuryStockSharesAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Adjustment",
        "label": "Treasury Stock, Shares, Adjustment",
        "terseLabel": "Correction of out-of-period error (Note 1) (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAdjustment",
     "nsuri": "http://mimedx.com/20210930",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r254",
      "r295",
      "r349",
      "r351",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r500",
      "r502",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r254",
      "r295",
      "r349",
      "r351",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r500",
      "r502",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r180",
      "r339",
      "r343",
      "r466",
      "r499",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r180",
      "r339",
      "r343",
      "r466",
      "r499",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r254",
      "r295",
      "r348",
      "r349",
      "r351",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r500",
      "r502",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r254",
      "r295",
      "r348",
      "r349",
      "r351",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r500",
      "r502",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r125",
      "r126",
      "r128",
      "r130",
      "r131",
      "r133",
      "r134",
      "r150",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r125",
      "r126",
      "r127",
      "r128",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r150",
      "r197",
      "r198",
      "r382",
      "r392",
      "r418",
      "r422",
      "r423",
      "r424",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r125",
      "r126",
      "r127",
      "r128",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r150",
      "r197",
      "r198",
      "r382",
      "r392",
      "r418",
      "r422",
      "r423",
      "r424",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r129",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r129",
      "r135",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r129",
      "r135",
      "r235",
      "r350",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsAndNontradeReceivableTextBlock": {
     "auth_ref": [
      "r190",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.",
        "label": "Accounts and Nontrade Receivable [Text Block]",
        "terseLabel": "Accounts and Nontrade Receivable"
       }
      }
     },
     "localname": "AccountsAndNontradeReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccountsReceivableNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r45",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r184",
      "r185"
     ],
     "calculation": {
      "http://mimedx.com/role/AccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, gross"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r26",
      "r184",
      "r185"
     ],
     "calculation": {
      "http://mimedx.com/role/AccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccountsReceivableNetDetails",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r479",
      "r493"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Legal costs"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r48"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions to sales agents"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r382",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r379",
      "r380",
      "r381",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r120",
      "r121",
      "r122",
      "r123",
      "r135",
      "r188",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r239",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r389",
      "r390",
      "r391",
      "r392",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r451",
      "r468",
      "r469",
      "r470",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares repurchased for tax withholding"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "auth_ref": [
      "r309",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "negatedTerseLabel": "Deemed dividends",
        "verboseLabel": "Deemed dividends"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Correction of out-of-period error (Note 1)",
        "verboseLabel": "Correction of error"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r186",
      "r199"
     ],
     "calculation": {
      "http://mimedx.com/role/AccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Less: allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r76",
      "r96",
      "r274",
      "r441"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Accretion of original issue discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r72",
      "r96",
      "r274",
      "r443"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r96",
      "r274",
      "r284",
      "r285",
      "r443"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r96",
      "r211",
      "r218"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potential common shares",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "auth_ref": [
      "r229",
      "r230"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "terseLabel": "Accretion of asset retirement obligation"
       }
      }
     },
     "localname": "AssetRetirementObligationAccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r112",
      "r169",
      "r172",
      "r178",
      "r192",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r404",
      "r407",
      "r425",
      "r452",
      "r454",
      "r474",
      "r488"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r61",
      "r112",
      "r192",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r404",
      "r407",
      "r425",
      "r452",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r354",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of equipment in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r41",
      "r98"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r90",
      "r98",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r434"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r109",
      "r112",
      "r139",
      "r140",
      "r141",
      "r144",
      "r146",
      "r156",
      "r157",
      "r158",
      "r192",
      "r240",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r293",
      "r294",
      "r298",
      "r302",
      "r425",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r53",
      "r234",
      "r480",
      "r492"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r236",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contractual Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock Issued"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance end of period (in shares)",
        "periodStartLabel": "Balance beginning of period (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,926,898 outstanding at September\u00a030, 2021 and 112,703,926 issued and 110,930,243 outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r320",
      "r321",
      "r340"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Accrued GPO fees"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
        "label": "Contract with Customer, Refund Liability, Current",
        "terseLabel": "Estimated returns"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r339",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r339",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r74",
      "r466"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r268",
      "r275",
      "r276",
      "r278",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r111",
      "r115",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r282",
      "r283",
      "r284",
      "r285",
      "r444",
      "r475",
      "r476",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r21",
      "r279",
      "r476",
      "r487"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r251",
      "r282",
      "r283",
      "r442",
      "r444",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal issued"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r50",
      "r271",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Interest rate at issuance (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r51",
      "r111",
      "r115",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r282",
      "r283",
      "r284",
      "r285",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r51",
      "r111",
      "r115",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r282",
      "r283",
      "r284",
      "r285",
      "r310",
      "r313",
      "r314",
      "r315",
      "r441",
      "r442",
      "r444",
      "r445",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r264",
      "r441",
      "r445"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Original issue discount",
        "verboseLabel": "Original issue discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "verboseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r44",
      "r264",
      "r443"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r96",
      "r224"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/PropertyandEquipmentNetDepreciationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]",
        "terseLabel": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]",
        "terseLabel": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r71",
      "r125",
      "r126",
      "r128",
      "r129",
      "r130",
      "r136",
      "r139",
      "r144",
      "r145",
      "r146",
      "r150",
      "r151",
      "r423",
      "r424",
      "r483",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net loss per common share (in dollars per share)",
        "verboseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r71",
      "r125",
      "r126",
      "r128",
      "r129",
      "r130",
      "r139",
      "r144",
      "r145",
      "r146",
      "r150",
      "r151",
      "r423",
      "r424",
      "r483",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share - diluted (in dollars per share)",
        "verboseLabel": "Diluted net (loss) income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Loss Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "verboseLabel": "Outstanding stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory and clean room equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r65",
      "r66",
      "r67",
      "r117",
      "r118",
      "r119",
      "r121",
      "r131",
      "r134",
      "r155",
      "r196",
      "r309",
      "r316",
      "r379",
      "r380",
      "r381",
      "r391",
      "r392",
      "r422",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r505",
      "r506",
      "r507",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r448",
      "r450"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Principal payments on finance lease"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "verboseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2021 (excluding the nine months ended September 30, 2021)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r212",
      "r214",
      "r217",
      "r221",
      "r467",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated future amortization expense [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r217",
      "r471"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r212",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r217",
      "r467"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on fixed asset disposal"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r96",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r204",
      "r206",
      "r454",
      "r473"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r96",
      "r205",
      "r207",
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r73",
      "r112",
      "r169",
      "r171",
      "r174",
      "r177",
      "r179",
      "r192",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r425"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health.",
        "label": "Health Care [Member]",
        "terseLabel": "Advanced Wound Care"
       }
      }
     },
     "localname": "HealthCareMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r169",
      "r171",
      "r174",
      "r177",
      "r179",
      "r472",
      "r481",
      "r485",
      "r497"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r386",
      "r387",
      "r388",
      "r393",
      "r395",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r133",
      "r134",
      "r168",
      "r384",
      "r394",
      "r396",
      "r498"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax provision (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r92",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r57",
      "r478",
      "r494"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash resulting from changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r213",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross carrying value, indefinite lived"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r213",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r210",
      "r215"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r76",
      "r272",
      "r281",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r78",
      "r273",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Stated interest"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r89",
      "r91",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r202"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r59",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mimedx.com/role/InventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r35",
      "r202"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r34",
      "r202"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r47",
      "r112",
      "r173",
      "r192",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r405",
      "r407",
      "r408",
      "r425",
      "r452",
      "r453"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r112",
      "r192",
      "r425",
      "r454",
      "r477",
      "r491"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, convertible preferred stock, and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r49",
      "r112",
      "r192",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r405",
      "r407",
      "r408",
      "r425",
      "r452",
      "r453",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r265",
      "r280",
      "r282",
      "r283",
      "r476",
      "r489"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Fair value of the Term Loan"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r115",
      "r237",
      "r270"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r115",
      "r237",
      "r270"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r115",
      "r237",
      "r270"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r115",
      "r237",
      "r270"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021 (excluding the nine months ended September\u00a030, 2021)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r51",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flows (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flows used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash\u00a0flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r94",
      "r97"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flows provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r63",
      "r64",
      "r67",
      "r70",
      "r97",
      "r112",
      "r120",
      "r125",
      "r126",
      "r128",
      "r129",
      "r133",
      "r134",
      "r142",
      "r169",
      "r171",
      "r174",
      "r177",
      "r179",
      "r192",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r424",
      "r425",
      "r482",
      "r495"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r125",
      "r126",
      "r128",
      "r129",
      "r136",
      "r137",
      "r143",
      "r146",
      "r169",
      "r171",
      "r174",
      "r177",
      "r179"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss available to common stockholders",
        "totalLabel": "Net loss available to common stockholders",
        "verboseLabel": "Net loss available to common shareholders (Note 9)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Adjustments to reconcile to net loss available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r169",
      "r171",
      "r174",
      "r177",
      "r179"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "verboseLabel": "Non-cash lease expenses"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NatureofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r48"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r60",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r410",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r48",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents and know-how"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Prepayment premium on early repayment of term loan"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Deferred financing cost"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Stock repurchased for tax withholdings on vesting of restricted stock"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMachineryAndEquipment": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of machinery and equipment.",
        "label": "Payments to Acquire Machinery and Equipment",
        "negatedTerseLabel": "Purchases of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireMachineryAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance stock unit awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class B [Member]",
        "terseLabel": "Preferred Class B Convertible Stock"
       }
      }
     },
     "localname": "PreferredClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r39",
      "r40"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "auth_ref": [
      "r94",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.",
        "label": "Proceeds from Income Tax Refunds",
        "terseLabel": "Federal tax refund"
       }
      }
     },
     "localname": "ProceedsFromIncomeTaxRefunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfMediumTermNotes": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.",
        "label": "Proceeds from Issuance of Medium-term Notes",
        "terseLabel": "Proceeds from term loans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r80",
      "r191"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities",
        "terseLabel": "Principal payments from note receivable"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r82",
      "r374"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r226",
      "r447",
      "r449"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r62",
      "r227",
      "r449"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r18",
      "r225",
      "r446"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "totalLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r228",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r225"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.",
        "label": "Repayments of Medium-term Notes",
        "negatedTerseLabel": "Repayment of term loans"
       }
      }
     },
     "localname": "RepaymentsOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r383",
      "r465",
      "r521"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock unit awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r316",
      "r382",
      "r454",
      "r490",
      "r509",
      "r514"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r117",
      "r118",
      "r119",
      "r121",
      "r131",
      "r134",
      "r196",
      "r379",
      "r380",
      "r381",
      "r391",
      "r392",
      "r422",
      "r505",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r166",
      "r167",
      "r170",
      "r175",
      "r176",
      "r180",
      "r181",
      "r183",
      "r338",
      "r339",
      "r466"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Collections on the Remaining Contracts"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r341",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Direct Customers"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Distributors"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccountsReceivableNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Summary of Antidilutive Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": {
     "auth_ref": [
      "r140",
      "r146",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "auth_ref": [
      "r140",
      "r146",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r212",
      "r216",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r212",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets Activity Summary - Finite-lived"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r220",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r220",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets Activity Summary - Indefinite-lived"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r36",
      "r37",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Future Principal Payments for the Term Loan"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r124",
      "r128",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Assessment of Revenue under ASC 606"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r68",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r354",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r356",
      "r367",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Awards by Award Type"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r54",
      "r109",
      "r156",
      "r157",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r302",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Future Amortization Expense for Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested, Ending Balance (in shares)",
        "periodStartLabel": "Unvested, Beginning Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, Ending Balance (in dollars per share)",
        "periodStartLabel": "Unvested, Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable options, vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Vested options expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Unvested options forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r358",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r352",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Vested options expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Unvested options forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding Options, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares repurchased for tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r105",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r109",
      "r112",
      "r139",
      "r140",
      "r141",
      "r144",
      "r146",
      "r156",
      "r157",
      "r158",
      "r192",
      "r240",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r293",
      "r294",
      "r298",
      "r302",
      "r309",
      "r425",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r56",
      "r65",
      "r66",
      "r67",
      "r117",
      "r118",
      "r119",
      "r121",
      "r131",
      "r134",
      "r155",
      "r196",
      "r309",
      "r316",
      "r379",
      "r380",
      "r381",
      "r391",
      "r392",
      "r422",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r505",
      "r506",
      "r507",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r155",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "terseLabel": "Restricted stock canceled/forfeited (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "negatedTerseLabel": "Issuance of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "negatedTerseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Restricted stock canceled/forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r309",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "verboseLabel": "Issuance of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r316",
      "r353",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Share-based compensation\u00a0expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r309",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r29",
      "r30",
      "r112",
      "r187",
      "r192",
      "r425",
      "r454"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:",
        "verboseLabel": "Stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r294",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r240",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Series B Preferred Stock, outstanding, ending",
        "periodStartLabel": "Series B Preferred Stock, outstanding, beginning",
        "terseLabel": "Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r17",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Series B convertible preferred stock par value (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Series B convertible preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Series B convertible preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Series B Preferred Stock, outstanding, ending (in shares)",
        "periodStartLabel": "Series B Preferred Stock, outstanding, beginning (in shares)",
        "terseLabel": "Series B convertible preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series B Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r17",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Series B Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Tradenames and trademarks"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r317",
      "r318"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock at cost; 777,028 shares at September\u00a030, 2021 and 1,773,683 shares at December\u00a031, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r120",
      "r121",
      "r122",
      "r123",
      "r135",
      "r188",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r239",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r389",
      "r390",
      "r391",
      "r392",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r451",
      "r468",
      "r469",
      "r470",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueCollectionsonRemainingContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual or Infrequent Item, or Both [Line Items]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemTable": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Table]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Table]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r138",
      "r146"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "totalLabel": "Weighted average shares outstanding adjusted for potential common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r136",
      "r146"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "310",
   "URI": "http://asc.fasb.org/topic&trid=2196771"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "326",
   "URI": "http://asc.fasb.org/topic&trid=82887179"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130611-203046-203046"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r522": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r523": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r524": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r525": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r526": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r527": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r528": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0001376339-21-000105-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001376339-21-000105-xbrl.zip
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MR*3<[)ZRZU<+.W]?4WSZ7_NXWQU=_@]02P,$%     @ I85B4^3)'?$(!0
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M612Q@!; (WC+WM+P!GXJ^"IOPED6F'"H2)X?=%W7'HQYFI-LHU?.X*@),1%
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M\-,I#<PI:G$ZR< 3+9T&6N(I</$FFJCC\=N-81I\#.6Q9-$&19ETC!J=G,#
M_10@IXDFZEA6=7Q0 92NPU@Q9@E(J@X6N8B,Y9KK:2B ]C!1AT#YW\$T>T>)
MH+-H07'@FHF0ZNU3!K((L(BJ@+$%7<LHGX;2ZA-$PK'82QFX4UY[;3UG)'I
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M:?[QJ\AX @?;&.13E?0,%ZF0^"'\T*Z='^7PRXW:>E&7Z)6FX)7R_F]@S\
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M9[O3&=A_;6-<?\ 8GYX<M#[31FOCLG&5^K>/ZL=@?'?>GS3V_LD;J;C[L;N
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M<NXY0VNRYJ??G83I 0"4BMEV:I4^K'T 3'JZ6-MHNZ5T?-HZ]";W!A!L<3K
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M-<4,PE()O@2OT$344DBE"9+_JFAS91KDWJY1JX5T&54T/PB:QXV@O53)L*!
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M[9&\2GXSD=_85I5<!4*M <%+0>V$Y&=9+*6UN0\TL1RD1/*3ILWIO'HZ-8(
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M1!,(.L5$92;&!@1N6VO>5J:J%56M:!I-39-(>S^2JHFT3\53XU+>PGB3*1-
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MH#,&<88#LCIJI"6C)B0CO*>@J_@^/2>JYV"I-#FX%(LW"K^[]D2TCKY[^B2
M^P?:;(TE6P?:W!'2YNH@*&*$4BHA5L3A"9F0(TJC0)E2$3O8DD3N5H'UU0;9
MU8NSJ4/PGAMUJ9&A6L@P)3N>"*FI84A1+A%7(2*3A$%1:4 (E0(7F>PTJ:;/
M !FNC\#3=01>'8%WAPB\QDSP76IW;=?7P7=U\%T=?'?+@_#R8*94G_@C]GU[
M$',DWF#8\]\:O9.\A[PV]VYU@_%FS]&R@'9*^6R.!!=JDK40R9I+@])@?&&I
M XK<YC0HX9!+SI=G9A1;$TC1QY1C7I>A>[D:O?32MK72+EUI9R+MA.7&8XN(
MT3SW]=1(AT11D%H0@14E0:ZL,56E7A>O+-BN6/.-?CP9!?J'O./EMH"-L_;P
M\+#7R0\U:(!6COW$0#_Z\&N_[8<QE$SDE87B53\?X&/L6)#.;F_7_O@RE>/;
M7O_3H>W'O[*@Z_J9=P:YSW/GTI%KCU-"T6F%N \.6>HQ8II:34Q2DA9%K)18
M@F/XF?I^7[B2/TV&0*WD#ZWD,QV-L768!8,\P0*!"4*1X=2C2#6FSDA/.,X^
M7GZO(^V*5JI[!C3FFIP!4-G2XQ@;G5QVZ96Y29XD"FX,46_+B?\GS_M$-&/<
MJG%H(1S:FZL&8RP5CDO$),.(!X.1(SPAV%RDAI>PD )PZ&I;]3H&KK*:6L6<
M@%J!EZK 4R+A@HQ& '.@"D?$E?#(4?@G)))$PH$XQI<6^U^[1>ZJD^,F$S.'
MECF4_I4Y.I[.S_&3;*41".VDC>B&6X/!:0:J(FZWQJ6%<&FNSH'1QABI, K:
M$,1-I$CKF! -6G*"?1)D>;A4.S,J; P\C3.C5N<EJ/.,OP(HAHL)R(44N<\X
M9SE91B,?4M)!<WB/%4U]EA&35OLK%E;(CW'DI\C'*</8/VYT>K8.Y:@ OYA(
M!B!I.X;VZ?$NB*?5&]9!L@L"TEQ% Z>#<XD3Q&C*]?4)1E9QB8ARGA!++1>D
MBG9/[<)XWORB5N<EJO.,&P,3HSW#"#O+$"<YYCT$BKSW#F1JJ3!^94VSIE;W
M(1BU V,YL:/W9!C/U_"I(L.8#3D;&SPU.-T/G+[-I>IQ1Q-.%!G,*7 -RI$V
MN7"C<])()8P3J?9EO *5?F171JW7#Z'74])A!%?<!XLHM38??A*D%8$_F=8@
M0^F9C"MKPC0%7E8OC-JU<4_F,8#%GGT<G^!B<(^_LH(6HW7P^DE_?,QR]S#2
MYVLT58F;E"511I)+,P#62[OQ^*37M_WS7'QV>%X#V ( !G]/B<G%.M[97?]*
M!8]$,XNB$QI0C.7RL\HB#4)F7& /PJT](:] J1^'G=2:_7":?3ZKV?XK-XYH
M+CVBPF#$K?;(!F60C,1:+:/QPJZLP3IIXOL3E-HU<K^4E_9(#>Y1(O%5V%!/
M$-A1"*@^"KX[-&U>(1W:<\TYX4B!$(%TZ( T5@*1P*1T7L;(9>T2>:[J7-WC
MEUJIEZG4E_A&EAM1AJ"$B4"<&88L8PDY)E+R*IH4PLJ:; IY-2>^#O)X#$_(
M),KCI!^/VZ?'.2DEVG[GO-&_-@"D]H!4B(;D@+3-'SGG^;0].,POUK"U.&QM
M7>$B1'%OO W(F4015UX@'1U'8"%A[AE)QBZ/B]0.D)J+U)K]4)I]B9 HE;-8
M@@(NDCMK 0U!UDJ,<, A!BZY<D6O<J J+RHHI-(LY%+AY]]&E9]_!TY2E@5M
MN/-K:_,]2!GHEPYIU:H!_78LUKK2Z_W/;SY\#4EIXI(%0),,<<U9+O61&W1Y
MRA*+P6N5:T SM02#ZW8J](P<*R\*$RK+<FHD>/CSG@]?960F!9V05,HB;IE"
M&AN,3%*P[I)7Q(,-(VE3W[\>X:/@P7,I^US]FL^OM^!SP30/;?<@YLXBF7.^
MLF.U9T 4\]Z0_\]'_M\!_8LZ4N-J?OF-]6Z8?V'FD^]A6GJPF?A^K@NQ$<N?
M\'?G-(MJ\T<I_8]V&#=3BK[NH71G7]F'KU9X6!?,(AHXR2D6V4V6$C*!:488
MTU33E371I/AJ&]BZKEQE,:*RQ+%&AFHCPY1\JB"-]RE7U#6Z3.YVDGJ$$]:!
M8ZE5#"MK'#<%E14ZRZ\8Q:ST-5X#72SZ@]AN*+V3<0HFS8:+!^UN=U1M^*3
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M FD^@X_$!GQPK(R-7O[667L0&_WLN^WG#^?<0CIE]@_TC,45_VP/84K];?A
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MO"CFRPLIGK]"ZW5!ZU/LVC:LVOXNR&E95<]$]SR4]NY?N+6W?W'0_:U]L',
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M$*O'UX!87PZX-G=C-28SX!5AL>>@T971)M\%9#VKO0][7V+6T2>+-Z=0'%>
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MI6$+GRM89B*E&E.C&+=,.!"2J0E6$QX%\3<'84]6Y[54;K>?)NV<]D$.^ ,
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M#/*@A.4*]H&Y5 .16&1E@9&F&KL08]#$)L D%RO5-H#9 &8#F(L!S ?Z8QO
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M7O+@Z?E^J);+ 'L2I4GE1 OL9/01L\(7MC#&Q?/]4*MEO[YUZ:6=1V]^T?S
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MS9=]Y:XO.WC'.3^OM:N*2=R%QIY$@XT_:S%HA_,' F]#1%?-_[Y4L>JU4W
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M9D\,BA+ +I6Z15J!!<F9!/8P5K*@7KQ2ZV1E5*CG4*X[<T ,347N:S0[[5C
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M;7Z@%H;$K3Q8#R0!^>Q(X!O]"H*=80>[;YE,=4DX09IY"H:ND=1(+(30V>?
M+U(!J#?=M/&/JZ4EC><<R Q@-P?I\7=%0ESI1<<#()L!*&>MW&83;A_VX>NA
M4W1\)9_2'_*4$OJ-NK6"Y>U@<)K<90GF>A'PKQ)HO?U6MU^6<)>%_Z7QC[H9
M'+-&MO'IS=^M#4#+DX../ZBOPCL[/;BWB $>T:U>%(L1K,L=(30&QG#!HK16
M<V^E \41>T>#!C1E'-\@Q&_)6V,1_V'0]S&&\NV@?S3EL#SPY\M)[9W/XBMG
MFFI.. JFP"G-R"*G0<0;I:6.T16A4'=R]B]@8R?Z^!UV>+*K;WXD[W_\,_9B
MT1D^[\T5!--"JXB4E0IQ8C7**64R>9-!7Y':Q0R3EYTHO@HW$PB"!=FI''\)
M 5RUUF/H*&%C6O:H/^H-IS[?GZ5675]DZ-:RMAV'[\<H^1\ R=<)0^'9*6+T
M;+6O]N'NV=?HO-:>*P0[%8"F"@]& - 4V-^1,Z\LH:!]M?L7"6A,)@<V=:".
MO2P0]WN=,Y J)YWAP5B"CJ78I:(JC&*Z;E,WZ^^=_JCLGJ*)8/UNN[5SV7:[
M_1/;\W']-EVM;Q=T276-;A5TJ4-(*(6S7Q)]J2.F^E,'I'YO^!*EFWY58(:N
M5\K&Q9^/'*YY;<N#M[!-?X^.C[LY1FN[T\A-N22A&[8]#KL>ONWN?=DZ:9]M
MX-V=O4Y[\^-I^_ -WSM\=Y!"HNV=CV>[]!WPR 8YSV7;7_[I[AYNL.W-3P?
MJ;@-G+F]<W"T??0&;V]^(^U-X*VC]N'V9C*UO_&OA0S<6NM088A!'$>#C+ 2
M!:FQI=Q%@R^TF&< G"0RS*0.<(<&@<N3T*6&!,6Y.A^ZF5WWUG3A$XRGK6FE
MO<EHW^[WD$]_V<K%,W-Y ?CSVTX/."S]ME&UI._<*P1TX[ 7GS]U+G7 '\0
MVO+[XB:*3 '=9TN6AQLG7U7 EDN%$?:% / 'X\M0AU,T!/[5@G ESI/9BKBH
M_XY=D#T@1#*E'U<9(F4RZWSL'*=/B>9[8U:P$Y)O6> 9FTRM)'/*5NJV.SP
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M^?*9O/_KS<G[S5WXWD<"]]#W7]YU88RL?>AAG-_PWN$6WMLY .;:_@'L^[4
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M3JOM[H^&OE[,[CS9SVS5>('3GW/;R\Y1"LJGXD[C-P]BV>^.JB_#"G1Z!W$
MX-0];058HXY/'2]AM,>#&#I^..XCG*;7AP<?V6^I>>?,O><;EN?O]E,&#,SL
M*-H>#* 8=5N):/( ZIYX,,_]_,L@VA(FZF $Q_VRS&F)]63S6<Z:2#H56]C]
M?9AO?LX@K7NGEY,<$]+F&]=;_^Z?1-C0M;2)-O6NB<B=IO,9,6UN)S>P =;\
M7G,)C O>W2D/)FU(^W!GM=O35U<M/V'BG3)-S^72%O7VI3YLK9-.MPO;GIH
M9A?;9 LJ8DX3*4?PB'RS!U2!>V_3B*T&GQHA.%U7R?$""Y7)XV5%8-]CW9ZF
M-@QFOE@C')Y^Q;I, %=_Y5ILG/3=^170F%3=N26;^7DPF/8]V8<M![+ZABSP
M]^"E[9[8T_+%O^9G"5,\MZKW6I!Y8?'J?]S@7Z\N&^6EPOQ&X7Q.F!=6@6X,
M6B(8 ]P[D/N&$ELPY0/U\7IAOE1";H;IQ\ 0YO#^_RT!8>T(4# UH.JGKH!E
M]2G7<<Z07&<= :-F]*YUK P:5_0KKGX;Q**;Q=S<ZS+? J<Z&- <6DWX?=(;
MN.S[2BCD)HUSLFVM;J\^R85*@ A8=@PSS7=_!P&=)'$9A\.JHQI@VB#&NKG6
M28+CECT^!@THO;1:E%J7K!Z8,1-6X7MZ1_7R"JC6TN1/(@ 1_)LFE^ZOA'DY
M*V\KW$K8!P.*25 -IY/L5[]7"Y#^D"4KP![\'M=@FJ<)NF;$-4SL '86G@-?
M[0+X)@RUO1GP*\>("UO\%FXZZF?!,U$3D@2S@U!/YX+$K[#XN&I8##=E!"_2
M:_JM7&V(\+56NIM.;=Z?K9]>3N4WZ/Z/.M1K!Y97B_PQ%JJYHS;LS%&+8/1_
MUV^I-?\J0_OR*6U<Q_?S&G/2&ZWW8*J%.W7HUI%;ZK63U!9<.N&HB@[@&C,9
MA;3NZ]:E+O&[->;.O74G='*ZD<9INQO#W&\7_I@//"U+$^=?8,5[O+WQ-41#
M>2$BD!(3B OLD2;,(BRU<\('K()Z\8JO7SQD.&G:/-,Q/M'&!9"9DT:Y\OW:
M&"]#9P#B W OJXM@5^T?9 NL R;!(">LU!IP$@=W(;"'!E_NV *^[N@(C/^?
M-/N_)Q)I:3K _WSZ.MS [?VO,5KLHU"H,)8A[K!#+G5X5IHJI[PC1L07K]3Z
MQ8+Q$_H:]FL3;\[D2M9;IK1Y4_B<Z&N%T6#\IUYJ"'C4SPT!XWQ#P'F,6V^M
MJ+?#UK;N/$A/3\^/T@&V8M _:ODX&((Q7S,@<%\2JOUDB<;!+/>!AI@D;+;G
M9KIBCVVS-> ZL! G1GUR*8!V64Z,W?S&DZ2(S33D3D(#?@\C/[;HYUPAV:P<
MJZ%CMT@%,?7S[[>K*RF,$W16W5_3A#MIY4(L_:!S/.:"\5;>Z,NX;;O8VRW
ME2D6OTY)_#L"559]<U]WP;;(O:/[O2NGO0R;3%(3U_>]UCL+YBSL%9&)6HFI
M6/AS+UMM?R=N*%,?[>&@ ^;6Z^SF&ON+VOU!$J:]Z76@BK]B'_;4MK*3(3M1
M6KF)SXS=EPCJ2I%:5FMYZM-"5A?/B5AJ"F.,=@'^Y88H4X *%Z52(1:LH"&)
M6&(P(1*-/\R*V*WVVSD9"VOGDYP]@6&6L3<7)IW1XI)2UQXE[GY?3/<[;W>U
MVU.)BY^=Q/7D_<>OS/O"&2Q0U"Z5]Z4$:5UH5' ><*&5UY:_>#4\Z5^4N,>C
M0>V'+:>LE"F@5=U2MGY;&KLP<\ZV]1\.8FQ]7V]M=[9C^-'Z"S#I>*VUU?/K
MH&:"==Y=_T7V81Y@J^AT83W?1C?(_$U9YF^=,7JYUO+_IC^MT$I62*E_K^R+
M"MT 6OK)Y]-/O5U#"TR]XXR 9>L#* X)X=Z.LJ;3V@+ELM<'@?K;+W9X7 C(
MY=F^_O!VZU>N=NW7^#TI:]UHPS3XL]X"<;5M052-)54::[T[=MZO:(\JE2R[
M[=+WUQ*L)\$#CP4Y 5=S!&E&75T#\O,'-G9;[]9!E>M]BZ 0?K"#;["[_UX?
M>Z<^Q&$<NU[@<P<>_"69"_:H]1KHP9["*L' #@8@$OO'R=3<7F^ENB:P,)4#
M"?X&1/1G_&9!?VK]'WMT_$?KWZG)/5S\SW\^U-["\^-O_9:&6@_B"GTCSR3?
M/5W$.H@&^G,5QJI=+-7]!/_F?A]'<V8>^N8'+$2*[6Q4,IT8QK-G<CRLV<',
MWCQ^[UKKTZ@;X?D.B61)'XVZ^Y6IGGRCP @IN),F/!X)Q;_9R4AFG[C>VAKF
MEB99.MA:**3X83]ST[8=^(.6RA3!)J;\NQ$ "C45GR:/Y5B/38\'@JDC:D?]
M:DG $ B=\J@#3W:G^9ZQBW=**C6UG< JY !?-CWL]YB^G$@P*3H7=FU]ED1S
MB/;"OMI]^*<<WH$2KR:[&^GKMUG"'%-EFE(8](^/QQ;29-*_IP!<M<*U,8/_
MF.6>:EZ7K&*_8M1J!RBN.3<]AXIY=U[2)\?K.7UR[3A.]MAQHI#O\9*WK*7H
M0>URML-JI;M@'"0M8FCK*_V6FUALF>ZZI]FO/PV?9^3V_5$WC+WF53!Q'.<;
ME95MXV+ZG$.G@#/I>]U$0SEN?V!AI,D56TNP8Z">[-Q.9K#O#P;U),(DAZ<.
MN]=3J3@C1SKS6FW  [HM2L=K-0=TU4ID+3S9MK/UZFH&JI^:XO"]*B0Z(=5,
M@/E#2,_J 6A/ #;_&2RVH^,<<@ XB/EQD]7,V0;SJY(.>,5SGK;DG 5RZJ=I
MI9%/P@#C/1P'5@^BS9O3KWS8)0PN4^-![(:JWDUM4+<H'WM(=B9DDUZ3=NP4
M5(3!J%O%_--SZM=<;7??*?9W%[OM9]BFUTKOK;G4CIOL[M17]5:NI"6TN3=C
M2H[)P3>@^G3&-OEGWF=/4E:S>ADZ@/;_BCW@CVYK;FT63AOW<-#]1&JY? T!
M:29:K;XLS#+QX-D4+CSNQYZM.#Z,!>7=MZ&,\5MB^H1=8'&?BQRF/B/E&,?.
MAQ&/.G[0KUUY29G.KGQ0+Y)#+TN&(H;\CJ.4^0+_%M:GGCTYG2HA87W9U\E]
ME1J0ACH7]*WR1U(%?CN\:J;_@!X(8@M4KZ*PG4'9JGTBEZY'A5J3%<P2)RU#
M>8<0*F@,1Z,>S*J"T''8NO5V<V/FFTD:C1=D'I2S\,M(7DYSK:;[=-'ILP&$
M/.C%TXF[YPMPSWEOSQ?0(>"]PZ1\YKRT5#FGK 1#E905XWA&YWRM=3X.J%RQ
MBK3WTJCA_2#[>KYSG,/2L/9V/P=?02IU^Z=7;4?ZR\;@Z+3U>I#RI<YS>T[A
MA*G/+TDGK6JUS6D$DR7=3P/OI4=/5G]N[)7:,!-3G^.93DY[R,E%DQRL\^E?
MERS'E/Q.#F(F[ LW51E*H#NDI*U4%3^E#E;Z<_:2CP-?$YUR5)Z/*#092C=G
M*+$GEJ'TD(RCE77)IU0(X*$W%6K$UH4\XRJN<U.2\5),_=8N?'J9#*_,AI0A
M/,X5>=T9^/1KI4:/C>YN_ YLEVQG0*R4D37!^4YO8D=L@\7909LV9"6\-P1;
M]2W,LQ/LY0[:Y:*,RG-[P<F87(^U41W!9+_"W?C+=_KW":YWJCSM1."OW[R_
MG9=JG&,^_M[[]Y>Z$,;:6?(" &>,L\;'EFX^/U0I4WVPDFL[HU(N4B)O/.IU
MBEI)F4F*JV1K'DG^;O6VF?BBG>AFAZ/!5.G9'W6ZP],6B.,L1<?SKQZ4<\ZG
M3JMB8$=A_NE5T.FX [K>:9W$=Y3,]W-?NJ 5S"Z"[]I!%<T\'(7]K&]D]:E*
M)$[V9[T052+*> UR9HD-WW,T>QR=3C=<6 3@+AAEKW:$Y84:1U:]K;]4Z4H7
MOCI[1&#BRA@//B<->B#R20K?-(Z>DV%:V:EQ8+M%VMW;C"NG/^=!_6P.H;?S
MU"\EWU[BS[G("95O)P%MF=(O\VZ.O9ZY]U$<C'U6%QV&E9LW;7K22&"/*DSO
M7,>2:_/WYGR*GJVTZ?U^'^#>IBW/P)]:)81HNQ,MN?;+U9E7-[PG'TNYP%$Y
M 6-LATSMS:,TN:M8*J]*S5-%K#QNU_).0Z:W)],+-%EVCL#0L+U8048&EW,^
MR!FL21[MV#U_CF2\6U5B2*+;E)'=J3IY5:+A$NPYES<\E]PS>?K8PWCEE^LQ
M9J*9N!J3>S'U1T_"H8H2L+%G<:.BQ<,4PAN?AQIS1XVR:W-NR_0LGZ;7[5:4
M:I,XF[U_[%'-0TA.B<E1HK&?U9Y++<LV994W\T>%M].OS;I&-T;[H(^V"!F/
MOAWW^\-.+8_SP:C>/LQD?_%>T"7U=-W9?P@OJIT#&5A7;;XW>?8R=?,J!+;6
M^ALH<@#$F:/0V[8'YFN5Y?:?#Y- ='W/)'@XC:Q>$ZS*_+4]F&C0,V<GID<#
MPW2QT^WU$<:I;E8;)K?*.OJ[/[J8=926;;<_^+8*5DB5,G;E?JQ_6+\\%V)9
MC9,\GSH98DHJE7_SJ-^+PV2;3DYU)C.D=SCJ50&Q0>QV8E$KKRE4787D9V*,
M26=/1T4S(5H@.>"Z[%D;@8[@\YG'TB<OVW!"X_DL9[>,<#'38.48S?!ITVG3
M01H=O&T >G6_%7O[-H7(@08[W4K@9!H=.Q*3BOR]4QU5+$&%MIFX\POFW+?9
M2IZ-G\&:=HY3*F3E'P05L'*U C7G627YF>I[S41'V22UP69S(UX3&[TD[ I#
M*$;=+JAVHV$EC!(WU:N2#_-4+>QOB%FGC=RV^XF]TN!3G"U9$D?UG3,P,2MG
M+PDSNNGX86A))E9!S]CKG/M3&MR[/&$;^L=UIL#,("8OFPQD?#JYGMUM0NPU
M2_TV0:L\-1=C;Q+_SCG*^3!!=:@Z1\ K[;W2$_!DN//^E>K\==+=T_HESW(Z
MK=K)>Y(H-+F43Q>;W[V$J/8^.ZX?X>3^+\>WS]G#D0,NM;_KS_HH/Q!"2EZL
M0" ES&0P.^?Z2.0Q/IU8^]*2%Z9.?"_K7( J)?Y<<8#.E>;0G1Z:L2[IA4?)
M>9<8KU+09^(&L\)[]N]@*::LFF%"P,HQD(]$Y,/N$^MQL@9K\W98_.'C\4RA
M@1FC8-8M4N%;K?%6]',QJ<!V$_S^_^Q]:7/;2)+H7T'XM=^3(P V[L/>=83:
M1X]W6Y+'UJRW^TM' 2B(L$&  Q"2U;_^9685#E*D3$IJ"92P,3LCDV"A*N_,
MRN-2"?%B:JG?0%NGB6D)57(IBRJON*5YE\K?[*(?Q\+OL3RR*=FEG<&B17/H
MI,:9F?O'Q]L6<#2U5$UMBTCY#U'[AB#"KE FZU,2)DUQ^ ?J.!($RW4RLF8U
M);QL:I"Q[NJS:YJ1@SF!3[5WA[&8DH1I/KS72""CV@. !BKSWD7=1'DKD"KN
MUD3?! 6,$4&L8N]=/8,J\M6:8O^\P)B,K%!I8Q?+_INH-,/V2J#Y9:^*E=NY
MBS;7:(K:DO6V&M.-J<*3!*,K,IUE,SC$52"YT/(:D]BL*ZIN[N.HKC?]=YT"
MEB\GVUP);MG,R=VRF9-L3*5AC\F7AK^6+<1'R++YXJ6&#SU0PR?#QD ZEO!<
M_>^_N?_3)[R$J?E[,$.:#D1?0)J^ 0@5\,:A='XZ3IL* _CWU_CK\>G_P)J'
M%T>GG[X=?_W=_N/+!^ODRQ]??S_]X]L?7S]<'KW]X^MJA0&\.\5W'G^!G<-[
MCW_]IWG\=9K]_C5R_I@=3X]GGV9'7S]<',^.L?.3=73X)V.>8_B&KCDAQW&4
MKJ6%%D\T%C#?-G3XQK=7^RW8GN[YMN58;N3;7F"%X-PF8,>9B1W%7(]7&S])
M#-R@K=./W[2\,^9&CN'H3I@DGNU&7ACIENM9NF<X=ISX_CZW=0+?O&GS(@6C
MA"O:$!]%@LI>EL5)'P*MD8TE3#(!YTY*SW>I5FK*DR1\AU.0=-_BXOBO=W^&
MW&(6#T+-]TQ7 V3&FF_$L080=HR0>R9SDTW52.#ZDU6"N>8B&ZW)J7JI'!@O
ME$-A.L;*%[3:L-@#+"-0L4TVN^6"']_\1!4SI2N9;496^X*2Z$2< 1"I5%/.
MA<<._G*RZ/V6LK;-%]W2CK%QY2U2YEK39,%[RY YI799R[@0%]4J[S#"$8DF
M)V\ITB)"T6@6U94LO@>K?+%L_\V![_$G.=@\2[EUP-33QO2.T11"$*!;0J9W
M7<'>BNH;S_@"[2'10T5D\ZZ#.IJ 25W*DOY6Y&"6&%]<H&._#B:G!/V?A;,J
MFGJ4<9<V-V9,[9HQ93^RC*DM-//?:P8NJ\^31"K/4TPK?-(VX-F?NN?8MAY$
MFNFZOH;UOUKH6N ZN[IM>(9GVZ&_:FE%%K?#.&&A'1JV;9J^&5@\TI,D "T,
M7LVJ#;@OQL@O'.\;R0VOZAGI+)"].:@2D48-MA9=\8NBJ4Z-*0?D@!=UA>G
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MV"D0]@,%9[?%(8!R11T!W:,T2_-:B'(2$I'%[3!.6&B'AFV;IF\&%@?/( E
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M]$;8<4H=J&C_+ +!+?JZ3<LB!_"!!M%P5_C#"U1ZL"Q^S_ TLY06!*ARK5H
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M+S3G6Q'($OW%#ZF3.=(]"K=?)+"'>L0=O7.0IB38(S0H@%WG=5G5>-:SLK@
M+4#!!4ZN%/ B_SZ7<UF0[LXX:K[YE(Q.,&[VU)S \_>B??+@Q7P.1C7>;0HW
MDGA2B![RTZZ"XSI# Q8 F93FY)(L2,G(Q5!GYLI_U6 K^J+]/$DZ4%:<G#D9
M$"K0XF\MQL:Q_"\&&T Q>"3B0*36_T%*355^8R%L2U@C7WB6X'Z&&2+ZKZ-_
M_/9E"$$B5!P]A26]SL;2 "(@@.-TFFYJ" [P:+7=15%^HW OAF#I6+@DK]")
M2*LI8#.=A<!B0I2#+1?!TT@!0%!LY5MD/%P=?DCA\-Z@&W0^Q" ;0#@H/%+*
M8K,8J&D"P3),BQ',LNIM?R.C#E-0&8Y@5.0)@C*XN,";9-?.-7*SP ]CDBW
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MY12$H/(;BKW#5NP=Q+R*RC3$JVRPM2_DKV3DY+?TWW4*SOREB%2P.=(F7C>
M (UX)2,&+\1YQ5NC-KS11%H!BZ3,X9#_5>?\9M?1 V9#T>3B@VQR\3A8\$KC
M#I5H..=GL#DR1(&>. ,]*6EYMRR-QX)Z621]RKYC-HXLDGZW4B2]1U8:LK&X
MP,78/=9^ER!9NMNTYEJ K/0#PY[X+YX34@_ %WFQ7?J$*%]8(HGUW^G+>3HD
M9$K>W/-@F)BC5TRBL.3@@Z>P" A+L7_I-EP]#5%N2O0M!)1(0"[::PDLFA,1
M+G&=)9T0P-=4_N+*[393SEE6RWN7#,0HWG6M(?(T_L]G:>1%CJ\;,?><R#82
M[L>&X0>)9R4Z8S%C?X*=\VR/6,-;GT0/GRA'@@+>;9(';U8RS+?XD;[+A6I/
MO#H;K&4J6>AL\A*T'Y9F9&Q>\9?-'Z^:7LII3B>E'[U:?A^^8*4\@]XGOI8F
MK.].3,=#*U86G\H72P-W0@;N2LV(^,[R)YZU^6M]8FS\[KIE#6MBZ>Z-EKW^
M.]?VQLWNU6:-[3;T@]+I'Q=]&5>>75/6)?CS?NJ=?JP<]2TDVB[UY7L(I"V+
MW^CRL*AAB;AZ<:<@Z14<"BF-4AU+Y>A&4FF.ME?@0B6XL9G.C@=^:H#31\#=
MI'Q=>3-E^=GF%DXC\*XI>5T'O"?0"ZPMT-RU3<S6J']DK1]V/OZ@*[V-P%!-
M_89CO';A_H=L]322\I,@92]07?^1D/*-%/1(YT^"S@W5,?7'0>9WT9SO=E0]
M./2Z$WMXN!U&#YK'W=1OJ0SY:373MTS5L785:6/SJWN.R_BJ8^PZDGE$TOTB
MR59UPQMQ-&@<&?;.K7D?4R>YQQU/Z_>P>%J]] W'5]UQ(OS@L62HAK>K&A^Q
M=+]8\E1''W$T;!PYDQL&89Z<%M\_7WR+MD)/RT,W;$<U@W&<VL"Q9)FJ9>QJ
M@HU8NF<LF6K@.2.2!HVD8/(PS?CW3[OOGX^^7<.QI^6]^ZJEW_#B:?0X[NN:
M)%!U=U?%,2+IGM.D+5WUW'&JY' 1Y/F3'08AC4[[OJCU3QOZ"STQ3]U4/6^\
M2Q\VDGS5],=@RK!Q9*NV'XPX&C2.''MBCF[Z(W735]O#76F5]K0\=-?>-;%G
M]"SN6:L;N\8,1PS=L^]G>*-G/ESLF/IDAXG83\,S;]J3Y$7.KZ>F\<GE)Y]
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MJT2S-FE#GN4 3!1BL-JB*"^5BS)=<"TN+D 4RZGNV]L4J&[3!#TRV*)L_X9
M6*/!5:EG\ 5)6<S$)'H@1"GGW[\]I$(D[Q5.$@:X1:*QW%LQR1Y7$U:#2N1;
MB&'UC770VLF !B6&G\#.T[R&ETT4,/KC0LD+;%('WF,ZQX'WP@[I'QZV+7_%
M&SV4U(NZ7#>S?O_XHM]>7Q&;W)T[?&NB/U^B=A\9X 94'O/.S#A;L[45XA>V
M1Q];K3^T%S0+AP:3!HBJ..-(N.H:^BOY'-XF["!PKY[C2_(K'IU<[X8D.7 M
MU7:/_K77/?IPJ7LTFF:88O(HPA%;=,MN<F)W]^D;1\:P5I16,/%!9Y$7:#N=
M.[GJ(8(FO)&KN:K'2IZ@?ULUO@9HG;8S25)GF08$SD 19=AX3-@F,P#GHJ?9
M%E.V$!XPL,AY6M05L:YP(I9E  @-V&JK*;("/K](R45H("*=D @LA=8EO[HX
M\'_GD,S26)@5:SV2B?*^+I&M9T7)U74:&2 [2ZN*_)T5D3(%>@#@]34W "&K
MA#8JT[!>=(&C9NE=W-#]8?^5]K*?5MK+?I*R>E4"/ 3GKEQ"[(2%08F@[5KZ
MWE *-5H>A-H<5.IWT.<+#MSUDZ5W(2.22=A:4@HEOR=VEB22%72QGMN8'&A;
M=.8T6[)%VG,NB@M6QJW,:F BXP1]*:,D:<[R* 7QG:(-,!/2K0DYL/@<OFU_
MG?$S>##A(N80\7+!A"4&,@\^ ;N$ET((QBG8." LJT[N ##R2XI_Q!PLC#1$
MR(;%>6NP+J8I;/K?-2O!@Y;02RN,#2_Y CO;3,)YX  S.&Z=QY607<WVFZT*
MRUP< K94U24>79D7P/\IAMQZD9N<GQ6+E(B+A*T,!N4]*:SU'!8!MQ8]$JH4
M,PWYE&7)&G#.Z!@$/^ 3=D9(>)RB<ZF%Y]NNA><H+._R("? ^N6&9JD=;?9L
M+WOE7@C;[C6VE]F+FM\BDN_?L94F[1$P/EHSA2/K+EDU(/E JN2=%=7(4W#+
M4:@*L7D.3P'3 OOQ!+:V(!][EI*VX<*72A(N@_L_CO4N[6#*61P5-< =UJSJ
M.<9ZE0A0AHY=AR3YXALR_:"([\LTS3A*XBD[YSTB0WV4DA9',FQ$: N*:E''
M)'LO,# 24QP$?@P_ I#.:H#1CRA:X !>&_<"*.C23M.*E.GR)<*"=&W&+I%
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M:S %L#7@*O*S8ME:Z %07!1(S0+FCM8H&=P@97/#9Y3+C9S4J&(E9%4JU2W
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M3/#+/QU^R=EF9#:!2LZ *ADA)B7 <G0L)?0YL?_]\9>(,7*K/5@M JCH,[B
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M,%]D968N>&UL[;U;<ULYLB;ZOG]%G9K7@R[<+QV[]X2OO3W'7?;8KNYY4R2
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M]SEY%U.AHY2'/"??!M>/?4Z^D^:V/1G=1^Q#GI,'411 T$QYS6M4S#+(R3#
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MT3EO70)LT_-M*WC#VT#=-;FZW?2NAEW[AUU]N_X188;_]1__%U!+ P04
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M/HMM-SLB+\P/WNN_U=V8AEK(M.RGINX=4>7WE5P*6;'E7M,@%?_^!_VW^;J
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MY6I-%TV+GS2-4*5GRO^[U@:&S!?/S6_NZ+.Q9O7?M,&;+?_O]5*&GL'O%_G
M9#[W/1[%.$Y@P ,"D4\H)'Y"88)]@GVI@EB%-M.\9[FF1A ;S4"C #"Z@5(Y
ML-%N^]M:/U I"+(E,"J"T)N5^P0[@NE[L-NIZ06'<&!2ZWOTP&^5BI;K1-_#
M*.HM:KF_FN)P[@GXSS2LUHO>0.!7RZ5IO%P#/1)ZY0K8=W>CK)T#8=2LND,U
M[[9>-VO_YZ\TEZ]H(<5M]O HET4Y-V[R7'_0TO3[ZGG[2"W*S3>:BS?_LTY7
MS^^6Q2HOYU3Q<?55YE^^TN7'1]-$\5^RT'N(=\MJES9GB# J50R34%*(.&>0
MADD($Q9&"&'I*<'GN]NDBZ;J6*);,<S%G62?!%/)!WY(EZ P&A9_<ML8C#;H
M=GN.20WD."M_J0\TIX<"["H-=K0&[!GL/M>L$J7J,U I#W:T!Z7Z8*7U!S4
M,U!_*_I3J4#H;^,T]K#UNB<;3?A1MWMC#\GA3G+T_KLM>E]R*N0#S?]>W"Q%
M^8\/9J[69FS,41!BG\*0JP B+XPA#H2Y]Q 1QXHE,<,N)TRMO4UM0UG*5SX
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M&%*>(!.BHH3OAR'VG&)27 68&EV\76NII;F/6/+T45OZ=3!1 51F(N D,'J
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ML7(1=>YY:O159A;<[O" RG)0T.IH^/%D$74'/RRG(6GGL4&!'IC(2K%W-GU
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MC15V93,V(-NH8<S!6@^@*D4<S).K1\W"-!QS+ 8FI8-4LS.PH\T,;/4!6X5
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MB><?Z'!V_I:F>9GZXJ/ZD"U-(2<3I).*,D=:MJR\[O76*<NKM!A-5HPY2^+
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M;GG\QI%[:F2V(W89."*RQ8+FA<F]4 61.,:0C#7\EF?'TQO4H4^?C3J0&7W
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M,X)N)I<-*JU65FL#XQE6-GKLV5)6+UR;"?3(3)M3CA(_I 1BCRJ($$T@-;<
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M KQRH$*D*BF0/BKPLO5)O_(S8@;]PB^;>?QUMUQY>V3@FX6O93UQ$[O 0BE
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MGS?2Q0J".?#$)C%X?9_?>'6S1E]?"Z_6N&Z#4^O<PY(N!J2T)SDA@H<]UXF
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MOLUF]ONC]BYG^A*Y;6 DI;6S@@;EHS93CXFD]=K$):I>/7MI51/.TD!N&;-
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M_(&!:9O'UX\>MD/\@3DG;> /_S5^LMP[OKC7__6T6ON?-I'TE.I<F@)P6B*
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MI#U2@YAW?IB:[+ZX]\Q7PQ(;Y?<W9+S#U>B?_?)AL389CUP[Q Z1@"AGAG-
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MM-2\C.IUU29L=,[6WOZ]U[;K*<D96&./06X#:\!SCJHY^S"'%Y<QZ>ETXHS
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M9OU]H0>*N.T =T^AN#&:O%",;@>P+@?O=GE8-UH]:CYSTK-$2V$D)!1(90J
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MVF>D:!M,/4>*GA7]PI&B;7!<CQ1MO;OK>=;\FR<X7QEGKVHG9-"4A=" %+8
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MC9N.TA?L41Y*[X?#GOH?ZT6]EA_J;U*\UR^-Q1>3V]L:LBGRLR3/](1+I)H
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MO6YF(J<H54:=*E6XTQEA*895:?I;*J9*XG7B>\K(U":RQD=HG+3*&'KIJ2V
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MY9RZ)^+U69HD@5CO@)*.DX?+</;S1520!N:*HPJ" \",J[$0\\@7B(7<2+D
MP0CZ'?&[H-)[?-][@_&.YEWB>'+L[G3!U7SY5BJZF3^IOY@E/!<F60P2Q/7Z
M*R\HI!@CR%1:)EB0C"1.$K]NYJ;&G)V+H'Y2LN59IN6(M#>?7HG?V*2ZQ?))
M>594!(/Y]4HD7XID_1"]AFI[ /+@VU-W>2G2[8FHAWG[KKKNG.''Y>J#_$+G
MG^1Z/;>;JLTL3VG&E, 0H5Q/6'-1PHJ6'.8E99BP%"$_*;T>6U,CWJVK]EA@
M;IP%S=[;L(W_4Q#[[>U?"=PXV_<M9M9/\,D!L^ ]^AXT!MF&/V7O17;:>P(_
MMYG>=TF,DON#SLTJ20477$&&E-++W$RS1F8EU1A!1:$9I/0J93UG:&J4<?1Z
MO*);]EEPW?@B!F1C3\\&:G)]"8H!*^-?JFWUI9#[J]^O;D1MMND[D<='E++/
M]=HD1#/,1,H1E)H ("ZK C)>"4@8+SE6*,%IY7J,]OSF4R,"ZY3)%T#I*_;#
M5F[545;\)'J7C\JNP63@)]T7#J^#L7-Q!QV''=ULM$.P<V$<'GV=_4R@;(;4
MGZ7S'S<+T>RJ*C[]01_,HN(G:8H-9TF1T:K"&:S*I( 8X016IFE.47&"\Z*J
MTL+K5>Y@<VH/LW896'_!OM[(%AG=?9.KA>EJ!(SFR7=@PO#84O 9!K>7?F1P
M!V8%?US!;VT0,14PW"&+JWKA8'=<I0MW(([4+3PNO5*VV8J/SW**\HQ1!CDF
M)<05(Y#*3$*".6."*$+]] ^?WGYJ_+,7&&ZUUT.5F#][%$B%(S(P:;B#$2ZN
M_'FPBJ9G)EY&0/ES7WW2F4^%/;:V(V K<[--\2ADE3.9I5 FU/3?4UC/)P2%
ME<B0PFF!2U;Z/+K')J;V^+;-1K=E2-2ZZO<$GX#1[2F^#IR!G^06EZW85?24
MF/.Q1WVB3Y@9]:D^'^;S)[OGDU<?VWY<R8=VF_&C7-#Y^I$V']L#RJ6ROZM%
MU^*-SKM?S"JD4DE5 FF*$<2L8I 5#$%158AP*7))G%86<=R9&FO8S;'Z8'/L
M81<3N*>_2_C'5^V*^>E]O;G7M *Z$V&SS'YH8]1_=D%&."\.&>)^EAI_X,;>
MT-R' [IXS$!]W ]4%Q/8!76S_>VHXQ1\:CWP>+W4J?80XW;-V?<5,'N<C8=8
M>:FS\RL0Z3E;O^:NH<H_?]QROMPL3('9Q]5RH?_*V\.YMF/D\QZF59DKUG84
MD3G$J#)-'26%!:(DHZ(24CHE0X4Z,+7WI&F9L%C/'\'[IC')UG0AP*U8/MB^
M_;O @%[6+ 1="6_M1L_A<9N7#PGZP.\X[?HAKD^='Z<-;2AZD55_/)T86?,G
M#*)CQ9_ ^_BQ8;-:SWXQE9RWW^MFQB@N"4\JF-&"0,PUN[&4F<.'0B&""TUU
MB0O%/;GKU'C+[+/4S;KF>G+^DZ3-9M7M:AEG'7?XGL+63SW!8(RPGQ> @S-I
MG(R[CPGT!0<LH/_UG &>WG&4Q_ID$-MG]?0O TO@Q#\WC4WK;CXO;X6HS<1;
MSW7TQ.?]HM,\M/L(,YIE29Z*!*J,I7KU3DI853*#947S+"U%E>2Y5SF<J^6I
M/<AOEJN5.?%8+LS"8+E9PZ6"#U8M ,C5:KD"KWY>KB5 GHH:'D/!,"DRI$<A
MD1SBHJQ@A4@.$6%$85I2+LCLFURQY8L.QJ$'8PV''8"A<'>;ZPV"Y<"D?."S
M*??<>PV,VZ;O7.?X32NE%;&0T1>MN$6-SM;'+7#T!>6HV-'[!O[Y7F^6^@'?
MR: 6A9(YD0ARB07$)<L@*4H,2Y0)5"1(,U/FFNSUY,[3HW_MG(N\Z07 ^LGD
M*A@&)@MG!+RRNDY&&Y32]?1.H^5SG0S@,)GK] >N*^'03S?_UZ9>R9\H_UHO
MY.KQ=F&%VA[,KV<R%Y4L*P2%$ SB"DO(<JX@+8E0%4\PY?R*QE#]UIV^LN.W
M@?K8M7^RS=+DUMFP\HX+\+M-&"*B.7+1AYDJM"Z#G<]V0^[=15B#*T#<4!JD
M&.2"Z1>I"W&#XUR)B./5@=FF]:)>RP_U-Z,)N=9?H)K-97L>_;-<SQ+.12((
M@1S+!.),SQ@88QA2)@B3BF4Y\>I/VV_.:QHQ0J_:5E-]M7JTNNGW9L?-,XFT
M'UTWZHF'V<"4TSH*K:=@[^HNFT1[&S%%U F5N-FA_2;'30QU"O\H)]3MJC J
M^>MR*?ZHY_-9@1@CJ,Q@ILR16%$@6*4J@T*6*>%%7A:9UR[4]L936V5L_?+C
MA!U,;D]_2/ #/^<7X_9^F)\'&?6QW=U\U ?T>4C/'\6CW_L?SGSB<D%7]?+7
MA9$FJE4M15>-F"45YYR44)2E?@)Q5D!:Y!DLF$R*+$TDEL+UL.:LE:D]CEM'
M/4L[^Y&\?'X3!9^ASW.<H?$ZPKD8^M5'.N<MC';$<S'(PR.?RQ^.< 2T5=61
M^IW=ZE08-9W/RS>T^?IQM?Q6"RE>/_[:F)?\3G#GUM1_V%;WN]VMBJ:4Y+F$
MBM#"'.DFL*)9 G-4$?T.+T6NPD^+(CDY-9)YM@F_VD9I1>&,%-Q6(([K.(&:
M+_]HP$,7KA%Q?+4QK9+KQ0\'"G)T%_6?KS@5B?6M"#A >8&Q'O>L91>@E2SK
MY'U>F2!_,+\V<8*/AZ/\ZW:4]_)F^WBC;LN.,2##'>?$<O3E3GXB0]U[2!3;
M5O"6$=4X?3!"2;^8@M [I4W:5>1KJ98K><OYYGYCFX3?WB]7Z_K?;0HSQ826
M+*,P)_IK@45.H/Z!A)DL"YYDB:R0\#L2#W5E>B?D721@;N7$0NJ1@H?%>1=J
M<*B'WY^R&-L8;H"-PN2%Z#C:/:H;P&PHX" 6<!A,U.VKJ^",O;$5YLS86UY7
M079B,^RZ^\7HS_2K_L+:6^N%0MW8I,Z9DLKT'=;#E)O5.\D$I(1P2#G5["D9
ME33QX\F+-J='B'>K^DMMDEMJDT(.1.?H->V:3F%=2%0HGF!8,:G70$H_' 29
M?O*L4*ED*,FHV!Z^CHGUTR/7_Q]8N[UHHGY7!WZC'-4H';@+WEZ"\<J>63W0
M#-@\ZY35%^RBU0-"?SNMO@M#-8B_F9JDU>.'>B'?K^5],Z-)P5->)9"E*(<X
MXP165$][TTJB4F8X*9G3/NQY$U/;']EY"'XS/@+KI&=OC!- NE''=? ,S!6>
MR 1H I\+/K+\[Y&9D95^SX5Y+.I[]I.!_6[X5RDV<WFG>LY1VWXN:8Y8A50"
MD9(2XK34$PR,*615(:G*<EH*I[9Z_J:G1@A;STTB5W^"0& C'?=!<2.18: >
M_( G&LK^'7J\ 8O;O<?=_+B=?;QA.>KZXW^'<\1V.-J:#G__RY^V/]'_9^0;
M__*G_P502P,$%     @ I85B4RRTC3P=@0  /MH% !4   !M9'AG+3(P,C$P
M.3,P7W!R92YX;6S<O5F7FSF2'GP_OZ*^]NT77=B7.3/CH]+2HV.5)$OJ:=LW
M/%@"$MU,4D,R5=+\>@>8BW(CQ>5%OE"WQZ5,98J(Y4$@(A"(^)?__O5L]LL7
M7*ZFB_F__HG_F?WI%YRG19[./_[KG_[ZX06X/_WW?_NG?_J7_P_@?_WV[M4O
MSQ;I_ SGZU^>+C&L,?_RQW3]Z9>_95S]_9>R7)S]\K?%\N_3+P'@WS;_Z.GB
M\[?E]..G]2^""7[WI\M_SMEF9#:!2LZ *ADA)B7 <G0L)?0YL?__XS]'C)%;
M[<%J$4!%G\$%1& Q6Y4B-YRGS8?.IO.__W/]3PPK_(68FZ\VW_[KGSZMUY__
M^==?__CCCS]_C<O9GQ?+C[\*QN2O5[_]I\M?_WKO]_^0F]_FWOM?-S^]_M75
M]*%?I(_EO_ZOWU^]3Y_P+,!TOEJ'>:H+K*;_O-K\Y:M%"NN-S'](UR];?Z-^
M!U>_!O6O@ N0_,]?5_E/__9/O_QR(8[E8H;OL/Q2__SKNY?72YY-SS!__7-:
MG/U:?_3KTP4!@8C<_*/UM\_XKW]:3<\^S_#J[SXML?SKG\[RUX]0M<F\9'6I
M_W;Q#W_]ON+G):X()!L.7]%?7/[[NLHAJ^/7-<XS7O!R]=FS1;KU2[,JR<7U
MOYR%B+/-WTXR3B>;3WT25^ME2.N)UU&$)#DPE2,H;Q5X0A1$Y#&[@DDF<YO9
M2NR*J-T(?H7ISQ\77WZE#_ZU"J!^L9'$1@KWEKN0R'%T7^VS#_2[$Y6EUIZT
MZU(@]'M"?] HP&GALS/H+,GH%+)OKG:;ZIN:?+),ORR6&9=D**Z6"\MT2ZOW
M07KY&[]^#DOZ($B?IK-K8JO%&$)7Z\4 DKM0"Y'[IU^(ZX++)>97%UK9RMR&
MLS693]S\YA :_Y_G84F?./OV#C\OENM)TC)99SWPPAR929,@))6 !V9%$E8Q
MY0=1_IV%]\*!Z!\'I\BS$TB\Q>5TD9_/\S,Z<B<N*^431M"1I*)0%@C<20B9
M&2.+8DG;00!Q:]F]X"#[A\/QLNP$#!^68;Z:5L%? EK%Z#0K!J)@Y$()*\$G
M&T!S%X1 J5*6PYP.=U;>"Q*J?TB<)-&14?%\OIZNO[V8SO#U^5G$Y:1H\HY]
M1'!>2U#*<3K[".#*F9QXL$5Q/ D-=U?<"P6Z7Q2<),$NM/\./TZK$.;KU^&,
M?![ZGRG!0$Z!$=710@@.(40I+458/OC3'(:'5MT+!:9W%)P@R2Z0\))"]R69
ML(W@WY/\\>GB?+Y>?GNZR#A!47P4JE"0F.FPDR&!1^- 2"F9RS;Z<%H8L0<1
M>^'$]HZ3X>3<!6P^A*\O,XEO6J8768E+2V@#XU(B U<,14\V41QE,H)-#M%'
MYIQQ P!FR_)[0<7U#I4A9-L%2)[D3"I87?[Q:CI'/A&282%ZH: EI+M$L50]
M+X6+B5PE'H,) P#D@:7W H?O'1RGRK0G8#RE+]\L/RS^F$\RMPJYUJ!*S*!T
MH(!*80(9.4O,9(U2#P>+[POOE[IB/PDJCA1H3YC8'(UOEF^7BR_3><))4/3+
MH8*9.^)#,$WA-IV,/ CZQK*8Q6FAZJ[5]T-'QYG-P43;$T3>+E;K,/L_T\\7
MKE.2-JBDR5?*JEX'.8C2.BA6*Z&B0:L&!,BMM?>#1\<)SX'$.C(XJM5[LL2P
MH9LQPFX2"5@P"91A"ASC%@PRFXT5%(25T^YK;JRV'P Z3G$>+;J155[O0F=O
M/RWF5QD8II)TTA/;.=1+X:(A*ILA>.D]-]I:PTY2^]T5]U-]QZG,DT0XLOK?
M8SI?$G2YB!^FZQE.DJ<H.1/M1002@HX%? H96$I<&1),+J>YCW=7W$_]'><P
M3Q+AR.K_L RUVN3]M[.XF$U8H<\/)H,.EMS=5,V6,Y%PFX+WFKY7ZB3=WUIN
M/\5WG+8\7GB=;/KG7].G,/^(FWRK-,9%+DD 5C)03!AR4W@$$9RWEA=R84_+
M-SVTZGX8Z#@E>;(HNP@'GIXOJ[@N;N JI$D'YZN)%L$';3UX%2THY4D>663@
MC,4DA=8A#I%*>'CU_:#1?0IR -%V 9&7<_HT$L?T"SX+ZW#)UD1ERX7@$KS4
M];:VIMN-$R"TS9SKI)DXS5O<M?I^$.D^$3F :+N 2+W&73X-:_RX6'Z;Z)(\
MTK$')D5>+6$"IS@)AGLAO=.9YR'N+VXMNE_95/<YR.,%V04.WI^%V>RW\]5T
MCJO5Q$;+K!"VUOY1+%PXA^@#)Q@;A=Q9F7,:  >W%MT/!]UG&X\79!<X>'Z&
MRX]TY/UEN?AC_>GIXNQSF'^;.&0I.&G V.Q()-R12%($'V..P@?,D0^ AP<7
MWP\7W:<93Q=L%_AX_PEGLVOJG<G:IQHO97*(',O@BO00;)(Q<,Q&#.%KWEQS
M/S1TG',\48Q=@( (/ZME'(OT]_>?2&ZK-^?K^F*C1M837H0JTF4@RZ= Y4""
M838#"L>5U(R<9#$ *';1L!](.LY.#BSF/D!#DEN&V<MYQJ__ []-4C$2A46*
MIJ2D@+NBGC8 B)*#<#[5'PZ!D]O+[@>-CC.7IPMS[/NJBU#IQ725PNQ_8UA>
ME9;+K+P)L9;U"$^QDW/@M$F 7#J1#'K'3W,RMJV\'R8Z3FH.(M).JO6_,_&"
M_F8UP>*X%!@A6:2(.B8+SJ$ KYD-F8A(^30?8\O"^X&BXRSG$ +M"A,7#U$N
MF.!28RZY0/:U>,,DA*@,@T#R*#8QH?QI3L;6I??#1<<ISF&$.C(RGA '></%
M+'R<F.S0,,& :"11<*G(X'FDKSP=?H8;*TY+6]U:;C\$=)S!/%YX@VG]7WZ]
M)[Q7]!='/,%^\_K9\]?OGS^C+]Z_>?7RV9,/SY_]]N35D]=/G[__]^?//[R_
M3?N>[[-__*FG/MX^D.X37W:?K^!C")\GFR*XJOHWY<5T'N9I2B9@<?&6ZQI7
M)FAE6;$0F9 UB6TI%"4[D&-0V3FKN=OU'J:$5=RH_W+1BSV%L_7JZF\VP@;&
M+U_>_[=#J#O6:ERM\62UPO7JFE<6%"&<)S#,:-I#V4!,F4.,'H/D2AO<Y70>
MS^MM.L9Y0]X,%5?69@"ACWC0W*;^TLF^9B(@T4D.$YV13("2S$,TY%M+D65*
MS)'YW=4:X53DW"%G7 "=HM\'H7**L#M S-.P^O1DGNL?S__S?/HES(B9U9/U
MT[!<?IO./_Y'F)WC1',?0XCU7B!Q$E/ ^FY2@>;)*9N"8;*-G=V+O!X0=1(,
M%JUUT@'0GJ14W]&MWF%"8BG.\#6NKRZCO2HL1AY 963DSY.3Z,BK RX4,1*U
M2SFVL5 [J!JG2T8[6 VF@0[0]'+^A:A>++\1"Y/@>=!,,G#U&:]"Q\ 3,Q0<
M2,Z+3\JJ7>_BCT?/32K&::+1#BU'2[@#=+Q=XN<PS<^_?L;Y"LF4OEE_HFCT
MIHPFENLH<VVK%6H9K2@((5!(RHR(6ABG0]E5C7H\:/8@;ISN&^VP-+0^CH;8
M%US&Q6 FB$)D_!"^X@V+.C$V15E2 2V* J6]HE,Y>I#:"V\\S[N?P9UBBQX@
M9YP&'BV-TJDR[\ Z/0#^VB$Q6QN!,TL1J_0!-F^Z3';*2(:R-#)&1]J>P6^8
MVD'F1&EW@)<[=M);;;2T((EF(CX1V+D+P+EDD7M3N&CD*A^,DL&OG!KZQD?+
M^'B +-9A-I"[L_B,R_6WM[- XICG&C1^KDDR^OHB2X:O,*SP76W6^J;\E8[@
MRNZ30ABEH.#\['Q6^[T^0V(@32^T.,]/SFI)^7]MOIV$$I7$%$#;^OQ$B031
MDJA+#HSY)'*);1( [7GK(<P;)!_5&0Q&M)SUFF3RAH01ZIN(#=/7,KCZBSM2
MF)@BBK#6@,S*U-9@"8(PQ*GDB8=DDV!W"HGO7\8<L6X/8>-)Z&LMZPX.X+\L
M%OF/Z6PV<3&C981\QG(F^0@!KG!3SQH3A8W%VEUW^<=;P2L*>@@,![%51XFT
M RB\)''//TXIZK@0QFM</_^:9N>UT/&:)\49LT%*$&0M*915Y#Z@RQ 2!EMD
M1J_;W-3M0UT/(>$@$!I<%1W ZT:P\GHQ3Y?NJ&&)"<3Z?$^38UL<!Z]5!.F<
M8UD;IUR;^[L'R>DA0!P$0*<+NP/$7- _"0Q1FU@@U]XORCM/$"\<C&9":>&5
MU+MJ#T^-"GL(!P>\TSU(G!T$@*^F(4YGT_445^1[;<KP/RUF)/15C0'6WZY%
MXX+VP6D+#!4C<\@=.!,E,%54X;EXXW:]IST>)OM2.&XPUKRZI(FB.K!"-_BZ
MFY51$3FY=A%294=Y0R&C8;59D5+1VYB9W_5X8A#(=56!T@8#VX%VBD*ZN&BY
MNK=^&[[5=/]5DDZBH>@Q9-"^Q@N.#'ZPJK9 (\\NY1#]SI>>I]<,W*:G&U"=
MI.\M)0,GB+X+"#T_^SQ;?$-\AYL4UWUI3;(3NJ9W(7)/3D.@'><"<2B,<=;F
M@!)W%68?CZ8?DC;ND=@(6,,JI(,3D';*\OQA1E+)F7B![,@355CKM#QQ@T+$
MB.0PB+2KD?))=NIADL;-.;8S50,HH ,D;<+2!]BPOK#B7>TJ+@NHS&,-3,D[
M(']3>ENXX&T<J2T$C9N+;(2B(83? 88>X*!P8V1*%,-BG5R0C0"?$^T'4UB.
M3D3:$H_DAX^;@FR$G!-%WD,683'_^ &79\\PKF\DQ*3.)6+M,ND]09\X@IA(
MS<E+(TS2Q33*9C],3S?N4,/@[71%=&"#[IK2&YQ$ K]55H.,M7X]Y02^)$;A
MA$9OI#:&MW&)MM/4C4_4#E8#*:0#:-U@8F)=RIX[#3S2UE"B;-Z'&R@Z**59
M<<8W,D_?B>C&%7J4A-)!(N_@7*O-::;KL\T;FGE^NIC70@6<I\J*DKS0D6SJ
M:$@%*C(-T0L$(] K$SEWO,W5V@ZBNG&/VJ%I*)5T8(L^X%F=%K;\=B&>JS=:
M3\YJXNS)>KV<QO-U39Y]6+S=*&#B,$KDF,%EYRD>31*\$19LD:J8PI/9V1'B
M>,P=3.JX5[V/@L2VZNL GSOD)AWM)Y,-X:4X4,P%"G<*0NT(RA/2EWS7"(Y3
M7L^?=/_7["+Y41 WD$*ZR*N_O5IYP]3%N]0<?%04.P-GU9=DG$%M5P[&2QT-
MM\Z(-@[9 \2,W:Q@&$W??TUUDM [,$HW^@5>T&^T3=&Q %G7P;RL/C"L(ZXL
MB2+5)V!!M[E^N4O)V 4(31!SDK@[@,N3G#<U&&'V-DSSR_G3\'E*T<$D2\]C
M\!S02P1EK*@]BU/M,8E*21^=:^-);2%HW"1"(_ ,(?P.,/1AB6%UOOQV8Q=$
M*3$6IL#H($ E)2#(H*!**H4<LL(V::C[M(R;06B$G!-%?CAH_ 5HYOBQ7BI_
M& P[[W =IG/,S\-R3L'!ZM9KF3)-T_4D(@_288 DZU 6;2-$YA+H6 )J:US
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M%<RES0/6[32-FU9O ;&!Y-\!DOZR7*Q6;Y>+,EU/I(F*^5@@"M2@G!,0C)'
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M/5&O^KM>/2ZZ8"-%&;-W#GBHUV*UH3"YS :*9]9%)JS(;4JT'B1G/US]5!6
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MF0)"7T?8Z,"%CFV*('>2U5MWPD>"V[&*Z?F ?KO$SV&:KZ*X5)B7CI&87'U
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M>_KM-:XG1MA<ZB /GFK7;A831,D"A1L*G4J:XH)60QJ_4]'ES> P>#I:V!T
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MU$>@'".@,FBDB"[LU\GF>+:WTM:OC3D$*UO=F&%TTD%6YYJCORV6?W\YWXR
M7]UA2>DD,$0/H@@)*I'$0@J!8KN:%T?#T;4YT/8@;MP,3G.<#:25GH#V8CJ?
MKNBHKF4H=UA*P7N1(H.@#$48DJ(!)^OT;2,,1J8-ZC9)PSV(&S>-TQQH VFE
M)Z#5-@G)1+04H$(P%+@JGNO+TQ*@R%BDDD9SUJ:;P,$]*9J5_S>'SJ%R[F"
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M#]H[2/^+2D,TM15\B@)<UI(V$$N)6>V$:S-%XCXMG7@?1VIW:^[E*%'W=V-
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MV%1Q'9S0#^RM^SQQC#X&KVFSB0S*9@<NU@KME R3WK,D6TU?_#%UX_8*> 0
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MA\NXQO^^I(>\_K-Z;8>DF']XQI%9Y*=I&BM1?.\EM_U;D;$2I8*@+=EHDGP
M;TB\I9A8A,V:Q3:C@QZCZ.A$\;WGWO:'%1()ZN0\I8*UU6,D#RKX '66L]1>
MQ&3;% L^2M+$>;,Q,/%#>G<4]K?7'+L?U \QK/%__Z__#U!+ 0(4 Q0    (
M *6%8E.WV@M$+0@  %(E   7              "  0    !E>&AI8FET,S$Q
M+3(P,C$P.3,P+FAT;5!+ 0(4 Q0    ( *6%8E,O@*.4,P@  -(D   7
M          "  6((  !E>&AI8FET,S$R+3(P,C$P.3,P+FAT;5!+ 0(4 Q0
M   ( *6%8E/DR1WQ" 4  #85   7              "  <H0  !E>&AI8FET
M,S(Q+3(P,C$P.3,P+FAT;5!+ 0(4 Q0    ( *6%8E,7<2)?"@4  +P5   7
M              "  0<6  !E>&AI8FET,S(R+3(P,C$P.3,P+FAT;5!+ 0(4
M Q0    ( *6%8E.]BN(\N_8! *ZE%P 1              "  48;  !M9'AG
M+3(P,C$P.3,P+FAT;5!+ 0(4 Q0    ( *6%8E-='_MIV1   +2L   1
M          "  3 2 @!M9'AG+3(P,C$P.3,P+GAS9%!+ 0(4 Q0    ( *6%
M8E.*W<AZ!B$  +A" 0 5              "  3@C @!M9'AG+3(P,C$P.3,P
M7V-A;"YX;6Q02P$"% ,4    " "EA6)3U,_DDPH_  "!L ( %0
M    @ %Q1 ( ;61X9RTR,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ I85B
M4[)(7^]JV   ?P0) !4              ( !KH," &UD>&<M,C R,3 Y,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( *6%8E,LM(T\'8$  #[:!0 5
M  "  4M< P!M9'AG+3(P,C$P.3,P7W!R92YX;6Q02P4&      H "@"> @
&F]T#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
